data_2mxa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mxa _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 4' ' ' ILE . 3.8 mp -43.74 -52.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.797 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.623 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -70.8 -36.92 66.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.079 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.41 -44.42 80.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.81 0.814 . . . . 0.0 110.334 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 11' ' ' THR . 19.7 mt -53.86 -24.76 10.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.933 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.3 86.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.888 0.375 . . . . 0.0 111.057 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.15 -18.57 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.416 0.627 . . . . 0.0 110.46 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 44.9 t30 -89.84 -25.33 21.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.476 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 8.9 p -57.76 133.9 82.9 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -174.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -78.01 66.05 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.918 2.412 . . . . 0.0 111.884 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.93 47.04 26.64 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.219 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.74 -172.93 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.15 0.5 . . . . 0.0 111.605 177.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -58.81 163.22 3.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.853 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 m -62.58 -19.28 63.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.64 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.38 -35.24 50.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.705 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.3 -27.47 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.509 0.671 . . . . 0.0 109.908 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.547 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 m -83.38 -28.2 29.1 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.757 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -61.13 -36.26 79.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.622 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.13 -36.81 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.978 -0.451 . . . . 0.0 110.427 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.547 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.1 mtmt -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.217 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 19' ' ' THR . 8.8 p -77.21 -34.66 21.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.544 0.688 . . . . 0.0 110.218 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -76.17 -2.47 31.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.368 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.84 15.4 10.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.125 0.97 . . . . 0.0 112.835 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 8.2 mp -91.46 7.62 40.31 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.927 -0.483 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -60.08 -37.02 71.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.492 . . . . 0.0 109.956 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.53 -18.89 32.12 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.788 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.76 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.2 mt -59.36 -10.47 3.16 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.623 ' NE2' HG13 ' A' ' 5' ' ' VAL . 47.0 mm-40 -67.97 -8.47 37.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -54.15 113.11 4.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.63 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.56 -12.89 15.1 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.725 2.284 . . . . 0.0 112.885 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.85 -137.34 0.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.711 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 57.9 Cg_endo -84.2 165.48 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.036 2.491 . . . . 0.0 113.967 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' HB3' HG22 ' A' ' 72' ' ' VAL . 49.6 m-85 -139.15 122.7 17.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 36.1 m -106.65 118.0 35.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.253 0.549 . . . . 0.0 110.996 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.38 121.06 60.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.443 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.424 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 1.4 m-30 -82.86 111.46 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.735 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -95.82 112.39 59.1 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.52 133.42 15.81 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.06 1.84 . . . . 0.0 111.538 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.808 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 32.2 p30 -72.61 -172.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.722 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.82 -27.13 68.67 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.528 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.34 -21.28 24.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.186 0.993 . . . . 0.0 109.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.439 -1.011 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.337 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.603 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 121.028 0.442 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.627 ' O ' HG13 ' A' ' 58' ' ' VAL . 67.8 m -65.07 -40.59 94.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 t -79.82 -29.65 40.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.032 0.92 . . . . 0.0 109.16 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 6.8 mp -70.58 -26.01 63.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.222 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 55' ' ' THR . 9.9 p -80.01 -28.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.156 0.503 . . . . 0.0 109.755 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 55' ' ' THR . 24.4 mm-40 -70.56 -25.54 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.651 1.215 . . . . 0.0 108.519 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.47 168.64 26.23 Favored Pre-proline 0 N--CA 1.437 -1.094 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.282 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.2 Cg_exo -38.16 169.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 124.633 3.555 . . . . 0.0 115.424 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 51.9 Cg_exo -40.58 -8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 1 C-N-CA 126.632 4.888 . . . . 0.0 118.296 -172.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HG2' ' HD2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -42.61 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.634 ' O ' HD22 ' A' ' 68' ' ' LEU . 13.4 tp -46.92 -50.98 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.35 0.26 . . . . 0.0 111.08 174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -53.26 -32.59 44.32 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.265 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HD2' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.26 -51.38 21.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.528 0.68 . . . . 0.0 109.53 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.5 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 62.2 mt -44.41 -53.89 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 113.969 -1.469 . . . . 0.0 113.359 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -47.19 -64.09 0.87 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.09 -62.06 1.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -122.48 -0.93 9.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.1 p80 43.04 51.6 5.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.775 0.798 . . . . 0.0 110.187 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 36' ' ' PHE . 12.9 p -120.98 159.15 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.903 -166.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 89' ' ' THR . 1.5 p -130.21 129.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 170.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -64.73 146.36 54.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.254 0.55 . . . . 0.0 111.168 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.81 99.1 2.57 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -63.65 101.9 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.162 0.506 . . . . 0.0 111.509 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -112.93 129.36 56.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.124 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -91.99 161.01 14.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -31.53 7.03 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.244 0.545 . . . . 0.0 112.046 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.9 t -72.39 -27.0 62.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.245 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.43 -50.36 14.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -54.38 -50.69 66.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.044 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -68.51 -35.85 78.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.747 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -56.88 -39.49 74.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.632 0.73 . . . . 0.0 110.115 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 81.1 mtp -80.49 -35.24 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.919 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.96 12.05 83.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.051 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -162.92 157.28 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.6 m -132.03 140.42 47.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.262 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.552 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.5 m -112.71 133.08 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.116 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.505 ' HB3' ' H ' ' A' ' 94' ' ' SER . 14.1 t -68.93 163.9 23.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.906 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 2.7 tp -55.38 -30.77 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.479 0.657 . . . . 0.0 110.148 174.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.459 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.4 -25.85 35.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.152 -178.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.4 18.29 7.19 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.33 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.505 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.8 OUTLIER -88.1 121.3 30.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.299 0.55 . . . . 0.0 111.332 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.51 138.01 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.9 mp -127.63 127.01 24.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.8 Cg_exo -70.39 132.03 21.51 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 121.98 1.786 . . . . 0.0 113.036 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' A' ' 98' ' ' ILE . 40.5 mm -94.55 136.14 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.38 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.561 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 91.7 m-70 -121.0 -179.24 3.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.199 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.31 94.06 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.042 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.09 -48.21 13.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.453 0.645 . . . . 0.0 109.606 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.48 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 6.9 m-80 -138.53 -53.19 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.003 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -87.77 173.25 5.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.123 1.882 . . . . 0.0 109.99 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 111' ' ' VAL . 16.3 tp -72.8 154.35 40.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.561 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 44.9 mt-10 -140.4 127.86 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.397 0.618 . . . . 0.0 109.523 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.545 HG13 ' HE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -129.08 122.61 56.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.013 -174.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.466 ' HG2' HG21 ' A' ' 106' ' ' VAL . 10.9 ptmm? 46.51 -123.46 1.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.163 0.585 . . . . 0.0 111.237 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -96.94 23.55 7.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 110.608 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -118.85 166.04 13.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 27.4 m -128.29 138.04 52.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.516 HG23 HD23 ' A' ' 104' ' ' LEU . 88.1 t -86.2 126.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.686 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.6 mp -89.63 -36.55 15.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.631 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.68 118.28 2.79 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.532 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.93 -174.54 3.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 32.2 t70 68.98 26.86 5.59 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -171.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -88.84 108.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.011 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.58 106.02 2.45 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.623 0.725 . . . . 0.0 110.72 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -81.38 178.89 8.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.716 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -44.2 -51.73 7.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.845 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 52.1 m-80 -117.87 -14.61 10.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.365 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.73 -110.76 0.44 Allowed Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.169 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.561 HG13 ' HE3' ' A' ' 78' ' ' LYS . 18.3 mm -142.66 143.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.097 -0.552 . . . . 0.0 111.387 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.497 HG13 ' HB1' ' A' ' 118' ' ' ALA . 16.9 mt -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.222 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.545 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.79 114.87 5.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.819 0.819 . . . . 0.0 112.043 -178.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 49.5 t -80.17 129.86 36.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.33 159.58 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.808 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -99.0 3.41 46.93 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.475 -173.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.598 ' O ' HG13 ' A' ' 126' ' ' ILE . 47.7 m -154.51 126.71 7.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.531 -172.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 45' ' ' ALA . 76.3 t . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.678 0.275 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -57.67 -20.15 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.682 HG11 ' NE2' ' A' ' 31' ' ' GLN . 2.2 p -90.34 -37.3 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.557 . . . . 0.0 110.205 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' CA ' HE22 ' A' ' 31' ' ' GLN . 28.1 t70 -56.95 -50.93 71.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.204 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.9 mt -54.42 -22.0 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.414 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.089 0.471 . . . . 0.0 110.607 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 37.8 t -74.48 -23.38 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.487 0.661 . . . . 0.0 110.291 175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -87.26 -25.44 23.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.76 -174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 6.5 p -60.82 134.26 92.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -171.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -81.95 67.33 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.052 2.501 . . . . 0.0 111.808 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.34 11.72 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.098 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.7 OUTLIER -67.14 -170.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.204 0.525 . . . . 0.0 111.35 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -60.46 157.63 13.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.506 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m -60.56 -19.03 56.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.341 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.98 -30.33 65.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.18 -30.25 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.325 0.583 . . . . 0.0 109.803 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.602 ' O ' HG12 ' A' ' 23' ' ' VAL . 2.2 m -83.52 -29.24 28.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -62.22 -31.4 71.93 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.111 0.257 . . . . 0.0 111.571 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.44 -37.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.506 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 41.3 mtmt -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.13 0.491 . . . . 0.0 111.315 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 19' ' ' THR . 8.5 p -75.21 -36.04 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.663 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 62' ' ' PRO . . . -74.38 -6.5 48.55 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.937 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 13.31 9.34 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.312 1.045 . . . . 0.0 113.172 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 66' ' ' ARG . 10.6 mp -85.77 8.97 17.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.972 -0.455 . . . . 0.0 111.437 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.68 -37.17 57.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.345 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.67 -20.77 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.692 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.79 -54.42 6.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.689 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 21.9 mt -58.76 -14.07 7.72 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.682 ' NE2' HG11 ' A' ' 5' ' ' VAL . 30.7 mm-40 -66.52 -5.75 12.42 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.768 0.427 . . . . 0.0 111.908 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -51.65 110.43 1.83 Allowed Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 123.423 0.689 . . . . 0.0 112.406 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.33 -17.86 8.77 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.126 2.55 . . . . 0.0 113.252 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.35 -140.5 0.8 Allowed Glycine 0 CA--C 1.518 0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.372 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 30.1 Cg_endo -76.2 163.08 33.24 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.018 1.812 . . . . 0.0 112.804 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -133.51 122.71 24.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.154 -171.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.6 m -116.6 136.27 53.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.168 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.526 HG13 HG12 ' A' ' 123' ' ' ILE . 5.5 p -133.02 156.13 41.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.641 . . . . 0.0 111.36 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 126' ' ' ILE . 93.3 m-85 -112.26 111.04 21.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -98.91 113.33 64.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.391 . . . . 0.0 111.513 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 130.59 10.79 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.588 2.192 . . . . 0.0 112.229 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.826 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.7 p30 -84.08 -174.14 5.11 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.675 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.42 -27.05 65.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 111.678 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.52 -22.71 34.92 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.693 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.639 176.532 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.5 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.254 0.549 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.574 ' O ' HG11 ' A' ' 58' ' ' VAL . 92.1 m -65.67 -32.7 74.4 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.926 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 t -81.04 -25.54 37.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.68 0.752 . . . . 0.0 109.342 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD22 ' NE2' ' A' ' 63' ' ' GLN . 8.1 mp -74.93 -25.64 59.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.041 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 55' ' ' THR . 11.4 p -76.97 -31.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.228 0.537 . . . . 0.0 109.756 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.4 mm-40 -71.59 -28.39 63.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 122.68 1.229 . . . . 0.0 108.578 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -81.78 169.39 18.89 Favored Pre-proline 0 N--CA 1.437 -1.085 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.972 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' GLN . 19.9 Cg_exo -37.06 170.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 125.023 3.815 . . . . 0.0 115.607 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 48.0 Cg_exo -39.4 -9.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.607 1 C-N-CA 126.566 4.844 . . . . 0.0 118.029 -172.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.539 ' NE2' HD22 ' A' ' 57' ' ' LEU . 4.7 tp60 -41.67 -26.5 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.153 0.981 . . . . 0.0 113.096 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HA ' HD13 ' A' ' 67' ' ' ILE . 5.5 tp -51.09 -50.89 57.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 111.754 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -50.29 -33.06 22.97 Favored Glycine 0 N--CA 1.459 0.174 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.928 -172.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.98 -35.25 50.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.994 0.426 . . . . 0.0 110.656 -178.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 64' ' ' LEU . 51.6 mt -59.76 -46.52 93.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.258 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -45.81 -63.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.926 0.766 . . . . 0.0 113.003 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -88.99 -60.01 2.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -121.13 -16.37 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 70.6 m80 64.67 33.35 10.62 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.5 p -94.47 155.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.073 -166.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 72' ' ' VAL . 2.4 p -141.43 119.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.625 -1.625 . . . . 0.0 108.888 166.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.52 142.21 58.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 111.216 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 112.24 98.27 2.38 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.98 102.67 0.09 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.175 0.512 . . . . 0.0 111.685 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 122' ' ' ILE . 12.4 m-85 -114.67 106.84 14.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.579 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HD2' ' OD1' ' A' ' 115' ' ' ASP . 21.3 mmtp -60.67 157.54 14.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 167.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -49.52 -35.41 20.0 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 123.461 0.475 . . . . 0.0 110.36 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 9.4 t -75.62 -28.53 58.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.176 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.51 -35.53 79.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -66.34 -50.55 63.18 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.105 176.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -68.08 -30.62 69.86 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 123.199 0.6 . . . . 0.0 112.264 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.26 -31.48 67.46 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-O 121.664 0.745 . . . . 0.0 109.433 172.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.7 -40.51 14.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.679 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 78.72 14.32 82.19 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.982 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.0 tt -164.39 159.92 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 95' ' ' THR . 11.9 m -131.97 137.92 53.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.428 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 m -106.77 126.91 52.91 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.397 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 94' ' ' SER . 72.5 m -68.45 163.87 22.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.416 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -51.45 -36.28 43.35 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.612 0.72 . . . . 0.0 110.877 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.49 -28.06 52.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.447 -179.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.32 10.81 7.76 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.696 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 90' ' ' SER . 0.7 OUTLIER -83.44 120.69 26.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.951 0.875 . . . . 0.0 111.759 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.15 138.06 32.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.585 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.5 mp -130.4 126.74 22.25 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.526 ' HA ' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -68.29 133.44 28.43 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 113.533 -173.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -103.25 142.75 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.4 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -141.19 177.3 8.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.682 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.08 121.31 0.55 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.091 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -101.34 -54.14 2.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 12.6 m120 -107.14 -61.8 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 172.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 16.0 Cg_endo -90.49 174.01 3.04 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.475 2.117 . . . . 0.0 111.244 174.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.57 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 21.3 tp -75.8 154.53 36.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -140.88 107.37 5.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.8 112.03 38.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.48 ' HB3' HG21 ' A' ' 96' ' ' ILE . 0.0 OUTLIER 48.54 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.321 1.448 . . . . 0.0 113.87 -174.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.85 23.23 3.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.526 0.679 . . . . 0.0 109.573 -175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -129.25 157.51 41.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.077 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 44.4 m -121.9 134.31 54.86 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -78.59 127.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.613 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 127' ' ' ASP . 6.9 mp -88.82 -38.87 14.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.105 175.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.97 110.53 3.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.148 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -133.04 -173.58 3.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.645 ' OD1' ' HD2' ' A' ' 78' ' ' LYS . 20.4 t70 71.47 28.34 2.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 122.794 1.283 . . . . 0.0 107.604 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.4 mt -95.14 110.05 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.04 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.424 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.48 114.34 6.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.969 0.89 . . . . 0.0 112.391 172.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.473 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -79.77 -173.49 3.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.023 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -49.08 -51.19 32.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.123 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.2 m-20 -115.23 -20.57 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.644 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.72 -114.77 1.05 Allowed Glycine 0 CA--C 1.505 -0.539 0 C-N-CA 119.447 -1.359 . . . . 0.0 114.047 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.637 HD12 ' CD ' ' A' ' 78' ' ' LYS . 17.8 mm -144.52 148.15 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.327 0.585 . . . . 0.0 110.951 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.526 HG12 HG13 ' A' ' 38' ' ' VAL . 94.6 mt -120.24 147.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.457 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 m80 -137.88 117.79 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 69.9 t -83.31 129.64 37.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.1 OUTLIER -124.99 161.76 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.619 0.724 . . . . 0.0 110.457 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.826 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -95.8 5.36 51.52 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.52 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.52 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 51.0 m -148.92 126.63 11.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.813 -171.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.603 169.628 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -54.86 -20.96 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -91.37 -37.23 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.155 0.502 . . . . 0.0 110.614 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.568 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.1 t70 -58.42 -44.5 89.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.373 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 9.1 mt -59.18 -21.69 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.637 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -34.15 76.29 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.826 -0.546 . . . . 0.0 110.751 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 6' ' ' ASP . 4.2 p -87.9 -9.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 110.112 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.511 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 54.4 t30 -92.72 -25.01 18.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.767 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 p -64.65 131.97 95.28 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.175 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.3 64.76 7.95 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.898 2.399 . . . . 0.0 112.288 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 46.96 11.95 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.898 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.63 -172.15 0.16 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.441 0.639 . . . . 0.0 112.508 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -61.3 163.13 6.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.559 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -61.44 -18.37 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.79 -37.78 52.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.35 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.85 -27.4 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.493 0.663 . . . . 0.0 110.116 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.56 ' O ' HG13 ' A' ' 23' ' ' VAL . 1.8 m -81.64 -25.7 35.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.686 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -62.17 -35.07 77.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.673 0.273 . . . . 0.0 111.524 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -78.29 -37.35 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.6 mtmt -62.5 -43.55 98.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.964 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 19' ' ' THR . 7.8 p -72.73 -35.02 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.113 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -76.44 -5.14 46.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.043 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.36 8.46 6.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.962 1.305 . . . . 0.0 113.128 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.42 9.24 16.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -37.66 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.84 -21.8 27.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.754 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.28 -55.4 5.6 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.9 mt -57.18 -13.83 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.209 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.652 ' NE2' HG12 ' A' ' 5' ' ' VAL . 45.9 mm-40 -65.16 -13.75 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.211 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 p -56.99 114.07 7.33 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.683 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.83 -14.25 11.3 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.982 2.455 . . . . 0.0 113.482 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.45 -149.87 1.04 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.275 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 37.8 Cg_endo -73.23 170.03 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.89 2.394 . . . . 0.0 112.821 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.507 ' HB3' HG22 ' A' ' 72' ' ' VAL . 45.2 m-85 -139.92 124.08 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 21.9 m -106.22 124.03 48.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 123' ' ' ILE . 41.3 t -113.88 134.07 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.962 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -100.25 116.27 31.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -104.93 117.78 57.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.317 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.79 125.86 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.023 1.816 . . . . 0.0 111.853 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.859 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -75.85 176.02 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.13 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -59.67 -35.4 74.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.83 -19.45 52.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.838 0.828 . . . . 0.0 108.816 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.568 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.482 177.6 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.684 ' O ' HG11 ' A' ' 58' ' ' VAL . 74.7 m -59.92 -32.55 70.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.83 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -83.56 -23.83 31.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.161 0.981 . . . . 0.0 109.121 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 9.0 mp -77.92 -20.39 52.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG11 ' O ' ' A' ' 55' ' ' THR . 8.0 p -91.71 -22.72 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.013 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 55' ' ' THR . 20.2 mm-40 -64.12 -44.87 90.91 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.535 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 64.2 t30 -162.9 14.33 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 57' ' ' LEU . 4.0 Cg_exo -91.38 150.94 3.63 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 CA-C-N 121.202 1.465 . . . . 0.0 111.435 153.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' PRO . 24.2 Cg_exo -66.51 -15.61 48.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.087 2.525 . . . . 0.0 112.805 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.644 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 1.1 tt0 -46.85 -29.75 2.14 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.3 tp -45.66 -50.03 13.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.441 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -44.91 -44.71 8.93 Favored Glycine 0 CA--C 1.511 -0.205 0 O-C-N 124.103 0.877 . . . . 0.0 114.218 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.715 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.63 -35.2 34.31 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.62 0.247 . . . . 0.0 110.57 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.5 mt -51.67 -47.51 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.184 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.92 -56.03 5.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.53 -64.0 1.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.89 -0.78 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 14.7 p-80 43.99 53.35 6.4 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.726 0.774 . . . . 0.0 110.041 -168.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 36' ' ' PHE . 10.2 p -123.82 154.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.271 -166.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.27 127.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.657 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -64.56 143.83 57.64 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.077 0.465 . . . . 0.0 111.156 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.72 99.48 2.6 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.888 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 35' ' ' PRO . . . -61.8 98.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.579 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.529 ' O ' HG21 ' A' ' 122' ' ' ILE . 5.1 m-85 -113.6 110.19 19.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.825 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.703 ' O ' HD23 ' A' ' 82' ' ' LEU . 26.1 mmtp -59.66 160.68 6.97 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 165.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.35 -23.64 65.9 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.2 t -72.57 -31.08 64.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.58 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -73.77 -43.59 58.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -62.34 -55.39 28.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.914 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.94 -35.19 77.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.147 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -51.34 -44.52 62.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.664 0.745 . . . . 0.0 110.23 173.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -38.68 49.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.272 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.15 6.66 86.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.043 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.551 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.6 tt -163.07 158.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 95' ' ' THR . 14.1 m -129.98 140.89 47.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.093 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -110.1 126.27 53.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.66 0.743 . . . . 0.0 110.64 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.631 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 75.0 m -72.18 168.61 17.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.386 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 4.7 tp -56.14 -37.7 69.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.873 0.844 . . . . 0.0 109.78 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.644 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 1.9 pm0 -75.36 -15.19 60.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.705 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.93 8.88 47.1 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.164 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -78.35 118.45 20.55 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -83.56 141.29 31.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.359 0.6 . . . . 0.0 111.997 176.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.562 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -133.99 126.22 18.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.957 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.6 Cg_exo -70.43 128.72 15.8 Favored 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 122.1 1.867 . . . . 0.0 112.604 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.0 mm -96.9 133.48 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.733 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.406 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 54.7 m80 -130.89 -179.77 5.51 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.589 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.67 114.01 0.4 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.653 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.98 -51.76 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -132.83 -57.59 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.332 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -85.02 172.8 8.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.153 1.902 . . . . 0.0 110.71 168.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.0 152.9 38.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.32 0.581 . . . . 0.0 110.72 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 8.7 mm-40 -130.96 106.93 8.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.454 -175.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.49 115.43 48.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.856 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HB3' ' CG2' ' A' ' 96' ' ' ILE . 20.9 ptmt 55.74 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.71 1.604 . . . . 0.0 113.213 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.4 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 2.9 p-10 -149.69 24.26 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -126.9 166.11 18.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.399 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 41.7 m -126.59 132.34 51.31 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 t -74.75 131.89 34.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.477 0.656 . . . . 0.0 111.422 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 127' ' ' ASP . 7.1 mp -91.7 -46.64 7.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.781 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -145.97 114.12 6.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.7 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB1' ' HD1' ' A' ' 124' ' ' HIS . . . -135.91 -173.39 3.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 49.2 m-20 67.81 28.47 7.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -172.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -86.62 114.32 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.104 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.96 106.91 2.48 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.45 ' CB ' HG13 ' A' ' 123' ' ' ILE . . . -82.7 -179.47 7.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.295 -175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.93 -49.53 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.6 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.06 -18.91 9.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.907 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.98 -108.08 0.49 Allowed Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 119.724 -1.227 . . . . 0.0 114.093 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' THR . 17.1 mm -142.9 153.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.401 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.45 HG13 ' CB ' ' A' ' 118' ' ' ALA . 89.0 mt -128.58 147.59 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.45 ' HD1' ' HB1' ' A' ' 114' ' ' ALA . 4.6 m-70 -138.09 117.4 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.736 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 95.4 t -82.2 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -122.97 156.33 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.028 0.918 . . . . 0.0 111.286 -176.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.859 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -98.68 19.52 14.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.971 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -158.89 131.47 6.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.874 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.689 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.8 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -56.56 -19.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.68 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.8 p -91.24 -36.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 0.0 110.705 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.454 ' CA ' HE22 ' A' ' 31' ' ' GLN . 23.4 t70 -58.12 -45.47 87.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.566 0.698 . . . . 0.0 110.253 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 14.3 mt -56.86 -21.55 14.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.873 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.12 74.57 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.978 -0.451 . . . . 0.0 110.936 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.35 -24.35 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 110.114 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 60.2 t30 -81.04 -25.43 37.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.175 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 5.8 p -63.21 130.63 94.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.4 Cg_exo -79.26 68.87 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.94 2.427 . . . . 0.0 111.932 175.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.25 46.83 14.41 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.456 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.562 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 1.1 t80 -65.9 -169.72 0.07 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.354 0.597 . . . . 0.0 111.329 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 m -62.78 159.91 15.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -61.02 -17.95 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.39 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 mp -52.34 -37.02 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.215 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -80.02 -27.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.596 0.712 . . . . 0.0 109.805 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.574 ' O ' HG11 ' A' ' 23' ' ' VAL . 1.5 m -83.29 -28.24 29.26 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.109 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -62.0 -32.38 72.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.708 0.29 . . . . 0.0 111.482 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.54 -37.44 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.499 171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 37.5 mtmt -61.97 -43.59 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.852 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 19' ' ' THR . 7.9 p -72.65 -35.57 50.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 62' ' ' PRO . . . -74.8 -7.89 54.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.847 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.31 10.66 6.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.767 1.227 . . . . 0.0 112.772 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 66' ' ' ARG . 9.5 mp -85.9 9.13 17.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.976 -0.452 . . . . 0.0 112.111 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.1 t -58.14 -36.53 57.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.005 0.431 . . . . 0.0 109.932 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.54 -21.25 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.659 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.06 -52.41 8.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.71 0.291 . . . . 0.0 111.759 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 26.3 mt -57.71 -15.35 7.61 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.68 ' NE2' HG13 ' A' ' 5' ' ' VAL . 40.7 mm-40 -65.54 -13.17 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.237 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.9 m -56.02 112.95 4.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 123.469 0.48 . . . . 0.0 111.726 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.72 -9.36 13.33 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.015 2.477 . . . . 0.0 113.043 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.72 -145.13 0.15 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.797 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 76' ' ' ALA . 2.1 Cg_endo -78.32 169.02 20.75 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB3' HG22 ' A' ' 72' ' ' VAL . 35.6 m-85 -139.65 121.33 15.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.304 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.7 m -108.33 115.58 30.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.284 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.47 124.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.784 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.698 ' HD1' ' NE2' ' A' ' 124' ' ' HIS . 38.1 m-85 -84.01 110.43 18.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -96.47 122.19 58.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.572 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.69 126.77 9.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.159 1.906 . . . . 0.0 112.274 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.858 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -74.88 178.44 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.42 177.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -57.21 -36.71 71.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.65 -19.83 48.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.647 0.736 . . . . 0.0 109.053 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.735 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.296 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.147 0.498 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.588 ' O ' HG11 ' A' ' 58' ' ' VAL . 86.8 m -59.23 -35.26 73.33 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -82.74 -24.91 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.991 0.901 . . . . 0.0 109.291 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.8 mp -75.27 -25.62 58.14 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 55' ' ' THR . 7.3 p -78.3 -29.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.2 mm-40 -71.4 -26.6 62.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.477 1.132 . . . . 0.0 108.668 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.45 167.77 31.65 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.532 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 63' ' ' GLN . 38.4 Cg_exo -38.88 168.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.369 3.379 . . . . 0.0 114.734 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 39.5 Cg_exo -39.08 -8.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.675 1 C-N-CA 126.547 4.832 . . . . 0.0 118.06 -173.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 66' ' ' ARG . 10.1 tt0 -42.2 -17.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.618 ' O ' HD21 ' A' ' 68' ' ' LEU . 16.2 tp -47.51 -51.6 20.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.403 0.281 . . . . 0.0 111.399 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -54.62 -32.81 54.13 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.973 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.25 -50.57 45.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 109.573 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.553 HD13 ' HA ' ' A' ' 64' ' ' LEU . 57.4 mt -46.92 -51.71 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.428 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.618 HD21 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -51.33 -61.55 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -171.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -81.76 -63.06 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -165.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.487 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 64.8 m-85 -124.39 -2.77 7.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.5 m80 59.63 34.21 22.18 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 70' ' ' TYR . 7.4 p -113.59 156.41 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -162.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 89' ' ' THR . 1.6 p -125.14 126.66 71.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.865 168.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 91' ' ' LEU . . . -65.3 140.91 58.74 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 120.945 0.402 . . . . 0.0 110.609 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.41 97.26 2.32 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.001 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -60.87 108.4 0.85 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.443 0.64 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.01 132.34 55.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.129 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.688 ' O ' HD21 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -88.86 165.42 14.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.9 58.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.255 0.55 . . . . 0.0 110.974 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 13.3 t -72.25 -26.08 61.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.585 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.35 -48.67 16.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.07 -51.26 70.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.605 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.68 -35.39 80.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.033 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -51.75 -44.32 63.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.732 0.777 . . . . 0.0 110.326 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -73.29 -39.04 65.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.257 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.79 7.11 88.92 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.472 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.8 tt -163.27 159.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 95' ' ' THR . 8.5 m -130.17 138.0 55.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.189 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.534 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.7 m -114.29 133.2 55.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.092 0.473 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.612 ' HB2' ' OE2' ' A' ' 92' ' ' GLU . 58.3 m -85.41 178.27 7.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.479 -174.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.449 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 1.7 tp -56.0 -39.35 71.75 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.748 ' OE1' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -84.42 -16.67 41.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA2' HG23 ' A' ' 89' ' ' THR . . . 113.15 22.22 5.65 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.114 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.748 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 5.5 p -86.86 120.56 28.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 117.714 0.757 . . . . 0.0 110.541 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -93.08 138.32 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.0 mp -130.88 125.99 21.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.715 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 87' ' ' ILE . 7.1 Cg_exo -68.76 133.79 28.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.192 1.928 . . . . 0.0 113.362 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.43 ' HA ' HD11 ' A' ' 98' ' ' ILE . 41.0 mm -98.95 136.03 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.317 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.525 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 18.0 m-70 -120.86 177.62 5.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.056 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.04 107.97 0.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.443 -1.36 . . . . 0.0 113.428 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -104.57 -41.09 5.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 109.908 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HB3' ' CD ' ' A' ' 103' ' ' PRO . 26.9 t-20 -127.12 -63.98 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.186 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -84.9 174.19 7.6 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.018 1.812 . . . . 0.0 110.74 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD22 HG23 ' A' ' 111' ' ' VAL . 14.8 tp -73.86 152.21 40.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 3.6 mm-40 -137.58 122.6 19.06 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.57 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -128.74 123.77 59.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.108 -175.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 11.2 ptmm? 46.9 -132.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.671 0.607 . . . . 0.0 110.768 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -88.27 25.67 1.58 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 0.0 110.473 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 126' ' ' ILE . . . -124.87 163.1 22.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.759 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 81.0 m -127.88 140.89 51.74 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 HD22 ' A' ' 104' ' ' LEU . 38.4 t -84.5 125.51 40.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.43 0.633 . . . . 0.0 112.394 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.2 -36.45 16.79 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.293 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.25 111.56 2.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.505 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -135.82 -174.21 3.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 19.3 t70 69.84 25.8 4.92 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -90.79 105.92 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.1 108.54 3.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 122.284 1.04 . . . . 0.0 112.485 177.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -83.67 -177.54 6.74 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.591 -175.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -43.98 -51.38 7.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.647 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.17 -13.61 9.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.878 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.44 -109.79 0.42 Allowed Glycine 0 CA--C 1.501 -0.825 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.356 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 10.4 mm -145.62 144.19 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.558 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.514 HG13 ' HB1' ' A' ' 118' ' ' ALA . 29.3 mt -113.61 150.91 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.453 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.698 ' NE2' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.11 115.17 6.14 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 122.12 0.962 . . . . 0.0 111.767 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 40.7 t -82.3 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.181 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -122.75 160.32 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.313 1.054 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.858 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 28.8 t70 -93.98 1.61 56.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.534 -169.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.58 ' O ' HG13 ' A' ' 126' ' ' ILE . 4.6 m -159.36 131.05 6.29 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.22 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 45' ' ' ALA . 77.0 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.751 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.7 -21.83 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.701 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.4 p -91.42 -34.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 110.28 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' CA ' HE22 ' A' ' 31' ' ' GLN . 15.5 t70 -55.3 -48.43 74.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.831 0.824 . . . . 0.0 109.751 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -55.05 -21.46 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.657 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.0 76.07 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.863 -0.523 . . . . 0.0 110.583 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.7 t -79.15 -15.38 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.453 0.644 . . . . 0.0 110.421 174.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -94.06 -24.5 17.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 -175.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.1 p -60.55 130.34 90.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 3.8 Cg_exo -79.1 64.53 8.84 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.966 2.444 . . . . 0.0 112.506 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.56 45.36 7.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.594 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.16 -175.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -58.31 154.34 13.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.316 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -57.94 -18.86 26.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.69 -32.77 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.98 -28.84 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.398 0.618 . . . . 0.0 109.623 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.579 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.7 m -82.46 -27.72 31.7 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -61.79 -37.52 84.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -36.46 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.004 -0.435 . . . . 0.0 110.513 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 39.1 mtmt -62.08 -43.24 99.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 111.027 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 19' ' ' THR . 8.6 p -74.69 -34.13 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.23 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -75.31 -8.04 55.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.913 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.418 HD21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 73.03 10.45 5.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.362 1.065 . . . . 0.0 112.976 177.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.681 HD21 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.83 6.9 26.05 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.99 -0.443 . . . . 0.0 112.038 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.22 -36.56 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.988 0.423 . . . . 0.0 110.455 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -86.21 -18.81 31.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.973 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.95 -54.92 5.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.694 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.5 mt -56.37 -13.9 2.56 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.701 ' NE2' HG13 ' A' ' 5' ' ' VAL . 42.8 mm-40 -64.39 -10.39 24.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.044 0.537 . . . . 0.0 112.215 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -61.62 110.77 3.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.346 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.48 -15.58 9.81 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.139 2.559 . . . . 0.0 113.593 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.68 -138.43 0.22 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.917 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 23.9 Cg_endo -74.85 165.37 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.223 1.949 . . . . 0.0 113.643 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.752 ' CD2' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.22 125.66 28.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.803 -170.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 38.1 m -124.6 119.79 30.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -118.0 152.1 20.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -108.95 106.94 17.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -99.23 112.22 62.73 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.24 130.61 13.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.407 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.763 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.6 p30 -81.55 -174.43 4.96 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.829 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -59.77 -30.0 68.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.654 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -81.84 -19.63 40.65 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.016 0.912 . . . . 0.0 109.17 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.74 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.047 177.209 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.392 0.615 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.597 ' O ' HG11 ' A' ' 58' ' ' VAL . 88.1 m -64.62 -34.13 77.55 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.367 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -81.81 -24.63 35.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.792 0.806 . . . . 0.0 109.101 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 7.6 mp -71.19 -31.29 67.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.993 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 55' ' ' THR . 9.8 p -73.72 -31.49 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.089 0.471 . . . . 0.0 109.731 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.9 mm-40 -73.0 -30.43 63.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.784 1.278 . . . . 0.0 108.325 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 1.6 m-80 -76.52 169.6 20.23 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.901 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 63' ' ' GLN . 26.2 Cg_exo -37.31 168.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 124.439 3.426 . . . . 0.0 115.191 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 43.3 Cg_exo -40.03 -11.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 1 C-N-CA 126.537 4.825 . . . . 0.0 118.905 -168.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.685 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 32.6 tt0 -43.79 -25.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.62 ' O ' HD23 ' A' ' 68' ' ' LEU . 12.7 tp -46.98 -48.67 21.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.585 0.354 . . . . 0.0 111.905 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.474 ' C ' HD21 ' A' ' 26' ' ' LEU . . . -49.64 -40.34 32.43 Favored Glycine 0 N--CA 1.458 0.14 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.829 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.681 ' N ' HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.61 -37.54 59.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.85 0.357 . . . . 0.0 110.049 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 64' ' ' LEU . 55.6 mt -57.06 -45.19 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.717 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -48.93 -59.1 3.88 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.739 0.649 . . . . 0.0 112.673 -176.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -83.8 -64.46 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.527 -169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' HIS . 2.8 m-85 -125.98 -13.25 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 11.1 t-80 68.09 40.44 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -175.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.752 HG23 ' CD2' ' A' ' 36' ' ' PHE . 13.2 p -121.55 159.77 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.444 -165.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.525 ' N ' HG22 ' A' ' 72' ' ' VAL . 1.9 p -128.72 128.53 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.15 170.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -68.23 140.72 56.06 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.318 0.58 . . . . 0.0 110.854 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 113.36 97.96 2.3 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.755 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.12 101.24 0.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 122.909 0.483 . . . . 0.0 111.86 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.03 117.54 29.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.695 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.9 mtpt -75.31 163.52 27.39 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.006 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.42 59.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.012 0.434 . . . . 0.0 110.714 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 10.0 t -71.29 -27.85 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.071 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -78.68 -49.07 13.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.323 0.582 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.695 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -55.41 -52.48 63.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.166 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.53 -33.9 75.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 80' ' ' THR . 1.1 ttt180 -54.51 -40.6 68.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.546 0.689 . . . . 0.0 110.077 176.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -80.21 -41.6 24.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.04 10.65 78.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.726 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.55 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.1 tt -162.64 156.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 95' ' ' THR . 13.3 m -131.1 139.13 51.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -107.3 128.02 54.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.648 0.737 . . . . 0.0 110.839 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.582 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 60.6 m -72.6 166.11 23.38 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.502 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 5.0 tp -56.98 -36.18 70.05 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-O 121.946 0.879 . . . . 0.0 109.642 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 3.6 pm0 -76.65 -12.31 59.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.86 6.48 57.08 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.602 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.5 m -77.85 119.96 22.07 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.98 133.78 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 88' ' ' VAL . 1.6 mp -122.23 127.05 26.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.55 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.2 Cg_exo -72.7 130.43 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.709 1.606 . . . . 0.0 112.852 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 82' ' ' LEU . 35.9 mm -94.53 134.34 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 68.8 m-70 -123.84 -179.27 4.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.738 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.87 97.04 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.998 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.07 -53.25 4.56 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 21.9 t-20 -118.0 -56.02 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 23.9 Cg_endo -90.7 174.13 2.89 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.613 2.209 . . . . 0.0 110.795 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 111' ' ' VAL . 13.0 tp -74.12 152.38 39.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 39.4 mt-10 -136.85 109.64 7.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 109.478 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.49 106.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -176.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 2.5 ptpt 43.49 -106.99 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 112.638 -170.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -89.26 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.622 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -108.55 166.04 11.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.454 0.645 . . . . 0.0 112.729 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.7 m -129.15 133.57 47.67 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.555 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 17.4 t -85.33 131.05 35.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.641 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 127' ' ' ASP . 6.9 mp -88.99 -46.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.201 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -146.77 118.76 8.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.791 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 124' ' ' HIS . . . -136.61 -174.7 3.78 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 27.5 m-20 67.74 27.09 7.63 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -87.06 116.2 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.386 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.47 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.35 108.61 2.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.456 ' CB ' HG13 ' A' ' 123' ' ' ILE . . . -82.85 -177.7 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.777 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 1.1 pt-20 -47.53 -53.51 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.567 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 46.5 m-80 -119.08 -9.36 10.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.4 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.32 -112.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.279 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' THR . 32.1 mm -143.03 148.0 19.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.329 0.585 . . . . 0.0 111.328 -171.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 38' ' ' VAL . 96.7 mt -119.18 147.7 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -137.57 118.75 14.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 85.1 t -83.12 128.04 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.04 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.1 OUTLIER -120.97 162.26 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.85 0.833 . . . . 0.0 110.479 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.763 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 38.1 t70 -107.79 16.53 23.5 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.345 -170.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 73.2 m -156.79 130.56 8.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.087 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.518 173.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.467 HD11 ' H ' ' A' ' 4' ' ' ILE . 4.2 mp -44.13 -47.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.501 0.667 . . . . 0.0 111.08 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.664 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.3 p -71.89 -36.06 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.688 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.457 ' CA ' HE22 ' A' ' 31' ' ' GLN . 16.0 t70 -54.84 -46.36 74.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.939 0.875 . . . . 0.0 109.673 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 10' ' ' ASN . 18.5 mt -56.8 -21.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.211 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . . . -61.39 -32.94 72.88 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.751 -0.593 . . . . 0.0 110.415 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.21 -34.85 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.381 0.61 . . . . 0.0 109.999 172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.547 ' CB ' ' HA ' ' A' ' 7' ' ' ILE . 17.5 t-20 -66.29 -25.22 66.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.529 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.2 p -62.45 138.48 96.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.043 -175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.7 Cg_exo -80.61 62.27 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.601 2.201 . . . . 0.0 112.315 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 46.84 20.51 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.998 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.73 -168.66 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.553 0.692 . . . . 0.0 112.423 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 18' ' ' VAL . 4.6 m -58.57 158.94 7.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.856 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -60.49 -17.99 48.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -52.6 -35.27 53.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 8' ' ' ALA . 3.9 m -80.92 -28.45 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.686 0.755 . . . . 0.0 109.967 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.544 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -79.79 -29.05 40.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 -177.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -62.83 -35.66 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.818 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 -36.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.11 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 27.2 mtmt -61.5 -43.86 98.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.299 0.571 . . . . 0.0 110.982 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 19' ' ' THR . 8.3 p -73.52 -35.93 46.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.98 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -74.04 -4.19 33.95 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.656 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.15 9.68 7.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.272 1.029 . . . . 0.0 112.842 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 66' ' ' ARG . 9.2 mp -87.25 7.34 28.91 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.91 -0.494 . . . . 0.0 111.805 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.41 -36.98 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.197 0.522 . . . . 0.0 109.792 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -85.85 -21.82 27.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.626 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.89 -54.89 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 19.8 mt -58.54 -9.81 1.86 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.664 ' NE2' HG13 ' A' ' 5' ' ' VAL . 39.7 mm-40 -70.98 4.64 2.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.826 0.45 . . . . 0.0 112.054 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -48.02 112.55 2.26 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 123.98 0.8 . . . . 0.0 112.412 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.98 -12.57 11.9 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.24 2.627 . . . . 0.0 111.254 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.79 -135.11 1.91 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.147 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 17.7 Cg_endo -84.3 170.94 10.41 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.917 2.412 . . . . 0.0 113.174 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.655 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -139.08 122.96 17.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.772 HG21 ' CG ' ' A' ' 77' ' ' TYR . 0.4 OUTLIER -126.83 119.88 27.9 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -174.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' CG1' HG12 ' A' ' 123' ' ' ILE . 7.4 p -117.42 145.03 23.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.245 0.545 . . . . 0.0 111.261 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.67 ' HD1' ' CE1' ' A' ' 124' ' ' HIS . 55.3 m-85 -93.06 109.25 20.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -91.35 111.86 51.08 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 120.673 0.273 . . . . 0.0 111.318 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.41 128.33 8.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.099 1.866 . . . . 0.0 111.739 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.835 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.2 p30 -80.91 -175.41 5.35 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.994 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.74 -32.0 59.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -83.22 -23.89 32.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.698 0.761 . . . . 0.0 109.185 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.788 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.621 177.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 67' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.599 ' O ' HG11 ' A' ' 58' ' ' VAL . 63.0 m -55.36 -37.37 67.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.732 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -81.8 -27.24 33.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.91 0.862 . . . . 0.0 109.369 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 10.1 mp -73.11 -25.17 60.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.838 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 55' ' ' THR . 9.0 p -79.14 -29.21 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 121.172 0.511 . . . . 0.0 109.865 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 55' ' ' THR . 27.5 mm-40 -71.79 -27.27 62.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 122.575 1.179 . . . . 0.0 108.706 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.58 166.69 37.17 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.057 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 30.5 Cg_exo -39.21 168.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.306 3.338 . . . . 0.0 114.641 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 21.6 Cg_exo -34.73 -10.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 1 C-N-CA 127.345 5.364 . . . . 0.0 119.393 -172.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 61' ' ' PRO . 1.7 tt0 -42.34 -24.93 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.581 ' HA ' HD11 ' A' ' 67' ' ' ILE . 11.5 tp -44.56 -49.02 10.31 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.378 0.671 . . . . 0.0 112.477 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.97 -31.73 33.06 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.843 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.62 ' N ' HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 0.0 110.02 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 54' ' ' ILE . 36.0 mt -68.64 -46.97 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.362 -169.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.576 HD21 ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -50.15 -59.37 3.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -174.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.79 -62.45 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -168.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.39 -13.78 7.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 t60 65.83 36.26 6.21 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.655 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.4 p -109.82 160.44 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.57 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' HG23 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -136.63 131.39 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -70.2 138.84 52.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 120.69 88.39 1.04 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.308 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.436 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -56.22 98.53 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 112.124 -171.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.995 ' CG ' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -95.66 147.72 23.3 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.042 179.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -110.73 152.75 26.21 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.37 -30.49 12.42 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 0.0 112.061 -169.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 12.2 t -75.42 -25.0 57.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.858 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.79 -51.61 18.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.857 0.836 . . . . 0.0 109.386 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.995 HD21 ' CG ' ' A' ' 77' ' ' TYR . 0.3 OUTLIER -57.72 -50.72 72.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.703 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -66.96 -33.0 74.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.741 0.305 . . . . 0.0 111.328 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -55.0 -40.95 70.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.432 0.634 . . . . 0.0 110.274 173.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.8 mtt -78.44 -41.82 31.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.716 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.85 10.71 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.907 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.516 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.1 tt -163.83 157.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 95' ' ' THR . 15.1 m -131.59 141.7 45.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.772 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.8 m -108.93 133.55 52.78 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.221 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 94' ' ' SER . 26.3 t -66.14 164.88 14.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.908 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 2.2 tp -56.89 -33.59 67.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.558 0.694 . . . . 0.0 109.78 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.48 ' HB3' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -27.24 41.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.749 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.21 3.27 11.88 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.893 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 90' ' ' SER . 1.8 m -78.34 120.44 23.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.788 0.794 . . . . 0.0 111.564 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -85.03 141.72 30.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.551 ' O ' HG21 ' A' ' 88' ' ' VAL . 1.8 mp -127.28 127.27 24.26 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.645 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.516 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.2 Cg_exo -72.59 130.06 15.47 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.021 1.814 . . . . 0.0 113.35 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.475 HG13 ' HB3' ' A' ' 82' ' ' LEU . 42.1 mm -98.89 141.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.344 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.433 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 31.1 m80 -134.92 178.8 6.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.543 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.58 110.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.612 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.27 -48.1 8.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.518 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 8.1 t30 -128.13 -55.69 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.138 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 15.9 Cg_endo -90.47 173.71 3.12 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.264 1.976 . . . . 0.0 110.8 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.516 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . 14.5 tp -74.48 153.99 38.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 4.3 mm-40 -138.65 119.29 14.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.612 -174.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.483 HG13 ' HE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -119.39 106.01 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.301 -173.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.528 ' HB3' HG21 ' A' ' 96' ' ' ILE . 20.8 pttp 49.83 -78.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.536 1.535 . . . . 0.0 113.812 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' OD1' ' HG3' ' A' ' 107' ' ' LYS . 30.3 p-10 -125.29 1.19 7.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.526 0.679 . . . . 0.0 109.344 -172.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 126' ' ' ILE . . . -117.6 165.31 13.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.431 -173.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -125.46 136.21 53.14 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' NE2' ' A' ' 124' ' ' HIS . 99.0 t -83.18 127.47 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.234 -174.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.3 mp -93.25 -32.87 14.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.865 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -162.99 116.53 1.64 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.434 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.79 -175.77 4.01 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 29.7 t70 68.11 25.65 7.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -169.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.5 mt -85.06 109.09 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.114 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.56 106.92 2.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.471 0.653 . . . . 0.0 111.14 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.409 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -80.27 -175.17 4.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.399 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.09 -52.26 45.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.429 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.7 m-20 -117.78 -12.78 10.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -149.13 -111.45 0.59 Allowed Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.565 -1.302 . . . . 0.0 112.79 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.612 HG13 ' HE3' ' A' ' 78' ' ' LYS . 7.6 mm -145.31 149.14 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.539 0.685 . . . . 0.0 111.676 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.521 HG12 ' CG1' ' A' ' 38' ' ' VAL . 87.9 mt -114.4 151.17 16.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.462 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.67 ' CE1' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.15 112.91 5.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.055 0.931 . . . . 0.0 112.178 -178.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 46.1 t -80.08 130.09 36.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.635 -174.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.66 163.34 25.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.672 0.749 . . . . 0.0 110.123 176.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.835 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 34.7 t70 -106.32 14.71 27.07 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.017 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.629 ' O ' HG13 ' A' ' 126' ' ' ILE . 15.9 m -164.26 131.0 3.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.248 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.648 176.355 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.522 HD11 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.61 -20.9 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.6 p -92.39 -37.32 8.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.175 0.512 . . . . 0.0 111.003 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.542 ' HA ' HE22 ' A' ' 31' ' ' GLN . 13.9 t70 -50.05 -48.91 52.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.586 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 11' ' ' THR . 7.5 mt -59.48 -22.14 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.932 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.52 77.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.314 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.67 -26.6 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 110.259 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 47.6 t30 -77.28 -25.27 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.365 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.6 p -65.89 138.9 96.58 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 59.12 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.516 2.811 . . . . 0.0 112.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.87 44.1 10.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.881 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -66.09 -178.31 0.6 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -55.43 158.34 3.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.985 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -58.37 -18.38 27.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.514 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -53.36 -35.94 60.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.112 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.26 -30.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.592 0.711 . . . . 0.0 110.064 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -80.82 -29.74 35.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.472 -173.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -64.66 -33.53 76.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -37.43 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 109.886 171.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 7.6 mtmt -61.52 -39.9 92.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.428 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 19' ' ' THR . 7.4 p -77.11 -36.18 24.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.393 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -73.84 -6.69 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.026 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.43 HD21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 72.64 10.99 5.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.181 0.992 . . . . 0.0 112.276 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 66' ' ' ARG . 7.8 mp -87.23 7.03 30.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.714 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -36.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.19 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.8 pt-20 -85.38 -21.62 28.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.829 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 31' ' ' GLN . . . -75.75 -53.75 8.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.1 mt -61.74 -5.65 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.299 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.679 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 41.7 mm-40 -74.29 10.44 1.27 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.497 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 m -92.85 95.27 1.05 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-O 120.944 0.402 . . . . 0.0 110.01 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 31' ' ' GLN . 53.8 Cg_endo -80.53 -8.01 13.7 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.072 2.515 . . . . 0.0 113.5 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -124.07 0.02 OUTLIER Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.881 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.491 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 37.9 Cg_endo -78.99 154.26 25.66 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.28 1.32 . . . . 0.0 112.597 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CD2' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -138.69 121.67 16.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.128 -168.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.4 m -119.63 124.23 45.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.271 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 123' ' ' ILE . 98.5 t -122.02 140.97 44.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.236 0.541 . . . . 0.0 111.949 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.49 115.3 29.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -105.65 117.98 56.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.167 -173.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.32 125.13 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.995 1.797 . . . . 0.0 111.582 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.691 HD21 ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -78.7 173.27 12.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.24 -46.01 8.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.609 0.719 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.9 -20.79 61.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.776 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 42' ' ' ASN . . . . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.314 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 120.993 0.425 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 58' ' ' VAL . 90.9 m -66.74 -35.64 80.58 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -79.3 -27.24 42.18 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.868 0.842 . . . . 0.0 109.262 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.3 mp -76.21 -25.71 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.43 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 55' ' ' THR . 9.0 p -75.28 -28.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.3 mm-40 -73.55 -27.14 61.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.64 1.21 . . . . 0.0 108.771 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 5.3 m-80 -84.44 168.37 21.7 Favored Pre-proline 0 N--CA 1.435 -1.197 0 CA-C-N 112.982 -1.917 . . . . 0.0 111.038 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.507 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 28.8 Cg_exo -38.3 168.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 124.543 3.495 . . . . 0.0 115.197 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 15.3 Cg_exo -34.08 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.896 1 C-N-CA 127.824 5.683 . . . . 0.0 120.551 -166.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.603 ' O ' HG13 ' A' ' 67' ' ' ILE . 1.2 tt0 -43.89 -28.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 68' ' ' LEU . 16.5 tp -44.83 -51.1 9.86 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.223 0.609 . . . . 0.0 112.305 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -51.72 -34.73 37.02 Favored Glycine 0 N--CA 1.461 0.307 0 O-C-N 123.599 0.562 . . . . 0.0 113.321 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.71 -40.11 61.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.434 0.635 . . . . 0.0 110.026 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 63' ' ' GLN . 46.1 mt -62.51 -47.52 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.828 -174.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.64 -62.35 1.33 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.949 0.781 . . . . 0.0 112.822 -173.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -88.96 -61.94 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -122.13 -12.81 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 59.9 38.01 21.33 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.638 HG23 ' CD2' ' A' ' 36' ' ' PHE . 14.5 p -106.7 159.39 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.586 -165.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 p -132.99 125.57 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.556 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 91' ' ' LEU . . . -67.36 141.96 56.93 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.346 0.593 . . . . 0.0 110.712 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.78 100.16 2.23 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.392 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' ' CB ' ' A' ' 35' ' ' PRO . . . -61.32 102.26 0.22 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.244 0.545 . . . . 0.0 111.834 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -120.71 122.4 40.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.135 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' O ' HD21 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.08 159.34 27.57 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 170.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -48.99 -36.78 18.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.45 0.469 . . . . 0.0 110.633 -172.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 6.5 t -72.36 -23.99 61.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.287 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.38 -40.17 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.594 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -62.08 -48.87 78.28 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.421 175.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.68 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.8 mtpt -66.53 -29.42 69.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 122.946 0.498 . . . . 0.0 112.218 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.12 -32.47 68.15 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 122.021 0.915 . . . . 0.0 109.299 173.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.1 -42.5 12.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.464 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' HB ' ' A' ' 98' ' ' ILE . . . 80.96 12.01 83.13 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.61 -172.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.9 tt -163.22 159.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.4 m -133.21 139.28 49.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.3 m -107.37 129.81 54.87 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.505 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.452 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 21.4 t -71.44 165.83 22.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.498 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.498 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 3.3 tp -56.74 -30.15 63.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.787 0.803 . . . . 0.0 109.894 173.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 8.0 pt-20 -78.37 -22.96 47.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.48 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.13 11.76 27.1 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.34 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.4 m -88.83 122.29 32.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 122.44 -0.447 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.3 137.71 32.79 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -128.05 130.08 23.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.509 177.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.7 Cg_exo -72.57 134.91 23.13 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.023 1.815 . . . . 0.0 113.328 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -98.61 135.31 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.743 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.403 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 53.2 m80 -127.88 -178.81 4.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.682 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.75 100.3 0.16 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.094 -1.051 . . . . 0.0 113.204 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.91 -35.36 26.16 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.5 t-20 -144.2 -55.83 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.185 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 42.2 Cg_endo -85.72 174.04 6.88 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.163 1.909 . . . . 0.0 110.623 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.68 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 16.1 tp -72.89 151.02 42.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 43.5 mt-10 -140.99 106.33 5.04 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -109.12 132.28 57.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.033 -173.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 108' ' ' ASN . 12.2 ptmm? 55.36 -82.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.646 1.179 . . . . 0.0 112.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.464 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 22.8 p-10 -146.04 23.03 1.37 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.626 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -125.86 162.99 23.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.252 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.8 m -122.33 131.24 53.81 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 t -78.58 127.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.399 0.619 . . . . 0.0 111.695 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 112' ' ' LEU . 6.4 mp -89.03 -39.0 13.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.222 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.07 118.35 5.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 124' ' ' HIS . . . -137.72 -174.23 3.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 10.5 m-20 66.26 27.15 10.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -173.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -85.0 114.16 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.5 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -66.24 108.83 2.43 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.389 0.614 . . . . 0.0 110.61 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.52 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.26 -172.75 3.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.705 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 3.2 pt-20 -53.26 -51.49 62.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 80.7 m-20 -120.12 -10.75 9.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.3 -118.23 1.17 Allowed Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.229 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 19.3 mm -146.18 146.66 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.349 0.595 . . . . 0.0 111.622 -172.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 118' ' ' ALA . 45.3 mt -118.83 146.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.654 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 m80 -133.59 116.4 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 84.4 t -81.17 127.72 39.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.259 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -125.65 160.51 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.462 0.649 . . . . 0.0 110.724 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.691 ' HA ' HD21 ' A' ' 42' ' ' ASN . 0.7 OUTLIER -98.16 9.21 43.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.904 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.626 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 23.1 m -146.94 129.17 15.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.18 0.514 . . . . 0.0 111.346 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 C--O 1.255 1.385 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.538 172.457 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.7 mp -49.75 -42.14 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.497 0.665 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.647 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.4 p -75.03 -36.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.14 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.443 ' HA ' HE22 ' A' ' 31' ' ' GLN . 17.8 t70 -52.14 -48.51 64.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 15.4 mt -56.88 -22.31 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.153 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.802 -0.561 . . . . 0.0 110.45 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.85 -18.38 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 110.111 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 40.4 t30 -95.95 -25.45 15.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.855 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 4.1 p -59.25 130.38 87.07 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.038 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.24 65.7 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.136 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.5 46.77 18.29 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.208 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -63.73 -174.56 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.072 0.463 . . . . 0.0 111.516 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.74 156.82 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 m -59.72 -18.17 40.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.322 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mp -54.12 -34.85 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.93 -39.09 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.568 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -68.9 -26.29 65.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.944 -175.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -66.98 -37.23 83.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -37.08 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.606 0.717 . . . . 0.0 109.872 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 1.8 mtpp -58.52 -41.14 84.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.949 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 19' ' ' THR . 7.1 p -78.16 -36.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.168 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 62' ' ' PRO . . . -72.85 -1.63 17.5 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.049 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.64 7.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.068 0.947 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 92' ' ' GLU . 9.6 mp -88.84 6.22 40.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.0 -0.438 . . . . 0.0 111.666 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.978 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.75 -22.16 29.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.812 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.77 7.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.71 0.29 . . . . 0.0 111.571 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.3 mt -57.09 -14.66 4.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.647 ' NE2' HG13 ' A' ' 5' ' ' VAL . 34.2 mm-40 -68.77 -3.31 11.83 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.03 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 p -49.47 115.84 5.3 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.933 0.397 . . . . 0.0 111.474 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.72 -18.26 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.87 2.38 . . . . 0.0 113.147 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 35' ' ' PRO . . . -78.4 -135.9 1.0 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.607 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 11.2 Cg_endo -85.78 166.56 10.1 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.027 2.485 . . . . 0.0 113.098 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -133.9 122.05 22.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.7 m -104.03 104.89 14.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.568 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 123' ' ' ILE . 37.2 t -95.59 123.06 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.792 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HB3' HD13 ' A' ' 126' ' ' ILE . 98.4 m-85 -86.56 108.04 18.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.2 128.82 39.29 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.872 -170.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HB3' HG23 ' A' ' 129' ' ' VAL . 98.6 Cg_endo -79.91 126.86 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.129 1.886 . . . . 0.0 112.55 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.866 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -78.52 177.69 8.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.4 -32.7 65.06 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.85 -19.99 33.93 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.972 0.892 . . . . 0.0 108.945 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.725 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.317 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.548 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.235 0.541 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.559 ' O ' HG11 ' A' ' 58' ' ' VAL . 85.3 m -57.67 -35.98 71.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.469 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -82.73 -25.35 32.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.839 0.828 . . . . 0.0 109.14 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.6 mp -73.1 -27.3 61.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.81 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG11 ' O ' ' A' ' 55' ' ' THR . 8.1 p -79.38 -29.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.064 0.459 . . . . 0.0 109.764 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 55' ' ' THR . 18.8 mm-40 -70.89 -27.47 63.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.699 1.238 . . . . 0.0 108.347 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -82.16 168.07 26.25 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.882 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 22.2 Cg_exo -37.45 168.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 125.008 3.805 . . . . 0.0 116.18 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 36.5 Cg_exo -40.42 -9.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.871 5.047 . . . . 0.0 118.518 -171.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' O ' HG13 ' A' ' 67' ' ' ILE . 9.6 tt0 -43.76 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.5 tp -44.39 -49.95 9.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.61 0.364 . . . . 0.0 110.928 173.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' CA ' HD21 ' A' ' 26' ' ' LEU . . . -53.37 -29.7 38.9 Favored Glycine 0 C--N 1.33 0.195 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.556 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -79.35 -39.73 31.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.245 0.545 . . . . 0.0 109.856 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 63' ' ' GLN . 54.6 mt -59.22 -45.39 92.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.524 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.05 -60.13 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -175.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -85.77 -63.09 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.448 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.97 -16.9 5.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -171.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 67.23 34.99 4.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 15.0 p -111.76 159.45 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.948 -167.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 89' ' ' THR . 1.6 p -132.59 131.78 59.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.9 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.23 144.32 57.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 111.661 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.488 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.41 99.86 2.59 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.226 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.454 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -57.22 110.31 0.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.824 0.849 . . . . 0.0 111.401 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.553 ' O ' HG22 ' A' ' 122' ' ' ILE . 10.5 m-85 -121.03 110.09 15.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.844 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.621 ' O ' HD21 ' A' ' 82' ' ' LEU . 20.3 mmtp -65.77 161.39 20.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 168.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.94 44.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 111.407 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 15.0 t -76.48 -31.38 57.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.646 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.29 -46.86 66.15 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -58.56 -54.06 51.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.136 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -68.47 -32.04 71.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.1 ttt180 -51.04 -45.22 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.757 0.789 . . . . 0.0 110.212 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.0 mtp -81.08 -39.24 26.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 12.82 79.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.846 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.566 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.7 tt -162.95 157.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 95' ' ' THR . 11.0 m -133.11 144.09 37.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.191 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 73' ' ' VAL . 3.4 m -107.03 134.63 49.89 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.675 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.5 m -73.17 162.41 29.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.4 tp -52.82 -36.63 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.425 0.631 . . . . 0.0 110.527 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' HB3' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.37 -28.71 59.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.288 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.1 5.36 8.88 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.673 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 120.43 24.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.818 0.809 . . . . 0.0 112.097 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -81.97 139.45 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.0 112.807 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.515 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.7 mp -127.69 127.85 23.98 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.617 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.1 Cg_exo -72.99 132.3 18.07 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.11 1.874 . . . . 0.0 113.102 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.435 HG13 ' HB3' ' A' ' 82' ' ' LEU . 41.2 mm -95.53 136.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.303 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 33.3 m-70 -127.53 178.14 6.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.771 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.86 115.19 0.32 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.463 -1.351 . . . . 0.0 113.294 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.89 -53.81 2.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 19.8 m120 -114.68 -59.9 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.287 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 17.2 Cg_endo -90.4 173.61 3.19 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.161 1.907 . . . . 0.0 110.916 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.0 tp -75.52 153.99 37.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 5.7 mm-40 -139.01 107.1 5.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.336 0.588 . . . . 0.0 109.691 -173.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.688 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -112.98 128.46 69.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.043 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 12.1 ptmm? 51.75 -138.23 1.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.592 0.558 . . . . 0.0 110.191 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -89.97 30.79 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.307 0.575 . . . . 0.0 110.084 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 126' ' ' ILE . . . -124.11 159.22 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.113 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 m -126.2 137.59 53.57 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.8 t -80.47 125.62 39.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.552 0.691 . . . . 0.0 111.732 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.77 -35.72 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.458 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -157.01 114.86 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.504 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.41 -173.88 3.6 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.584 ' CG ' ' HD2' ' A' ' 78' ' ' LYS . 12.3 t70 71.58 31.45 2.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.717 1.246 . . . . 0.0 107.646 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 10.0 mt -94.67 116.43 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.461 -1.699 . . . . 0.0 109.538 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.73 107.3 2.52 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.088 0.471 . . . . 0.0 109.759 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 123' ' ' ILE . . . -78.98 -177.05 5.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.126 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.86 -50.09 46.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.415 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -118.55 -16.09 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.924 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.01 -109.23 0.51 Allowed Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.556 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.581 HD11 ' CD ' ' A' ' 78' ' ' LYS . 23.1 mm -141.06 150.77 20.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.055 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.523 HG13 ' CB ' ' A' ' 118' ' ' ALA . 82.5 mt -123.32 143.43 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.727 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 3.6 m80 -135.57 114.02 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 60.2 t -78.46 128.86 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -128.74 165.94 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 122.162 0.982 . . . . 0.0 111.412 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.866 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -97.6 10.61 39.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.114 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.584 ' O ' HG13 ' A' ' 126' ' ' ILE . 18.1 m -164.18 123.39 1.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.859 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 45' ' ' ALA . 21.4 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.903 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.532 HD13 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -56.3 -23.68 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.612 HG12 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -91.68 -36.55 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.276 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.586 ' O ' HG13 ' A' ' 9' ' ' VAL . 33.0 t70 -57.76 -46.42 84.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.046 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 11' ' ' THR . 14.0 mt -57.7 -25.28 24.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.579 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -31.49 72.06 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.176 -0.327 . . . . 0.0 111.021 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 6' ' ' ASP . 7.1 p -91.27 -12.75 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.238 0.542 . . . . 0.0 110.501 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 7' ' ' ILE . 82.2 m-20 -91.99 -14.72 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 7' ' ' ILE . 11.0 p -59.83 138.02 90.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.186 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.84 65.61 8.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.815 2.343 . . . . 0.0 111.962 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.6 47.41 41.68 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.058 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.558 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.46 -173.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.308 0.575 . . . . 0.0 111.977 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -62.76 166.22 5.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.748 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -63.13 -19.23 64.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.8 mt -53.52 -36.81 62.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.251 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.2 -27.98 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.619 0.723 . . . . 0.0 109.853 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.577 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -79.38 -26.62 41.96 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.446 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -63.3 -40.58 97.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.747 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 p -74.75 -36.1 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.855 -0.528 . . . . 0.0 110.288 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 24.1 mtmt -61.11 -44.16 97.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.258 0.551 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 19' ' ' THR . 9.0 p -75.42 -34.83 31.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.113 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.65 -1.58 22.37 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.757 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.85 7.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 112.849 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 66' ' ' ARG . 8.7 mp -89.95 6.55 41.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.42 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -85.64 -17.71 35.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.262 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 91' ' ' LEU . . . -79.72 -58.49 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 14.5 mt -51.91 -13.25 0.27 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.612 ' NE2' HG12 ' A' ' 5' ' ' VAL . 48.1 mm-40 -66.33 -2.85 4.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.503 0.721 . . . . 0.0 112.73 -174.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -54.52 110.35 2.09 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 123.386 0.429 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.46 -18.02 9.79 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.698 2.265 . . . . 0.0 111.839 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -133.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.276 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.469 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 44.3 Cg_endo -80.78 159.1 21.52 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.025 1.817 . . . . 0.0 113.3 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.68 ' CD2' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -142.7 122.15 13.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.427 -169.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.6 m -118.71 123.24 44.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -172.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.444 ' HB ' HG12 ' A' ' 123' ' ' ILE . 81.8 t -117.46 143.53 27.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.303 0.573 . . . . 0.0 111.729 -174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -106.14 109.3 21.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -97.1 120.48 61.24 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.474 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.24 136.47 16.09 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.661 2.241 . . . . 0.0 112.687 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.754 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.9 p30 -85.87 -173.78 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.2 -31.08 63.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -87.41 -21.5 25.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' O ' HG21 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.051 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.593 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.971 0.415 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.814 ' O ' HG13 ' A' ' 58' ' ' VAL . 84.7 m -60.03 -40.82 90.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.902 174.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.5 t -77.81 -34.51 52.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.22 1.009 . . . . 0.0 108.74 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.615 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 10.9 mp -66.8 -19.39 65.73 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.408 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 55' ' ' THR . 3.8 p -93.98 -21.02 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.539 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.1 mm-40 -71.11 -47.55 57.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -147.83 10.29 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -177.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 57' ' ' LEU . 5.0 Cg_exo -93.46 152.67 2.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 CA-C-N 121.886 1.709 . . . . 0.0 112.226 157.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -63.97 -17.31 59.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.325 2.683 . . . . 0.0 112.789 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.727 ' NE2' HD11 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -51.06 -18.52 0.84 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.536 ' O ' HD21 ' A' ' 68' ' ' LEU . 3.9 tp -45.32 -47.42 13.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.592 0.357 . . . . 0.0 111.725 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -50.02 -33.32 21.29 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.352 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.53 -36.45 65.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.139 0.971 . . . . 0.0 109.932 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.727 HD11 ' NE2' ' A' ' 63' ' ' GLN . 38.8 mt -69.45 -44.71 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.286 -169.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -49.91 -53.51 25.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.725 0.641 . . . . 0.0 112.495 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -87.14 -63.01 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -124.31 -13.48 7.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t60 64.11 41.19 6.45 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.68 HG23 ' CD2' ' A' ' 36' ' ' PHE . 14.7 p -109.86 160.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.85 -165.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 89' ' ' THR . 2.1 p -136.86 135.67 48.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.302 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.8 141.19 51.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.176 0.512 . . . . 0.0 110.956 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 98.92 2.3 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.891 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' A' ' 35' ' ' PRO . . . -60.52 103.32 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.279 0.561 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -120.04 123.48 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.385 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.6 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -80.05 161.28 25.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.31 -38.35 12.58 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 123.459 0.474 . . . . 0.0 110.837 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.1 t -71.46 -25.29 62.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.973 -172.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.25 -40.62 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.6 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -62.29 -42.72 99.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.478 175.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.642 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.4 mtpt -72.78 -30.57 64.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 122.581 0.353 . . . . 0.0 111.8 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -38.07 75.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.6 mtt -77.25 -45.0 27.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.981 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 79.73 9.75 86.46 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.454 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.7 tt -162.97 159.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG21 ' HB ' ' A' ' 96' ' ' ILE . 8.3 m -135.01 138.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.496 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' VAL . 2.8 m -111.68 135.94 51.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.056 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.467 ' HB3' ' H ' ' A' ' 94' ' ' SER . 15.6 t -71.08 168.63 16.72 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.537 0.735 . . . . 0.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -52.7 -37.73 59.44 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.538 0.685 . . . . 0.0 109.468 172.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HB3' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.79 -25.26 48.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.579 -173.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.74 12.44 9.43 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.252 -0.886 . . . . 0.0 113.537 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.467 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.7 OUTLIER -80.48 120.51 24.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.756 0.778 . . . . 0.0 111.205 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.34 137.95 31.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 112.522 178.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 88' ' ' VAL . 1.7 mp -130.16 126.59 22.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.984 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.533 ' HA ' HG13 ' A' ' 87' ' ' ILE . 5.0 Cg_exo -71.83 133.24 21.46 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.156 1.904 . . . . 0.0 113.192 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.508 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.3 mm -95.64 139.38 19.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.025 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 37.7 m-70 -139.94 -178.92 5.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.215 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 142.3 115.62 1.13 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.905 -1.14 . . . . 0.0 113.93 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -83.09 -48.8 10.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 40.5 t30 -116.71 -53.73 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.111 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 17.8 Cg_endo -90.09 174.06 3.27 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.09 1.86 . . . . 0.0 110.419 172.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.642 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 17.7 tp -80.02 155.38 27.64 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.645 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 33.7 mt-10 -138.08 111.25 7.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.378 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.41 118.96 51.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.976 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 22.7 pttt 48.3 -107.01 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.986 0.914 . . . . 0.0 112.269 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.23 9.48 25.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.453 0.644 . . . . 0.0 110.375 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -104.13 163.25 12.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.193 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -128.8 135.18 48.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 4.1 t -82.98 126.66 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.431 0.634 . . . . 0.0 111.434 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 127' ' ' ASP . 6.7 mp -89.4 -39.24 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.783 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.49 116.57 4.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.334 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -137.48 -173.67 3.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.785 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 31.7 t70 71.15 28.4 3.08 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 122.867 1.317 . . . . 0.0 107.933 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 11.9 mt -89.54 111.13 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.69 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -68.09 108.95 3.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.046 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 123' ' ' ILE . . . -79.13 179.57 7.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.939 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 2.0 pt-20 -46.52 -50.76 16.68 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.817 0.698 . . . . 0.0 111.301 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 94.3 m-20 -120.58 -15.48 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.103 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.53 -118.77 1.39 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.625 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.574 HG13 ' HE3' ' A' ' 78' ' ' LYS . 16.3 mm -145.49 145.08 20.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.181 0.515 . . . . 0.0 111.747 -171.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 118' ' ' ALA . 22.7 mt -116.44 148.65 19.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.46 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 4.0 m80 -138.35 117.2 12.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 87.7 t -79.45 128.86 38.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.9 169.35 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 122.08 0.943 . . . . 0.0 110.909 -177.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.754 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 38.9 t70 -109.63 21.0 17.5 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.657 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.622 ' O ' HG13 ' A' ' 126' ' ' ILE . 10.7 m -163.99 124.6 2.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.669 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 45' ' ' ALA . 50.0 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.979 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.7 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -43.05 -50.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.19 0.519 . . . . 0.0 111.75 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.66 HG12 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -67.93 -37.13 77.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.973 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.544 ' CA ' HE22 ' A' ' 31' ' ' GLN . 27.8 t70 -59.23 -44.33 92.32 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.78 0.8 . . . . 0.0 110.173 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 11.1 mt -56.63 -22.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.7 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.23 -32.45 71.14 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.854 -0.529 . . . . 0.0 110.988 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.59 -30.39 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.415 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 55.3 t30 -74.2 -24.93 59.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.505 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.2 p -62.6 144.82 95.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.825 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -80.44 59.84 7.61 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.977 2.451 . . . . 0.0 112.117 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.24 46.71 62.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.497 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.47 -169.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.854 0.835 . . . . 0.0 112.864 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m -56.87 160.38 3.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -61.94 -19.46 62.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.601 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.0 tp -57.24 -33.57 67.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 m -80.7 -27.15 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 109.829 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 23' ' ' VAL . 1.4 m -83.48 -27.58 29.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -61.13 -36.95 81.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 0.0 111.609 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.48 -37.69 30.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.964 -0.46 . . . . 0.0 110.445 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 38.0 mtmt -62.19 -41.51 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.451 . . . . 0.0 111.175 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 19' ' ' THR . 7.3 p -74.5 -35.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.111 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.08 -7.72 53.56 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.181 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.95 16.96 7.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.566 1.146 . . . . 0.0 112.62 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.4 mp -92.83 9.35 35.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 121.999 -0.438 . . . . 0.0 112.097 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.44 -36.92 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -86.04 -19.07 30.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.011 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.15 -54.88 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 23.1 mt -55.61 -13.35 1.56 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.66 ' NE2' HG12 ' A' ' 5' ' ' VAL . 46.1 mm-40 -66.16 -9.37 30.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 m -51.92 114.25 5.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 123.257 0.348 . . . . 0.0 111.221 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.38 -20.29 7.17 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.817 2.345 . . . . 0.0 113.628 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.3 -135.74 0.61 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -172.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 54.2 Cg_endo -78.76 162.66 26.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.819 2.346 . . . . 0.0 113.057 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 29.5 m-85 -136.62 121.97 19.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.651 -172.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 45.7 m -107.69 136.21 47.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.026 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.506 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -129.22 153.7 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.161 0.505 . . . . 0.0 110.492 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.72 107.23 16.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.55 111.43 53.92 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.677 -171.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HB3' HG23 ' A' ' 129' ' ' VAL . 72.5 Cg_endo -77.33 130.17 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.058 1.839 . . . . 0.0 111.612 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.811 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 4.0 p30 -72.16 -176.34 1.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.69 -28.35 55.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.54 -24.18 24.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.842 0.829 . . . . 0.0 109.608 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.873 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.427 177.424 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 121.11 0.481 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 58' ' ' VAL . 98.6 m -65.15 -38.47 90.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.433 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -79.55 -27.59 41.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.0 109.201 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD22 ' NE2' ' A' ' 63' ' ' GLN . 8.0 mp -72.57 -27.94 62.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.21 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 55' ' ' THR . 7.8 p -77.9 -27.67 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.141 0.496 . . . . 0.0 109.938 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 55' ' ' THR . 22.5 mm-40 -71.55 -29.77 65.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.513 1.149 . . . . 0.0 108.842 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.91 166.08 46.14 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.64 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 63' ' ' GLN . 48.0 Cg_exo -40.46 169.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.355 3.37 . . . . 0.0 114.171 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 31.2 Cg_exo -33.45 -8.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.047 1 C-N-CA 127.802 5.668 . . . . 0.0 120.175 -167.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.61 ' NE2' HD22 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -41.65 -25.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.534 ' O ' HD22 ' A' ' 68' ' ' LEU . 10.6 tp -52.25 -50.89 61.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.599 0.36 . . . . 0.0 111.883 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' CA ' HD23 ' A' ' 26' ' ' LEU . . . -52.03 -31.09 32.1 Favored Glycine 0 N--CA 1.461 0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.348 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.76 -49.29 21.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.356 0.598 . . . . 0.0 110.587 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' A' ' 64' ' ' LEU . 63.0 mt -44.88 -48.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.119 174.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.16 -65.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -166.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -89.44 -69.2 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.197 -1.001 . . . . 0.0 113.619 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.622 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -126.46 18.58 7.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -175.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.1 t60 59.24 30.98 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 164.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.622 HG12 ' CZ ' ' A' ' 70' ' ' TYR . 4.8 p -105.25 159.86 5.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.119 0.962 . . . . 0.0 113.517 -164.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 p -132.94 120.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.944 163.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -64.58 145.97 55.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 0.0 111.62 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 97.43 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.28 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -58.78 106.2 0.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.232 0.539 . . . . 0.0 111.105 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -115.64 119.78 37.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.591 ' HG3' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -77.05 158.75 30.35 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.21 -37.45 10.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.553 0.533 . . . . 0.0 111.268 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.468 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.7 t -74.98 -24.37 58.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 -168.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.47 -45.72 75.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.19 -52.32 65.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.461 177.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.97 -34.68 75.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.0 ttt180 -51.47 -43.29 62.1 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.102 0.953 . . . . 0.0 109.19 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.3 mtp -75.98 -42.91 46.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.014 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 77.87 15.49 81.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.098 -172.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -163.66 157.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 95' ' ' THR . 11.0 m -130.7 143.06 42.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.396 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 73' ' ' VAL . 3.1 m -110.6 133.52 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.924 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.9 m -77.31 166.18 23.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.138 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 3.8 tp -51.89 -37.59 52.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.125 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HB3' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -76.54 -24.94 53.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.61 -178.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.51 20.08 5.57 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.597 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.447 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 8.2 t -88.16 119.41 28.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.156 0.478 . . . . 0.0 110.536 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.78 139.25 30.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.65 . . . . 0.0 112.636 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.54 ' O ' HG21 ' A' ' 88' ' ' VAL . 1.3 mp -131.93 128.12 21.41 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.938 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HA ' HG13 ' A' ' 87' ' ' ILE . 8.1 Cg_exo -69.16 133.27 26.25 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.142 1.895 . . . . 0.0 113.355 -173.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.7 mm -102.09 138.0 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.049 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -140.82 179.98 6.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.595 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.582 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 173.93 93.26 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.72 -172.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.89 -44.33 55.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 109.288 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 11.6 m-80 -140.83 -53.11 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.983 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.3 Cg_endo -88.17 173.28 4.87 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.165 1.91 . . . . 0.0 110.298 168.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 24.8 tp -73.34 153.67 40.42 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.582 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 26.8 mt-10 -140.91 106.78 5.14 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.42 ' CG2' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -105.74 126.52 61.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.823 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HB3' HG23 ' A' ' 96' ' ' ILE . 13.5 ptmt 46.52 -114.51 0.52 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.604 0.762 . . . . 0.0 112.046 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' C ' HD21 ' A' ' 108' ' ' ASN . 0.3 OUTLIER -102.99 22.14 14.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.203 0.525 . . . . 0.0 111.094 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -123.97 166.48 15.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.938 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 12.1 m -128.78 137.44 51.54 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -81.02 129.89 36.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.545 0.688 . . . . 0.0 111.886 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.8 mp -91.6 -37.86 12.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.389 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.59 112.08 2.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.849 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 124' ' ' HIS . . . -141.01 -173.25 3.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 71.46 26.28 3.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -90.46 109.66 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.738 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.52 110.97 3.36 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.278 1.037 . . . . 0.0 112.031 174.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' HB3' HG13 ' A' ' 123' ' ' ILE . . . -79.24 -170.5 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.465 -1.698 . . . . 0.0 111.772 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -50.94 -49.04 60.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.863 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -119.66 -18.35 8.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.072 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.54 -112.4 0.77 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.397 -173.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.591 HD11 ' HG3' ' A' ' 78' ' ' LYS . 9.8 mm -146.56 142.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.547 0.689 . . . . 0.0 112.355 -174.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 38' ' ' VAL . 92.2 mt -113.19 146.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.619 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 114' ' ' ALA . 10.6 m80 -137.22 113.3 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 57.6 t -81.12 128.08 39.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 123.178 0.299 . . . . 0.0 110.31 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -127.25 164.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 0.0 110.94 -176.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.811 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 38.8 t70 -108.89 19.47 19.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.752 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.633 ' O ' HG13 ' A' ' 126' ' ' ILE . 16.2 m -168.77 134.5 1.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 41' ' ' PRO . 73.1 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.637 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.792 0.33 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.21 151.93 24.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.849 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -68.09 143.96 55.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.904 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 4' ' ' ILE . 3.8 mp -43.74 -52.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.797 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.623 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -70.8 -36.92 66.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.079 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.41 -44.42 80.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.81 0.814 . . . . 0.0 110.334 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 11' ' ' THR . 19.7 mt -53.86 -24.76 10.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.933 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.3 86.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.888 0.375 . . . . 0.0 111.057 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.15 -18.57 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.416 0.627 . . . . 0.0 110.46 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 44.9 t30 -89.84 -25.33 21.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.476 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 8.9 p -57.76 133.9 82.9 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -174.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -78.01 66.05 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.918 2.412 . . . . 0.0 111.884 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.93 47.04 26.64 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.219 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.74 -172.93 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.15 0.5 . . . . 0.0 111.605 177.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -58.81 163.22 3.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.853 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 m -62.58 -19.28 63.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.64 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.38 -35.24 50.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.705 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.3 -27.47 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.509 0.671 . . . . 0.0 109.908 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.547 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 m -83.38 -28.2 29.1 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.757 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -61.13 -36.26 79.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.622 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.13 -36.81 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.978 -0.451 . . . . 0.0 110.427 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.547 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.1 mtmt -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.217 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 19' ' ' THR . 8.8 p -77.21 -34.66 21.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.544 0.688 . . . . 0.0 110.218 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -76.17 -2.47 31.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.368 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.84 15.4 10.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.125 0.97 . . . . 0.0 112.835 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 8.2 mp -91.46 7.62 40.31 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.927 -0.483 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -60.08 -37.02 71.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.492 . . . . 0.0 109.956 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -85.53 -18.89 32.12 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.788 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.76 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.2 mt -59.36 -10.47 3.16 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.623 ' NE2' HG13 ' A' ' 5' ' ' VAL . 47.0 mm-40 -67.97 -8.47 37.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -54.15 113.11 4.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.63 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.56 -12.89 15.1 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.725 2.284 . . . . 0.0 112.885 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.85 -137.34 0.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.711 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 57.9 Cg_endo -84.2 165.48 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.036 2.491 . . . . 0.0 113.967 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' HB3' HG22 ' A' ' 72' ' ' VAL . 49.6 m-85 -139.15 122.7 17.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 36.1 m -106.65 118.0 35.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.253 0.549 . . . . 0.0 110.996 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.38 121.06 60.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.443 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.424 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 1.4 m-30 -82.86 111.46 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.735 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -95.82 112.39 59.1 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.52 133.42 15.81 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.06 1.84 . . . . 0.0 111.538 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.808 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 32.2 p30 -72.61 -172.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.722 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.82 -27.13 68.67 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.528 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 23.8 t70 -88.34 -21.28 24.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.186 0.993 . . . . 0.0 109.068 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -84.91 -35.54 22.07 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.337 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -62.21 -20.6 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.953 0.882 . . . . 0.0 108.746 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' ASP . . . -81.19 -9.78 59.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.573 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 28.1 mmmt -89.08 -25.14 22.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 28.6 mt -54.31 -53.89 54.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.231 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 9.5 Cg_endo -53.29 95.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.203 2.602 . . . . 0.0 113.561 -170.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 t70 47.12 50.37 14.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.061 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.61 -99.56 0.96 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.589 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -61.97 -58.51 7.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.46 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.603 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp -58.55 -25.53 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.929 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.627 ' O ' HG13 ' A' ' 58' ' ' VAL . 67.8 m -65.07 -40.59 94.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 t -79.82 -29.65 40.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.032 0.92 . . . . 0.0 109.16 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 6.8 mp -70.58 -26.01 63.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.222 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 55' ' ' THR . 9.9 p -80.01 -28.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.156 0.503 . . . . 0.0 109.755 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 55' ' ' THR . 24.4 mm-40 -70.56 -25.54 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.651 1.215 . . . . 0.0 108.519 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.47 168.64 26.23 Favored Pre-proline 0 N--CA 1.437 -1.094 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.282 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.2 Cg_exo -38.16 169.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 124.633 3.555 . . . . 0.0 115.424 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 51.9 Cg_exo -40.58 -8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 1 C-N-CA 126.632 4.888 . . . . 0.0 118.296 -172.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HG2' ' HD2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -42.61 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.634 ' O ' HD22 ' A' ' 68' ' ' LEU . 13.4 tp -46.92 -50.98 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.35 0.26 . . . . 0.0 111.08 174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -53.26 -32.59 44.32 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.265 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HD2' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.26 -51.38 21.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.528 0.68 . . . . 0.0 109.53 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.5 ' N ' ' HD3' ' A' ' 66' ' ' ARG . 62.2 mt -44.41 -53.89 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 113.969 -1.469 . . . . 0.0 113.359 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -47.19 -64.09 0.87 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.09 -62.06 1.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -122.48 -0.93 9.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.1 p80 43.04 51.6 5.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.775 0.798 . . . . 0.0 110.187 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 36' ' ' PHE . 12.9 p -120.98 159.15 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.903 -166.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 89' ' ' THR . 1.5 p -130.21 129.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 170.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -64.73 146.36 54.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.254 0.55 . . . . 0.0 111.168 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.81 99.1 2.57 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -63.65 101.9 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.162 0.506 . . . . 0.0 111.509 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -112.93 129.36 56.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.124 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -91.99 161.01 14.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -31.53 7.03 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.244 0.545 . . . . 0.0 112.046 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.9 t -72.39 -27.0 62.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.245 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.43 -50.36 14.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -54.38 -50.69 66.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.044 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -68.51 -35.85 78.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.747 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -56.88 -39.49 74.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.632 0.73 . . . . 0.0 110.115 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 81.1 mtp -80.49 -35.24 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.919 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.96 12.05 83.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.051 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -162.92 157.28 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 95' ' ' THR . 10.6 m -132.03 140.42 47.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.262 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.552 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.5 m -112.71 133.08 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.116 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.505 ' HB3' ' H ' ' A' ' 94' ' ' SER . 14.1 t -68.93 163.9 23.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.906 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 2.7 tp -55.38 -30.77 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.479 0.657 . . . . 0.0 110.148 174.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.459 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.4 -25.85 35.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.152 -178.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.4 18.29 7.19 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.33 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.505 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.8 OUTLIER -88.1 121.3 30.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.299 0.55 . . . . 0.0 111.332 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.51 138.01 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.9 mp -127.63 127.01 24.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.8 Cg_exo -70.39 132.03 21.51 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 121.98 1.786 . . . . 0.0 113.036 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' A' ' 98' ' ' ILE . 40.5 mm -94.55 136.14 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.38 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.561 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 91.7 m-70 -121.0 -179.24 3.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.199 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.31 94.06 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.042 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.09 -48.21 13.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.453 0.645 . . . . 0.0 109.606 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.48 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 6.9 m-80 -138.53 -53.19 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.003 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -87.77 173.25 5.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.123 1.882 . . . . 0.0 109.99 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 111' ' ' VAL . 16.3 tp -72.8 154.35 40.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.561 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 44.9 mt-10 -140.4 127.86 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.397 0.618 . . . . 0.0 109.523 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.545 HG13 ' HE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -129.08 122.61 56.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.013 -174.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.466 ' HG2' HG21 ' A' ' 106' ' ' VAL . 10.9 ptmm? 46.51 -123.46 1.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.163 0.585 . . . . 0.0 111.237 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -96.94 23.55 7.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 110.608 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -118.85 166.04 13.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 27.4 m -128.29 138.04 52.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.516 HG23 HD23 ' A' ' 104' ' ' LEU . 88.1 t -86.2 126.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.686 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.496 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.6 mp -89.63 -36.55 15.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.631 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.68 118.28 2.79 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.532 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.93 -174.54 3.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 32.2 t70 68.98 26.86 5.59 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -171.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -88.84 108.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.011 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.58 106.02 2.45 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.623 0.725 . . . . 0.0 110.72 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -81.38 178.89 8.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.716 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -44.2 -51.73 7.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.845 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 52.1 m-80 -117.87 -14.61 10.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.365 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.73 -110.76 0.44 Allowed Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.169 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.561 HG13 ' HE3' ' A' ' 78' ' ' LYS . 18.3 mm -142.66 143.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.097 -0.552 . . . . 0.0 111.387 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.497 HG13 ' HB1' ' A' ' 118' ' ' ALA . 16.9 mt -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.222 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.545 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -148.79 114.87 5.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.819 0.819 . . . . 0.0 112.043 -178.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 49.5 t -80.17 129.86 36.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.33 159.58 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.808 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -99.0 3.41 46.93 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.475 -173.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.598 ' O ' HG13 ' A' ' 126' ' ' ILE . 47.7 m -154.51 126.71 7.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.531 -172.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 45' ' ' ALA . 76.3 t . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.075 0.464 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.7 148.66 34.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.042 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 m -61.11 145.02 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.398 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -57.67 -20.15 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.682 HG11 ' NE2' ' A' ' 31' ' ' GLN . 2.2 p -90.34 -37.3 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.557 . . . . 0.0 110.205 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' CA ' HE22 ' A' ' 31' ' ' GLN . 28.1 t70 -56.95 -50.93 71.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.204 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.9 mt -54.42 -22.0 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.414 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.089 0.471 . . . . 0.0 110.607 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 37.8 t -74.48 -23.38 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.487 0.661 . . . . 0.0 110.291 175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -87.26 -25.44 23.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.76 -174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 6.5 p -60.82 134.26 92.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -171.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -81.95 67.33 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.052 2.501 . . . . 0.0 111.808 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.34 11.72 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.098 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.7 OUTLIER -67.14 -170.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.204 0.525 . . . . 0.0 111.35 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -60.46 157.63 13.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.506 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m -60.56 -19.03 56.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.341 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.98 -30.33 65.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.18 -30.25 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.325 0.583 . . . . 0.0 109.803 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.602 ' O ' HG12 ' A' ' 23' ' ' VAL . 2.2 m -83.52 -29.24 28.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -62.22 -31.4 71.93 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.111 0.257 . . . . 0.0 111.571 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.44 -37.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.506 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 41.3 mtmt -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.13 0.491 . . . . 0.0 111.315 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 19' ' ' THR . 8.5 p -75.21 -36.04 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.663 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 62' ' ' PRO . . . -74.38 -6.5 48.55 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.937 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 13.31 9.34 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.312 1.045 . . . . 0.0 113.172 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 66' ' ' ARG . 10.6 mp -85.77 8.97 17.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.972 -0.455 . . . . 0.0 111.437 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.68 -37.17 57.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.345 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.67 -20.77 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.692 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.79 -54.42 6.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.689 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 21.9 mt -58.76 -14.07 7.72 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.682 ' NE2' HG11 ' A' ' 5' ' ' VAL . 30.7 mm-40 -66.52 -5.75 12.42 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.768 0.427 . . . . 0.0 111.908 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -51.65 110.43 1.83 Allowed Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 123.423 0.689 . . . . 0.0 112.406 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.33 -17.86 8.77 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.126 2.55 . . . . 0.0 113.252 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.35 -140.5 0.8 Allowed Glycine 0 CA--C 1.518 0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.372 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 30.1 Cg_endo -76.2 163.08 33.24 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.018 1.812 . . . . 0.0 112.804 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -133.51 122.71 24.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.154 -171.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.6 m -116.6 136.27 53.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.168 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.526 HG13 HG12 ' A' ' 123' ' ' ILE . 5.5 p -133.02 156.13 41.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.641 . . . . 0.0 111.36 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 126' ' ' ILE . 93.3 m-85 -112.26 111.04 21.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -98.91 113.33 64.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.391 . . . . 0.0 111.513 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 130.59 10.79 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.588 2.192 . . . . 0.0 112.229 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.826 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.7 p30 -84.08 -174.14 5.11 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.675 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.42 -27.05 65.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 111.678 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 34.2 t70 -82.52 -22.71 34.92 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -79.84 -36.86 36.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.639 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.15 -24.26 62.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.969 0.89 . . . . 0.0 109.208 171.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.35 -9.97 55.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.931 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.65 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 29.2 mmmt -87.3 -24.59 24.27 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -42.52 -42.42 6.85 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 114.439 -1.255 . . . . 0.0 114.302 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 58.5 Cg_exo -41.2 -39.48 3.82 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.873 2.382 . . . . 0.0 113.508 171.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.72 -68.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.07 76.18 1.19 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.905 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.412 ' O ' HD12 ' A' ' 57' ' ' LEU . 99.7 m -65.54 -52.15 54.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.26 0.552 . . . . 0.0 109.952 171.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.5 mp -57.98 -25.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.853 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.574 ' O ' HG11 ' A' ' 58' ' ' VAL . 92.1 m -65.67 -32.7 74.4 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.926 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 t -81.04 -25.54 37.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.68 0.752 . . . . 0.0 109.342 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD22 ' NE2' ' A' ' 63' ' ' GLN . 8.1 mp -74.93 -25.64 59.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.041 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 55' ' ' THR . 11.4 p -76.97 -31.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.228 0.537 . . . . 0.0 109.756 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.4 mm-40 -71.59 -28.39 63.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 122.68 1.229 . . . . 0.0 108.578 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -81.78 169.39 18.89 Favored Pre-proline 0 N--CA 1.437 -1.085 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.972 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' GLN . 19.9 Cg_exo -37.06 170.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 125.023 3.815 . . . . 0.0 115.607 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 48.0 Cg_exo -39.4 -9.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.607 1 C-N-CA 126.566 4.844 . . . . 0.0 118.029 -172.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.539 ' NE2' HD22 ' A' ' 57' ' ' LEU . 4.7 tp60 -41.67 -26.5 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.153 0.981 . . . . 0.0 113.096 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HA ' HD13 ' A' ' 67' ' ' ILE . 5.5 tp -51.09 -50.89 57.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 111.754 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -50.29 -33.06 22.97 Favored Glycine 0 N--CA 1.459 0.174 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.928 -172.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.98 -35.25 50.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.994 0.426 . . . . 0.0 110.656 -178.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 64' ' ' LEU . 51.6 mt -59.76 -46.52 93.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.258 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -45.81 -63.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.926 0.766 . . . . 0.0 113.003 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -88.99 -60.01 2.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -121.13 -16.37 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 70.6 m80 64.67 33.35 10.62 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.5 p -94.47 155.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.073 -166.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 72' ' ' VAL . 2.4 p -141.43 119.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.625 -1.625 . . . . 0.0 108.888 166.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.52 142.21 58.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 111.216 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 112.24 98.27 2.38 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.98 102.67 0.09 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.175 0.512 . . . . 0.0 111.685 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 122' ' ' ILE . 12.4 m-85 -114.67 106.84 14.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.579 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HD2' ' OD1' ' A' ' 115' ' ' ASP . 21.3 mmtp -60.67 157.54 14.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 167.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -49.52 -35.41 20.0 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 123.461 0.475 . . . . 0.0 110.36 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 9.4 t -75.62 -28.53 58.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.176 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.51 -35.53 79.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.606 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -66.34 -50.55 63.18 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.105 176.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -68.08 -30.62 69.86 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 123.199 0.6 . . . . 0.0 112.264 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.26 -31.48 67.46 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-O 121.664 0.745 . . . . 0.0 109.433 172.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.7 -40.51 14.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.679 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 78.72 14.32 82.19 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.982 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.0 tt -164.39 159.92 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 95' ' ' THR . 11.9 m -131.97 137.92 53.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.428 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 m -106.77 126.91 52.91 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.397 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 94' ' ' SER . 72.5 m -68.45 163.87 22.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.416 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -51.45 -36.28 43.35 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.612 0.72 . . . . 0.0 110.877 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.49 -28.06 52.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.447 -179.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.32 10.81 7.76 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.696 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 90' ' ' SER . 0.7 OUTLIER -83.44 120.69 26.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.951 0.875 . . . . 0.0 111.759 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.15 138.06 32.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.585 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.5 mp -130.4 126.74 22.25 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.526 ' HA ' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -68.29 133.44 28.43 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 113.533 -173.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -103.25 142.75 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.4 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -141.19 177.3 8.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.682 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.08 121.31 0.55 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.091 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -101.34 -54.14 2.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 12.6 m120 -107.14 -61.8 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 172.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 16.0 Cg_endo -90.49 174.01 3.04 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.475 2.117 . . . . 0.0 111.244 174.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.57 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 21.3 tp -75.8 154.53 36.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -140.88 107.37 5.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.8 112.03 38.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.48 ' HB3' HG21 ' A' ' 96' ' ' ILE . 0.0 OUTLIER 48.54 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.321 1.448 . . . . 0.0 113.87 -174.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.85 23.23 3.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.526 0.679 . . . . 0.0 109.573 -175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -129.25 157.51 41.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.077 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 44.4 m -121.9 134.31 54.86 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -78.59 127.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.613 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 127' ' ' ASP . 6.9 mp -88.82 -38.87 14.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.105 175.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.97 110.53 3.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.148 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -133.04 -173.58 3.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.645 ' OD1' ' HD2' ' A' ' 78' ' ' LYS . 20.4 t70 71.47 28.34 2.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 122.794 1.283 . . . . 0.0 107.604 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.4 mt -95.14 110.05 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.04 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.424 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.48 114.34 6.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.969 0.89 . . . . 0.0 112.391 172.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.473 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -79.77 -173.49 3.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.023 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -49.08 -51.19 32.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.123 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.2 m-20 -115.23 -20.57 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.644 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.72 -114.77 1.05 Allowed Glycine 0 CA--C 1.505 -0.539 0 C-N-CA 119.447 -1.359 . . . . 0.0 114.047 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.637 HD12 ' CD ' ' A' ' 78' ' ' LYS . 17.8 mm -144.52 148.15 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.327 0.585 . . . . 0.0 110.951 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.526 HG12 HG13 ' A' ' 38' ' ' VAL . 94.6 mt -120.24 147.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.457 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 m80 -137.88 117.79 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 69.9 t -83.31 129.64 37.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.1 OUTLIER -124.99 161.76 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.619 0.724 . . . . 0.0 110.457 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.826 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -95.8 5.36 51.52 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.52 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.65 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 51.0 m -148.92 126.63 11.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.813 -171.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.603 169.628 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.88 119.36 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.723 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -61.24 146.81 46.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.094 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -54.86 -20.96 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -91.37 -37.23 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.155 0.502 . . . . 0.0 110.614 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.568 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.1 t70 -58.42 -44.5 89.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.373 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 9.1 mt -59.18 -21.69 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.637 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -34.15 76.29 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.826 -0.546 . . . . 0.0 110.751 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 6' ' ' ASP . 4.2 p -87.9 -9.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 110.112 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.511 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 54.4 t30 -92.72 -25.01 18.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.767 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 p -64.65 131.97 95.28 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.175 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.3 64.76 7.95 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.898 2.399 . . . . 0.0 112.288 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 46.96 11.95 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.898 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.63 -172.15 0.16 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.441 0.639 . . . . 0.0 112.508 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -61.3 163.13 6.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.559 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -61.44 -18.37 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.79 -37.78 52.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.35 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.85 -27.4 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.493 0.663 . . . . 0.0 110.116 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.56 ' O ' HG13 ' A' ' 23' ' ' VAL . 1.8 m -81.64 -25.7 35.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.686 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.442 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -62.17 -35.07 77.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.673 0.273 . . . . 0.0 111.524 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -78.29 -37.35 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.6 mtmt -62.5 -43.55 98.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.964 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 19' ' ' THR . 7.8 p -72.73 -35.02 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.113 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -76.44 -5.14 46.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.043 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.36 8.46 6.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.962 1.305 . . . . 0.0 113.128 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.42 9.24 16.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -37.66 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.84 -21.8 27.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.754 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.28 -55.4 5.6 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.9 mt -57.18 -13.83 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.209 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.652 ' NE2' HG12 ' A' ' 5' ' ' VAL . 45.9 mm-40 -65.16 -13.75 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.211 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 p -56.99 114.07 7.33 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.683 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.83 -14.25 11.3 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.982 2.455 . . . . 0.0 113.482 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.45 -149.87 1.04 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.275 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 37.8 Cg_endo -73.23 170.03 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.89 2.394 . . . . 0.0 112.821 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' HB3' HG22 ' A' ' 72' ' ' VAL . 45.2 m-85 -139.92 124.08 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 21.9 m -106.22 124.03 48.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 123' ' ' ILE . 41.3 t -113.88 134.07 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.962 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -100.25 116.27 31.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -104.93 117.78 57.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.317 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.79 125.86 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.023 1.816 . . . . 0.0 111.853 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.859 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -75.85 176.02 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.13 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -59.67 -35.4 74.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 12.4 t70 -78.83 -19.45 52.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.838 0.828 . . . . 0.0 108.816 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.47 -40.93 56.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.482 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -61.34 -24.55 66.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.568 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.01 -21.46 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 28.5 mmmt -63.06 -44.68 95.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.256 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' CD2' HG12 ' A' ' 129' ' ' VAL . 94.6 mt -32.23 97.52 0.11 Allowed Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 125.724 1.89 . . . . 0.0 113.924 -164.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.38 82.28 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.055 1 C-N-CA 125.321 4.014 . . . . 0.0 111.825 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 64.31 14.9 9.08 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.111 0.481 . . . . 0.0 110.393 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . 92.39 99.16 1.38 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.211 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.419 ' HB ' HG11 ' A' ' 129' ' ' VAL . 95.5 m -59.04 -50.56 73.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.573 0.701 . . . . 0.0 110.044 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -58.29 -23.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.771 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.684 ' O ' HG11 ' A' ' 58' ' ' VAL . 74.7 m -59.92 -32.55 70.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.83 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -83.56 -23.83 31.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.161 0.981 . . . . 0.0 109.121 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 9.0 mp -77.92 -20.39 52.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG11 ' O ' ' A' ' 55' ' ' THR . 8.0 p -91.71 -22.72 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.013 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 55' ' ' THR . 20.2 mm-40 -64.12 -44.87 90.91 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.535 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 64.2 t30 -162.9 14.33 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 57' ' ' LEU . 4.0 Cg_exo -91.38 150.94 3.63 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 CA-C-N 121.202 1.465 . . . . 0.0 111.435 153.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 61' ' ' PRO . 24.2 Cg_exo -66.51 -15.61 48.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.087 2.525 . . . . 0.0 112.805 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.644 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 1.1 tt0 -46.85 -29.75 2.14 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.3 tp -45.66 -50.03 13.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.441 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -44.91 -44.71 8.93 Favored Glycine 0 CA--C 1.511 -0.205 0 O-C-N 124.103 0.877 . . . . 0.0 114.218 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.715 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.63 -35.2 34.31 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.62 0.247 . . . . 0.0 110.57 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.5 mt -51.67 -47.51 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.184 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.92 -56.03 5.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.53 -64.0 1.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.89 -0.78 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 14.7 p-80 43.99 53.35 6.4 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.726 0.774 . . . . 0.0 110.041 -168.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 36' ' ' PHE . 10.2 p -123.82 154.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.271 -166.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.27 127.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.657 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -64.56 143.83 57.64 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.077 0.465 . . . . 0.0 111.156 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.72 99.48 2.6 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.888 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 35' ' ' PRO . . . -61.8 98.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.579 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.529 ' O ' HG21 ' A' ' 122' ' ' ILE . 5.1 m-85 -113.6 110.19 19.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.825 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.703 ' O ' HD23 ' A' ' 82' ' ' LEU . 26.1 mmtp -59.66 160.68 6.97 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 165.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.35 -23.64 65.9 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.2 t -72.57 -31.08 64.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.58 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -73.77 -43.59 58.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -62.34 -55.39 28.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.914 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.94 -35.19 77.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.147 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -51.34 -44.52 62.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.664 0.745 . . . . 0.0 110.23 173.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -38.68 49.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.272 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.15 6.66 86.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.043 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.551 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.6 tt -163.07 158.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 95' ' ' THR . 14.1 m -129.98 140.89 47.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.093 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -110.1 126.27 53.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.66 0.743 . . . . 0.0 110.64 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.631 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 75.0 m -72.18 168.61 17.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.386 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 4.7 tp -56.14 -37.7 69.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.873 0.844 . . . . 0.0 109.78 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.644 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 1.9 pm0 -75.36 -15.19 60.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.705 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.93 8.88 47.1 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.164 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -78.35 118.45 20.55 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -83.56 141.29 31.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.359 0.6 . . . . 0.0 111.997 176.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.562 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -133.99 126.22 18.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.957 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.6 Cg_exo -70.43 128.72 15.8 Favored 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 122.1 1.867 . . . . 0.0 112.604 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.0 mm -96.9 133.48 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.733 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.406 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 54.7 m80 -130.89 -179.77 5.51 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.589 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.67 114.01 0.4 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.653 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.98 -51.76 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -132.83 -57.59 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.332 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -85.02 172.8 8.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.153 1.902 . . . . 0.0 110.71 168.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.0 152.9 38.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.32 0.581 . . . . 0.0 110.72 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 8.7 mm-40 -130.96 106.93 8.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.454 -175.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.49 115.43 48.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.856 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HB3' ' CG2' ' A' ' 96' ' ' ILE . 20.9 ptmt 55.74 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.71 1.604 . . . . 0.0 113.213 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 2.9 p-10 -149.69 24.26 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -126.9 166.11 18.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.399 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 41.7 m -126.59 132.34 51.31 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 t -74.75 131.89 34.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.477 0.656 . . . . 0.0 111.422 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 127' ' ' ASP . 7.1 mp -91.7 -46.64 7.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.781 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -145.97 114.12 6.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.7 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HB1' ' HD1' ' A' ' 124' ' ' HIS . . . -135.91 -173.39 3.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 49.2 m-20 67.81 28.47 7.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -172.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -86.62 114.32 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.104 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.96 106.91 2.48 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.45 ' CB ' HG13 ' A' ' 123' ' ' ILE . . . -82.7 -179.47 7.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.295 -175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.93 -49.53 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.6 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.06 -18.91 9.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.907 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.98 -108.08 0.49 Allowed Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 119.724 -1.227 . . . . 0.0 114.093 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' THR . 17.1 mm -142.9 153.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.401 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.45 HG13 ' CB ' ' A' ' 118' ' ' ALA . 89.0 mt -128.58 147.59 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.45 ' HD1' ' HB1' ' A' ' 114' ' ' ALA . 4.6 m-70 -138.09 117.4 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.736 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 95.4 t -82.2 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -122.97 156.33 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.028 0.918 . . . . 0.0 111.286 -176.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.859 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -98.68 19.52 14.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.971 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.543 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 19.3 m -158.89 131.47 6.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.874 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 49' ' ' LEU . 75.4 t . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.91 120.02 12.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.011 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.8 m -60.16 145.62 46.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.72 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -56.56 -19.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.68 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.8 p -91.24 -36.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 0.0 110.705 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.454 ' CA ' HE22 ' A' ' 31' ' ' GLN . 23.4 t70 -58.12 -45.47 87.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.566 0.698 . . . . 0.0 110.253 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 14.3 mt -56.86 -21.55 14.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.873 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.12 74.57 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.978 -0.451 . . . . 0.0 110.936 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.35 -24.35 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 110.114 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 60.2 t30 -81.04 -25.43 37.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.175 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 5.8 p -63.21 130.63 94.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.4 Cg_exo -79.26 68.87 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.94 2.427 . . . . 0.0 111.932 175.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.25 46.83 14.41 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.456 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.562 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 1.1 t80 -65.9 -169.72 0.07 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.354 0.597 . . . . 0.0 111.329 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 m -62.78 159.91 15.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -61.02 -17.95 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.39 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 mp -52.34 -37.02 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.215 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -80.02 -27.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.596 0.712 . . . . 0.0 109.805 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.574 ' O ' HG11 ' A' ' 23' ' ' VAL . 1.5 m -83.29 -28.24 29.26 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.109 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -62.0 -32.38 72.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.708 0.29 . . . . 0.0 111.482 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.54 -37.44 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.499 171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 37.5 mtmt -61.97 -43.59 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.852 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 19' ' ' THR . 7.9 p -72.65 -35.57 50.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 62' ' ' PRO . . . -74.8 -7.89 54.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.847 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.31 10.66 6.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.767 1.227 . . . . 0.0 112.772 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 66' ' ' ARG . 9.5 mp -85.9 9.13 17.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.976 -0.452 . . . . 0.0 112.111 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.1 t -58.14 -36.53 57.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.005 0.431 . . . . 0.0 109.932 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.54 -21.25 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.659 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.06 -52.41 8.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.71 0.291 . . . . 0.0 111.759 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 26.3 mt -57.71 -15.35 7.61 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.68 ' NE2' HG13 ' A' ' 5' ' ' VAL . 40.7 mm-40 -65.54 -13.17 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.237 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.9 m -56.02 112.95 4.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 123.469 0.48 . . . . 0.0 111.726 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.72 -9.36 13.33 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.015 2.477 . . . . 0.0 113.043 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.72 -145.13 0.15 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.797 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 76' ' ' ALA . 2.1 Cg_endo -78.32 169.02 20.75 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB3' HG22 ' A' ' 72' ' ' VAL . 35.6 m-85 -139.65 121.33 15.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.304 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.7 m -108.33 115.58 30.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.284 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.47 124.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.784 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.698 ' HD1' ' NE2' ' A' ' 124' ' ' HIS . 38.1 m-85 -84.01 110.43 18.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -96.47 122.19 58.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.572 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.69 126.77 9.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.159 1.906 . . . . 0.0 112.274 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.858 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -74.88 178.44 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.42 177.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -57.21 -36.71 71.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 26.4 t70 -79.65 -19.83 48.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.647 0.736 . . . . 0.0 109.053 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -81.79 -37.9 26.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.296 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -62.28 -20.66 64.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.979 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.16 -8.7 58.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 26.1 mmmt -89.98 -24.14 21.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.506 0.67 . . . . 0.0 109.45 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 38.2 mt -47.7 -48.66 59.39 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.51 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 19.6 Cg_endo -64.02 -10.49 23.26 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.139 1.893 . . . . 0.0 112.889 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -90.07 -14.68 33.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.404 0.621 . . . . 0.0 110.144 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.72 55.72 2.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.777 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 129' ' ' VAL . 88.8 m -67.45 -56.98 7.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.423 0.612 . . . . 0.0 110.442 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp -58.02 -24.99 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.229 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.588 ' O ' HG11 ' A' ' 58' ' ' VAL . 86.8 m -59.23 -35.26 73.33 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -82.74 -24.91 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.991 0.901 . . . . 0.0 109.291 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.8 mp -75.27 -25.62 58.14 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 55' ' ' THR . 7.3 p -78.3 -29.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.2 mm-40 -71.4 -26.6 62.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.477 1.132 . . . . 0.0 108.668 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.45 167.77 31.65 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.532 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 63' ' ' GLN . 38.4 Cg_exo -38.88 168.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.369 3.379 . . . . 0.0 114.734 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 39.5 Cg_exo -39.08 -8.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.675 1 C-N-CA 126.547 4.832 . . . . 0.0 118.06 -173.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 66' ' ' ARG . 10.1 tt0 -42.2 -17.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.618 ' O ' HD21 ' A' ' 68' ' ' LEU . 16.2 tp -47.51 -51.6 20.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.403 0.281 . . . . 0.0 111.399 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -54.62 -32.81 54.13 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.973 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.25 -50.57 45.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 109.573 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.553 HD13 ' HA ' ' A' ' 64' ' ' LEU . 57.4 mt -46.92 -51.71 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.428 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.618 HD21 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -51.33 -61.55 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -171.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -81.76 -63.06 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -165.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 64.8 m-85 -124.39 -2.77 7.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.5 m80 59.63 34.21 22.18 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 70' ' ' TYR . 7.4 p -113.59 156.41 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -162.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 89' ' ' THR . 1.6 p -125.14 126.66 71.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.865 168.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB1' ' CD1' ' A' ' 91' ' ' LEU . . . -65.3 140.91 58.74 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 120.945 0.402 . . . . 0.0 110.609 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.41 97.26 2.32 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.001 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -60.87 108.4 0.85 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.443 0.64 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.01 132.34 55.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.129 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.688 ' O ' HD21 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -88.86 165.42 14.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.9 58.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.255 0.55 . . . . 0.0 110.974 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 13.3 t -72.25 -26.08 61.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.585 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.35 -48.67 16.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.688 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.07 -51.26 70.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.605 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.68 -35.39 80.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.033 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -51.75 -44.32 63.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.732 0.777 . . . . 0.0 110.326 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -73.29 -39.04 65.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.257 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.79 7.11 88.92 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.472 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.8 tt -163.27 159.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 95' ' ' THR . 8.5 m -130.17 138.0 55.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.189 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.534 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.7 m -114.29 133.2 55.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.092 0.473 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.612 ' HB2' ' OE2' ' A' ' 92' ' ' GLU . 58.3 m -85.41 178.27 7.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.479 -174.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.449 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 1.7 tp -56.0 -39.35 71.75 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.748 ' OE1' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -84.42 -16.67 41.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA2' HG23 ' A' ' 89' ' ' THR . . . 113.15 22.22 5.65 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.114 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.748 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 5.5 p -86.86 120.56 28.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 117.714 0.757 . . . . 0.0 110.541 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -93.08 138.32 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.0 mp -130.88 125.99 21.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.715 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 87' ' ' ILE . 7.1 Cg_exo -68.76 133.79 28.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.192 1.928 . . . . 0.0 113.362 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.43 ' HA ' HD11 ' A' ' 98' ' ' ILE . 41.0 mm -98.95 136.03 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.317 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.525 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 18.0 m-70 -120.86 177.62 5.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.056 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.04 107.97 0.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.443 -1.36 . . . . 0.0 113.428 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -104.57 -41.09 5.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 109.908 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HB3' ' CD ' ' A' ' 103' ' ' PRO . 26.9 t-20 -127.12 -63.98 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.186 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -84.9 174.19 7.6 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.018 1.812 . . . . 0.0 110.74 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD22 HG23 ' A' ' 111' ' ' VAL . 14.8 tp -73.86 152.21 40.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 3.6 mm-40 -137.58 122.6 19.06 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.57 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -128.74 123.77 59.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.108 -175.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 11.2 ptmm? 46.9 -132.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.671 0.607 . . . . 0.0 110.768 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -88.27 25.67 1.58 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 0.0 110.473 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 126' ' ' ILE . . . -124.87 163.1 22.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.759 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 81.0 m -127.88 140.89 51.74 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 HD22 ' A' ' 104' ' ' LEU . 38.4 t -84.5 125.51 40.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.43 0.633 . . . . 0.0 112.394 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.2 -36.45 16.79 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.293 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.25 111.56 2.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.505 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -135.82 -174.21 3.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 19.3 t70 69.84 25.8 4.92 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -90.79 105.92 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.1 108.54 3.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 122.284 1.04 . . . . 0.0 112.485 177.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -83.67 -177.54 6.74 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.591 -175.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -43.98 -51.38 7.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.647 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.17 -13.61 9.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.878 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.44 -109.79 0.42 Allowed Glycine 0 CA--C 1.501 -0.825 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.356 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 10.4 mm -145.62 144.19 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.558 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.514 HG13 ' HB1' ' A' ' 118' ' ' ALA . 29.3 mt -113.61 150.91 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.453 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.698 ' NE2' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.11 115.17 6.14 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 122.12 0.962 . . . . 0.0 111.767 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 40.7 t -82.3 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.181 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -122.75 160.32 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.313 1.054 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.858 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 28.8 t70 -93.98 1.61 56.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.534 -169.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.58 ' O ' HG13 ' A' ' 126' ' ' ILE . 4.6 m -159.36 131.05 6.29 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.22 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.557 ' O ' HG22 ' A' ' 53' ' ' THR . 77.0 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.751 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.61 0.243 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.87 108.75 16.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.869 0.366 . . . . 0.0 110.153 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.5 m -60.77 150.57 32.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.976 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.7 -21.83 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.701 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.4 p -91.42 -34.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 110.28 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' CA ' HE22 ' A' ' 31' ' ' GLN . 15.5 t70 -55.3 -48.43 74.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.831 0.824 . . . . 0.0 109.751 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.2 mt -55.05 -21.46 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.657 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.0 76.07 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.863 -0.523 . . . . 0.0 110.583 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.7 t -79.15 -15.38 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.453 0.644 . . . . 0.0 110.421 174.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -94.06 -24.5 17.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 -175.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.1 p -60.55 130.34 90.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 3.8 Cg_exo -79.1 64.53 8.84 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.966 2.444 . . . . 0.0 112.506 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.56 45.36 7.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.594 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.16 -175.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -58.31 154.34 13.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.316 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -57.94 -18.86 26.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.69 -32.77 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.98 -28.84 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.398 0.618 . . . . 0.0 109.623 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.579 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.7 m -82.46 -27.72 31.7 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -61.79 -37.52 84.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -36.46 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.004 -0.435 . . . . 0.0 110.513 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 39.1 mtmt -62.08 -43.24 99.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 111.027 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 19' ' ' THR . 8.6 p -74.69 -34.13 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.23 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -75.31 -8.04 55.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.913 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.418 HD21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 73.03 10.45 5.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.362 1.065 . . . . 0.0 112.976 177.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.681 HD21 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.83 6.9 26.05 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.99 -0.443 . . . . 0.0 112.038 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.22 -36.56 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.988 0.423 . . . . 0.0 110.455 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -86.21 -18.81 31.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.973 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.95 -54.92 5.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.694 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.5 mt -56.37 -13.9 2.56 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.701 ' NE2' HG13 ' A' ' 5' ' ' VAL . 42.8 mm-40 -64.39 -10.39 24.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.044 0.537 . . . . 0.0 112.215 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -61.62 110.77 3.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.346 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.48 -15.58 9.81 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.139 2.559 . . . . 0.0 113.593 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.68 -138.43 0.22 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.917 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 23.9 Cg_endo -74.85 165.37 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.223 1.949 . . . . 0.0 113.643 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.752 ' CD2' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.22 125.66 28.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.803 -170.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 38.1 m -124.6 119.79 30.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -118.0 152.1 20.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -108.95 106.94 17.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -99.23 112.22 62.73 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.24 130.61 13.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.407 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.763 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.6 p30 -81.55 -174.43 4.96 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.829 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -59.77 -30.0 68.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.654 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 15.4 t70 -81.84 -19.63 40.65 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.016 0.912 . . . . 0.0 109.17 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.75 -40.33 33.64 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.047 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -64.3 -24.71 67.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.237 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.63 -21.17 38.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.235 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -61.39 -43.77 98.3 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.423 173.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD2' HG11 ' A' ' 129' ' ' VAL . 97.0 mt -40.46 103.63 0.3 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 O-C-N 125.707 1.88 . . . . 0.0 112.542 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.09 -80.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 111.493 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -122.01 27.65 7.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . 89.52 101.49 1.07 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.216 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.476 ' HB ' HG13 ' A' ' 129' ' ' VAL . 61.6 m -59.51 -48.6 81.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.617 0.722 . . . . 0.0 109.875 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -57.82 -24.43 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.662 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.597 ' O ' HG11 ' A' ' 58' ' ' VAL . 88.1 m -64.62 -34.13 77.55 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.367 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -81.81 -24.63 35.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.792 0.806 . . . . 0.0 109.101 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 7.6 mp -71.19 -31.29 67.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.993 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 55' ' ' THR . 9.8 p -73.72 -31.49 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.089 0.471 . . . . 0.0 109.731 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.9 mm-40 -73.0 -30.43 63.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.784 1.278 . . . . 0.0 108.325 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 1.6 m-80 -76.52 169.6 20.23 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.901 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 63' ' ' GLN . 26.2 Cg_exo -37.31 168.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 124.439 3.426 . . . . 0.0 115.191 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 43.3 Cg_exo -40.03 -11.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 1 C-N-CA 126.537 4.825 . . . . 0.0 118.905 -168.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.685 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 32.6 tt0 -43.79 -25.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.62 ' O ' HD23 ' A' ' 68' ' ' LEU . 12.7 tp -46.98 -48.67 21.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.585 0.354 . . . . 0.0 111.905 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.474 ' C ' HD21 ' A' ' 26' ' ' LEU . . . -49.64 -40.34 32.43 Favored Glycine 0 N--CA 1.458 0.14 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.829 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.681 ' N ' HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.61 -37.54 59.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.85 0.357 . . . . 0.0 110.049 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 64' ' ' LEU . 55.6 mt -57.06 -45.19 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.717 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -48.93 -59.1 3.88 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.739 0.649 . . . . 0.0 112.673 -176.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -83.8 -64.46 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.527 -169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' HIS . 2.8 m-85 -125.98 -13.25 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.412 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 11.1 t-80 68.09 40.44 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -175.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.752 HG23 ' CD2' ' A' ' 36' ' ' PHE . 13.2 p -121.55 159.77 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.444 -165.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.525 ' N ' HG22 ' A' ' 72' ' ' VAL . 1.9 p -128.72 128.53 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.15 170.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -68.23 140.72 56.06 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.318 0.58 . . . . 0.0 110.854 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 113.36 97.96 2.3 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.755 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.12 101.24 0.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 122.909 0.483 . . . . 0.0 111.86 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.03 117.54 29.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.695 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.9 mtpt -75.31 163.52 27.39 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.006 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.42 59.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.012 0.434 . . . . 0.0 110.714 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 10.0 t -71.29 -27.85 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.071 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -78.68 -49.07 13.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.323 0.582 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.695 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -55.41 -52.48 63.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.166 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.53 -33.9 75.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 80' ' ' THR . 1.1 ttt180 -54.51 -40.6 68.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.546 0.689 . . . . 0.0 110.077 176.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -80.21 -41.6 24.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.04 10.65 78.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.726 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.55 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.1 tt -162.64 156.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 95' ' ' THR . 13.3 m -131.1 139.13 51.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -107.3 128.02 54.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.648 0.737 . . . . 0.0 110.839 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.582 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 60.6 m -72.6 166.11 23.38 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.502 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 5.0 tp -56.98 -36.18 70.05 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-O 121.946 0.879 . . . . 0.0 109.642 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 3.6 pm0 -76.65 -12.31 59.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.86 6.48 57.08 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.602 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.5 m -77.85 119.96 22.07 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.98 133.78 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 88' ' ' VAL . 1.6 mp -122.23 127.05 26.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.55 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.2 Cg_exo -72.7 130.43 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.709 1.606 . . . . 0.0 112.852 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 82' ' ' LEU . 35.9 mm -94.53 134.34 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 68.8 m-70 -123.84 -179.27 4.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.738 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.87 97.04 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.998 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.07 -53.25 4.56 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 21.9 t-20 -118.0 -56.02 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 23.9 Cg_endo -90.7 174.13 2.89 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.613 2.209 . . . . 0.0 110.795 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 111' ' ' VAL . 13.0 tp -74.12 152.38 39.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 39.4 mt-10 -136.85 109.64 7.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 109.478 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.49 106.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -176.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 2.5 ptpt 43.49 -106.99 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 112.638 -170.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -89.26 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.622 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -108.55 166.04 11.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.454 0.645 . . . . 0.0 112.729 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.7 m -129.15 133.57 47.67 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.555 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 17.4 t -85.33 131.05 35.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.641 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 127' ' ' ASP . 6.9 mp -88.99 -46.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.201 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -146.77 118.76 8.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.791 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 124' ' ' HIS . . . -136.61 -174.7 3.78 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 27.5 m-20 67.74 27.09 7.63 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -87.06 116.2 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.386 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.47 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.35 108.61 2.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.456 ' CB ' HG13 ' A' ' 123' ' ' ILE . . . -82.85 -177.7 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.777 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 1.1 pt-20 -47.53 -53.51 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.567 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 46.5 m-80 -119.08 -9.36 10.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.4 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.32 -112.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.279 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' THR . 32.1 mm -143.03 148.0 19.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.329 0.585 . . . . 0.0 111.328 -171.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 38' ' ' VAL . 96.7 mt -119.18 147.7 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -137.57 118.75 14.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 85.1 t -83.12 128.04 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.04 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.1 OUTLIER -120.97 162.26 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.85 0.833 . . . . 0.0 110.479 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.763 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 38.1 t70 -107.79 16.53 23.5 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.345 -170.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 73.2 m -156.79 130.56 8.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.087 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 53' ' ' THR . 43.3 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.518 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.848 0.356 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.99 110.71 20.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.585 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.3 m -59.43 149.8 28.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.065 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.467 HD11 ' H ' ' A' ' 4' ' ' ILE . 4.2 mp -44.13 -47.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.501 0.667 . . . . 0.0 111.08 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.664 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.3 p -71.89 -36.06 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.688 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' CA ' HE22 ' A' ' 31' ' ' GLN . 16.0 t70 -54.84 -46.36 74.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.939 0.875 . . . . 0.0 109.673 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 10' ' ' ASN . 18.5 mt -56.8 -21.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.211 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . . . -61.39 -32.94 72.88 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.751 -0.593 . . . . 0.0 110.415 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.21 -34.85 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.381 0.61 . . . . 0.0 109.999 172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.547 ' CB ' ' HA ' ' A' ' 7' ' ' ILE . 17.5 t-20 -66.29 -25.22 66.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.529 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.2 p -62.45 138.48 96.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.043 -175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.7 Cg_exo -80.61 62.27 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.601 2.201 . . . . 0.0 112.315 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 46.84 20.51 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.998 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.73 -168.66 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.553 0.692 . . . . 0.0 112.423 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 18' ' ' VAL . 4.6 m -58.57 158.94 7.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.856 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -60.49 -17.99 48.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -52.6 -35.27 53.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 8' ' ' ALA . 3.9 m -80.92 -28.45 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.686 0.755 . . . . 0.0 109.967 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.544 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -79.79 -29.05 40.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 -177.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -62.83 -35.66 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.818 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 -36.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.11 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 27.2 mtmt -61.5 -43.86 98.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.299 0.571 . . . . 0.0 110.982 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 19' ' ' THR . 8.3 p -73.52 -35.93 46.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.98 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -74.04 -4.19 33.95 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.656 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.15 9.68 7.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.272 1.029 . . . . 0.0 112.842 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 66' ' ' ARG . 9.2 mp -87.25 7.34 28.91 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.91 -0.494 . . . . 0.0 111.805 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.41 -36.98 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.197 0.522 . . . . 0.0 109.792 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -85.85 -21.82 27.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.626 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.89 -54.89 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 19.8 mt -58.54 -9.81 1.86 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.664 ' NE2' HG13 ' A' ' 5' ' ' VAL . 39.7 mm-40 -70.98 4.64 2.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.826 0.45 . . . . 0.0 112.054 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -48.02 112.55 2.26 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 123.98 0.8 . . . . 0.0 112.412 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.98 -12.57 11.9 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.24 2.627 . . . . 0.0 111.254 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.79 -135.11 1.91 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.147 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 17.7 Cg_endo -84.3 170.94 10.41 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.917 2.412 . . . . 0.0 113.174 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.655 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -139.08 122.96 17.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.772 HG21 ' CG ' ' A' ' 77' ' ' TYR . 0.4 OUTLIER -126.83 119.88 27.9 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -174.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' CG1' HG12 ' A' ' 123' ' ' ILE . 7.4 p -117.42 145.03 23.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.245 0.545 . . . . 0.0 111.261 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.67 ' HD1' ' CE1' ' A' ' 124' ' ' HIS . 55.3 m-85 -93.06 109.25 20.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -91.35 111.86 51.08 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 120.673 0.273 . . . . 0.0 111.318 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.41 128.33 8.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.099 1.866 . . . . 0.0 111.739 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.835 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.2 p30 -80.91 -175.41 5.35 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.994 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.74 -32.0 59.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 11.4 t70 -83.22 -23.89 32.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.698 0.761 . . . . 0.0 109.185 -174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -80.44 -34.57 35.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.621 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -61.49 -22.94 65.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.875 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 44' ' ' ASP . . . -85.52 -9.0 58.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.686 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 27.7 mmmt -91.09 -25.99 19.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' CD2' HG23 ' A' ' 129' ' ' VAL . 38.9 mt -46.09 -48.41 42.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.825 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 18.2 Cg_endo -63.25 -21.12 71.93 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.901 1.734 . . . . 0.0 112.859 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.53 -35.17 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.367 0.603 . . . . 0.0 110.081 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.18 56.92 1.09 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.222 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 129' ' ' VAL . 97.6 m -68.31 -57.75 5.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.486 0.66 . . . . 0.0 109.993 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 67' ' ' ILE . 1.1 mp -58.91 -24.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.701 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.599 ' O ' HG11 ' A' ' 58' ' ' VAL . 63.0 m -55.36 -37.37 67.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.732 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -81.8 -27.24 33.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.91 0.862 . . . . 0.0 109.369 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 10.1 mp -73.11 -25.17 60.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.838 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 55' ' ' THR . 9.0 p -79.14 -29.21 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 121.172 0.511 . . . . 0.0 109.865 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 55' ' ' THR . 27.5 mm-40 -71.79 -27.27 62.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 122.575 1.179 . . . . 0.0 108.706 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.58 166.69 37.17 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.057 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 30.5 Cg_exo -39.21 168.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.306 3.338 . . . . 0.0 114.641 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 21.6 Cg_exo -34.73 -10.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 1 C-N-CA 127.345 5.364 . . . . 0.0 119.393 -172.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 61' ' ' PRO . 1.7 tt0 -42.34 -24.93 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.581 ' HA ' HD11 ' A' ' 67' ' ' ILE . 11.5 tp -44.56 -49.02 10.31 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.378 0.671 . . . . 0.0 112.477 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.97 -31.73 33.06 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.843 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.62 ' N ' HD21 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 0.0 110.02 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 54' ' ' ILE . 36.0 mt -68.64 -46.97 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.362 -169.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.576 HD21 ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -50.15 -59.37 3.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -174.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.79 -62.45 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -168.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.39 -13.78 7.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 t60 65.83 36.26 6.21 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.655 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.4 p -109.82 160.44 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.57 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' N ' HG23 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -136.63 131.39 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -70.2 138.84 52.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 120.69 88.39 1.04 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.308 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.436 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -56.22 98.53 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 112.124 -171.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.995 ' CG ' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -95.66 147.72 23.3 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.042 179.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -110.73 152.75 26.21 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.37 -30.49 12.42 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 0.0 112.061 -169.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 12.2 t -75.42 -25.0 57.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.858 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.79 -51.61 18.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.857 0.836 . . . . 0.0 109.386 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.995 HD21 ' CG ' ' A' ' 77' ' ' TYR . 0.3 OUTLIER -57.72 -50.72 72.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.703 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -66.96 -33.0 74.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.741 0.305 . . . . 0.0 111.328 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -55.0 -40.95 70.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.432 0.634 . . . . 0.0 110.274 173.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.8 mtt -78.44 -41.82 31.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.716 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.85 10.71 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.907 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.516 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.1 tt -163.83 157.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 95' ' ' THR . 15.1 m -131.59 141.7 45.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.772 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.8 m -108.93 133.55 52.78 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.221 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 94' ' ' SER . 26.3 t -66.14 164.88 14.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.908 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 2.2 tp -56.89 -33.59 67.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.558 0.694 . . . . 0.0 109.78 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.48 ' HB3' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -27.24 41.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.749 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.21 3.27 11.88 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.893 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.455 ' H ' ' HB3' ' A' ' 90' ' ' SER . 1.8 m -78.34 120.44 23.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.788 0.794 . . . . 0.0 111.564 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -85.03 141.72 30.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.551 ' O ' HG21 ' A' ' 88' ' ' VAL . 1.8 mp -127.28 127.27 24.26 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.645 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.516 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.2 Cg_exo -72.59 130.06 15.47 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.021 1.814 . . . . 0.0 113.35 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.475 HG13 ' HB3' ' A' ' 82' ' ' LEU . 42.1 mm -98.89 141.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.344 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.433 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 31.1 m80 -134.92 178.8 6.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.543 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.58 110.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.612 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.27 -48.1 8.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.518 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 8.1 t30 -128.13 -55.69 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.138 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 15.9 Cg_endo -90.47 173.71 3.12 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.264 1.976 . . . . 0.0 110.8 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.516 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . 14.5 tp -74.48 153.99 38.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 4.3 mm-40 -138.65 119.29 14.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.612 -174.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.483 HG13 ' HE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -119.39 106.01 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.301 -173.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.528 ' HB3' HG21 ' A' ' 96' ' ' ILE . 20.8 pttp 49.83 -78.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.536 1.535 . . . . 0.0 113.812 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' OD1' ' HG3' ' A' ' 107' ' ' LYS . 30.3 p-10 -125.29 1.19 7.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.526 0.679 . . . . 0.0 109.344 -172.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 126' ' ' ILE . . . -117.6 165.31 13.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.431 -173.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -125.46 136.21 53.14 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG21 ' NE2' ' A' ' 124' ' ' HIS . 99.0 t -83.18 127.47 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.234 -174.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.3 mp -93.25 -32.87 14.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.865 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -162.99 116.53 1.64 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.434 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.79 -175.77 4.01 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 29.7 t70 68.11 25.65 7.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -169.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.5 mt -85.06 109.09 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.114 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.56 106.92 2.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.471 0.653 . . . . 0.0 111.14 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.409 ' HB1' HG13 ' A' ' 123' ' ' ILE . . . -80.27 -175.17 4.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.399 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.09 -52.26 45.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.429 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.7 m-20 -117.78 -12.78 10.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -149.13 -111.45 0.59 Allowed Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.565 -1.302 . . . . 0.0 112.79 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.612 HG13 ' HE3' ' A' ' 78' ' ' LYS . 7.6 mm -145.31 149.14 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.539 0.685 . . . . 0.0 111.676 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.521 HG12 ' CG1' ' A' ' 38' ' ' VAL . 87.9 mt -114.4 151.17 16.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.462 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.67 ' CE1' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.15 112.91 5.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.055 0.931 . . . . 0.0 112.178 -178.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 46.1 t -80.08 130.09 36.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.635 -174.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.66 163.34 25.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.672 0.749 . . . . 0.0 110.123 176.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.835 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 34.7 t70 -106.32 14.71 27.07 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.017 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.629 ' O ' HG13 ' A' ' 126' ' ' ILE . 15.9 m -164.26 131.0 3.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.248 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 53' ' ' THR . 54.6 t . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.648 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.56 0.219 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.46 122.17 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.3 m -63.68 148.7 48.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.4 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.522 HD11 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.61 -20.9 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.6 p -92.39 -37.32 8.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.175 0.512 . . . . 0.0 111.003 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.542 ' HA ' HE22 ' A' ' 31' ' ' GLN . 13.9 t70 -50.05 -48.91 52.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.586 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 11' ' ' THR . 7.5 mt -59.48 -22.14 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.932 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.52 77.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.314 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.67 -26.6 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 110.259 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 47.6 t30 -77.28 -25.27 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.365 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.6 p -65.89 138.9 96.58 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 59.12 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.516 2.811 . . . . 0.0 112.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.87 44.1 10.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.881 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -66.09 -178.31 0.6 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -55.43 158.34 3.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.985 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -58.37 -18.38 27.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.514 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -53.36 -35.94 60.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.112 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.26 -30.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.592 0.711 . . . . 0.0 110.064 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -80.82 -29.74 35.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.472 -173.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -64.66 -33.53 76.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -37.43 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 109.886 171.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 7.6 mtmt -61.52 -39.9 92.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.428 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 19' ' ' THR . 7.4 p -77.11 -36.18 24.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.393 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -73.84 -6.69 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.026 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.43 HD21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 72.64 10.99 5.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.181 0.992 . . . . 0.0 112.276 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 66' ' ' ARG . 7.8 mp -87.23 7.03 30.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.714 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -36.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.19 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.8 pt-20 -85.38 -21.62 28.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.829 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 31' ' ' GLN . . . -75.75 -53.75 8.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.1 mt -61.74 -5.65 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.299 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.679 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 41.7 mm-40 -74.29 10.44 1.27 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.497 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 m -92.85 95.27 1.05 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-O 120.944 0.402 . . . . 0.0 110.01 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 31' ' ' GLN . 53.8 Cg_endo -80.53 -8.01 13.7 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.072 2.515 . . . . 0.0 113.5 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -124.07 0.02 OUTLIER Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.881 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.491 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 37.9 Cg_endo -78.99 154.26 25.66 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.28 1.32 . . . . 0.0 112.597 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CD2' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -138.69 121.67 16.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.128 -168.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.4 m -119.63 124.23 45.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.271 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 123' ' ' ILE . 98.5 t -122.02 140.97 44.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.236 0.541 . . . . 0.0 111.949 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.49 115.3 29.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -105.65 117.98 56.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.167 -173.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.32 125.13 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.995 1.797 . . . . 0.0 111.582 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.691 HD21 ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -78.7 173.27 12.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.24 -46.01 8.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.609 0.719 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.9 -20.79 61.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.776 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 42' ' ' ASN . . . -78.8 -38.59 37.97 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.314 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -62.82 -26.02 68.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.026 0.917 . . . . 0.0 109.02 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.94 -22.57 39.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.209 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 26.9 mmmt -62.46 -46.6 87.79 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.948 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD2' HG23 ' A' ' 129' ' ' VAL . 95.3 mt -33.64 101.8 0.2 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 O-C-N 125.879 1.987 . . . . 0.0 113.576 -166.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -84.1 -141.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 124.87 3.713 . . . . 0.0 110.796 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.19 -32.91 64.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.55 105.72 0.47 Allowed Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.591 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' HD12 ' A' ' 57' ' ' LEU . 58.3 m -56.89 -54.35 47.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -63.76 -25.57 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.648 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 58' ' ' VAL . 90.9 m -66.74 -35.64 80.58 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -79.3 -27.24 42.18 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.868 0.842 . . . . 0.0 109.262 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.3 mp -76.21 -25.71 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.43 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 55' ' ' THR . 9.0 p -75.28 -28.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.3 mm-40 -73.55 -27.14 61.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.64 1.21 . . . . 0.0 108.771 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 5.3 m-80 -84.44 168.37 21.7 Favored Pre-proline 0 N--CA 1.435 -1.197 0 CA-C-N 112.982 -1.917 . . . . 0.0 111.038 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.507 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 28.8 Cg_exo -38.3 168.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 124.543 3.495 . . . . 0.0 115.197 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 15.3 Cg_exo -34.08 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.896 1 C-N-CA 127.824 5.683 . . . . 0.0 120.551 -166.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.603 ' O ' HG13 ' A' ' 67' ' ' ILE . 1.2 tt0 -43.89 -28.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 68' ' ' LEU . 16.5 tp -44.83 -51.1 9.86 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.223 0.609 . . . . 0.0 112.305 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -51.72 -34.73 37.02 Favored Glycine 0 N--CA 1.461 0.307 0 O-C-N 123.599 0.562 . . . . 0.0 113.321 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.71 -40.11 61.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.434 0.635 . . . . 0.0 110.026 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 63' ' ' GLN . 46.1 mt -62.51 -47.52 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.828 -174.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.64 -62.35 1.33 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.949 0.781 . . . . 0.0 112.822 -173.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -88.96 -61.94 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -122.13 -12.81 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 59.9 38.01 21.33 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.638 HG23 ' CD2' ' A' ' 36' ' ' PHE . 14.5 p -106.7 159.39 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.586 -165.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 p -132.99 125.57 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.556 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 91' ' ' LEU . . . -67.36 141.96 56.93 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.346 0.593 . . . . 0.0 110.712 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.78 100.16 2.23 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.392 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' ' CB ' ' A' ' 35' ' ' PRO . . . -61.32 102.26 0.22 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.244 0.545 . . . . 0.0 111.834 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -120.71 122.4 40.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.135 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' O ' HD21 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.08 159.34 27.57 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 170.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -48.99 -36.78 18.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.45 0.469 . . . . 0.0 110.633 -172.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 6.5 t -72.36 -23.99 61.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.287 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.38 -40.17 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -62.08 -48.87 78.28 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.421 175.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.68 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.8 mtpt -66.53 -29.42 69.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 122.946 0.498 . . . . 0.0 112.218 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.12 -32.47 68.15 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 122.021 0.915 . . . . 0.0 109.299 173.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.1 -42.5 12.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.464 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' HB ' ' A' ' 98' ' ' ILE . . . 80.96 12.01 83.13 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.61 -172.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.9 tt -163.22 159.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 95' ' ' THR . 9.4 m -133.21 139.28 49.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 73' ' ' VAL . 4.3 m -107.37 129.81 54.87 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.505 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.452 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 21.4 t -71.44 165.83 22.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.498 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.498 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 3.3 tp -56.74 -30.15 63.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.787 0.803 . . . . 0.0 109.894 173.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 8.0 pt-20 -78.37 -22.96 47.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.48 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.13 11.76 27.1 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.34 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.4 m -88.83 122.29 32.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 122.44 -0.447 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.3 137.71 32.79 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -128.05 130.08 23.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.509 177.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.568 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.7 Cg_exo -72.57 134.91 23.13 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.023 1.815 . . . . 0.0 113.328 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.5 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -98.61 135.31 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.743 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.403 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 53.2 m80 -127.88 -178.81 4.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.682 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.75 100.3 0.16 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.094 -1.051 . . . . 0.0 113.204 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.91 -35.36 26.16 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.5 t-20 -144.2 -55.83 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.185 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 42.2 Cg_endo -85.72 174.04 6.88 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.163 1.909 . . . . 0.0 110.623 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.68 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 16.1 tp -72.89 151.02 42.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 43.5 mt-10 -140.99 106.33 5.04 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -109.12 132.28 57.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.033 -173.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 108' ' ' ASN . 12.2 ptmm? 55.36 -82.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.646 1.179 . . . . 0.0 112.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.464 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 22.8 p-10 -146.04 23.03 1.37 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.626 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -125.86 162.99 23.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.252 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.8 m -122.33 131.24 53.81 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 t -78.58 127.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.399 0.619 . . . . 0.0 111.695 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 112' ' ' LEU . 6.4 mp -89.03 -39.0 13.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.222 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.07 118.35 5.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 124' ' ' HIS . . . -137.72 -174.23 3.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 10.5 m-20 66.26 27.15 10.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -173.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -85.0 114.16 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.5 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -66.24 108.83 2.43 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.389 0.614 . . . . 0.0 110.61 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.52 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.26 -172.75 3.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.705 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 3.2 pt-20 -53.26 -51.49 62.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 35' ' ' PRO . 80.7 m-20 -120.12 -10.75 9.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.3 -118.23 1.17 Allowed Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.229 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 19.3 mm -146.18 146.66 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.349 0.595 . . . . 0.0 111.622 -172.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 118' ' ' ALA . 45.3 mt -118.83 146.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.654 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 1.7 m80 -133.59 116.4 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 84.4 t -81.17 127.72 39.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.259 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -125.65 160.51 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.462 0.649 . . . . 0.0 110.724 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.691 ' HA ' HD21 ' A' ' 42' ' ' ASN . 0.7 OUTLIER -98.16 9.21 43.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.904 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.626 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 23.1 m -146.94 129.17 15.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.18 0.514 . . . . 0.0 111.346 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 49' ' ' LEU . 89.0 t . . . . . 0 C--O 1.255 1.385 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.538 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.723 0.297 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.27 117.72 18.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.196 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -67.34 152.36 45.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.554 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.7 mp -49.75 -42.14 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.497 0.665 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.4 p -75.03 -36.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.14 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' HA ' HE22 ' A' ' 31' ' ' GLN . 17.8 t70 -52.14 -48.51 64.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 15.4 mt -56.88 -22.31 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.153 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.802 -0.561 . . . . 0.0 110.45 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.85 -18.38 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 110.111 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 40.4 t30 -95.95 -25.45 15.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.855 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 4.1 p -59.25 130.38 87.07 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.038 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.24 65.7 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.136 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.5 46.77 18.29 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.208 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -63.73 -174.56 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.072 0.463 . . . . 0.0 111.516 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.74 156.82 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 m -59.72 -18.17 40.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.322 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mp -54.12 -34.85 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.93 -39.09 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.568 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -68.9 -26.29 65.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.944 -175.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -66.98 -37.23 83.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -37.08 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.606 0.717 . . . . 0.0 109.872 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 1.8 mtpp -58.52 -41.14 84.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.949 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 19' ' ' THR . 7.1 p -78.16 -36.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.168 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 62' ' ' PRO . . . -72.85 -1.63 17.5 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.049 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.64 7.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.068 0.947 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 92' ' ' GLU . 9.6 mp -88.84 6.22 40.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.0 -0.438 . . . . 0.0 111.666 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.978 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.75 -22.16 29.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.812 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.25 -54.77 7.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.71 0.29 . . . . 0.0 111.571 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.3 mt -57.09 -14.66 4.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.647 ' NE2' HG13 ' A' ' 5' ' ' VAL . 34.2 mm-40 -68.77 -3.31 11.83 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.03 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 p -49.47 115.84 5.3 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.933 0.397 . . . . 0.0 111.474 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.72 -18.26 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.87 2.38 . . . . 0.0 113.147 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 35' ' ' PRO . . . -78.4 -135.9 1.0 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.607 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 11.2 Cg_endo -85.78 166.56 10.1 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.027 2.485 . . . . 0.0 113.098 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -133.9 122.05 22.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.7 m -104.03 104.89 14.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.568 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 123' ' ' ILE . 37.2 t -95.59 123.06 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.792 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HB3' HD13 ' A' ' 126' ' ' ILE . 98.4 m-85 -86.56 108.04 18.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.2 128.82 39.29 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.872 -170.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HB3' HG23 ' A' ' 129' ' ' VAL . 98.6 Cg_endo -79.91 126.86 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.129 1.886 . . . . 0.0 112.55 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.866 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -78.52 177.69 8.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.4 -32.7 65.06 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 14.2 t70 -83.85 -19.99 33.93 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.972 0.892 . . . . 0.0 108.945 -176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 129' ' ' VAL . . . -84.37 -36.31 22.57 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.317 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -57.93 -20.34 36.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.15 0.976 . . . . 0.0 109.054 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -83.93 -9.29 58.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.789 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 27.8 mmmt -93.57 -25.82 17.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.184 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' CD2' HG21 ' A' ' 129' ' ' VAL . 34.9 mt -50.45 -49.68 76.11 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 37.9 Cg_endo -67.91 81.78 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.134 1.889 . . . . 0.0 112.846 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 49.69 63.19 2.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.705 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.02 -89.07 0.73 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.593 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.0 m -82.86 -53.55 5.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.385 0.612 . . . . 0.0 110.819 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.548 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp -58.19 -23.72 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.452 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.559 ' O ' HG11 ' A' ' 58' ' ' VAL . 85.3 m -57.67 -35.98 71.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.469 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -82.73 -25.35 32.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.839 0.828 . . . . 0.0 109.14 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.6 mp -73.1 -27.3 61.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.81 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG11 ' O ' ' A' ' 55' ' ' THR . 8.1 p -79.38 -29.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.064 0.459 . . . . 0.0 109.764 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 55' ' ' THR . 18.8 mm-40 -70.89 -27.47 63.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.699 1.238 . . . . 0.0 108.347 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -82.16 168.07 26.25 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.882 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 22.2 Cg_exo -37.45 168.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 125.008 3.805 . . . . 0.0 116.18 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 36.5 Cg_exo -40.42 -9.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.871 5.047 . . . . 0.0 118.518 -171.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' O ' HG13 ' A' ' 67' ' ' ILE . 9.6 tt0 -43.76 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.666 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.5 tp -44.39 -49.95 9.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.61 0.364 . . . . 0.0 110.928 173.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' CA ' HD21 ' A' ' 26' ' ' LEU . . . -53.37 -29.7 38.9 Favored Glycine 0 C--N 1.33 0.195 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.556 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -79.35 -39.73 31.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.245 0.545 . . . . 0.0 109.856 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 63' ' ' GLN . 54.6 mt -59.22 -45.39 92.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.524 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.05 -60.13 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -175.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -85.77 -63.09 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.448 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.97 -16.9 5.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -171.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 67.23 34.99 4.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 15.0 p -111.76 159.45 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.948 -167.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 89' ' ' THR . 1.6 p -132.59 131.78 59.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.9 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.23 144.32 57.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 111.661 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.488 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.41 99.86 2.59 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.226 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -57.22 110.31 0.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.824 0.849 . . . . 0.0 111.401 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.553 ' O ' HG22 ' A' ' 122' ' ' ILE . 10.5 m-85 -121.03 110.09 15.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.844 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.621 ' O ' HD21 ' A' ' 82' ' ' LEU . 20.3 mmtp -65.77 161.39 20.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 168.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.94 44.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 111.407 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 15.0 t -76.48 -31.38 57.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.646 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.29 -46.86 66.15 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -58.56 -54.06 51.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.136 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -68.47 -32.04 71.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.1 ttt180 -51.04 -45.22 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.757 0.789 . . . . 0.0 110.212 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.0 mtp -81.08 -39.24 26.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 12.82 79.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.846 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.566 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.7 tt -162.95 157.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 95' ' ' THR . 11.0 m -133.11 144.09 37.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.191 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 73' ' ' VAL . 3.4 m -107.03 134.63 49.89 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.675 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.5 m -73.17 162.41 29.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.794 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.4 tp -52.82 -36.63 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.425 0.631 . . . . 0.0 110.527 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' HB3' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.37 -28.71 59.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.288 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.1 5.36 8.88 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.673 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 120.43 24.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.818 0.809 . . . . 0.0 112.097 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -81.97 139.45 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.0 112.807 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.515 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.7 mp -127.69 127.85 23.98 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.617 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.1 Cg_exo -72.99 132.3 18.07 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.11 1.874 . . . . 0.0 113.102 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.435 HG13 ' HB3' ' A' ' 82' ' ' LEU . 41.2 mm -95.53 136.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.303 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 33.3 m-70 -127.53 178.14 6.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.771 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.86 115.19 0.32 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.463 -1.351 . . . . 0.0 113.294 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.89 -53.81 2.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 19.8 m120 -114.68 -59.9 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.287 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 17.2 Cg_endo -90.4 173.61 3.19 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.161 1.907 . . . . 0.0 110.916 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.0 tp -75.52 153.99 37.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 5.7 mm-40 -139.01 107.1 5.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.336 0.588 . . . . 0.0 109.691 -173.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.688 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -112.98 128.46 69.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.043 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 12.1 ptmm? 51.75 -138.23 1.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.592 0.558 . . . . 0.0 110.191 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -89.97 30.79 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.307 0.575 . . . . 0.0 110.084 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' A' ' 126' ' ' ILE . . . -124.11 159.22 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.113 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 m -126.2 137.59 53.57 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.8 t -80.47 125.62 39.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.552 0.691 . . . . 0.0 111.732 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.77 -35.72 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.458 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -157.01 114.86 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.504 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.41 -173.88 3.6 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.584 ' CG ' ' HD2' ' A' ' 78' ' ' LYS . 12.3 t70 71.58 31.45 2.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.717 1.246 . . . . 0.0 107.646 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 10.0 mt -94.67 116.43 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.461 -1.699 . . . . 0.0 109.538 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.73 107.3 2.52 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.088 0.471 . . . . 0.0 109.759 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 123' ' ' ILE . . . -78.98 -177.05 5.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.126 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.86 -50.09 46.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.415 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -118.55 -16.09 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.924 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.01 -109.23 0.51 Allowed Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.556 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.581 HD11 ' CD ' ' A' ' 78' ' ' LYS . 23.1 mm -141.06 150.77 20.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.055 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.523 HG13 ' CB ' ' A' ' 118' ' ' ALA . 82.5 mt -123.32 143.43 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.727 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 3.6 m80 -135.57 114.02 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 60.2 t -78.46 128.86 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -128.74 165.94 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 122.162 0.982 . . . . 0.0 111.412 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.866 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -97.6 10.61 39.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.114 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.584 ' O ' HG13 ' A' ' 126' ' ' ILE . 18.1 m -164.18 123.39 1.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.859 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 45' ' ' ALA . 21.4 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.903 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.239 0.542 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.78 168.45 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.733 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.9 m -71.26 144.55 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.088 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.532 HD13 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -56.3 -23.68 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.612 HG12 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -91.68 -36.55 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.276 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.586 ' O ' HG13 ' A' ' 9' ' ' VAL . 33.0 t70 -57.76 -46.42 84.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.046 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 11' ' ' THR . 14.0 mt -57.7 -25.28 24.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.579 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -31.49 72.06 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.176 -0.327 . . . . 0.0 111.021 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 6' ' ' ASP . 7.1 p -91.27 -12.75 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.238 0.542 . . . . 0.0 110.501 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 7' ' ' ILE . 82.2 m-20 -91.99 -14.72 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 7' ' ' ILE . 11.0 p -59.83 138.02 90.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.186 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.84 65.61 8.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.815 2.343 . . . . 0.0 111.962 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.6 47.41 41.68 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.058 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.558 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.46 -173.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.308 0.575 . . . . 0.0 111.977 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -62.76 166.22 5.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.748 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -63.13 -19.23 64.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.8 mt -53.52 -36.81 62.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.251 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.2 -27.98 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.619 0.723 . . . . 0.0 109.853 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.577 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -79.38 -26.62 41.96 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.446 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -63.3 -40.58 97.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.747 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 p -74.75 -36.1 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.855 -0.528 . . . . 0.0 110.288 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 24.1 mtmt -61.11 -44.16 97.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.258 0.551 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 19' ' ' THR . 9.0 p -75.42 -34.83 31.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.113 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.65 -1.58 22.37 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.757 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.85 7.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 112.849 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 66' ' ' ARG . 8.7 mp -89.95 6.55 41.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.42 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -85.64 -17.71 35.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.262 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 91' ' ' LEU . . . -79.72 -58.49 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 14.5 mt -51.91 -13.25 0.27 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.612 ' NE2' HG12 ' A' ' 5' ' ' VAL . 48.1 mm-40 -66.33 -2.85 4.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.503 0.721 . . . . 0.0 112.73 -174.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -54.52 110.35 2.09 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 123.386 0.429 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.46 -18.02 9.79 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.698 2.265 . . . . 0.0 111.839 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -133.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.276 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.469 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 44.3 Cg_endo -80.78 159.1 21.52 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.025 1.817 . . . . 0.0 113.3 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.68 ' CD2' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -142.7 122.15 13.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.427 -169.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.6 m -118.71 123.24 44.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -172.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.444 ' HB ' HG12 ' A' ' 123' ' ' ILE . 81.8 t -117.46 143.53 27.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.303 0.573 . . . . 0.0 111.729 -174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -106.14 109.3 21.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -97.1 120.48 61.24 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.474 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.24 136.47 16.09 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.661 2.241 . . . . 0.0 112.687 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.754 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.9 p30 -85.87 -173.78 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.2 -31.08 63.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 17.4 t70 -87.41 -21.5 25.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -79.04 -36.13 41.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.051 175.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.15 -21.51 61.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.116 0.96 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 44' ' ' ASP . . . -85.69 -11.41 53.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.862 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 22.0 mmmt -88.42 -26.07 22.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.451 0.643 . . . . 0.0 109.441 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.488 ' CD2' HG23 ' A' ' 129' ' ' VAL . 38.2 mt -43.59 -49.49 18.6 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 114.292 -1.322 . . . . 0.0 114.234 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.26 -51.22 2.1 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.015 2.477 . . . . 0.0 113.071 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -164.73 93.91 0.66 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . -140.11 -146.47 4.85 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.991 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -64.5 -57.84 8.09 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.593 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.1 mp -54.68 -24.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.561 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.814 ' O ' HG13 ' A' ' 58' ' ' VAL . 84.7 m -60.03 -40.82 90.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.902 174.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.5 t -77.81 -34.51 52.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.22 1.009 . . . . 0.0 108.74 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.615 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 10.9 mp -66.8 -19.39 65.73 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.408 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 55' ' ' THR . 3.8 p -93.98 -21.02 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.539 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.1 mm-40 -71.11 -47.55 57.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -147.83 10.29 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -177.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 57' ' ' LEU . 5.0 Cg_exo -93.46 152.67 2.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 CA-C-N 121.886 1.709 . . . . 0.0 112.226 157.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -63.97 -17.31 59.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.325 2.683 . . . . 0.0 112.789 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.727 ' NE2' HD11 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -51.06 -18.52 0.84 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.536 ' O ' HD21 ' A' ' 68' ' ' LEU . 3.9 tp -45.32 -47.42 13.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.592 0.357 . . . . 0.0 111.725 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -50.02 -33.32 21.29 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.352 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.53 -36.45 65.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.139 0.971 . . . . 0.0 109.932 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.727 HD11 ' NE2' ' A' ' 63' ' ' GLN . 38.8 mt -69.45 -44.71 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.286 -169.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -49.91 -53.51 25.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.725 0.641 . . . . 0.0 112.495 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -87.14 -63.01 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -124.31 -13.48 7.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t60 64.11 41.19 6.45 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.68 HG23 ' CD2' ' A' ' 36' ' ' PHE . 14.7 p -109.86 160.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.85 -165.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 89' ' ' THR . 2.1 p -136.86 135.67 48.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.302 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.8 141.19 51.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.176 0.512 . . . . 0.0 110.956 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 98.92 2.3 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.891 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' A' ' 35' ' ' PRO . . . -60.52 103.32 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.279 0.561 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -120.04 123.48 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.385 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.6 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -80.05 161.28 25.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.31 -38.35 12.58 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 123.459 0.474 . . . . 0.0 110.837 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.1 t -71.46 -25.29 62.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.973 -172.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.25 -40.62 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.6 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -62.29 -42.72 99.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.478 175.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.642 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.4 mtpt -72.78 -30.57 64.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 122.581 0.353 . . . . 0.0 111.8 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -38.07 75.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.6 mtt -77.25 -45.0 27.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.981 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 79.73 9.75 86.46 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.454 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.7 tt -162.97 159.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG21 ' HB ' ' A' ' 96' ' ' ILE . 8.3 m -135.01 138.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.496 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' VAL . 2.8 m -111.68 135.94 51.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.056 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.467 ' HB3' ' H ' ' A' ' 94' ' ' SER . 15.6 t -71.08 168.63 16.72 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.537 0.735 . . . . 0.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -52.7 -37.73 59.44 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.538 0.685 . . . . 0.0 109.468 172.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.532 ' HB3' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.79 -25.26 48.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.579 -173.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.74 12.44 9.43 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.252 -0.886 . . . . 0.0 113.537 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.467 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.7 OUTLIER -80.48 120.51 24.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.756 0.778 . . . . 0.0 111.205 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.34 137.95 31.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 112.522 178.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 88' ' ' VAL . 1.7 mp -130.16 126.59 22.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.984 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.533 ' HA ' HG13 ' A' ' 87' ' ' ILE . 5.0 Cg_exo -71.83 133.24 21.46 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.156 1.904 . . . . 0.0 113.192 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.508 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.3 mm -95.64 139.38 19.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.025 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 37.7 m-70 -139.94 -178.92 5.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.215 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 142.3 115.62 1.13 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.905 -1.14 . . . . 0.0 113.93 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -83.09 -48.8 10.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 40.5 t30 -116.71 -53.73 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.111 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 17.8 Cg_endo -90.09 174.06 3.27 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.09 1.86 . . . . 0.0 110.419 172.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.642 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 17.7 tp -80.02 155.38 27.64 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.645 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 33.7 mt-10 -138.08 111.25 7.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.378 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.41 118.96 51.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.976 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 22.7 pttt 48.3 -107.01 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.986 0.914 . . . . 0.0 112.269 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.23 9.48 25.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.453 0.644 . . . . 0.0 110.375 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -104.13 163.25 12.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.193 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -128.8 135.18 48.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 4.1 t -82.98 126.66 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.431 0.634 . . . . 0.0 111.434 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 127' ' ' ASP . 6.7 mp -89.4 -39.24 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.783 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.49 116.57 4.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.334 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -137.48 -173.67 3.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.785 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 31.7 t70 71.15 28.4 3.08 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 122.867 1.317 . . . . 0.0 107.933 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 11.9 mt -89.54 111.13 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.69 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -68.09 108.95 3.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.046 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HB3' HG13 ' A' ' 123' ' ' ILE . . . -79.13 179.57 7.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.939 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 2.0 pt-20 -46.52 -50.76 16.68 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.817 0.698 . . . . 0.0 111.301 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 94.3 m-20 -120.58 -15.48 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.103 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.53 -118.77 1.39 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.625 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.574 HG13 ' HE3' ' A' ' 78' ' ' LYS . 16.3 mm -145.49 145.08 20.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.181 0.515 . . . . 0.0 111.747 -171.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 118' ' ' ALA . 22.7 mt -116.44 148.65 19.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.46 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 4.0 m80 -138.35 117.2 12.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 87.7 t -79.45 128.86 38.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.9 169.35 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 122.08 0.943 . . . . 0.0 110.909 -177.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.754 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 38.9 t70 -109.63 21.0 17.5 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.657 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.622 ' O ' HG13 ' A' ' 126' ' ' ILE . 10.7 m -163.99 124.6 2.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.669 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 49' ' ' LEU . 50.0 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.979 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.568 0.223 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.51 140.44 49.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.939 0.399 . . . . 0.0 110.702 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.7 m -70.99 145.99 49.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.908 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -43.05 -50.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.19 0.519 . . . . 0.0 111.75 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.66 HG12 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -67.93 -37.13 77.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.973 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.544 ' CA ' HE22 ' A' ' 31' ' ' GLN . 27.8 t70 -59.23 -44.33 92.32 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.78 0.8 . . . . 0.0 110.173 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 11.1 mt -56.63 -22.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.7 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.23 -32.45 71.14 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.854 -0.529 . . . . 0.0 110.988 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.59 -30.39 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.415 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 55.3 t30 -74.2 -24.93 59.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.505 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.2 p -62.6 144.82 95.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.825 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -80.44 59.84 7.61 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.977 2.451 . . . . 0.0 112.117 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.24 46.71 62.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.497 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.47 -169.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.854 0.835 . . . . 0.0 112.864 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m -56.87 160.38 3.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -61.94 -19.46 62.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.601 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.0 tp -57.24 -33.57 67.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 m -80.7 -27.15 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 109.829 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 23' ' ' VAL . 1.4 m -83.48 -27.58 29.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -61.13 -36.95 81.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 0.0 111.609 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.48 -37.69 30.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.964 -0.46 . . . . 0.0 110.445 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 38.0 mtmt -62.19 -41.51 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.451 . . . . 0.0 111.175 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 19' ' ' THR . 7.3 p -74.5 -35.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.111 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.08 -7.72 53.56 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.181 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.95 16.96 7.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.566 1.146 . . . . 0.0 112.62 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.4 mp -92.83 9.35 35.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 121.999 -0.438 . . . . 0.0 112.097 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.44 -36.92 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -86.04 -19.07 30.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.011 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.15 -54.88 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 23.1 mt -55.61 -13.35 1.56 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.66 ' NE2' HG12 ' A' ' 5' ' ' VAL . 46.1 mm-40 -66.16 -9.37 30.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 m -51.92 114.25 5.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 123.257 0.348 . . . . 0.0 111.221 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.38 -20.29 7.17 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.817 2.345 . . . . 0.0 113.628 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.3 -135.74 0.61 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -172.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 54.2 Cg_endo -78.76 162.66 26.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.819 2.346 . . . . 0.0 113.057 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 29.5 m-85 -136.62 121.97 19.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.651 -172.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 45.7 m -107.69 136.21 47.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.026 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.506 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -129.22 153.7 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.161 0.505 . . . . 0.0 110.492 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.72 107.23 16.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.55 111.43 53.92 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.677 -171.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HB3' HG23 ' A' ' 129' ' ' VAL . 72.5 Cg_endo -77.33 130.17 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.058 1.839 . . . . 0.0 111.612 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.811 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 4.0 p30 -72.16 -176.34 1.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.69 -28.35 55.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 37.0 t70 -87.54 -24.18 24.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.842 0.829 . . . . 0.0 109.608 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -85.33 -33.27 22.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.427 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.68 -19.97 65.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 44' ' ' ASP . . . -82.52 -8.99 59.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.786 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 25.9 mmmt -90.94 -25.89 19.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.775 0.798 . . . . 0.0 109.517 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 56.7 mt -53.66 -52.29 68.53 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.303 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 17.0 Cg_endo -58.52 94.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.681 2.254 . . . . 0.0 113.345 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 51.91 50.86 17.69 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.119 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.82 0.89 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.213 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.433 ' O ' HD12 ' A' ' 57' ' ' LEU . 70.9 m -56.97 -59.13 5.52 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.539 0.335 . . . . 0.0 111.768 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp -59.47 -25.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.024 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 58' ' ' VAL . 98.6 m -65.15 -38.47 90.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.433 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -79.55 -27.59 41.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.0 109.201 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD22 ' NE2' ' A' ' 63' ' ' GLN . 8.0 mp -72.57 -27.94 62.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.21 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 55' ' ' THR . 7.8 p -77.9 -27.67 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.141 0.496 . . . . 0.0 109.938 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 55' ' ' THR . 22.5 mm-40 -71.55 -29.77 65.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.513 1.149 . . . . 0.0 108.842 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.91 166.08 46.14 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.64 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 63' ' ' GLN . 48.0 Cg_exo -40.46 169.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.355 3.37 . . . . 0.0 114.171 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 31.2 Cg_exo -33.45 -8.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.047 1 C-N-CA 127.802 5.668 . . . . 0.0 120.175 -167.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.61 ' NE2' HD22 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -41.65 -25.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.534 ' O ' HD22 ' A' ' 68' ' ' LEU . 10.6 tp -52.25 -50.89 61.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.599 0.36 . . . . 0.0 111.883 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' CA ' HD23 ' A' ' 26' ' ' LEU . . . -52.03 -31.09 32.1 Favored Glycine 0 N--CA 1.461 0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.348 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' N ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.76 -49.29 21.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.356 0.598 . . . . 0.0 110.587 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' A' ' 64' ' ' LEU . 63.0 mt -44.88 -48.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.119 174.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.16 -65.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -166.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -89.44 -69.2 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.197 -1.001 . . . . 0.0 113.619 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.622 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -126.46 18.58 7.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -175.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.1 t60 59.24 30.98 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 164.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.622 HG12 ' CZ ' ' A' ' 70' ' ' TYR . 4.8 p -105.25 159.86 5.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.119 0.962 . . . . 0.0 113.517 -164.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 p -132.94 120.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.944 163.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . . . -64.58 145.97 55.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 0.0 111.62 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 97.43 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.28 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -58.78 106.2 0.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.232 0.539 . . . . 0.0 111.105 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -115.64 119.78 37.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.591 ' HG3' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -77.05 158.75 30.35 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.21 -37.45 10.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.553 0.533 . . . . 0.0 111.268 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.468 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.7 t -74.98 -24.37 58.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 -168.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.47 -45.72 75.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.19 -52.32 65.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.461 177.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.97 -34.68 75.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.0 ttt180 -51.47 -43.29 62.1 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.102 0.953 . . . . 0.0 109.19 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.3 mtp -75.98 -42.91 46.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.014 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 77.87 15.49 81.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.098 -172.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -163.66 157.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 95' ' ' THR . 11.0 m -130.7 143.06 42.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.396 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 73' ' ' VAL . 3.1 m -110.6 133.52 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.924 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.9 m -77.31 166.18 23.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.138 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 74' ' ' ALA . 3.8 tp -51.89 -37.59 52.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.125 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HB3' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -76.54 -24.94 53.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.61 -178.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.51 20.08 5.57 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.597 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.447 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 8.2 t -88.16 119.41 28.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.156 0.478 . . . . 0.0 110.536 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.78 139.25 30.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.65 . . . . 0.0 112.636 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.54 ' O ' HG21 ' A' ' 88' ' ' VAL . 1.3 mp -131.93 128.12 21.41 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.938 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HA ' HG13 ' A' ' 87' ' ' ILE . 8.1 Cg_exo -69.16 133.27 26.25 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.142 1.895 . . . . 0.0 113.355 -173.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.7 mm -102.09 138.0 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.049 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -140.82 179.98 6.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.595 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.582 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 173.93 93.26 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.72 -172.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.89 -44.33 55.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 109.288 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 11.6 m-80 -140.83 -53.11 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.983 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.3 Cg_endo -88.17 173.28 4.87 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.165 1.91 . . . . 0.0 110.298 168.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 24.8 tp -73.34 153.67 40.42 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.582 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 26.8 mt-10 -140.91 106.78 5.14 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.42 ' CG2' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -105.74 126.52 61.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.823 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HB3' HG23 ' A' ' 96' ' ' ILE . 13.5 ptmt 46.52 -114.51 0.52 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.604 0.762 . . . . 0.0 112.046 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' C ' HD21 ' A' ' 108' ' ' ASN . 0.3 OUTLIER -102.99 22.14 14.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.203 0.525 . . . . 0.0 111.094 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -123.97 166.48 15.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.938 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 12.1 m -128.78 137.44 51.54 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -81.02 129.89 36.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.545 0.688 . . . . 0.0 111.886 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.8 mp -91.6 -37.86 12.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.389 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.59 112.08 2.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.849 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB3' ' CD2' ' A' ' 124' ' ' HIS . . . -141.01 -173.25 3.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 71.46 26.28 3.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -90.46 109.66 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.738 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.52 110.97 3.36 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.278 1.037 . . . . 0.0 112.031 174.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' HB3' HG13 ' A' ' 123' ' ' ILE . . . -79.24 -170.5 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.465 -1.698 . . . . 0.0 111.772 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -50.94 -49.04 60.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.863 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -119.66 -18.35 8.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.072 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.54 -112.4 0.77 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.397 -173.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.591 HD11 ' HG3' ' A' ' 78' ' ' LYS . 9.8 mm -146.56 142.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.547 0.689 . . . . 0.0 112.355 -174.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 38' ' ' VAL . 92.2 mt -113.19 146.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.619 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 114' ' ' ALA . 10.6 m80 -137.22 113.3 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 57.6 t -81.12 128.08 39.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 123.178 0.299 . . . . 0.0 110.31 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -127.25 164.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 0.0 110.94 -176.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.811 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 38.8 t70 -108.89 19.47 19.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.752 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.633 ' O ' HG13 ' A' ' 126' ' ' ILE . 16.2 m -168.77 134.5 1.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 49' ' ' LEU . 73.1 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.637 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp -43.74 -52.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.797 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.573 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.1 p -70.8 -36.92 66.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.079 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.41 -44.42 80.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.81 0.814 . . . . 0.0 110.334 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 19.7 mt -53.86 -24.76 10.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.933 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.3 86.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.888 0.375 . . . . 0.0 111.057 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.15 -18.57 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.416 0.627 . . . . 0.0 110.46 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 44.9 t30 -89.84 -25.33 21.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.476 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 8.9 p -57.76 133.9 82.9 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -174.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -78.01 66.05 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.918 2.412 . . . . 0.0 111.884 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.93 47.04 26.64 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.219 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.74 -172.93 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.15 0.5 . . . . 0.0 111.605 177.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -58.81 163.22 3.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.853 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 m -62.58 -19.28 63.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.64 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.38 -35.24 50.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.705 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.3 -27.47 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.509 0.671 . . . . 0.0 109.908 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.589 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 m -83.38 -28.2 29.1 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.757 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.26 79.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.622 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.13 -36.81 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.978 -0.451 . . . . 0.0 110.427 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.1 mtmt -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.217 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 19' ' ' THR . 8.8 p -77.21 -34.66 21.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.544 0.688 . . . . 0.0 110.218 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.17 -2.47 31.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.368 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.84 15.4 10.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.125 0.97 . . . . 0.0 112.835 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 8.2 mp -91.46 7.62 40.31 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.927 -0.483 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -60.08 -37.02 71.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.492 . . . . 0.0 109.956 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.9 pt-20 -85.53 -18.89 32.12 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.788 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.76 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.2 mt -59.36 -10.47 3.16 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.573 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.6 mm100 -67.97 -8.47 37.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -54.15 113.11 4.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.63 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.56 -12.89 15.1 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.725 2.284 . . . . 0.0 112.885 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.85 -137.34 0.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.711 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 57.9 Cg_endo -84.2 165.48 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.036 2.491 . . . . 0.0 113.967 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' VAL . 49.6 m-85 -139.15 122.7 17.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 36.1 m -106.65 118.0 35.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.253 0.549 . . . . 0.0 110.996 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.38 121.06 60.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.443 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.423 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 1.4 m-30 -82.86 111.46 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.741 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -95.82 112.39 59.1 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.52 133.42 15.81 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.06 1.84 . . . . 0.0 111.538 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.806 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 32.2 p30 -72.61 -172.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.722 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.82 -27.13 68.67 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.528 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.34 -21.28 24.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.186 0.993 . . . . 0.0 109.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' HB2' ' C ' ' A' ' 127' ' ' ASP . . . . . . . . 0 N--CA 1.439 -1.011 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.337 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.725 HD12 HD22 ' A' ' 57' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 121.028 0.442 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HG12 ' A' ' 58' ' ' VAL . 67.8 m -65.07 -40.59 94.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 t -79.82 -29.65 40.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.032 0.92 . . . . 0.0 109.16 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.725 HD22 HD12 ' A' ' 54' ' ' ILE . 6.8 mp -70.58 -26.01 63.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.222 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 55' ' ' THR . 9.9 p -80.01 -28.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.156 0.503 . . . . 0.0 109.755 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 55' ' ' THR . 24.4 mm-40 -70.56 -25.54 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.651 1.215 . . . . 0.0 108.519 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.47 168.64 26.23 Favored Pre-proline 0 N--CA 1.437 -1.094 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.282 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.2 Cg_exo -38.16 169.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 124.633 3.555 . . . . 0.0 115.424 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 51.9 Cg_exo -40.58 -8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 1 C-N-CA 126.632 4.888 . . . . 0.0 118.296 -172.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.558 ' HG2' ' HD2' ' A' ' 66' ' ' ARG . 9.4 tt0 -42.61 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 67' ' ' ILE . 13.4 tp -46.92 -50.98 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.35 0.26 . . . . 0.0 111.08 174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.26 -32.59 44.32 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.265 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.26 -51.38 21.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.528 0.68 . . . . 0.0 109.53 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 64' ' ' LEU . 62.2 mt -44.41 -53.89 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 113.969 -1.469 . . . . 0.0 113.359 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -47.19 -64.09 0.87 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.09 -62.06 1.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -122.48 -0.93 9.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.1 p80 43.04 51.6 5.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.775 0.798 . . . . 0.0 110.187 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 36' ' ' PHE . 12.9 p -120.98 159.15 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.903 -166.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 89' ' ' THR . 1.5 p -130.21 129.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 170.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.538 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.73 146.36 54.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.254 0.55 . . . . 0.0 111.168 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.81 99.1 2.57 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -63.65 101.9 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.162 0.506 . . . . 0.0 111.509 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -112.93 129.36 56.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.124 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -91.99 161.01 14.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -31.53 7.03 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.244 0.545 . . . . 0.0 112.046 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.9 t -72.39 -27.0 62.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.245 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.43 -50.36 14.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.718 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -54.38 -50.69 66.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.044 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -68.51 -35.85 78.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.747 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -56.88 -39.49 74.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.632 0.73 . . . . 0.0 110.115 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 81.1 mtp -80.49 -35.24 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.919 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.96 12.05 83.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.051 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -162.92 157.28 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.718 HG12 HD12 ' A' ' 82' ' ' LEU . 10.6 m -132.03 140.42 47.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.262 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.5 m -112.71 133.08 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.116 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 94' ' ' SER . 14.1 t -68.93 163.9 23.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.906 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.538 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -55.38 -30.77 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.479 0.657 . . . . 0.0 110.148 174.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.4 -25.85 35.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.152 -178.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.4 18.29 7.19 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.33 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.591 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.8 OUTLIER -88.1 121.3 30.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.299 0.55 . . . . 0.0 111.332 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.51 138.01 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.9 mp -127.63 127.01 24.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.8 Cg_exo -70.39 132.03 21.51 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 121.98 1.786 . . . . 0.0 113.036 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.465 ' CG1' HG13 ' A' ' 88' ' ' VAL . 40.5 mm -94.55 136.14 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.38 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 91.7 m-70 -121.0 -179.24 3.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.199 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.31 94.06 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.042 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.09 -48.21 13.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.453 0.645 . . . . 0.0 109.606 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.585 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 6.9 m-80 -138.53 -53.19 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.003 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -87.77 173.25 5.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.123 1.882 . . . . 0.0 109.99 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.808 HD23 HG21 ' A' ' 111' ' ' VAL . 16.3 tp -72.8 154.35 40.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 44.9 mt-10 -140.4 127.86 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.397 0.618 . . . . 0.0 109.523 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -129.08 122.61 56.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.013 -174.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 106' ' ' VAL . 10.9 ptmm? 46.51 -123.46 1.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.163 0.585 . . . . 0.0 111.237 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -96.94 23.55 7.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 110.608 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -118.85 166.04 13.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -128.29 138.04 52.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.808 HG21 HD23 ' A' ' 104' ' ' LEU . 88.1 t -86.2 126.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.686 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 127' ' ' ASP . 6.6 mp -89.63 -36.55 15.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.631 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.68 118.28 2.79 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.532 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.93 -174.54 3.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 32.2 t70 68.98 26.86 5.59 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -171.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -88.84 108.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.011 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.692 ' HA ' HD13 ' A' ' 122' ' ' ILE . 43.3 mt-10 -68.58 106.02 2.45 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.623 0.725 . . . . 0.0 110.72 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -81.38 178.89 8.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.716 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -44.2 -51.73 7.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.845 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -117.87 -14.61 10.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.365 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.73 -110.76 0.44 Allowed Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.169 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 117' ' ' GLU . 18.3 mm -142.66 143.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.097 -0.552 . . . . 0.0 111.387 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 116' ' ' ILE . 16.9 mt -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.222 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.547 ' CD2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.79 114.87 5.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.819 0.819 . . . . 0.0 112.043 -178.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 49.5 t -80.17 129.86 36.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.33 159.58 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.806 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -99.0 3.41 46.93 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.475 -173.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.616 ' O ' HG13 ' A' ' 126' ' ' ILE . 47.7 m -154.51 126.71 7.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.531 -172.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 54' ' ' ILE . 76.3 t . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 5' ' ' VAL . 13.5 m . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.678 0.275 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -57.67 -20.15 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.613 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.2 p -90.34 -37.3 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.557 . . . . 0.0 110.205 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.95 -50.93 71.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.204 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG22 HG23 ' A' ' 11' ' ' THR . 21.9 mt -54.42 -22.0 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.414 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.089 0.471 . . . . 0.0 110.607 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 37.8 t -74.48 -23.38 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.487 0.661 . . . . 0.0 110.291 175.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 50.6 t30 -87.26 -25.44 23.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.76 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 6.5 p -60.82 134.26 92.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -171.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -81.95 67.33 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.052 2.501 . . . . 0.0 111.808 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.34 11.72 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.098 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.7 OUTLIER -67.14 -170.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.204 0.525 . . . . 0.0 111.35 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -60.46 157.63 13.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.506 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m -60.56 -19.03 56.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.341 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.454 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.2 mm? -57.98 -30.33 65.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.18 -30.25 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.325 0.583 . . . . 0.0 109.803 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 2.2 m -83.52 -29.24 28.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.22 -31.4 71.93 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.111 0.257 . . . . 0.0 111.571 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 21' ' ' VAL . 1.2 p -81.44 -37.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.506 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 41.3 mtmt -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.13 0.491 . . . . 0.0 111.315 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 19' ' ' THR . 8.5 p -75.21 -36.04 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.663 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.38 -6.5 48.55 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.937 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 13.31 9.34 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.312 1.045 . . . . 0.0 113.172 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 92' ' ' GLU . 10.6 mp -85.77 8.97 17.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.972 -0.455 . . . . 0.0 111.437 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.68 -37.17 57.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.345 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.7 pt-20 -85.67 -20.77 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.692 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.79 -54.42 6.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.689 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 21.9 mt -58.76 -14.07 7.72 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.613 ' OE1' HG13 ' A' ' 5' ' ' VAL . 4.2 mm100 -66.52 -5.75 12.42 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.768 0.427 . . . . 0.0 111.908 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -51.65 110.43 1.83 Allowed Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 123.423 0.689 . . . . 0.0 112.406 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.33 -17.86 8.77 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.126 2.55 . . . . 0.0 113.252 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.35 -140.5 0.8 Allowed Glycine 0 CA--C 1.518 0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.372 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 30.1 Cg_endo -76.2 163.08 33.24 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.018 1.812 . . . . 0.0 112.804 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -133.51 122.71 24.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.154 -171.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.6 m -116.6 136.27 53.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.168 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 123' ' ' ILE . 5.5 p -133.02 156.13 41.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.641 . . . . 0.0 111.36 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.461 ' HB3' HD12 ' A' ' 126' ' ' ILE . 93.3 m-85 -112.26 111.04 21.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -98.91 113.33 64.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.391 . . . . 0.0 111.513 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 130.59 10.79 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.588 2.192 . . . . 0.0 112.229 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.842 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.7 p30 -84.08 -174.14 5.11 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.675 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.42 -27.05 65.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 111.678 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.52 -22.71 34.92 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.693 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.639 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.5 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.254 0.549 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 92.1 m -65.67 -32.7 74.4 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.926 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 t -81.04 -25.54 37.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.68 0.752 . . . . 0.0 109.342 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.1 mp -74.93 -25.64 59.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.041 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 11.4 p -76.97 -31.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.228 0.537 . . . . 0.0 109.756 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.4 mm-40 -71.59 -28.39 63.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 122.68 1.229 . . . . 0.0 108.578 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 3.3 m-80 -81.78 169.39 18.89 Favored Pre-proline 0 N--CA 1.437 -1.085 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 19.9 Cg_exo -37.06 170.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 125.023 3.815 . . . . 0.0 115.607 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 48.0 Cg_exo -39.4 -9.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.607 1 C-N-CA 126.566 4.844 . . . . 0.0 118.029 -172.188 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.569 ' NE2' HD23 ' A' ' 57' ' ' LEU . 4.7 tp60 -41.67 -26.5 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.153 0.981 . . . . 0.0 113.096 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.616 HD13 HG23 ' A' ' 58' ' ' VAL . 5.5 tp -51.09 -50.89 57.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 111.754 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.29 -33.06 22.97 Favored Glycine 0 N--CA 1.459 0.174 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.928 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.98 -35.25 50.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.994 0.426 . . . . 0.0 110.656 -178.084 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 64' ' ' LEU . 51.6 mt -59.76 -46.52 93.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.258 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -45.81 -63.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.926 0.766 . . . . 0.0 113.003 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -88.99 -60.01 2.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -121.13 -16.37 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 70.6 m80 64.67 33.35 10.62 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.5 p -94.47 155.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.073 -166.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.471 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.4 p -141.43 119.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.625 -1.625 . . . . 0.0 108.888 166.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.665 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.52 142.21 58.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 111.216 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 112.24 98.27 2.38 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.98 102.67 0.09 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.175 0.512 . . . . 0.0 111.685 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.462 ' O ' HG21 ' A' ' 122' ' ' ILE . 12.4 m-85 -114.67 106.84 14.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.579 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.712 ' HD3' HD12 ' A' ' 122' ' ' ILE . 21.3 mmtp -60.67 157.54 14.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 167.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -49.52 -35.41 20.0 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 123.461 0.475 . . . . 0.0 110.36 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 9.4 t -75.62 -28.53 58.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.176 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.51 -35.53 79.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.721 HD12 HG12 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -66.34 -50.55 63.18 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.105 176.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -68.08 -30.62 69.86 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 123.199 0.6 . . . . 0.0 112.264 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.26 -31.48 67.46 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-O 121.664 0.745 . . . . 0.0 109.433 172.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.7 -40.51 14.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.679 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 78.72 14.32 82.19 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.982 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.0 tt -164.39 159.92 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 HD12 ' A' ' 82' ' ' LEU . 11.9 m -131.97 137.92 53.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.428 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 m -106.77 126.91 52.91 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.397 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' H ' ' A' ' 94' ' ' SER . 72.5 m -68.45 163.87 22.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.416 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -51.45 -36.28 43.35 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.612 0.72 . . . . 0.0 110.877 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.49 -28.06 52.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.447 -179.207 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.32 10.81 7.76 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.696 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.497 ' H ' ' HB2' ' A' ' 90' ' ' SER . 0.7 OUTLIER -83.44 120.69 26.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.951 0.875 . . . . 0.0 111.759 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.15 138.06 32.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.5 mp -130.4 126.74 22.25 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.549 ' HA ' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -68.29 133.44 28.43 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 113.533 -173.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.584 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.4 mm -103.25 142.75 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.4 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -141.19 177.3 8.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.682 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.08 121.31 0.55 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.091 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -101.34 -54.14 2.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 92.8 m-20 -107.14 -61.8 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 172.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 16.0 Cg_endo -90.49 174.01 3.04 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.475 2.117 . . . . 0.0 111.244 174.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.585 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 21.3 tp -75.8 154.53 36.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -140.88 107.37 5.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.8 112.03 38.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.642 ' HB3' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER 48.54 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.321 1.448 . . . . 0.0 113.87 -174.132 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 3.1 p-10 -134.85 23.23 3.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.526 0.679 . . . . 0.0 109.573 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -129.25 157.51 41.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.077 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 44.4 m -121.9 134.31 54.86 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -78.59 127.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.613 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 112' ' ' LEU . 6.9 mp -88.82 -38.87 14.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.105 175.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.97 110.53 3.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.148 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -133.04 -173.58 3.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.65 ' OD1' ' HD2' ' A' ' 78' ' ' LYS . 20.4 t70 71.47 28.34 2.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 122.794 1.283 . . . . 0.0 107.604 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.4 mt -95.14 110.05 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.04 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.852 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.48 114.34 6.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.969 0.89 . . . . 0.0 112.391 172.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.842 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.77 -173.49 3.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.023 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -49.08 -51.19 32.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.123 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 4.2 m-20 -115.23 -20.57 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.644 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.72 -114.77 1.05 Allowed Glycine 0 CA--C 1.505 -0.539 0 C-N-CA 119.447 -1.359 . . . . 0.0 114.047 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 117' ' ' GLU . 17.8 mm -144.52 148.15 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.327 0.585 . . . . 0.0 110.951 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.842 HG13 ' HB2' ' A' ' 118' ' ' ALA . 94.6 mt -120.24 147.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.457 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -137.88 117.79 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 69.9 t -83.31 129.64 37.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.496 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -124.99 161.76 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.619 0.724 . . . . 0.0 110.457 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.842 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -95.8 5.36 51.52 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.52 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 51.0 m -148.92 126.63 11.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.813 -171.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG23 ' HB1' ' A' ' 45' ' ' ALA . 69.5 t . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.603 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 HG12 ' A' ' 5' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -54.86 -20.96 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.581 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.1 p -91.37 -37.23 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.155 0.502 . . . . 0.0 110.614 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.1 t70 -58.42 -44.5 89.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.373 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 9.1 mt -59.18 -21.69 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.637 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -34.15 76.29 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.826 -0.546 . . . . 0.0 110.751 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 6' ' ' ASP . 4.2 p -87.9 -9.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 110.112 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 54.4 t30 -92.72 -25.01 18.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.767 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 p -64.65 131.97 95.28 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.175 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.3 64.76 7.95 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.898 2.399 . . . . 0.0 112.288 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 46.96 11.95 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.898 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.63 -172.15 0.16 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.441 0.639 . . . . 0.0 112.508 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -61.3 163.13 6.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.559 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -61.44 -18.37 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.79 -37.78 52.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.35 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.85 -27.4 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.493 0.663 . . . . 0.0 110.116 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.584 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.8 m -81.64 -25.7 35.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.686 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.17 -35.07 77.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.673 0.273 . . . . 0.0 111.524 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -78.29 -37.35 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.6 mtmt -62.5 -43.55 98.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.964 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 19' ' ' THR . 7.8 p -72.73 -35.02 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.113 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.44 -5.14 46.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.043 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.36 8.46 6.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.962 1.305 . . . . 0.0 113.128 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.3 mp -85.42 9.24 16.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -37.66 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.84 -21.8 27.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.754 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -76.28 -55.4 5.6 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -176.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.9 mt -57.18 -13.83 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.209 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.581 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.7 mm100 -65.16 -13.75 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.211 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 p -56.99 114.07 7.33 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.683 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.83 -14.25 11.3 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.982 2.455 . . . . 0.0 113.482 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.45 -149.87 1.04 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.275 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 37.8 Cg_endo -73.23 170.03 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.89 2.394 . . . . 0.0 112.821 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' HB3' HG21 ' A' ' 72' ' ' VAL . 45.2 m-85 -139.92 124.08 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 21.9 m -106.22 124.03 48.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 123' ' ' ILE . 41.3 t -113.88 134.07 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.962 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -100.25 116.27 31.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -104.93 117.78 57.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.317 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.79 125.86 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.023 1.816 . . . . 0.0 111.853 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.753 ' OD1' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -75.85 176.02 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.13 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -59.67 -35.4 74.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.636 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 12.4 t70 -78.83 -19.45 52.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.838 0.828 . . . . 0.0 108.816 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.568 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.482 177.6 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 58' ' ' VAL . 74.7 m -59.92 -32.55 70.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.83 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -83.56 -23.83 31.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.161 0.981 . . . . 0.0 109.121 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 9.0 mp -77.92 -20.39 52.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 55' ' ' THR . 8.0 p -91.71 -22.72 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.013 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 55' ' ' THR . 20.2 mm-40 -64.12 -44.87 90.91 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.67 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 64.2 t30 -162.9 14.33 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 4.0 Cg_exo -91.38 150.94 3.63 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 CA-C-N 121.202 1.465 . . . . 0.0 111.435 153.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 61' ' ' PRO . 24.2 Cg_exo -66.51 -15.61 48.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.087 2.525 . . . . 0.0 112.805 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 3.2 tt0 -46.85 -29.75 2.14 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 67' ' ' ILE . 9.3 tp -45.66 -50.03 13.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -44.91 -44.71 8.93 Favored Glycine 0 CA--C 1.511 -0.205 0 O-C-N 124.103 0.877 . . . . 0.0 114.218 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.71 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.63 -35.2 34.31 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.62 0.247 . . . . 0.0 110.57 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.5 mt -51.67 -47.51 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.184 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -45.92 -56.03 5.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.53 -64.0 1.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 79.1 m-85 -125.89 -0.78 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 14.7 p-80 43.99 53.35 6.4 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.726 0.774 . . . . 0.0 110.041 -168.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 36' ' ' PHE . 10.2 p -123.82 154.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.271 -166.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.466 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.8 p -125.27 127.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.657 171.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.518 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.56 143.83 57.64 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.077 0.465 . . . . 0.0 111.156 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.72 99.48 2.6 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.888 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . . . -61.8 98.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.579 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' HG21 ' A' ' 122' ' ' ILE . 5.1 m-85 -113.6 110.19 19.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.825 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.722 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.1 mmtp -59.66 160.68 6.97 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 165.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.35 -23.64 65.9 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.2 t -72.57 -31.08 64.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.58 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -73.77 -43.59 58.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.722 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -62.34 -55.39 28.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.914 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.94 -35.19 77.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.147 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -51.34 -44.52 62.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.664 0.745 . . . . 0.0 110.23 173.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -38.68 49.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.272 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.15 6.66 86.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.043 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.6 tt -163.07 158.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG12 HD12 ' A' ' 82' ' ' LEU . 14.1 m -129.98 140.89 47.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.093 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -110.1 126.27 53.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.66 0.743 . . . . 0.0 110.64 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 75.0 m -72.18 168.61 17.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.386 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 74' ' ' ALA . 4.7 tp -56.14 -37.7 69.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.873 0.844 . . . . 0.0 109.78 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.9 pm0 -75.36 -15.19 60.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.705 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.93 8.88 47.1 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.164 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -78.35 118.45 20.55 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -83.56 141.29 31.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.359 0.6 . . . . 0.0 111.997 176.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.594 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -133.99 126.22 18.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.957 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.6 Cg_exo -70.43 128.72 15.8 Favored 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 122.1 1.867 . . . . 0.0 112.604 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.559 ' CG1' HG13 ' A' ' 88' ' ' VAL . 39.0 mm -96.9 133.48 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.733 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 54.7 m80 -130.89 -179.77 5.51 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.589 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.67 114.01 0.4 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.653 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.98 -51.76 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.503 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 78.2 m-20 -132.83 -57.59 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.332 171.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 45.4 Cg_endo -85.02 172.8 8.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.153 1.902 . . . . 0.0 110.71 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.0 152.9 38.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.32 0.581 . . . . 0.0 110.72 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 8.7 mm-40 -130.96 106.93 8.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.454 -175.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.49 115.43 48.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.856 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.9 ptmt 55.74 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.71 1.604 . . . . 0.0 113.213 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 2.9 p-10 -149.69 24.26 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -126.9 166.11 18.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.399 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 41.7 m -126.59 132.34 51.31 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 t -74.75 131.89 34.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.477 0.656 . . . . 0.0 111.422 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 127' ' ' ASP . 7.1 mp -91.7 -46.64 7.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.781 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -145.97 114.12 6.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.7 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HB1' ' ND1' ' A' ' 124' ' ' HIS . . . -135.91 -173.39 3.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 49.2 m-20 67.81 28.47 7.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -172.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -86.62 114.32 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.104 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' HA ' HD13 ' A' ' 122' ' ' ILE . 37.1 mt-10 -67.96 106.91 2.48 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.928 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.7 -179.47 7.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.295 -175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.93 -49.53 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.6 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.06 -18.91 9.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.907 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -147.98 -108.08 0.49 Allowed Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 119.724 -1.227 . . . . 0.0 114.093 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.58 HD12 ' HD3' ' A' ' 78' ' ' LYS . 17.1 mm -142.9 153.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.401 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.928 HG13 ' HB2' ' A' ' 118' ' ' ALA . 89.0 mt -128.58 147.59 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.53 ' ND1' ' HB1' ' A' ' 114' ' ' ALA . 4.6 m-70 -138.09 117.4 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.736 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 95.4 t -82.2 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -122.97 156.33 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.028 0.918 . . . . 0.0 111.286 -176.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.753 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 32.1 t70 -98.68 19.52 14.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.971 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.552 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -158.89 131.47 6.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.874 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.689 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 5' ' ' VAL . 42.8 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -56.56 -19.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' OE1' ' A' ' 31' ' ' GLN . 1.8 p -91.24 -36.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 0.0 110.705 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.12 -45.47 87.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.566 0.698 . . . . 0.0 110.253 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 14.3 mt -56.86 -21.55 14.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.873 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.12 74.57 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.978 -0.451 . . . . 0.0 110.936 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.35 -24.35 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 110.114 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 60.2 t30 -81.04 -25.43 37.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.175 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 5.8 p -63.21 130.63 94.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.4 Cg_exo -79.26 68.87 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.94 2.427 . . . . 0.0 111.932 175.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.25 46.83 14.41 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.456 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 1.1 t80 -65.9 -169.72 0.07 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.354 0.597 . . . . 0.0 111.329 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 m -62.78 159.91 15.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -61.02 -17.95 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.39 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 mp -52.34 -37.02 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.215 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -80.02 -27.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.596 0.712 . . . . 0.0 109.805 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.601 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.5 m -83.29 -28.24 29.26 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.109 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.0 -32.38 72.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.708 0.29 . . . . 0.0 111.482 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.54 -37.44 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.499 171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 37.5 mtmt -61.97 -43.59 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.852 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 19' ' ' THR . 7.9 p -72.65 -35.57 50.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.8 -7.89 54.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.847 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.31 10.66 6.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.767 1.227 . . . . 0.0 112.772 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 66' ' ' ARG . 9.5 mp -85.9 9.13 17.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.976 -0.452 . . . . 0.0 112.111 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.1 t -58.14 -36.53 57.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.005 0.431 . . . . 0.0 109.932 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.54 -21.25 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.659 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.06 -52.41 8.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.71 0.291 . . . . 0.0 111.759 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 26.3 mt -57.71 -15.35 7.61 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.598 ' OE1' HG13 ' A' ' 5' ' ' VAL . 6.6 mm100 -65.54 -13.17 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.237 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.9 m -56.02 112.95 4.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 123.469 0.48 . . . . 0.0 111.726 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.72 -9.36 13.33 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.015 2.477 . . . . 0.0 113.043 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.72 -145.13 0.15 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.797 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 76' ' ' ALA . 2.1 Cg_endo -78.32 169.02 20.75 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB3' HG21 ' A' ' 72' ' ' VAL . 35.6 m-85 -139.65 121.33 15.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.304 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.7 m -108.33 115.58 30.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.284 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.47 124.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.784 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.686 ' HD1' ' NE2' ' A' ' 124' ' ' HIS . 38.1 m-85 -84.01 110.43 18.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -96.47 122.19 58.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.572 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 129' ' ' VAL . 69.8 Cg_endo -76.69 126.77 9.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.159 1.906 . . . . 0.0 112.274 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.891 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -74.88 178.44 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.42 177.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -57.21 -36.71 71.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.65 -19.83 48.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.647 0.736 . . . . 0.0 109.053 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.735 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.296 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.631 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.147 0.498 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.684 ' O ' HG12 ' A' ' 58' ' ' VAL . 86.8 m -59.23 -35.26 73.33 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -82.74 -24.91 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.991 0.901 . . . . 0.0 109.291 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.8 mp -75.27 -25.62 58.14 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 55' ' ' THR . 7.3 p -78.3 -29.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.2 mm-40 -71.4 -26.6 62.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.477 1.132 . . . . 0.0 108.668 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.45 167.77 31.65 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.532 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 63' ' ' GLN . 38.4 Cg_exo -38.88 168.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.369 3.379 . . . . 0.0 114.734 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 39.5 Cg_exo -39.08 -8.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.675 1 C-N-CA 126.547 4.832 . . . . 0.0 118.06 -173.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 66' ' ' ARG . 21.8 tt0 -42.2 -17.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.661 ' HA ' HD12 ' A' ' 67' ' ' ILE . 16.2 tp -47.51 -51.6 20.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.403 0.281 . . . . 0.0 111.399 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -54.62 -32.81 54.13 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.973 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.522 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.25 -50.57 45.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 109.573 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 64' ' ' LEU . 57.4 mt -46.92 -51.71 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.428 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -51.33 -61.55 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -171.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -81.76 -63.06 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -165.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.502 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 64.8 m-85 -124.39 -2.77 7.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.5 m80 59.63 34.21 22.18 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 70' ' ' TYR . 7.4 p -113.59 156.41 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -162.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.554 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.6 p -125.14 126.66 71.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.865 168.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.3 140.91 58.74 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 120.945 0.402 . . . . 0.0 110.609 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.41 97.26 2.32 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.001 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -60.87 108.4 0.85 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.443 0.64 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.01 132.34 55.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.129 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.73 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -88.86 165.42 14.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.9 58.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.255 0.55 . . . . 0.0 110.974 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 13.3 t -72.25 -26.08 61.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.585 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.35 -48.67 16.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.07 -51.26 70.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.605 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 98' ' ' ILE . 6.9 ttpm? -65.68 -35.39 80.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.033 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -51.75 -44.32 63.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.732 0.777 . . . . 0.0 110.326 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -73.29 -39.04 65.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.257 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.79 7.11 88.92 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.472 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.58 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.8 tt -163.27 159.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.657 HG12 HD12 ' A' ' 82' ' ' LEU . 8.5 m -130.17 138.0 55.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.189 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.494 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.7 m -114.29 133.2 55.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.092 0.473 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB2' ' OE2' ' A' ' 92' ' ' GLU . 58.3 m -85.41 178.27 7.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.479 -174.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 74' ' ' ALA . 1.7 tp -56.0 -39.35 71.75 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.728 ' OE1' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -84.42 -16.67 41.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 89' ' ' THR . . . 113.15 22.22 5.65 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.114 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.728 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 5.5 p -86.86 120.56 28.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 117.714 0.757 . . . . 0.0 110.541 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -93.08 138.32 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.0 mp -130.88 125.99 21.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.715 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' A' ' 87' ' ' ILE . 7.1 Cg_exo -68.76 133.79 28.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.192 1.928 . . . . 0.0 113.362 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.468 ' CG1' HG13 ' A' ' 88' ' ' VAL . 41.0 mm -98.95 136.03 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.317 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.53 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 18.0 m-70 -120.86 177.62 5.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.056 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.04 107.97 0.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.443 -1.36 . . . . 0.0 113.428 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -104.57 -41.09 5.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 109.908 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.9 t-20 -127.12 -63.98 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.186 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -84.9 174.19 7.6 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.018 1.812 . . . . 0.0 110.74 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 111' ' ' VAL . 14.8 tp -73.86 152.21 40.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 3.6 mm-40 -137.58 122.6 19.06 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.615 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -128.74 123.77 59.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.108 -175.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 11.2 ptmm? 46.9 -132.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.671 0.607 . . . . 0.0 110.768 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -88.27 25.67 1.58 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 0.0 110.473 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.87 163.1 22.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.759 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 81.0 m -127.88 140.89 51.74 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.746 HG21 HD23 ' A' ' 104' ' ' LEU . 38.4 t -84.5 125.51 40.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.43 0.633 . . . . 0.0 112.394 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.2 -36.45 16.79 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.293 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.25 111.56 2.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.505 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -135.82 -174.21 3.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 19.3 t70 69.84 25.8 4.92 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -90.79 105.92 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.774 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.1 108.54 3.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 122.284 1.04 . . . . 0.0 112.485 177.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -83.67 -177.54 6.74 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.591 -175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -43.98 -51.38 7.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.647 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.17 -13.61 9.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.878 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.44 -109.79 0.42 Allowed Glycine 0 CA--C 1.501 -0.825 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.356 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 117' ' ' GLU . 10.4 mm -145.62 144.19 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.558 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB2' ' A' ' 118' ' ' ALA . 29.3 mt -113.61 150.91 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.453 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.686 ' NE2' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.11 115.17 6.14 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 122.12 0.962 . . . . 0.0 111.767 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 40.7 t -82.3 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.181 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -122.75 160.32 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.313 1.054 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.891 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 28.8 t70 -93.98 1.61 56.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.534 -169.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.597 ' O ' HG13 ' A' ' 126' ' ' ILE . 4.6 m -159.36 131.05 6.29 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.22 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 45' ' ' ALA . 77.0 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.751 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.482 HG22 HG12 ' A' ' 5' ' ' VAL . 46.5 m . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.7 -21.83 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' OE1' ' A' ' 31' ' ' GLN . 1.4 p -91.42 -34.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 110.28 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.3 -48.43 74.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.831 0.824 . . . . 0.0 109.751 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 24.2 mt -55.05 -21.46 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.657 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.0 76.07 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.863 -0.523 . . . . 0.0 110.583 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.7 t -79.15 -15.38 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.453 0.644 . . . . 0.0 110.421 174.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 64.6 t30 -94.06 -24.5 17.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.1 p -60.55 130.34 90.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 3.8 Cg_exo -79.1 64.53 8.84 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.966 2.444 . . . . 0.0 112.506 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.56 45.36 7.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.594 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.606 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.16 -175.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -58.31 154.34 13.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.316 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -57.94 -18.86 26.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.69 -32.77 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.98 -28.84 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.398 0.618 . . . . 0.0 109.623 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.63 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.7 m -82.46 -27.72 31.7 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.79 -37.52 84.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -36.46 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.004 -0.435 . . . . 0.0 110.513 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 39.1 mtmt -62.08 -43.24 99.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 111.027 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 19' ' ' THR . 8.6 p -74.69 -34.13 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.23 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -75.31 -8.04 55.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.913 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 73.03 10.45 5.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.362 1.065 . . . . 0.0 112.976 177.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.83 6.9 26.05 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.99 -0.443 . . . . 0.0 112.038 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.22 -36.56 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.988 0.423 . . . . 0.0 110.455 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 4.0 pt-20 -86.21 -18.81 31.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.973 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.95 -54.92 5.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.694 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.5 mt -56.37 -13.9 2.56 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.598 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.1 mm100 -64.39 -10.39 24.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.044 0.537 . . . . 0.0 112.215 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -61.62 110.77 3.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.346 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.48 -15.58 9.81 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.139 2.559 . . . . 0.0 113.593 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.68 -138.43 0.22 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.917 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 23.9 Cg_endo -74.85 165.37 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.223 1.949 . . . . 0.0 113.643 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.22 125.66 28.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.803 -170.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 38.1 m -124.6 119.79 30.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -118.0 152.1 20.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -108.95 106.94 17.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -99.23 112.22 62.73 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.24 130.61 13.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.407 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.779 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.6 p30 -81.55 -174.43 4.96 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.829 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -59.77 -30.0 68.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.654 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 15.4 t70 -81.84 -19.63 40.65 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.016 0.912 . . . . 0.0 109.17 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.74 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.047 177.209 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.392 0.615 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.688 ' O ' HG12 ' A' ' 58' ' ' VAL . 88.1 m -64.62 -34.13 77.55 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.367 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -81.81 -24.63 35.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.792 0.806 . . . . 0.0 109.101 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 7.6 mp -71.19 -31.29 67.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.993 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 55' ' ' THR . 9.8 p -73.72 -31.49 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.089 0.471 . . . . 0.0 109.731 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.9 mm-40 -73.0 -30.43 63.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.784 1.278 . . . . 0.0 108.325 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 1.6 m-80 -76.52 169.6 20.23 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.901 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 26.2 Cg_exo -37.31 168.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 124.439 3.426 . . . . 0.0 115.191 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 43.3 Cg_exo -40.03 -11.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 1 C-N-CA 126.537 4.825 . . . . 0.0 118.905 -168.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.679 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 7.5 tt0 -43.79 -25.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 68' ' ' LEU . 12.7 tp -46.98 -48.67 21.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.585 0.354 . . . . 0.0 111.905 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.473 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -49.64 -40.34 32.43 Favored Glycine 0 N--CA 1.458 0.14 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.829 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.697 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.61 -37.54 59.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.85 0.357 . . . . 0.0 110.049 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.6 mt -57.06 -45.19 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.717 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -48.93 -59.1 3.88 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.739 0.649 . . . . 0.0 112.673 -176.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -83.8 -64.46 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.527 -169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 71' ' ' HIS . 2.8 m-85 -125.98 -13.25 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 70' ' ' TYR . 11.1 t-80 68.09 40.44 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -175.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CD2' ' A' ' 36' ' ' PHE . 13.2 p -121.55 159.77 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.444 -165.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 72' ' ' VAL . 1.9 p -128.72 128.53 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.15 170.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' HD13 ' A' ' 91' ' ' LEU . . . -68.23 140.72 56.06 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.318 0.58 . . . . 0.0 110.854 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 113.36 97.96 2.3 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.755 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.12 101.24 0.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 122.909 0.483 . . . . 0.0 111.86 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' HD11 ' A' ' 82' ' ' LEU . 2.7 m-85 -119.03 117.54 29.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.706 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.9 mtpt -75.31 163.52 27.39 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.006 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.42 59.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.012 0.434 . . . . 0.0 110.714 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 10.0 t -71.29 -27.85 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.071 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -78.68 -49.07 13.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.323 0.582 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -55.41 -52.48 63.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.166 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.53 -33.9 75.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 80' ' ' THR . 1.1 ttt180 -54.51 -40.6 68.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.546 0.689 . . . . 0.0 110.077 176.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -80.21 -41.6 24.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.04 10.65 78.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.726 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.1 tt -162.64 156.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.694 HG12 HD12 ' A' ' 82' ' ' LEU . 13.3 m -131.1 139.13 51.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -107.3 128.02 54.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.648 0.737 . . . . 0.0 110.839 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.597 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 60.6 m -72.6 166.11 23.38 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.502 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 74' ' ' ALA . 5.0 tp -56.98 -36.18 70.05 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-O 121.946 0.879 . . . . 0.0 109.642 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.679 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 3.6 pm0 -76.65 -12.31 59.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.86 6.48 57.08 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.602 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 90' ' ' SER . 57.5 m -77.85 119.96 22.07 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.98 133.78 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.551 ' HB ' HG23 ' A' ' 88' ' ' VAL . 1.6 mp -122.23 127.05 26.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.2 Cg_exo -72.7 130.43 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.709 1.606 . . . . 0.0 112.852 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HG13 ' A' ' 88' ' ' VAL . 35.9 mm -94.53 134.34 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 68.8 m-70 -123.84 -179.27 4.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.738 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.87 97.04 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.998 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.07 -53.25 4.56 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.555 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 21.9 t-20 -118.0 -56.02 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 23.9 Cg_endo -90.7 174.13 2.89 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.613 2.209 . . . . 0.0 110.795 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 111' ' ' VAL . 13.0 tp -74.12 152.38 39.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 39.4 mt-10 -136.85 109.64 7.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 109.478 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.49 106.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -176.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 2.5 ptpt 43.49 -106.99 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 112.638 -170.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -89.26 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.622 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -108.55 166.04 11.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.454 0.645 . . . . 0.0 112.729 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.7 m -129.15 133.57 47.67 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.555 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 HD23 ' A' ' 104' ' ' LEU . 17.4 t -85.33 131.05 35.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.641 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.9 mp -88.99 -46.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.201 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -146.77 118.76 8.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.791 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -136.61 -174.7 3.78 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 27.5 m-20 67.74 27.09 7.63 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -87.06 116.2 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.386 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.696 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.35 108.61 2.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.959 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.85 -177.7 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.777 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 1.1 pt-20 -47.53 -53.51 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.567 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 46.5 m-80 -119.08 -9.36 10.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.4 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.32 -112.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.279 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 117' ' ' GLU . 32.1 mm -143.03 148.0 19.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.329 0.585 . . . . 0.0 111.328 -171.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.959 HG13 ' HB2' ' A' ' 118' ' ' ALA . 96.7 mt -119.18 147.7 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -137.57 118.75 14.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 85.1 t -83.12 128.04 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.04 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.459 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -120.97 162.26 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.85 0.833 . . . . 0.0 110.479 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.835 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.1 t70 -107.79 16.53 23.5 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.345 -170.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 73.2 m -156.79 130.56 8.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.087 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.518 173.813 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 HG12 ' A' ' 5' ' ' VAL . 41.3 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.2 mp -44.13 -47.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.501 0.667 . . . . 0.0 111.08 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.592 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.3 p -71.89 -36.06 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.688 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.84 -46.36 74.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.939 0.875 . . . . 0.0 109.673 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.575 ' HA ' ' CB ' ' A' ' 10' ' ' ASN . 18.5 mt -56.8 -21.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.211 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . . . -61.39 -32.94 72.88 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.751 -0.593 . . . . 0.0 110.415 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.21 -34.85 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.381 0.61 . . . . 0.0 109.999 172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.575 ' CB ' ' HA ' ' A' ' 7' ' ' ILE . 17.5 t-20 -66.29 -25.22 66.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.529 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.2 p -62.45 138.48 96.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.043 -175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.7 Cg_exo -80.61 62.27 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.601 2.201 . . . . 0.0 112.315 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 46.84 20.51 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.998 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.73 -168.66 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.553 0.692 . . . . 0.0 112.423 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' HG22 ' A' ' 18' ' ' VAL . 4.6 m -58.57 158.94 7.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.856 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -60.49 -17.99 48.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -52.6 -35.27 53.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 8' ' ' ALA . 3.9 m -80.92 -28.45 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.686 0.755 . . . . 0.0 109.967 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.578 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -79.79 -29.05 40.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 -177.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.83 -35.66 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.818 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 -36.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.11 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 27.2 mtmt -61.5 -43.86 98.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.299 0.571 . . . . 0.0 110.982 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 19' ' ' THR . 8.3 p -73.52 -35.93 46.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.98 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.04 -4.19 33.95 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.656 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.15 9.68 7.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.272 1.029 . . . . 0.0 112.842 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.2 mp -87.25 7.34 28.91 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.91 -0.494 . . . . 0.0 111.805 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -59.41 -36.98 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.197 0.522 . . . . 0.0 109.792 176.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 6.1 pt-20 -85.85 -21.82 27.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.626 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.89 -54.89 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 19.8 mt -58.54 -9.81 1.86 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.592 ' OE1' HG13 ' A' ' 5' ' ' VAL . 6.4 mm100 -70.98 4.64 2.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.826 0.45 . . . . 0.0 112.054 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.2 p -48.02 112.55 2.26 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 123.98 0.8 . . . . 0.0 112.412 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 32' ' ' SER . 4.5 Cg_exo -80.98 -12.57 11.9 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.24 2.627 . . . . 0.0 111.254 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.79 -135.11 1.91 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.147 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 17.7 Cg_endo -84.3 170.94 10.41 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.917 2.412 . . . . 0.0 113.174 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.702 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -139.08 122.96 17.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.702 HG21 ' CG ' ' A' ' 77' ' ' TYR . 0.4 OUTLIER -126.83 119.88 27.9 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -174.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 123' ' ' ILE . 7.4 p -117.42 145.03 23.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.245 0.545 . . . . 0.0 111.261 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.663 ' HD1' ' CE1' ' A' ' 124' ' ' HIS . 55.3 m-85 -93.06 109.25 20.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -91.35 111.86 51.08 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 120.673 0.273 . . . . 0.0 111.318 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.41 128.33 8.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.099 1.866 . . . . 0.0 111.739 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.849 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.2 p30 -80.91 -175.41 5.35 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.994 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.74 -32.0 59.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -83.22 -23.89 32.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.698 0.761 . . . . 0.0 109.185 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.788 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.621 177.9 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 57' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 58' ' ' VAL . 63.0 m -55.36 -37.37 67.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.732 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -81.8 -27.24 33.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.91 0.862 . . . . 0.0 109.369 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 54' ' ' ILE . 10.1 mp -73.11 -25.17 60.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.838 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -79.14 -29.21 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 121.172 0.511 . . . . 0.0 109.865 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 55' ' ' THR . 27.5 mm-40 -71.79 -27.27 62.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 122.575 1.179 . . . . 0.0 108.706 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.58 166.69 37.17 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.057 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 30.5 Cg_exo -39.21 168.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.306 3.338 . . . . 0.0 114.641 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 21.6 Cg_exo -34.73 -10.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 1 C-N-CA 127.345 5.364 . . . . 0.0 119.393 -172.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.631 HE21 ' NH1' ' A' ' 66' ' ' ARG . 19.6 tt0 -42.34 -24.93 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 ' O ' HD22 ' A' ' 68' ' ' LEU . 11.5 tp -44.56 -49.02 10.31 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.378 0.671 . . . . 0.0 112.477 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.97 -31.73 33.06 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.843 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.631 ' NH1' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 0.0 110.02 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.696 HD13 HG13 ' A' ' 54' ' ' ILE . 36.0 mt -68.64 -46.97 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.362 -169.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -50.15 -59.37 3.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -174.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.79 -62.45 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -168.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.39 -13.78 7.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 t60 65.83 36.26 6.21 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.4 p -109.82 160.44 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.57 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.53 ' HB ' HH21 ' A' ' 66' ' ' ARG . 0.8 OUTLIER -136.63 131.39 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -70.2 138.84 52.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 120.69 88.39 1.04 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.308 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -56.22 98.53 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 112.124 -171.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 1.002 ' CG ' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -95.66 147.72 23.3 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.042 179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.668 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -110.73 152.75 26.21 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.37 -30.49 12.42 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 0.0 112.061 -169.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 12.2 t -75.42 -25.0 57.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.858 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.79 -51.61 18.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.857 0.836 . . . . 0.0 109.386 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.002 HD21 ' CG ' ' A' ' 77' ' ' TYR . 0.3 OUTLIER -57.72 -50.72 72.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.703 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -66.96 -33.0 74.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.741 0.305 . . . . 0.0 111.328 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -55.0 -40.95 70.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.432 0.634 . . . . 0.0 110.274 173.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.8 mtt -78.44 -41.82 31.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.716 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.85 10.71 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.907 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.1 tt -163.83 157.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 95' ' ' THR . 15.1 m -131.59 141.7 45.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.772 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.8 m -108.93 133.55 52.78 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.221 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 94' ' ' SER . 26.3 t -66.14 164.88 14.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.908 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.2 tp -56.89 -33.59 67.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.558 0.694 . . . . 0.0 109.78 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -27.24 41.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.749 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.21 3.27 11.88 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.893 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.531 ' H ' ' HB3' ' A' ' 90' ' ' SER . 1.8 m -78.34 120.44 23.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.788 0.794 . . . . 0.0 111.564 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -85.03 141.72 30.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.8 mp -127.28 127.27 24.26 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.645 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.2 Cg_exo -72.59 130.06 15.47 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.021 1.814 . . . . 0.0 113.35 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.564 ' CG1' HG13 ' A' ' 88' ' ' VAL . 42.1 mm -98.89 141.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.344 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.433 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 31.1 m80 -134.92 178.8 6.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.543 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.58 110.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.612 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.27 -48.1 8.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 8.1 t30 -128.13 -55.69 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.138 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 15.9 Cg_endo -90.47 173.71 3.12 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.264 1.976 . . . . 0.0 110.8 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 111' ' ' VAL . 14.5 tp -74.48 153.99 38.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 4.3 mm-40 -138.65 119.29 14.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.612 -174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.513 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -119.39 106.01 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.301 -173.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.672 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.8 pttp 49.83 -78.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.536 1.535 . . . . 0.0 113.812 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.481 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 30.3 p-10 -125.29 1.19 7.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.526 0.679 . . . . 0.0 109.344 -172.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -117.6 165.31 13.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.431 -173.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -125.46 136.21 53.14 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.874 HG21 HD23 ' A' ' 104' ' ' LEU . 99.0 t -83.18 127.47 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.234 -174.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.3 mp -93.25 -32.87 14.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.865 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -162.99 116.53 1.64 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.434 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.79 -175.77 4.01 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 29.7 t70 68.11 25.65 7.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -169.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.5 mt -85.06 109.09 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.114 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.554 ' HA ' HD13 ' A' ' 122' ' ' ILE . 35.8 mt-10 -67.56 106.92 2.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.471 0.653 . . . . 0.0 111.14 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.808 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -80.27 -175.17 4.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.399 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.09 -52.26 45.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.429 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.7 m-20 -117.78 -12.78 10.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -149.13 -111.45 0.59 Allowed Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.565 -1.302 . . . . 0.0 112.79 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.668 HG13 ' HE3' ' A' ' 78' ' ' LYS . 7.6 mm -145.31 149.14 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.539 0.685 . . . . 0.0 111.676 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.808 HG13 ' HB2' ' A' ' 118' ' ' ALA . 87.9 mt -114.4 151.17 16.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.462 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.713 ' NE2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.15 112.91 5.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.055 0.931 . . . . 0.0 112.178 -178.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 46.1 t -80.08 130.09 36.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.635 -174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.66 163.34 25.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.672 0.749 . . . . 0.0 110.123 176.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.849 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 34.7 t70 -106.32 14.71 27.07 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.017 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.643 ' O ' HG13 ' A' ' 126' ' ' ILE . 15.9 m -164.26 131.0 3.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.248 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.648 176.355 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.577 HG22 HG12 ' A' ' 5' ' ' VAL . 57.3 m . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.61 -20.9 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 3' ' ' THR . 2.6 p -92.39 -37.32 8.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.175 0.512 . . . . 0.0 111.003 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.05 -48.91 52.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.586 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 7.5 mt -59.48 -22.14 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.932 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.52 77.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.314 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.67 -26.6 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 110.259 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 47.6 t30 -77.28 -25.27 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.365 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 7' ' ' ILE . 12.6 p -65.89 138.9 96.58 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 59.12 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.516 2.811 . . . . 0.0 112.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.87 44.1 10.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.881 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -66.09 -178.31 0.6 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -55.43 158.34 3.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.985 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -58.37 -18.38 27.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.514 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -53.36 -35.94 60.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.112 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.26 -30.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.592 0.711 . . . . 0.0 110.064 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -80.82 -29.74 35.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.472 -173.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -64.66 -33.53 76.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -37.43 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 109.886 171.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 7.6 mtmt -61.52 -39.9 92.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.428 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' THR . 7.4 p -77.11 -36.18 24.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.393 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -73.84 -6.69 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.026 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 72.64 10.99 5.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.181 0.992 . . . . 0.0 112.276 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 66' ' ' ARG . 7.8 mp -87.23 7.03 30.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.714 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -36.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.19 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.8 pt-20 -85.38 -21.62 28.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.829 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.75 -53.75 8.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.1 mt -61.74 -5.65 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.299 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.687 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 6.7 mm100 -74.29 10.44 1.27 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.497 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 m -92.85 95.27 1.05 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-O 120.944 0.402 . . . . 0.0 110.01 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 31' ' ' GLN . 53.8 Cg_endo -80.53 -8.01 13.7 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.072 2.515 . . . . 0.0 113.5 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -124.07 0.02 OUTLIER Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.881 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 37.9 Cg_endo -78.99 154.26 25.66 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.28 1.32 . . . . 0.0 112.597 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.657 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -138.69 121.67 16.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.128 -168.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.4 m -119.63 124.23 45.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.271 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' HG12 ' A' ' 123' ' ' ILE . 98.5 t -122.02 140.97 44.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.236 0.541 . . . . 0.0 111.949 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.49 115.3 29.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -105.65 117.98 56.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.167 -173.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.32 125.13 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.995 1.797 . . . . 0.0 111.582 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.768 HD22 ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -78.7 173.27 12.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.24 -46.01 8.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.609 0.719 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.9 -20.79 61.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.776 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 42' ' ' ASN . . . . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.314 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 120.993 0.425 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.742 ' O ' HG12 ' A' ' 58' ' ' VAL . 90.9 m -66.74 -35.64 80.58 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -79.3 -27.24 42.18 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.868 0.842 . . . . 0.0 109.262 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.3 mp -76.21 -25.71 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.43 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -75.28 -28.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.3 mm-40 -73.55 -27.14 61.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.64 1.21 . . . . 0.0 108.771 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 5.3 m-80 -84.44 168.37 21.7 Favored Pre-proline 0 N--CA 1.435 -1.197 0 CA-C-N 112.982 -1.917 . . . . 0.0 111.038 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 28.8 Cg_exo -38.3 168.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 124.543 3.495 . . . . 0.0 115.197 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 15.3 Cg_exo -34.08 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.896 1 C-N-CA 127.824 5.683 . . . . 0.0 120.551 -166.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.602 ' O ' HG13 ' A' ' 67' ' ' ILE . 3.5 tt0 -43.89 -28.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.664 ' O ' HD22 ' A' ' 68' ' ' LEU . 16.5 tp -44.83 -51.1 9.86 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.223 0.609 . . . . 0.0 112.305 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.72 -34.73 37.02 Favored Glycine 0 N--CA 1.461 0.307 0 O-C-N 123.599 0.562 . . . . 0.0 113.321 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.596 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.71 -40.11 61.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.434 0.635 . . . . 0.0 110.026 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.1 mt -62.51 -47.52 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.828 -174.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.64 -62.35 1.33 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.949 0.781 . . . . 0.0 112.822 -173.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -88.96 -61.94 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -122.13 -12.81 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 59.9 38.01 21.33 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.5 p -106.7 159.39 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.586 -165.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.1 p -132.99 125.57 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.556 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.562 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -67.36 141.96 56.93 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.346 0.593 . . . . 0.0 110.712 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.78 100.16 2.23 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.392 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -61.32 102.26 0.22 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.244 0.545 . . . . 0.0 111.834 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 82' ' ' LEU . 3.2 m-85 -120.71 122.4 40.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.135 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.603 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.08 159.34 27.57 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 170.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -48.99 -36.78 18.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.45 0.469 . . . . 0.0 110.633 -172.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 6.5 t -72.36 -23.99 61.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.287 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.38 -40.17 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.08 -48.87 78.28 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.421 175.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.704 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.8 mtpt -66.53 -29.42 69.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 122.946 0.498 . . . . 0.0 112.218 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.12 -32.47 68.15 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 122.021 0.915 . . . . 0.0 109.299 173.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.1 -42.5 12.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.464 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' HB ' ' A' ' 98' ' ' ILE . . . 80.96 12.01 83.13 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.61 -172.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.9 tt -163.22 159.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 HD12 ' A' ' 82' ' ' LEU . 9.4 m -133.21 139.28 49.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 73' ' ' VAL . 4.3 m -107.37 129.81 54.87 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.505 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 21.4 t -71.44 165.83 22.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.498 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.3 tp -56.74 -30.15 63.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.787 0.803 . . . . 0.0 109.894 173.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 8.0 pt-20 -78.37 -22.96 47.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.48 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.13 11.76 27.1 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.34 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 90' ' ' SER . 73.4 m -88.83 122.29 32.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 122.44 -0.447 . . . . 0.0 111.99 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.3 137.71 32.79 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -128.05 130.08 23.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.509 177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.7 Cg_exo -72.57 134.91 23.13 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.023 1.815 . . . . 0.0 113.328 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -98.61 135.31 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.743 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 53.2 m80 -127.88 -178.81 4.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.682 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.75 100.3 0.16 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.094 -1.051 . . . . 0.0 113.204 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.91 -35.36 26.16 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.5 t-20 -144.2 -55.83 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.185 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 42.2 Cg_endo -85.72 174.04 6.88 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.163 1.909 . . . . 0.0 110.623 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.704 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 16.1 tp -72.89 151.02 42.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 43.5 mt-10 -140.99 106.33 5.04 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -109.12 132.28 57.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.033 -173.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HG2' HG22 ' A' ' 106' ' ' VAL . 12.2 ptmm? 55.36 -82.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.646 1.179 . . . . 0.0 112.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.504 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 22.8 p-10 -146.04 23.03 1.37 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.642 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -125.86 162.99 23.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.252 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.8 m -122.33 131.24 53.81 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 t -78.58 127.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.399 0.619 . . . . 0.0 111.695 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.03 -39.0 13.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.222 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.07 118.35 5.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.72 -174.23 3.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 10.5 m-20 66.26 27.15 10.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -173.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -85.0 114.16 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.5 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.1 mt-10 -66.24 108.83 2.43 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.389 0.614 . . . . 0.0 110.61 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.508 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.26 -172.75 3.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.705 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 3.2 pt-20 -53.26 -51.49 62.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 80.7 m-20 -120.12 -10.75 9.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.3 -118.23 1.17 Allowed Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.229 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 117' ' ' GLU . 19.3 mm -146.18 146.66 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.349 0.595 . . . . 0.0 111.622 -172.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 118' ' ' ALA . 45.3 mt -118.83 146.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.654 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -133.59 116.4 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 84.4 t -81.17 127.72 39.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.259 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.591 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -125.65 160.51 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.462 0.649 . . . . 0.0 110.724 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 42' ' ' ASN . 0.7 OUTLIER -98.16 9.21 43.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.904 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.642 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 23.1 m -146.94 129.17 15.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.18 0.514 . . . . 0.0 111.346 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 C--O 1.255 1.385 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.538 172.457 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.7 mp -49.75 -42.14 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.497 0.665 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.4 p -75.03 -36.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.14 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -52.14 -48.51 64.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.509 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 15.4 mt -56.88 -22.31 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.153 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.802 -0.561 . . . . 0.0 110.45 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.85 -18.38 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 110.111 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 40.4 t30 -95.95 -25.45 15.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.855 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 4.1 p -59.25 130.38 87.07 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.038 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.24 65.7 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.136 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.5 46.77 18.29 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.208 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.62 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -63.73 -174.56 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.072 0.463 . . . . 0.0 111.516 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.74 156.82 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 m -59.72 -18.17 40.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.322 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mp -54.12 -34.85 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.408 ' C ' ' HD3' ' A' ' 22' ' ' LYS . 3.5 m -79.93 -39.09 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -68.9 -26.29 65.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.944 -175.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.615 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -66.98 -37.23 83.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -37.08 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.606 0.717 . . . . 0.0 109.872 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 1.8 mtpp -58.52 -41.14 84.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.949 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 19' ' ' THR . 7.1 p -78.16 -36.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.168 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -72.85 -1.63 17.5 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.049 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.64 7.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.068 0.947 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 92' ' ' GLU . 9.6 mp -88.84 6.22 40.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.0 -0.438 . . . . 0.0 111.666 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.978 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.2 pt-20 -84.75 -22.16 29.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.812 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -73.25 -54.77 7.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.71 0.29 . . . . 0.0 111.571 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 HD23 ' A' ' 91' ' ' LEU . 25.3 mt -57.09 -14.66 4.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' OE1' HG13 ' A' ' 5' ' ' VAL . 5.0 mm100 -68.77 -3.31 11.83 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.03 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 p -49.47 115.84 5.3 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.933 0.397 . . . . 0.0 111.474 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.72 -18.26 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.87 2.38 . . . . 0.0 113.147 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 35' ' ' PRO . . . -78.4 -135.9 1.0 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.607 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 11.2 Cg_endo -85.78 166.56 10.1 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.027 2.485 . . . . 0.0 113.098 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 72' ' ' VAL . 60.3 m-85 -133.9 122.05 22.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.7 m -104.03 104.89 14.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.568 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.467 ' HB ' HG12 ' A' ' 123' ' ' ILE . 37.2 t -95.59 123.06 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.792 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 126' ' ' ILE . 98.4 m-85 -86.56 108.04 18.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.2 128.82 39.29 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.872 -170.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HB3' HG22 ' A' ' 129' ' ' VAL . 98.6 Cg_endo -79.91 126.86 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.129 1.886 . . . . 0.0 112.55 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -78.52 177.69 8.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.4 -32.7 65.06 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.85 -19.99 33.93 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.972 0.892 . . . . 0.0 108.945 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.725 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.317 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 57' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.235 0.541 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 85.3 m -57.67 -35.98 71.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.469 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -82.73 -25.35 32.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.839 0.828 . . . . 0.0 109.14 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 54' ' ' ILE . 8.6 mp -73.1 -27.3 61.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.81 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 8.1 p -79.38 -29.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.064 0.459 . . . . 0.0 109.764 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 55' ' ' THR . 18.8 mm-40 -70.89 -27.47 63.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.699 1.238 . . . . 0.0 108.347 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -82.16 168.07 26.25 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.882 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 22.2 Cg_exo -37.45 168.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 125.008 3.805 . . . . 0.0 116.18 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 36.5 Cg_exo -40.42 -9.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.871 5.047 . . . . 0.0 118.518 -171.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.516 ' O ' HG13 ' A' ' 67' ' ' ILE . 22.9 tt0 -43.76 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' O ' HD22 ' A' ' 68' ' ' LEU . 9.5 tp -44.39 -49.95 9.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.61 0.364 . . . . 0.0 110.928 173.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -53.37 -29.7 38.9 Favored Glycine 0 C--N 1.33 0.195 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.556 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -79.35 -39.73 31.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.245 0.545 . . . . 0.0 109.856 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 64' ' ' LEU . 54.6 mt -59.22 -45.39 92.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.524 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.05 -60.13 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -175.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -85.77 -63.09 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.437 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.97 -16.9 5.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -171.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 67.23 34.99 4.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 15.0 p -111.76 159.45 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.948 -167.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 89' ' ' THR . 1.6 p -132.59 131.78 59.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.9 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.622 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.23 144.32 57.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 111.661 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.41 99.86 2.59 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.226 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -57.22 110.31 0.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.824 0.849 . . . . 0.0 111.401 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 122' ' ' ILE . 10.5 m-85 -121.03 110.09 15.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.844 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HD3' HD12 ' A' ' 122' ' ' ILE . 20.3 mmtp -65.77 161.39 20.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 168.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.94 44.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 111.407 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 15.0 t -76.48 -31.38 57.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.646 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.29 -46.86 66.15 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.735 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -58.56 -54.06 51.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.136 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -68.47 -32.04 71.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.1 ttt180 -51.04 -45.22 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.757 0.789 . . . . 0.0 110.212 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.0 mtp -81.08 -39.24 26.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 12.82 79.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.846 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.7 tt -162.95 157.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.735 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -133.11 144.09 37.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.191 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.4 m -107.03 134.63 49.89 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.675 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 94' ' ' SER . 67.5 m -73.17 162.41 29.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.794 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.4 tp -52.82 -36.63 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.425 0.631 . . . . 0.0 110.527 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.37 -28.71 59.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.288 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.1 5.36 8.88 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.673 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' A' ' 90' ' ' SER . 1.4 m -80.32 120.43 24.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.818 0.809 . . . . 0.0 112.097 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -81.97 139.45 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.0 112.807 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.7 mp -127.69 127.85 23.98 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.617 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.578 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.1 Cg_exo -72.99 132.3 18.07 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.11 1.874 . . . . 0.0 113.102 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.438 HG13 ' HB3' ' A' ' 82' ' ' LEU . 41.2 mm -95.53 136.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.303 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 33.3 m-70 -127.53 178.14 6.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.771 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.86 115.19 0.32 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.463 -1.351 . . . . 0.0 113.294 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.89 -53.81 2.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.608 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 19.8 m120 -114.68 -59.9 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.287 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 17.2 Cg_endo -90.4 173.61 3.19 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.161 1.907 . . . . 0.0 110.916 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.0 tp -75.52 153.99 37.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 5.7 mm-40 -139.01 107.1 5.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.336 0.588 . . . . 0.0 109.691 -173.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.702 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -112.98 128.46 69.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.043 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 12.1 ptmm? 51.75 -138.23 1.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.592 0.558 . . . . 0.0 110.191 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -89.97 30.79 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.307 0.575 . . . . 0.0 110.084 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.11 159.22 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.113 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 m -126.2 137.59 53.57 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.8 t -80.47 125.62 39.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.552 0.691 . . . . 0.0 111.732 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.77 -35.72 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.458 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -157.01 114.86 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.504 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -137.41 -173.88 3.6 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.591 ' CG ' ' HD2' ' A' ' 78' ' ' LYS . 12.3 t70 71.58 31.45 2.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.717 1.246 . . . . 0.0 107.646 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 10.0 mt -94.67 116.43 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.461 -1.699 . . . . 0.0 109.538 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.73 107.3 2.52 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.088 0.471 . . . . 0.0 109.759 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.908 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -78.98 -177.05 5.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.126 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.86 -50.09 46.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.415 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -118.55 -16.09 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.924 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -149.01 -109.23 0.51 Allowed Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.556 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 78' ' ' LYS . 23.1 mm -141.06 150.77 20.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.055 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.908 HG13 ' HB2' ' A' ' 118' ' ' ALA . 82.5 mt -123.32 143.43 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.727 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -135.57 114.02 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 60.2 t -78.46 128.86 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -128.74 165.94 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 122.162 0.982 . . . . 0.0 111.412 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.892 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -97.6 10.61 39.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.114 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.598 ' O ' HG13 ' A' ' 126' ' ' ILE . 18.1 m -164.18 123.39 1.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.859 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 41' ' ' PRO . 21.4 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.903 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.427 HG22 HG12 ' A' ' 5' ' ' VAL . 32.9 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -56.3 -23.68 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.572 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.0 p -91.68 -36.55 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.276 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 9' ' ' VAL . 33.0 t70 -57.76 -46.42 84.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.046 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 11' ' ' THR . 14.0 mt -57.7 -25.28 24.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.579 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -31.49 72.06 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.176 -0.327 . . . . 0.0 111.021 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 6' ' ' ASP . 7.1 p -91.27 -12.75 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.238 0.542 . . . . 0.0 110.501 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' ILE . 82.2 m-20 -91.99 -14.72 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 7' ' ' ILE . 11.0 p -59.83 138.02 90.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.186 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.84 65.61 8.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.815 2.343 . . . . 0.0 111.962 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.6 47.41 41.68 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.058 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.46 -173.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.308 0.575 . . . . 0.0 111.977 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -62.76 166.22 5.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.748 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -63.13 -19.23 64.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.8 mt -53.52 -36.81 62.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.251 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.2 -27.98 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.619 0.723 . . . . 0.0 109.853 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.621 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -79.38 -26.62 41.96 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.446 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.3 -40.58 97.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.747 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 p -74.75 -36.1 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.855 -0.528 . . . . 0.0 110.288 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 24.1 mtmt -61.11 -44.16 97.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.258 0.551 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 19' ' ' THR . 9.0 p -75.42 -34.83 31.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.113 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.65 -1.58 22.37 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.757 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.85 7.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 112.849 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.7 mp -89.95 6.55 41.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.42 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.3 pt-20 -85.64 -17.71 35.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.262 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.72 -58.49 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 14.5 mt -51.91 -13.25 0.27 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' OE1' HG13 ' A' ' 5' ' ' VAL . 8.3 mm100 -66.33 -2.85 4.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.503 0.721 . . . . 0.0 112.73 -174.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -54.52 110.35 2.09 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 123.386 0.429 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.46 -18.02 9.79 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.698 2.265 . . . . 0.0 111.839 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -133.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.276 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 44.3 Cg_endo -80.78 159.1 21.52 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.025 1.817 . . . . 0.0 113.3 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -142.7 122.15 13.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.427 -169.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.493 ' HB ' HG13 ' A' ' 73' ' ' VAL . 51.6 m -118.71 123.24 44.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -172.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' HB ' HG12 ' A' ' 123' ' ' ILE . 81.8 t -117.46 143.53 27.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.303 0.573 . . . . 0.0 111.729 -174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HB3' HD12 ' A' ' 126' ' ' ILE . 97.8 m-85 -106.14 109.3 21.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -97.1 120.48 61.24 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.474 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' HG22 ' A' ' 129' ' ' VAL . 73.5 Cg_endo -77.24 136.47 16.09 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.661 2.241 . . . . 0.0 112.687 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.76 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.9 p30 -85.87 -173.78 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.2 -31.08 63.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -87.41 -21.5 25.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.051 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.664 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.971 0.415 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.786 ' O ' HG12 ' A' ' 58' ' ' VAL . 84.7 m -60.03 -40.82 90.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.902 174.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.5 t -77.81 -34.51 52.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.22 1.009 . . . . 0.0 108.74 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 10.9 mp -66.8 -19.39 65.73 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.408 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 55' ' ' THR . 3.8 p -93.98 -21.02 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.539 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.1 mm-40 -71.11 -47.55 57.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.694 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -147.83 10.29 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -177.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.694 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 5.0 Cg_exo -93.46 152.67 2.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 CA-C-N 121.886 1.709 . . . . 0.0 112.226 157.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.451 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -63.97 -17.31 59.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.325 2.683 . . . . 0.0 112.789 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -51.06 -18.52 0.84 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 24' ' ' ALA . 3.9 tp -45.32 -47.42 13.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.592 0.357 . . . . 0.0 111.725 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -50.02 -33.32 21.29 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.352 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.591 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.53 -36.45 65.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.139 0.971 . . . . 0.0 109.932 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.752 HD11 ' NE2' ' A' ' 63' ' ' GLN . 38.8 mt -69.45 -44.71 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.286 -169.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.574 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -49.91 -53.51 25.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.725 0.641 . . . . 0.0 112.495 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -87.14 -63.01 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -124.31 -13.48 7.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t60 64.11 41.19 6.45 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.7 p -109.86 160.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.85 -165.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 89' ' ' THR . 2.1 p -136.86 135.67 48.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.302 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.8 141.19 51.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.176 0.512 . . . . 0.0 110.956 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 98.92 2.3 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.891 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -60.52 103.32 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.279 0.561 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -120.04 123.48 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.385 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -80.05 161.28 25.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.589 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.31 -38.35 12.58 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 123.459 0.474 . . . . 0.0 110.837 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.1 t -71.46 -25.29 62.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.973 -172.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.25 -40.62 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.677 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.29 -42.72 99.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.478 175.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.4 mtpt -72.78 -30.57 64.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 122.581 0.353 . . . . 0.0 111.8 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -38.07 75.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.6 mtt -77.25 -45.0 27.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.981 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 79.73 9.75 86.46 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.454 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.7 tt -162.97 159.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.677 HG12 HD12 ' A' ' 82' ' ' LEU . 8.3 m -135.01 138.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.496 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.8 m -111.68 135.94 51.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.056 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' A' ' 94' ' ' SER . 15.6 t -71.08 168.63 16.72 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.537 0.735 . . . . 0.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -52.7 -37.73 59.44 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.538 0.685 . . . . 0.0 109.468 172.154 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.79 -25.26 48.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.579 -173.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.74 12.44 9.43 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.252 -0.886 . . . . 0.0 113.537 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.549 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.7 OUTLIER -80.48 120.51 24.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.756 0.778 . . . . 0.0 111.205 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.34 137.95 31.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 112.522 178.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.7 mp -130.16 126.59 22.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.984 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HA ' HG13 ' A' ' 87' ' ' ILE . 5.0 Cg_exo -71.83 133.24 21.46 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.156 1.904 . . . . 0.0 113.192 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.3 mm -95.64 139.38 19.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.025 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 37.7 m-70 -139.94 -178.92 5.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.215 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.484 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 142.3 115.62 1.13 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.905 -1.14 . . . . 0.0 113.93 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -83.09 -48.8 10.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 40.5 t30 -116.71 -53.73 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.111 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 17.8 Cg_endo -90.09 174.06 3.27 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.09 1.86 . . . . 0.0 110.419 172.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.662 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 17.7 tp -80.02 155.38 27.64 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.645 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 33.7 mt-10 -138.08 111.25 7.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.378 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.41 118.96 51.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.976 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB3' HG23 ' A' ' 96' ' ' ILE . 22.7 pttt 48.3 -107.01 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.986 0.914 . . . . 0.0 112.269 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.23 9.48 25.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.453 0.644 . . . . 0.0 110.375 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -104.13 163.25 12.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.193 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -128.8 135.18 48.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 4.1 t -82.98 126.66 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.431 0.634 . . . . 0.0 111.434 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.7 mp -89.4 -39.24 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.783 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.49 116.57 4.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.334 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.48 -173.67 3.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.785 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 31.7 t70 71.15 28.4 3.08 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 122.867 1.317 . . . . 0.0 107.933 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 11.9 mt -89.54 111.13 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.69 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 122' ' ' ILE . 39.4 mt-10 -68.09 108.95 3.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.046 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.13 179.57 7.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.939 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 2.0 pt-20 -46.52 -50.76 16.68 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.817 0.698 . . . . 0.0 111.301 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 94.3 m-20 -120.58 -15.48 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.103 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.53 -118.77 1.39 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.625 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.706 HD13 ' HA ' ' A' ' 117' ' ' GLU . 16.3 mm -145.49 145.08 20.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.181 0.515 . . . . 0.0 111.747 -171.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 118' ' ' ALA . 22.7 mt -116.44 148.65 19.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.46 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -138.35 117.2 12.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 87.7 t -79.45 128.86 38.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.9 169.35 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 122.08 0.943 . . . . 0.0 110.909 -177.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.772 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.9 t70 -109.63 21.0 17.5 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.657 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.636 ' O ' HG13 ' A' ' 126' ' ' ILE . 10.7 m -163.99 124.6 2.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.669 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.5 ' C ' HD13 ' A' ' 54' ' ' ILE . 50.0 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.979 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 5' ' ' VAL . 92.7 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -43.05 -50.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.19 0.519 . . . . 0.0 111.75 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.596 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.0 p -67.93 -37.13 77.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.973 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.23 -44.33 92.32 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.78 0.8 . . . . 0.0 110.173 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 11.1 mt -56.63 -22.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.7 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.23 -32.45 71.14 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.854 -0.529 . . . . 0.0 110.988 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.59 -30.39 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.415 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 55.3 t30 -74.2 -24.93 59.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.505 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.2 p -62.6 144.82 95.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.825 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -80.44 59.84 7.61 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.977 2.451 . . . . 0.0 112.117 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.24 46.71 62.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.497 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.579 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.47 -169.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.854 0.835 . . . . 0.0 112.864 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m -56.87 160.38 3.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -61.94 -19.46 62.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.601 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.0 tp -57.24 -33.57 67.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 m -80.7 -27.15 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 109.829 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.565 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.4 m -83.48 -27.58 29.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.95 81.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 0.0 111.609 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.48 -37.69 30.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.964 -0.46 . . . . 0.0 110.445 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 38.0 mtmt -62.19 -41.51 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.451 . . . . 0.0 111.175 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 19' ' ' THR . 7.3 p -74.5 -35.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.111 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.08 -7.72 53.56 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.181 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.95 16.96 7.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.566 1.146 . . . . 0.0 112.62 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.4 mp -92.83 9.35 35.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 121.999 -0.438 . . . . 0.0 112.097 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -59.44 -36.92 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.5 pt-20 -86.04 -19.07 30.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.011 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.15 -54.88 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 23.1 mt -55.61 -13.35 1.56 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.596 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.7 mm100 -66.16 -9.37 30.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 m -51.92 114.25 5.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 123.257 0.348 . . . . 0.0 111.221 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.38 -20.29 7.17 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.817 2.345 . . . . 0.0 113.628 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.3 -135.74 0.61 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -172.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 54.2 Cg_endo -78.76 162.66 26.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.819 2.346 . . . . 0.0 113.057 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 29.5 m-85 -136.62 121.97 19.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.651 -172.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 45.7 m -107.69 136.21 47.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.026 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -129.22 153.7 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.161 0.505 . . . . 0.0 110.492 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.72 107.23 16.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.55 111.43 53.92 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.677 -171.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 72.5 Cg_endo -77.33 130.17 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.058 1.839 . . . . 0.0 111.612 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.815 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 4.0 p30 -72.16 -176.34 1.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.69 -28.35 55.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.54 -24.18 24.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.842 0.829 . . . . 0.0 109.608 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.873 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.427 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 121.11 0.481 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.699 ' O ' HG12 ' A' ' 58' ' ' VAL . 98.6 m -65.15 -38.47 90.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.433 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -79.55 -27.59 41.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.0 109.201 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.0 mp -72.57 -27.94 62.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.21 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 55' ' ' THR . 7.8 p -77.9 -27.67 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.141 0.496 . . . . 0.0 109.938 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 55' ' ' THR . 22.5 mm-40 -71.55 -29.77 65.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.513 1.149 . . . . 0.0 108.842 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.91 166.08 46.14 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.64 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.0 Cg_exo -40.46 169.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.355 3.37 . . . . 0.0 114.171 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 31.2 Cg_exo -33.45 -8.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.047 1 C-N-CA 127.802 5.668 . . . . 0.0 120.175 -167.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -41.65 -25.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 HG23 ' A' ' 58' ' ' VAL . 10.6 tp -52.25 -50.89 61.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.599 0.36 . . . . 0.0 111.883 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -52.03 -31.09 32.1 Favored Glycine 0 N--CA 1.461 0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.348 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' NH1' HE22 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -74.76 -49.29 21.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.356 0.598 . . . . 0.0 110.587 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 64' ' ' LEU . 63.0 mt -44.88 -48.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.119 174.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -48.16 -65.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -166.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -89.44 -69.2 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.197 -1.001 . . . . 0.0 113.619 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.647 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -126.46 18.58 7.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -175.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.1 t60 59.24 30.98 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 164.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.647 HG11 ' CZ ' ' A' ' 70' ' ' TYR . 4.8 p -105.25 159.86 5.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.119 0.962 . . . . 0.0 113.517 -164.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 89' ' ' THR . 2.0 p -132.94 120.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.944 163.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.657 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.58 145.97 55.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 0.0 111.62 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 97.43 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.28 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -58.78 106.2 0.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.232 0.539 . . . . 0.0 111.105 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CB ' HD11 ' A' ' 82' ' ' LEU . 6.0 m-85 -115.64 119.78 37.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -77.05 158.75 30.35 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.21 -37.45 10.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.553 0.533 . . . . 0.0 111.268 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.7 t -74.98 -24.37 58.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 -168.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.47 -45.72 75.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.713 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -57.19 -52.32 65.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.461 177.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.97 -34.68 75.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.0 ttt180 -51.47 -43.29 62.1 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.102 0.953 . . . . 0.0 109.19 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.3 mtp -75.98 -42.91 46.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.014 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' ILE . . . 77.87 15.49 81.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.098 -172.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -163.66 157.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.713 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -130.7 143.06 42.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.396 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.1 m -110.6 133.52 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.924 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 94' ' ' SER . 70.9 m -77.31 166.18 23.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.138 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.8 tp -51.89 -37.59 52.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.125 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -76.54 -24.94 53.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.61 -178.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.51 20.08 5.57 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.597 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' SER . 8.2 t -88.16 119.41 28.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.156 0.478 . . . . 0.0 110.536 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.78 139.25 30.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.65 . . . . 0.0 112.636 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.617 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -131.93 128.12 21.41 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.938 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HA ' HG13 ' A' ' 87' ' ' ILE . 8.1 Cg_exo -69.16 133.27 26.25 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.142 1.895 . . . . 0.0 113.355 -173.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.546 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.7 mm -102.09 138.0 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.049 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -140.82 179.98 6.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.595 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.603 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 173.93 93.26 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.72 -172.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.89 -44.33 55.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 109.288 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.564 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 11.6 m-80 -140.83 -53.11 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.983 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.3 Cg_endo -88.17 173.28 4.87 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.165 1.91 . . . . 0.0 110.298 168.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.499 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 24.8 tp -73.34 153.67 40.42 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 26.8 mt-10 -140.91 106.78 5.14 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -105.74 126.52 61.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.823 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HG2' HG22 ' A' ' 106' ' ' VAL . 13.5 ptmt 46.52 -114.51 0.52 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.604 0.762 . . . . 0.0 112.046 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -102.99 22.14 14.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.203 0.525 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -123.97 166.48 15.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.938 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 m -128.78 137.44 51.54 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -81.02 129.89 36.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.545 0.688 . . . . 0.0 111.886 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.8 mp -91.6 -37.86 12.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.389 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.59 112.08 2.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.849 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.01 -173.25 3.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 71.46 26.28 3.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -90.46 109.66 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.738 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.783 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.52 110.97 3.36 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.278 1.037 . . . . 0.0 112.031 174.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.24 -170.5 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.465 -1.698 . . . . 0.0 111.772 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -50.94 -49.04 60.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.863 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -119.66 -18.35 8.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.072 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.54 -112.4 0.77 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.397 -173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.783 HD13 ' HA ' ' A' ' 117' ' ' GLU . 9.8 mm -146.56 142.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.547 0.689 . . . . 0.0 112.355 -174.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 118' ' ' ALA . 92.2 mt -113.19 146.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.619 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -137.22 113.3 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 57.6 t -81.12 128.08 39.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 123.178 0.299 . . . . 0.0 110.31 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -127.25 164.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 0.0 110.94 -176.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.8 t70 -108.89 19.47 19.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.752 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.647 ' O ' HG13 ' A' ' 126' ' ' ILE . 16.2 m -168.77 134.5 1.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 41' ' ' PRO . 73.1 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.637 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.792 0.33 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.21 151.93 24.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.849 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -68.09 143.96 55.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.904 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp -43.74 -52.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.797 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.573 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.1 p -70.8 -36.92 66.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.079 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -56.41 -44.42 80.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.81 0.814 . . . . 0.0 110.334 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 19.7 mt -53.86 -24.76 10.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.933 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.3 86.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.888 0.375 . . . . 0.0 111.057 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.15 -18.57 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.416 0.627 . . . . 0.0 110.46 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 44.9 t30 -89.84 -25.33 21.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.476 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 8.9 p -57.76 133.9 82.9 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -174.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -78.01 66.05 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.918 2.412 . . . . 0.0 111.884 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.93 47.04 26.64 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.219 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.74 -172.93 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.15 0.5 . . . . 0.0 111.605 177.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -58.81 163.22 3.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.853 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 m -62.58 -19.28 63.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.64 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.38 -35.24 50.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.705 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.3 -27.47 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.509 0.671 . . . . 0.0 109.908 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.589 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 m -83.38 -28.2 29.1 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.757 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.26 79.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.622 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.13 -36.81 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.978 -0.451 . . . . 0.0 110.427 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.1 mtmt -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.217 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 19' ' ' THR . 8.8 p -77.21 -34.66 21.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.544 0.688 . . . . 0.0 110.218 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.17 -2.47 31.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.368 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.84 15.4 10.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.125 0.97 . . . . 0.0 112.835 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 8.2 mp -91.46 7.62 40.31 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.927 -0.483 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -60.08 -37.02 71.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.492 . . . . 0.0 109.956 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.9 pt-20 -85.53 -18.89 32.12 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.788 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.76 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.2 mt -59.36 -10.47 3.16 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.573 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.6 mm100 -67.97 -8.47 37.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -54.15 113.11 4.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.63 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.56 -12.89 15.1 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.725 2.284 . . . . 0.0 112.885 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.85 -137.34 0.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.711 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 57.9 Cg_endo -84.2 165.48 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.036 2.491 . . . . 0.0 113.967 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' VAL . 49.6 m-85 -139.15 122.7 17.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 36.1 m -106.65 118.0 35.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.253 0.549 . . . . 0.0 110.996 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.38 121.06 60.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.443 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.423 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 1.4 m-30 -82.86 111.46 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.741 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -95.82 112.39 59.1 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.52 133.42 15.81 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.06 1.84 . . . . 0.0 111.538 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.806 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 32.2 p30 -72.61 -172.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.722 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.82 -27.13 68.67 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.528 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 23.8 t70 -88.34 -21.28 24.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.186 0.993 . . . . 0.0 109.068 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -84.91 -35.54 22.07 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.337 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -62.21 -20.6 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.953 0.882 . . . . 0.0 108.746 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -81.19 -9.78 59.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.573 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 28.1 mmmt -89.08 -25.14 22.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.541 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 28.6 mt -54.31 -53.89 54.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.231 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 9.5 Cg_endo -53.29 95.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.203 2.602 . . . . 0.0 113.561 -170.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 t70 47.12 50.37 14.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.061 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.61 -99.56 0.96 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.589 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.436 HG21 HG12 ' A' ' 129' ' ' VAL . 32.3 m -61.97 -58.51 7.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.46 -175.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.725 HD12 HD22 ' A' ' 57' ' ' LEU . 1.2 mp -58.55 -25.53 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.929 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HG12 ' A' ' 58' ' ' VAL . 67.8 m -65.07 -40.59 94.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 t -79.82 -29.65 40.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.032 0.92 . . . . 0.0 109.16 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.725 HD22 HD12 ' A' ' 54' ' ' ILE . 6.8 mp -70.58 -26.01 63.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.222 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 55' ' ' THR . 9.9 p -80.01 -28.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.156 0.503 . . . . 0.0 109.755 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 55' ' ' THR . 24.4 mm-40 -70.56 -25.54 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.651 1.215 . . . . 0.0 108.519 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.47 168.64 26.23 Favored Pre-proline 0 N--CA 1.437 -1.094 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.282 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.2 Cg_exo -38.16 169.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 124.633 3.555 . . . . 0.0 115.424 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 51.9 Cg_exo -40.58 -8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 1 C-N-CA 126.632 4.888 . . . . 0.0 118.296 -172.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.558 ' HG2' ' HD2' ' A' ' 66' ' ' ARG . 9.4 tt0 -42.61 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 67' ' ' ILE . 13.4 tp -46.92 -50.98 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.35 0.26 . . . . 0.0 111.08 174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.26 -32.59 44.32 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.265 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.26 -51.38 21.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.528 0.68 . . . . 0.0 109.53 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 64' ' ' LEU . 62.2 mt -44.41 -53.89 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 113.969 -1.469 . . . . 0.0 113.359 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -47.19 -64.09 0.87 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.09 -62.06 1.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -122.48 -0.93 9.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.1 p80 43.04 51.6 5.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.775 0.798 . . . . 0.0 110.187 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 36' ' ' PHE . 12.9 p -120.98 159.15 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.903 -166.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 89' ' ' THR . 1.5 p -130.21 129.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 170.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.538 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.73 146.36 54.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.254 0.55 . . . . 0.0 111.168 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.81 99.1 2.57 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -63.65 101.9 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.162 0.506 . . . . 0.0 111.509 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -112.93 129.36 56.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.124 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -91.99 161.01 14.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -31.53 7.03 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.244 0.545 . . . . 0.0 112.046 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.9 t -72.39 -27.0 62.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.245 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.43 -50.36 14.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.718 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -54.38 -50.69 66.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.044 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -68.51 -35.85 78.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.747 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -56.88 -39.49 74.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.632 0.73 . . . . 0.0 110.115 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 81.1 mtp -80.49 -35.24 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.919 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.96 12.05 83.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.051 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -162.92 157.28 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.718 HG12 HD12 ' A' ' 82' ' ' LEU . 10.6 m -132.03 140.42 47.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.262 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.5 m -112.71 133.08 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.116 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 94' ' ' SER . 14.1 t -68.93 163.9 23.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.906 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.538 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -55.38 -30.77 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.479 0.657 . . . . 0.0 110.148 174.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.4 -25.85 35.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.152 -178.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.4 18.29 7.19 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.33 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.591 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.8 OUTLIER -88.1 121.3 30.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.299 0.55 . . . . 0.0 111.332 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.51 138.01 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.9 mp -127.63 127.01 24.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.8 Cg_exo -70.39 132.03 21.51 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 121.98 1.786 . . . . 0.0 113.036 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.465 ' CG1' HG13 ' A' ' 88' ' ' VAL . 40.5 mm -94.55 136.14 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.38 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 91.7 m-70 -121.0 -179.24 3.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.199 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.31 94.06 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.042 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.09 -48.21 13.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.453 0.645 . . . . 0.0 109.606 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.585 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 6.9 m-80 -138.53 -53.19 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.003 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -87.77 173.25 5.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.123 1.882 . . . . 0.0 109.99 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.808 HD23 HG21 ' A' ' 111' ' ' VAL . 16.3 tp -72.8 154.35 40.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 44.9 mt-10 -140.4 127.86 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.397 0.618 . . . . 0.0 109.523 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -129.08 122.61 56.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.013 -174.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 106' ' ' VAL . 10.9 ptmm? 46.51 -123.46 1.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.163 0.585 . . . . 0.0 111.237 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -96.94 23.55 7.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 110.608 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -118.85 166.04 13.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -128.29 138.04 52.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.808 HG21 HD23 ' A' ' 104' ' ' LEU . 88.1 t -86.2 126.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.686 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 127' ' ' ASP . 6.6 mp -89.63 -36.55 15.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.631 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.68 118.28 2.79 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.532 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.93 -174.54 3.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 32.2 t70 68.98 26.86 5.59 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -171.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -88.84 108.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.011 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.692 ' HA ' HD13 ' A' ' 122' ' ' ILE . 43.3 mt-10 -68.58 106.02 2.45 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.623 0.725 . . . . 0.0 110.72 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -81.38 178.89 8.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.716 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -44.2 -51.73 7.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.845 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -117.87 -14.61 10.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.365 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.73 -110.76 0.44 Allowed Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.169 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 117' ' ' GLU . 18.3 mm -142.66 143.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.097 -0.552 . . . . 0.0 111.387 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 116' ' ' ILE . 16.9 mt -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.222 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' CD2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.79 114.87 5.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.819 0.819 . . . . 0.0 112.043 -178.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 49.5 t -80.17 129.86 36.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.33 159.58 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.806 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -99.0 3.41 46.93 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.475 -173.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.616 ' O ' HG13 ' A' ' 126' ' ' ILE . 47.7 m -154.51 126.71 7.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.531 -172.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 54' ' ' ILE . 76.3 t . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.075 0.464 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.7 148.66 34.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.042 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 5' ' ' VAL . 13.5 m -61.11 145.02 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.398 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -57.67 -20.15 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.613 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.2 p -90.34 -37.3 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.557 . . . . 0.0 110.205 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.95 -50.93 71.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.204 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG22 HG23 ' A' ' 11' ' ' THR . 21.9 mt -54.42 -22.0 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.414 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.089 0.471 . . . . 0.0 110.607 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 37.8 t -74.48 -23.38 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.487 0.661 . . . . 0.0 110.291 175.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 50.6 t30 -87.26 -25.44 23.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.76 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 6.5 p -60.82 134.26 92.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -171.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -81.95 67.33 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.052 2.501 . . . . 0.0 111.808 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.34 11.72 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.098 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.7 OUTLIER -67.14 -170.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.204 0.525 . . . . 0.0 111.35 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -60.46 157.63 13.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.506 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m -60.56 -19.03 56.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.341 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.454 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.2 mm? -57.98 -30.33 65.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.18 -30.25 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.325 0.583 . . . . 0.0 109.803 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 2.2 m -83.52 -29.24 28.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.22 -31.4 71.93 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.111 0.257 . . . . 0.0 111.571 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 21' ' ' VAL . 1.2 p -81.44 -37.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.506 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 41.3 mtmt -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.13 0.491 . . . . 0.0 111.315 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 19' ' ' THR . 8.5 p -75.21 -36.04 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.663 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.38 -6.5 48.55 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.937 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 13.31 9.34 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.312 1.045 . . . . 0.0 113.172 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 92' ' ' GLU . 10.6 mp -85.77 8.97 17.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.972 -0.455 . . . . 0.0 111.437 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.68 -37.17 57.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.345 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.7 pt-20 -85.67 -20.77 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.692 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.79 -54.42 6.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.689 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 21.9 mt -58.76 -14.07 7.72 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.613 ' OE1' HG13 ' A' ' 5' ' ' VAL . 4.2 mm100 -66.52 -5.75 12.42 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.768 0.427 . . . . 0.0 111.908 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -51.65 110.43 1.83 Allowed Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 123.423 0.689 . . . . 0.0 112.406 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.33 -17.86 8.77 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.126 2.55 . . . . 0.0 113.252 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.35 -140.5 0.8 Allowed Glycine 0 CA--C 1.518 0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.372 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 30.1 Cg_endo -76.2 163.08 33.24 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.018 1.812 . . . . 0.0 112.804 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -133.51 122.71 24.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.154 -171.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.6 m -116.6 136.27 53.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.168 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 123' ' ' ILE . 5.5 p -133.02 156.13 41.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.641 . . . . 0.0 111.36 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.461 ' HB3' HD12 ' A' ' 126' ' ' ILE . 93.3 m-85 -112.26 111.04 21.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -98.91 113.33 64.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.391 . . . . 0.0 111.513 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 130.59 10.79 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.588 2.192 . . . . 0.0 112.229 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.842 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.7 p30 -84.08 -174.14 5.11 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.675 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.42 -27.05 65.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 111.678 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 34.2 t70 -82.52 -22.71 34.92 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -79.84 -36.86 36.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.639 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.15 -24.26 62.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.969 0.89 . . . . 0.0 109.208 171.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.35 -9.97 55.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.931 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 29.2 mmmt -87.3 -24.59 24.27 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 49' ' ' LEU . 45.7 mt -42.52 -42.42 6.85 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 114.439 -1.255 . . . . 0.0 114.302 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 58.5 Cg_exo -41.2 -39.48 3.82 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.873 2.382 . . . . 0.0 113.508 171.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.72 -68.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.07 76.18 1.19 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.905 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' HD13 ' A' ' 57' ' ' LEU . 99.7 m -65.54 -52.15 54.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.26 0.552 . . . . 0.0 109.952 171.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.5 mp -57.98 -25.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.853 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 92.1 m -65.67 -32.7 74.4 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.926 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 t -81.04 -25.54 37.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.68 0.752 . . . . 0.0 109.342 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.1 mp -74.93 -25.64 59.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.041 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 11.4 p -76.97 -31.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.228 0.537 . . . . 0.0 109.756 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.4 mm-40 -71.59 -28.39 63.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 122.68 1.229 . . . . 0.0 108.578 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 3.3 m-80 -81.78 169.39 18.89 Favored Pre-proline 0 N--CA 1.437 -1.085 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 19.9 Cg_exo -37.06 170.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 125.023 3.815 . . . . 0.0 115.607 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 48.0 Cg_exo -39.4 -9.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.607 1 C-N-CA 126.566 4.844 . . . . 0.0 118.029 -172.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.569 ' NE2' HD23 ' A' ' 57' ' ' LEU . 4.7 tp60 -41.67 -26.5 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.153 0.981 . . . . 0.0 113.096 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.616 HD13 HG23 ' A' ' 58' ' ' VAL . 5.5 tp -51.09 -50.89 57.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 111.754 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.29 -33.06 22.97 Favored Glycine 0 N--CA 1.459 0.174 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.928 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.98 -35.25 50.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.994 0.426 . . . . 0.0 110.656 -178.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 64' ' ' LEU . 51.6 mt -59.76 -46.52 93.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.258 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -45.81 -63.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.926 0.766 . . . . 0.0 113.003 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -88.99 -60.01 2.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -121.13 -16.37 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 70.6 m80 64.67 33.35 10.62 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.5 p -94.47 155.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.073 -166.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.471 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.4 p -141.43 119.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.625 -1.625 . . . . 0.0 108.888 166.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.665 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.52 142.21 58.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 111.216 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 112.24 98.27 2.38 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.98 102.67 0.09 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.175 0.512 . . . . 0.0 111.685 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.462 ' O ' HG21 ' A' ' 122' ' ' ILE . 12.4 m-85 -114.67 106.84 14.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.579 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.712 ' HD3' HD12 ' A' ' 122' ' ' ILE . 21.3 mmtp -60.67 157.54 14.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 167.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -49.52 -35.41 20.0 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 123.461 0.475 . . . . 0.0 110.36 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 9.4 t -75.62 -28.53 58.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.176 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.51 -35.53 79.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.721 HD12 HG12 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -66.34 -50.55 63.18 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.105 176.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -68.08 -30.62 69.86 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 123.199 0.6 . . . . 0.0 112.264 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.26 -31.48 67.46 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-O 121.664 0.745 . . . . 0.0 109.433 172.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.7 -40.51 14.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.679 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 78.72 14.32 82.19 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.982 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.0 tt -164.39 159.92 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 HD12 ' A' ' 82' ' ' LEU . 11.9 m -131.97 137.92 53.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.428 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 m -106.77 126.91 52.91 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.397 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' H ' ' A' ' 94' ' ' SER . 72.5 m -68.45 163.87 22.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.416 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -51.45 -36.28 43.35 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.612 0.72 . . . . 0.0 110.877 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.49 -28.06 52.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.447 -179.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.32 10.81 7.76 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.696 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.497 ' H ' ' HB2' ' A' ' 90' ' ' SER . 0.7 OUTLIER -83.44 120.69 26.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.951 0.875 . . . . 0.0 111.759 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.15 138.06 32.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.5 mp -130.4 126.74 22.25 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.549 ' HA ' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -68.29 133.44 28.43 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 113.533 -173.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.584 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.4 mm -103.25 142.75 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.4 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -141.19 177.3 8.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.682 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.08 121.31 0.55 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.091 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -101.34 -54.14 2.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 92.8 m-20 -107.14 -61.8 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 172.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 16.0 Cg_endo -90.49 174.01 3.04 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.475 2.117 . . . . 0.0 111.244 174.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.585 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 21.3 tp -75.8 154.53 36.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -140.88 107.37 5.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.8 112.03 38.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.642 ' HB3' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER 48.54 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.321 1.448 . . . . 0.0 113.87 -174.132 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 3.1 p-10 -134.85 23.23 3.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.526 0.679 . . . . 0.0 109.573 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -129.25 157.51 41.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.077 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 44.4 m -121.9 134.31 54.86 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -78.59 127.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.613 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 112' ' ' LEU . 6.9 mp -88.82 -38.87 14.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.105 175.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.97 110.53 3.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.148 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -133.04 -173.58 3.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.65 ' OD1' ' HD2' ' A' ' 78' ' ' LYS . 20.4 t70 71.47 28.34 2.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 122.794 1.283 . . . . 0.0 107.604 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.4 mt -95.14 110.05 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.04 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.852 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.48 114.34 6.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.969 0.89 . . . . 0.0 112.391 172.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.842 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.77 -173.49 3.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.023 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -49.08 -51.19 32.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.123 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 4.2 m-20 -115.23 -20.57 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.644 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.72 -114.77 1.05 Allowed Glycine 0 CA--C 1.505 -0.539 0 C-N-CA 119.447 -1.359 . . . . 0.0 114.047 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 117' ' ' GLU . 17.8 mm -144.52 148.15 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.327 0.585 . . . . 0.0 110.951 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.842 HG13 ' HB2' ' A' ' 118' ' ' ALA . 94.6 mt -120.24 147.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.457 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -137.88 117.79 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 69.9 t -83.31 129.64 37.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.496 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -124.99 161.76 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.619 0.724 . . . . 0.0 110.457 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.842 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -95.8 5.36 51.52 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.52 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.683 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 51.0 m -148.92 126.63 11.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.813 -171.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG23 ' HB1' ' A' ' 45' ' ' ALA . 69.5 t . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.603 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.88 119.36 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.723 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 HG12 ' A' ' 5' ' ' VAL . 28.5 m -61.24 146.81 46.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.094 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -54.86 -20.96 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.581 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.1 p -91.37 -37.23 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.155 0.502 . . . . 0.0 110.614 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.1 t70 -58.42 -44.5 89.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.373 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 9.1 mt -59.18 -21.69 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.637 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -34.15 76.29 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.826 -0.546 . . . . 0.0 110.751 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 6' ' ' ASP . 4.2 p -87.9 -9.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 110.112 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 54.4 t30 -92.72 -25.01 18.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.767 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 p -64.65 131.97 95.28 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.175 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.3 64.76 7.95 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.898 2.399 . . . . 0.0 112.288 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 46.96 11.95 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.898 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.63 -172.15 0.16 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.441 0.639 . . . . 0.0 112.508 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -61.3 163.13 6.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.559 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -61.44 -18.37 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.79 -37.78 52.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.35 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.85 -27.4 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.493 0.663 . . . . 0.0 110.116 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.584 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.8 m -81.64 -25.7 35.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.686 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.17 -35.07 77.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.673 0.273 . . . . 0.0 111.524 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -78.29 -37.35 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.6 mtmt -62.5 -43.55 98.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.964 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 19' ' ' THR . 7.8 p -72.73 -35.02 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.113 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.44 -5.14 46.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.043 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.36 8.46 6.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.962 1.305 . . . . 0.0 113.128 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.3 mp -85.42 9.24 16.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -37.66 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.84 -21.8 27.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.754 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -76.28 -55.4 5.6 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -176.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.9 mt -57.18 -13.83 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.209 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.581 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.7 mm100 -65.16 -13.75 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.211 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 p -56.99 114.07 7.33 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.683 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.83 -14.25 11.3 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.982 2.455 . . . . 0.0 113.482 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.45 -149.87 1.04 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.275 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 37.8 Cg_endo -73.23 170.03 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.89 2.394 . . . . 0.0 112.821 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' HB3' HG21 ' A' ' 72' ' ' VAL . 45.2 m-85 -139.92 124.08 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 21.9 m -106.22 124.03 48.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 123' ' ' ILE . 41.3 t -113.88 134.07 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.962 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -100.25 116.27 31.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -104.93 117.78 57.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.317 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.79 125.86 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.023 1.816 . . . . 0.0 111.853 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.753 ' OD1' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -75.85 176.02 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.13 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -59.67 -35.4 74.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.636 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 12.4 t70 -78.83 -19.45 52.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.838 0.828 . . . . 0.0 108.816 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HA ' ' CG ' ' A' ' 48' ' ' LYS . . . -75.47 -40.93 56.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.482 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -61.34 -24.55 66.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.568 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.01 -21.46 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 28.5 mmmt -63.06 -44.68 95.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.256 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.53 HD21 HG21 ' A' ' 129' ' ' VAL . 94.6 mt -32.23 97.52 0.11 Allowed Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 125.724 1.89 . . . . 0.0 113.924 -164.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.38 82.28 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.055 1 C-N-CA 125.321 4.014 . . . . 0.0 111.825 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 64.31 14.9 9.08 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.111 0.481 . . . . 0.0 110.393 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . 92.39 99.16 1.38 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.211 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.687 ' HB ' HG12 ' A' ' 129' ' ' VAL . 95.5 m -59.04 -50.56 73.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.573 0.701 . . . . 0.0 110.044 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -58.29 -23.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.771 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 58' ' ' VAL . 74.7 m -59.92 -32.55 70.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.83 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -83.56 -23.83 31.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.161 0.981 . . . . 0.0 109.121 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 9.0 mp -77.92 -20.39 52.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 55' ' ' THR . 8.0 p -91.71 -22.72 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.013 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 55' ' ' THR . 20.2 mm-40 -64.12 -44.87 90.91 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.67 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 64.2 t30 -162.9 14.33 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 4.0 Cg_exo -91.38 150.94 3.63 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 CA-C-N 121.202 1.465 . . . . 0.0 111.435 153.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 61' ' ' PRO . 24.2 Cg_exo -66.51 -15.61 48.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.087 2.525 . . . . 0.0 112.805 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 3.2 tt0 -46.85 -29.75 2.14 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 67' ' ' ILE . 9.3 tp -45.66 -50.03 13.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -44.91 -44.71 8.93 Favored Glycine 0 CA--C 1.511 -0.205 0 O-C-N 124.103 0.877 . . . . 0.0 114.218 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.71 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.63 -35.2 34.31 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.62 0.247 . . . . 0.0 110.57 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.5 mt -51.67 -47.51 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.184 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -45.92 -56.03 5.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.53 -64.0 1.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 79.1 m-85 -125.89 -0.78 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 14.7 p-80 43.99 53.35 6.4 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.726 0.774 . . . . 0.0 110.041 -168.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 36' ' ' PHE . 10.2 p -123.82 154.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.271 -166.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.466 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.8 p -125.27 127.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.657 171.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.518 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.56 143.83 57.64 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.077 0.465 . . . . 0.0 111.156 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.72 99.48 2.6 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.888 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . . . -61.8 98.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.579 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' HG21 ' A' ' 122' ' ' ILE . 5.1 m-85 -113.6 110.19 19.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.825 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.722 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.1 mmtp -59.66 160.68 6.97 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 165.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.35 -23.64 65.9 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.2 t -72.57 -31.08 64.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.58 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -73.77 -43.59 58.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.722 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -62.34 -55.39 28.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.914 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.94 -35.19 77.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.147 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -51.34 -44.52 62.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.664 0.745 . . . . 0.0 110.23 173.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -38.68 49.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.272 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.15 6.66 86.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.043 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.6 tt -163.07 158.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG12 HD12 ' A' ' 82' ' ' LEU . 14.1 m -129.98 140.89 47.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.093 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -110.1 126.27 53.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.66 0.743 . . . . 0.0 110.64 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 75.0 m -72.18 168.61 17.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.386 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 74' ' ' ALA . 4.7 tp -56.14 -37.7 69.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.873 0.844 . . . . 0.0 109.78 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.9 pm0 -75.36 -15.19 60.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.705 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.93 8.88 47.1 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.164 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -78.35 118.45 20.55 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -83.56 141.29 31.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.359 0.6 . . . . 0.0 111.997 176.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.594 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -133.99 126.22 18.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.957 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.6 Cg_exo -70.43 128.72 15.8 Favored 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 122.1 1.867 . . . . 0.0 112.604 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.559 ' CG1' HG13 ' A' ' 88' ' ' VAL . 39.0 mm -96.9 133.48 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.733 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 54.7 m80 -130.89 -179.77 5.51 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.589 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.67 114.01 0.4 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.653 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.98 -51.76 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 78.2 m-20 -132.83 -57.59 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.332 171.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 45.4 Cg_endo -85.02 172.8 8.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.153 1.902 . . . . 0.0 110.71 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.0 152.9 38.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.32 0.581 . . . . 0.0 110.72 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 8.7 mm-40 -130.96 106.93 8.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.454 -175.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.49 115.43 48.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.856 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.9 ptmt 55.74 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.71 1.604 . . . . 0.0 113.213 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 2.9 p-10 -149.69 24.26 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -126.9 166.11 18.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.399 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 41.7 m -126.59 132.34 51.31 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 t -74.75 131.89 34.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.477 0.656 . . . . 0.0 111.422 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 127' ' ' ASP . 7.1 mp -91.7 -46.64 7.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.781 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -145.97 114.12 6.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.7 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HB1' ' ND1' ' A' ' 124' ' ' HIS . . . -135.91 -173.39 3.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 49.2 m-20 67.81 28.47 7.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -172.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -86.62 114.32 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.104 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' HA ' HD13 ' A' ' 122' ' ' ILE . 37.1 mt-10 -67.96 106.91 2.48 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.928 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.7 -179.47 7.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.295 -175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.93 -49.53 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.6 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.06 -18.91 9.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.907 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -147.98 -108.08 0.49 Allowed Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 119.724 -1.227 . . . . 0.0 114.093 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.58 HD12 ' HD3' ' A' ' 78' ' ' LYS . 17.1 mm -142.9 153.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.401 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.928 HG13 ' HB2' ' A' ' 118' ' ' ALA . 89.0 mt -128.58 147.59 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.53 ' ND1' ' HB1' ' A' ' 114' ' ' ALA . 4.6 m-70 -138.09 117.4 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.736 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 95.4 t -82.2 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -122.97 156.33 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.028 0.918 . . . . 0.0 111.286 -176.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.753 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 32.1 t70 -98.68 19.52 14.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.971 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.574 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 19.3 m -158.89 131.47 6.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.874 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.687 HG12 ' HB ' ' A' ' 53' ' ' THR . 75.4 t . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.91 120.02 12.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.011 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 5' ' ' VAL . 42.8 m -60.16 145.62 46.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.72 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -56.56 -19.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' OE1' ' A' ' 31' ' ' GLN . 1.8 p -91.24 -36.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 0.0 110.705 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.12 -45.47 87.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.566 0.698 . . . . 0.0 110.253 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 14.3 mt -56.86 -21.55 14.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.873 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.12 74.57 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.978 -0.451 . . . . 0.0 110.936 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.35 -24.35 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 110.114 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 60.2 t30 -81.04 -25.43 37.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.175 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 5.8 p -63.21 130.63 94.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.4 Cg_exo -79.26 68.87 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.94 2.427 . . . . 0.0 111.932 175.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.25 46.83 14.41 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.456 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 1.1 t80 -65.9 -169.72 0.07 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.354 0.597 . . . . 0.0 111.329 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 m -62.78 159.91 15.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -61.02 -17.95 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.39 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 mp -52.34 -37.02 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.215 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -80.02 -27.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.596 0.712 . . . . 0.0 109.805 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.601 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.5 m -83.29 -28.24 29.26 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.109 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.0 -32.38 72.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.708 0.29 . . . . 0.0 111.482 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.54 -37.44 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.499 171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 37.5 mtmt -61.97 -43.59 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.852 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 19' ' ' THR . 7.9 p -72.65 -35.57 50.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.8 -7.89 54.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.847 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.31 10.66 6.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.767 1.227 . . . . 0.0 112.772 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 66' ' ' ARG . 9.5 mp -85.9 9.13 17.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.976 -0.452 . . . . 0.0 112.111 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.1 t -58.14 -36.53 57.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.005 0.431 . . . . 0.0 109.932 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.54 -21.25 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.659 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.06 -52.41 8.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.71 0.291 . . . . 0.0 111.759 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 26.3 mt -57.71 -15.35 7.61 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.598 ' OE1' HG13 ' A' ' 5' ' ' VAL . 6.6 mm100 -65.54 -13.17 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.237 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.9 m -56.02 112.95 4.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 123.469 0.48 . . . . 0.0 111.726 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.72 -9.36 13.33 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.015 2.477 . . . . 0.0 113.043 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.72 -145.13 0.15 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.797 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 76' ' ' ALA . 2.1 Cg_endo -78.32 169.02 20.75 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB3' HG21 ' A' ' 72' ' ' VAL . 35.6 m-85 -139.65 121.33 15.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.304 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.7 m -108.33 115.58 30.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.284 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.47 124.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.784 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.686 ' HD1' ' NE2' ' A' ' 124' ' ' HIS . 38.1 m-85 -84.01 110.43 18.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -96.47 122.19 58.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.572 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 129' ' ' VAL . 69.8 Cg_endo -76.69 126.77 9.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.159 1.906 . . . . 0.0 112.274 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.891 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -74.88 178.44 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.42 177.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -57.21 -36.71 71.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 26.4 t70 -79.65 -19.83 48.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.647 0.736 . . . . 0.0 109.053 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -81.79 -37.9 26.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.296 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -62.28 -20.66 64.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.979 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.16 -8.7 58.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.58 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 26.1 mmmt -89.98 -24.14 21.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.506 0.67 . . . . 0.0 109.45 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 38.2 mt -47.7 -48.66 59.39 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.51 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 19.6 Cg_endo -64.02 -10.49 23.26 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.139 1.893 . . . . 0.0 112.889 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -90.07 -14.68 33.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.404 0.621 . . . . 0.0 110.144 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.72 55.72 2.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.777 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 129' ' ' VAL . 88.8 m -67.45 -56.98 7.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.423 0.612 . . . . 0.0 110.442 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.631 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp -58.02 -24.99 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.229 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.684 ' O ' HG12 ' A' ' 58' ' ' VAL . 86.8 m -59.23 -35.26 73.33 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -82.74 -24.91 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.991 0.901 . . . . 0.0 109.291 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.8 mp -75.27 -25.62 58.14 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 55' ' ' THR . 7.3 p -78.3 -29.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.2 mm-40 -71.4 -26.6 62.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.477 1.132 . . . . 0.0 108.668 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.45 167.77 31.65 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.532 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 63' ' ' GLN . 38.4 Cg_exo -38.88 168.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.369 3.379 . . . . 0.0 114.734 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 39.5 Cg_exo -39.08 -8.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.675 1 C-N-CA 126.547 4.832 . . . . 0.0 118.06 -173.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 66' ' ' ARG . 21.8 tt0 -42.2 -17.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.661 ' HA ' HD12 ' A' ' 67' ' ' ILE . 16.2 tp -47.51 -51.6 20.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.403 0.281 . . . . 0.0 111.399 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -54.62 -32.81 54.13 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.973 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.25 -50.57 45.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 109.573 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 64' ' ' LEU . 57.4 mt -46.92 -51.71 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.428 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -51.33 -61.55 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -171.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -81.76 -63.06 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -165.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.502 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 64.8 m-85 -124.39 -2.77 7.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.5 m80 59.63 34.21 22.18 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 70' ' ' TYR . 7.4 p -113.59 156.41 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -162.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.554 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.6 p -125.14 126.66 71.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.865 168.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.3 140.91 58.74 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 120.945 0.402 . . . . 0.0 110.609 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.41 97.26 2.32 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.001 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -60.87 108.4 0.85 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.443 0.64 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.01 132.34 55.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.129 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.73 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -88.86 165.42 14.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.9 58.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.255 0.55 . . . . 0.0 110.974 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 13.3 t -72.25 -26.08 61.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.585 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.35 -48.67 16.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.07 -51.26 70.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.605 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 98' ' ' ILE . 6.9 ttpm? -65.68 -35.39 80.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.033 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -51.75 -44.32 63.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.732 0.777 . . . . 0.0 110.326 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -73.29 -39.04 65.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.257 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.79 7.11 88.92 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.472 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.58 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.8 tt -163.27 159.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.657 HG12 HD12 ' A' ' 82' ' ' LEU . 8.5 m -130.17 138.0 55.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.189 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.494 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.7 m -114.29 133.2 55.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.092 0.473 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB2' ' OE2' ' A' ' 92' ' ' GLU . 58.3 m -85.41 178.27 7.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.479 -174.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 74' ' ' ALA . 1.7 tp -56.0 -39.35 71.75 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.728 ' OE1' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -84.42 -16.67 41.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 89' ' ' THR . . . 113.15 22.22 5.65 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.114 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.728 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 5.5 p -86.86 120.56 28.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 117.714 0.757 . . . . 0.0 110.541 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -93.08 138.32 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.0 mp -130.88 125.99 21.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.715 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' A' ' 87' ' ' ILE . 7.1 Cg_exo -68.76 133.79 28.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.192 1.928 . . . . 0.0 113.362 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.468 ' CG1' HG13 ' A' ' 88' ' ' VAL . 41.0 mm -98.95 136.03 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.317 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.53 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 18.0 m-70 -120.86 177.62 5.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.056 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.04 107.97 0.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.443 -1.36 . . . . 0.0 113.428 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -104.57 -41.09 5.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 109.908 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.9 t-20 -127.12 -63.98 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.186 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -84.9 174.19 7.6 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.018 1.812 . . . . 0.0 110.74 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 111' ' ' VAL . 14.8 tp -73.86 152.21 40.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 3.6 mm-40 -137.58 122.6 19.06 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.615 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -128.74 123.77 59.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.108 -175.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 11.2 ptmm? 46.9 -132.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.671 0.607 . . . . 0.0 110.768 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -88.27 25.67 1.58 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 0.0 110.473 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.87 163.1 22.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.759 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 81.0 m -127.88 140.89 51.74 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.746 HG21 HD23 ' A' ' 104' ' ' LEU . 38.4 t -84.5 125.51 40.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.43 0.633 . . . . 0.0 112.394 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.2 -36.45 16.79 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.293 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.25 111.56 2.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.505 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -135.82 -174.21 3.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 19.3 t70 69.84 25.8 4.92 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -90.79 105.92 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.774 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.1 108.54 3.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 122.284 1.04 . . . . 0.0 112.485 177.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -83.67 -177.54 6.74 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.591 -175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -43.98 -51.38 7.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.647 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.17 -13.61 9.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.878 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.44 -109.79 0.42 Allowed Glycine 0 CA--C 1.501 -0.825 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.356 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 117' ' ' GLU . 10.4 mm -145.62 144.19 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.558 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB2' ' A' ' 118' ' ' ALA . 29.3 mt -113.61 150.91 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.453 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.686 ' NE2' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.11 115.17 6.14 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 122.12 0.962 . . . . 0.0 111.767 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 40.7 t -82.3 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.181 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -122.75 160.32 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.313 1.054 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.891 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 28.8 t70 -93.98 1.61 56.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.534 -169.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.597 ' O ' HG13 ' A' ' 126' ' ' ILE . 4.6 m -159.36 131.05 6.29 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.22 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.505 ' O ' HG21 ' A' ' 53' ' ' THR . 77.0 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.751 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.61 0.243 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.87 108.75 16.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.869 0.366 . . . . 0.0 110.153 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.482 HG22 HG12 ' A' ' 5' ' ' VAL . 46.5 m -60.77 150.57 32.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.976 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.7 -21.83 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' OE1' ' A' ' 31' ' ' GLN . 1.4 p -91.42 -34.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 110.28 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.3 -48.43 74.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.831 0.824 . . . . 0.0 109.751 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 24.2 mt -55.05 -21.46 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.657 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.0 76.07 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.863 -0.523 . . . . 0.0 110.583 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.7 t -79.15 -15.38 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.453 0.644 . . . . 0.0 110.421 174.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 64.6 t30 -94.06 -24.5 17.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.1 p -60.55 130.34 90.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 3.8 Cg_exo -79.1 64.53 8.84 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.966 2.444 . . . . 0.0 112.506 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.56 45.36 7.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.594 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.606 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.16 -175.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -58.31 154.34 13.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.316 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -57.94 -18.86 26.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.69 -32.77 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.98 -28.84 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.398 0.618 . . . . 0.0 109.623 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.63 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.7 m -82.46 -27.72 31.7 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.79 -37.52 84.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -36.46 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.004 -0.435 . . . . 0.0 110.513 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 39.1 mtmt -62.08 -43.24 99.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 111.027 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 19' ' ' THR . 8.6 p -74.69 -34.13 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.23 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -75.31 -8.04 55.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.913 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 73.03 10.45 5.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.362 1.065 . . . . 0.0 112.976 177.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.83 6.9 26.05 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.99 -0.443 . . . . 0.0 112.038 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.22 -36.56 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.988 0.423 . . . . 0.0 110.455 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 4.0 pt-20 -86.21 -18.81 31.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.973 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.95 -54.92 5.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.694 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.5 mt -56.37 -13.9 2.56 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.598 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.1 mm100 -64.39 -10.39 24.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.044 0.537 . . . . 0.0 112.215 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -61.62 110.77 3.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.346 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.48 -15.58 9.81 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.139 2.559 . . . . 0.0 113.593 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.68 -138.43 0.22 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.917 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 23.9 Cg_endo -74.85 165.37 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.223 1.949 . . . . 0.0 113.643 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.22 125.66 28.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.803 -170.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 38.1 m -124.6 119.79 30.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -118.0 152.1 20.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -108.95 106.94 17.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -99.23 112.22 62.73 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.24 130.61 13.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.407 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.779 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.6 p30 -81.55 -174.43 4.96 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.829 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -59.77 -30.0 68.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.654 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 15.4 t70 -81.84 -19.63 40.65 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.016 0.912 . . . . 0.0 109.17 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . . . -78.75 -40.33 33.64 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.047 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -64.3 -24.71 67.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.237 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.63 -21.17 38.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.235 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -61.39 -43.77 98.3 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.423 173.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.473 ' CD2' HG11 ' A' ' 129' ' ' VAL . 97.0 mt -40.46 103.63 0.3 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 O-C-N 125.707 1.88 . . . . 0.0 112.542 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.09 -80.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 111.493 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -122.01 27.65 7.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . 89.52 101.49 1.07 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.216 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.799 ' HB ' HG12 ' A' ' 129' ' ' VAL . 61.6 m -59.51 -48.6 81.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.617 0.722 . . . . 0.0 109.875 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -57.82 -24.43 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.662 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.688 ' O ' HG12 ' A' ' 58' ' ' VAL . 88.1 m -64.62 -34.13 77.55 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.367 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -81.81 -24.63 35.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.792 0.806 . . . . 0.0 109.101 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 7.6 mp -71.19 -31.29 67.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.993 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 55' ' ' THR . 9.8 p -73.72 -31.49 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.089 0.471 . . . . 0.0 109.731 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.9 mm-40 -73.0 -30.43 63.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.784 1.278 . . . . 0.0 108.325 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 1.6 m-80 -76.52 169.6 20.23 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.901 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 26.2 Cg_exo -37.31 168.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 124.439 3.426 . . . . 0.0 115.191 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 43.3 Cg_exo -40.03 -11.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 1 C-N-CA 126.537 4.825 . . . . 0.0 118.905 -168.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.679 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 7.5 tt0 -43.79 -25.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 68' ' ' LEU . 12.7 tp -46.98 -48.67 21.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.585 0.354 . . . . 0.0 111.905 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -49.64 -40.34 32.43 Favored Glycine 0 N--CA 1.458 0.14 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.829 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.697 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.61 -37.54 59.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.85 0.357 . . . . 0.0 110.049 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.6 mt -57.06 -45.19 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.717 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -48.93 -59.1 3.88 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.739 0.649 . . . . 0.0 112.673 -176.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -83.8 -64.46 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.527 -169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 71' ' ' HIS . 2.8 m-85 -125.98 -13.25 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 70' ' ' TYR . 11.1 t-80 68.09 40.44 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -175.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CD2' ' A' ' 36' ' ' PHE . 13.2 p -121.55 159.77 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.444 -165.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 72' ' ' VAL . 1.9 p -128.72 128.53 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.15 170.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' HD13 ' A' ' 91' ' ' LEU . . . -68.23 140.72 56.06 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.318 0.58 . . . . 0.0 110.854 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 113.36 97.96 2.3 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.755 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.12 101.24 0.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 122.909 0.483 . . . . 0.0 111.86 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' HD11 ' A' ' 82' ' ' LEU . 2.7 m-85 -119.03 117.54 29.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.706 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.9 mtpt -75.31 163.52 27.39 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.006 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.42 59.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.012 0.434 . . . . 0.0 110.714 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 10.0 t -71.29 -27.85 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.071 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -78.68 -49.07 13.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.323 0.582 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -55.41 -52.48 63.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.166 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.53 -33.9 75.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 80' ' ' THR . 1.1 ttt180 -54.51 -40.6 68.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.546 0.689 . . . . 0.0 110.077 176.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -80.21 -41.6 24.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.04 10.65 78.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.726 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.1 tt -162.64 156.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.694 HG12 HD12 ' A' ' 82' ' ' LEU . 13.3 m -131.1 139.13 51.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -107.3 128.02 54.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.648 0.737 . . . . 0.0 110.839 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.597 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 60.6 m -72.6 166.11 23.38 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.502 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 74' ' ' ALA . 5.0 tp -56.98 -36.18 70.05 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-O 121.946 0.879 . . . . 0.0 109.642 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.679 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 3.6 pm0 -76.65 -12.31 59.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.86 6.48 57.08 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.602 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 90' ' ' SER . 57.5 m -77.85 119.96 22.07 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.98 133.78 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.551 ' HB ' HG23 ' A' ' 88' ' ' VAL . 1.6 mp -122.23 127.05 26.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.2 Cg_exo -72.7 130.43 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.709 1.606 . . . . 0.0 112.852 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HG13 ' A' ' 88' ' ' VAL . 35.9 mm -94.53 134.34 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 68.8 m-70 -123.84 -179.27 4.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.738 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.87 97.04 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.998 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.07 -53.25 4.56 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.555 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 21.9 t-20 -118.0 -56.02 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 23.9 Cg_endo -90.7 174.13 2.89 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.613 2.209 . . . . 0.0 110.795 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 111' ' ' VAL . 13.0 tp -74.12 152.38 39.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 39.4 mt-10 -136.85 109.64 7.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 109.478 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.49 106.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -176.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 2.5 ptpt 43.49 -106.99 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 112.638 -170.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -89.26 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.622 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -108.55 166.04 11.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.454 0.645 . . . . 0.0 112.729 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.7 m -129.15 133.57 47.67 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.555 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 HD23 ' A' ' 104' ' ' LEU . 17.4 t -85.33 131.05 35.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.641 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.9 mp -88.99 -46.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.201 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -146.77 118.76 8.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.791 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -136.61 -174.7 3.78 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 27.5 m-20 67.74 27.09 7.63 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -87.06 116.2 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.386 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.696 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.35 108.61 2.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.959 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.85 -177.7 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.777 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 1.1 pt-20 -47.53 -53.51 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.567 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 46.5 m-80 -119.08 -9.36 10.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.4 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.32 -112.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.279 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 117' ' ' GLU . 32.1 mm -143.03 148.0 19.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.329 0.585 . . . . 0.0 111.328 -171.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.959 HG13 ' HB2' ' A' ' 118' ' ' ALA . 96.7 mt -119.18 147.7 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -137.57 118.75 14.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 85.1 t -83.12 128.04 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.04 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.459 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -120.97 162.26 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.85 0.833 . . . . 0.0 110.479 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.835 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.1 t70 -107.79 16.53 23.5 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.345 -170.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.619 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 73.2 m -156.79 130.56 8.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.087 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.799 HG12 ' HB ' ' A' ' 53' ' ' THR . 43.3 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.518 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.848 0.356 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.99 110.71 20.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.585 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 HG12 ' A' ' 5' ' ' VAL . 41.3 m -59.43 149.8 28.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.065 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.2 mp -44.13 -47.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.501 0.667 . . . . 0.0 111.08 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.592 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.3 p -71.89 -36.06 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.688 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -54.84 -46.36 74.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.939 0.875 . . . . 0.0 109.673 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.575 ' HA ' ' CB ' ' A' ' 10' ' ' ASN . 18.5 mt -56.8 -21.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.211 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . . . -61.39 -32.94 72.88 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.751 -0.593 . . . . 0.0 110.415 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.21 -34.85 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.381 0.61 . . . . 0.0 109.999 172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.575 ' CB ' ' HA ' ' A' ' 7' ' ' ILE . 17.5 t-20 -66.29 -25.22 66.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.529 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.2 p -62.45 138.48 96.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.043 -175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.7 Cg_exo -80.61 62.27 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.601 2.201 . . . . 0.0 112.315 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 46.84 20.51 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.998 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.73 -168.66 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.553 0.692 . . . . 0.0 112.423 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' HG22 ' A' ' 18' ' ' VAL . 4.6 m -58.57 158.94 7.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.856 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -60.49 -17.99 48.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -52.6 -35.27 53.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 8' ' ' ALA . 3.9 m -80.92 -28.45 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.686 0.755 . . . . 0.0 109.967 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.578 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -79.79 -29.05 40.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 -177.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.83 -35.66 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.818 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 -36.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.11 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 27.2 mtmt -61.5 -43.86 98.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.299 0.571 . . . . 0.0 110.982 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 19' ' ' THR . 8.3 p -73.52 -35.93 46.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.98 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.04 -4.19 33.95 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.656 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.15 9.68 7.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.272 1.029 . . . . 0.0 112.842 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.2 mp -87.25 7.34 28.91 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.91 -0.494 . . . . 0.0 111.805 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -59.41 -36.98 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.197 0.522 . . . . 0.0 109.792 176.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 6.1 pt-20 -85.85 -21.82 27.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.626 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.89 -54.89 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 19.8 mt -58.54 -9.81 1.86 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.592 ' OE1' HG13 ' A' ' 5' ' ' VAL . 6.4 mm100 -70.98 4.64 2.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.826 0.45 . . . . 0.0 112.054 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.2 p -48.02 112.55 2.26 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 123.98 0.8 . . . . 0.0 112.412 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 32' ' ' SER . 4.5 Cg_exo -80.98 -12.57 11.9 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.24 2.627 . . . . 0.0 111.254 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.79 -135.11 1.91 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.147 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 17.7 Cg_endo -84.3 170.94 10.41 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.917 2.412 . . . . 0.0 113.174 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.702 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -139.08 122.96 17.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.702 HG21 ' CG ' ' A' ' 77' ' ' TYR . 0.4 OUTLIER -126.83 119.88 27.9 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -174.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 123' ' ' ILE . 7.4 p -117.42 145.03 23.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.245 0.545 . . . . 0.0 111.261 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.663 ' HD1' ' CE1' ' A' ' 124' ' ' HIS . 55.3 m-85 -93.06 109.25 20.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -91.35 111.86 51.08 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 120.673 0.273 . . . . 0.0 111.318 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.41 128.33 8.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.099 1.866 . . . . 0.0 111.739 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.849 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.2 p30 -80.91 -175.41 5.35 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.994 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.74 -32.0 59.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 11.4 t70 -83.22 -23.89 32.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.698 0.761 . . . . 0.0 109.185 -174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -80.44 -34.57 35.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.621 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -61.49 -22.94 65.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.875 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.52 -9.0 58.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.686 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.651 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 27.7 mmmt -91.09 -25.99 19.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' CD2' HG21 ' A' ' 129' ' ' VAL . 38.9 mt -46.09 -48.41 42.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.825 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 18.2 Cg_endo -63.25 -21.12 71.93 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.901 1.734 . . . . 0.0 112.859 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.53 -35.17 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.367 0.603 . . . . 0.0 110.081 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.18 56.92 1.09 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.222 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.501 HG21 ' O ' ' A' ' 129' ' ' VAL . 97.6 m -68.31 -57.75 5.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.486 0.66 . . . . 0.0 109.993 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 57' ' ' LEU . 1.1 mp -58.91 -24.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.701 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 58' ' ' VAL . 63.0 m -55.36 -37.37 67.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.732 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -81.8 -27.24 33.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.91 0.862 . . . . 0.0 109.369 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 54' ' ' ILE . 10.1 mp -73.11 -25.17 60.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.838 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -79.14 -29.21 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 121.172 0.511 . . . . 0.0 109.865 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 55' ' ' THR . 27.5 mm-40 -71.79 -27.27 62.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 122.575 1.179 . . . . 0.0 108.706 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.58 166.69 37.17 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.057 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 30.5 Cg_exo -39.21 168.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.306 3.338 . . . . 0.0 114.641 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 21.6 Cg_exo -34.73 -10.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 1 C-N-CA 127.345 5.364 . . . . 0.0 119.393 -172.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.631 HE21 ' NH1' ' A' ' 66' ' ' ARG . 19.6 tt0 -42.34 -24.93 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 ' O ' HD22 ' A' ' 68' ' ' LEU . 11.5 tp -44.56 -49.02 10.31 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.378 0.671 . . . . 0.0 112.477 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.97 -31.73 33.06 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.843 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.631 ' NH1' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 0.0 110.02 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.696 HD13 HG13 ' A' ' 54' ' ' ILE . 36.0 mt -68.64 -46.97 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.362 -169.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -50.15 -59.37 3.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -174.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.79 -62.45 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -168.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.39 -13.78 7.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 t60 65.83 36.26 6.21 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.4 p -109.82 160.44 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.57 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.53 ' HB ' HH21 ' A' ' 66' ' ' ARG . 0.8 OUTLIER -136.63 131.39 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -70.2 138.84 52.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 120.69 88.39 1.04 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.308 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -56.22 98.53 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 112.124 -171.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 1.002 ' CG ' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -95.66 147.72 23.3 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.042 179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.668 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -110.73 152.75 26.21 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.37 -30.49 12.42 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 0.0 112.061 -169.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 12.2 t -75.42 -25.0 57.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.858 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.79 -51.61 18.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.857 0.836 . . . . 0.0 109.386 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.002 HD21 ' CG ' ' A' ' 77' ' ' TYR . 0.3 OUTLIER -57.72 -50.72 72.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.703 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -66.96 -33.0 74.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.741 0.305 . . . . 0.0 111.328 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -55.0 -40.95 70.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.432 0.634 . . . . 0.0 110.274 173.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.8 mtt -78.44 -41.82 31.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.716 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.85 10.71 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.907 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.1 tt -163.83 157.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 95' ' ' THR . 15.1 m -131.59 141.7 45.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.772 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.8 m -108.93 133.55 52.78 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.221 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 94' ' ' SER . 26.3 t -66.14 164.88 14.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.908 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.2 tp -56.89 -33.59 67.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.558 0.694 . . . . 0.0 109.78 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -27.24 41.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.749 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.21 3.27 11.88 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.893 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.531 ' H ' ' HB3' ' A' ' 90' ' ' SER . 1.8 m -78.34 120.44 23.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.788 0.794 . . . . 0.0 111.564 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -85.03 141.72 30.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.8 mp -127.28 127.27 24.26 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.645 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.2 Cg_exo -72.59 130.06 15.47 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.021 1.814 . . . . 0.0 113.35 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.564 ' CG1' HG13 ' A' ' 88' ' ' VAL . 42.1 mm -98.89 141.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.344 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.433 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 31.1 m80 -134.92 178.8 6.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.543 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.58 110.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.612 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.27 -48.1 8.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 8.1 t30 -128.13 -55.69 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.138 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 15.9 Cg_endo -90.47 173.71 3.12 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.264 1.976 . . . . 0.0 110.8 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 111' ' ' VAL . 14.5 tp -74.48 153.99 38.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 4.3 mm-40 -138.65 119.29 14.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.612 -174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.513 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -119.39 106.01 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.301 -173.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.672 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.8 pttp 49.83 -78.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.536 1.535 . . . . 0.0 113.812 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.481 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 30.3 p-10 -125.29 1.19 7.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.526 0.679 . . . . 0.0 109.344 -172.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -117.6 165.31 13.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.431 -173.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -125.46 136.21 53.14 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.874 HG21 HD23 ' A' ' 104' ' ' LEU . 99.0 t -83.18 127.47 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.234 -174.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.3 mp -93.25 -32.87 14.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.865 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -162.99 116.53 1.64 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.434 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.79 -175.77 4.01 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 29.7 t70 68.11 25.65 7.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -169.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.5 mt -85.06 109.09 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.114 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.554 ' HA ' HD13 ' A' ' 122' ' ' ILE . 35.8 mt-10 -67.56 106.92 2.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.471 0.653 . . . . 0.0 111.14 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.808 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -80.27 -175.17 4.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.399 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.09 -52.26 45.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.429 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.7 m-20 -117.78 -12.78 10.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -149.13 -111.45 0.59 Allowed Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.565 -1.302 . . . . 0.0 112.79 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.668 HG13 ' HE3' ' A' ' 78' ' ' LYS . 7.6 mm -145.31 149.14 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.539 0.685 . . . . 0.0 111.676 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.808 HG13 ' HB2' ' A' ' 118' ' ' ALA . 87.9 mt -114.4 151.17 16.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.462 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.713 ' NE2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.15 112.91 5.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.055 0.931 . . . . 0.0 112.178 -178.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 46.1 t -80.08 130.09 36.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.635 -174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.66 163.34 25.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.672 0.749 . . . . 0.0 110.123 176.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.849 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 34.7 t70 -106.32 14.71 27.07 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.017 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.651 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 15.9 m -164.26 131.0 3.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.248 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.501 ' O ' HG21 ' A' ' 53' ' ' THR . 54.6 t . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.648 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.56 0.219 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.46 122.17 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.577 HG22 HG12 ' A' ' 5' ' ' VAL . 57.3 m -63.68 148.7 48.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.4 172.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.61 -20.9 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 3' ' ' THR . 2.6 p -92.39 -37.32 8.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.175 0.512 . . . . 0.0 111.003 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -50.05 -48.91 52.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.586 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 7.5 mt -59.48 -22.14 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.932 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.52 77.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.314 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.67 -26.6 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 110.259 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 47.6 t30 -77.28 -25.27 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.365 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 7' ' ' ILE . 12.6 p -65.89 138.9 96.58 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 59.12 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.516 2.811 . . . . 0.0 112.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.87 44.1 10.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.881 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -66.09 -178.31 0.6 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -55.43 158.34 3.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.985 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -58.37 -18.38 27.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.514 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -53.36 -35.94 60.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.112 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.26 -30.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.592 0.711 . . . . 0.0 110.064 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -80.82 -29.74 35.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.472 -173.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -64.66 -33.53 76.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -37.43 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 109.886 171.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 7.6 mtmt -61.52 -39.9 92.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.428 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' THR . 7.4 p -77.11 -36.18 24.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.393 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -73.84 -6.69 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.026 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 72.64 10.99 5.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.181 0.992 . . . . 0.0 112.276 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 66' ' ' ARG . 7.8 mp -87.23 7.03 30.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.714 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -36.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.19 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.8 pt-20 -85.38 -21.62 28.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.829 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.75 -53.75 8.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.1 mt -61.74 -5.65 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.299 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.687 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 6.7 mm100 -74.29 10.44 1.27 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.497 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 m -92.85 95.27 1.05 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-O 120.944 0.402 . . . . 0.0 110.01 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 31' ' ' GLN . 53.8 Cg_endo -80.53 -8.01 13.7 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.072 2.515 . . . . 0.0 113.5 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -124.07 0.02 OUTLIER Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.881 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 37.9 Cg_endo -78.99 154.26 25.66 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.28 1.32 . . . . 0.0 112.597 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.657 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -138.69 121.67 16.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.128 -168.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.4 m -119.63 124.23 45.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.271 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' HG12 ' A' ' 123' ' ' ILE . 98.5 t -122.02 140.97 44.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.236 0.541 . . . . 0.0 111.949 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.49 115.3 29.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -105.65 117.98 56.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.167 -173.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.32 125.13 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.995 1.797 . . . . 0.0 111.582 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.768 HD22 ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -78.7 173.27 12.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.24 -46.01 8.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.609 0.719 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.9 -20.79 61.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.776 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -78.8 -38.59 37.97 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.314 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -62.82 -26.02 68.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.026 0.917 . . . . 0.0 109.02 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.94 -22.57 39.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.209 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 26.9 mmmt -62.46 -46.6 87.79 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.948 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 129' ' ' VAL . 95.3 mt -33.64 101.8 0.2 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 O-C-N 125.879 1.987 . . . . 0.0 113.576 -166.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' A' ' 51' ' ' ASP . 72.7 Cg_endo -84.1 -141.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 124.87 3.713 . . . . 0.0 110.796 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 50' ' ' PRO . 6.8 m-20 -56.19 -32.91 64.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 171.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.55 105.72 0.47 Allowed Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.591 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.648 ' HB ' HG12 ' A' ' 129' ' ' VAL . 58.3 m -56.89 -54.35 47.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -63.76 -25.57 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.648 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.742 ' O ' HG12 ' A' ' 58' ' ' VAL . 90.9 m -66.74 -35.64 80.58 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -79.3 -27.24 42.18 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.868 0.842 . . . . 0.0 109.262 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.3 mp -76.21 -25.71 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.43 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -75.28 -28.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.3 mm-40 -73.55 -27.14 61.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.64 1.21 . . . . 0.0 108.771 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 5.3 m-80 -84.44 168.37 21.7 Favored Pre-proline 0 N--CA 1.435 -1.197 0 CA-C-N 112.982 -1.917 . . . . 0.0 111.038 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 28.8 Cg_exo -38.3 168.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 124.543 3.495 . . . . 0.0 115.197 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 15.3 Cg_exo -34.08 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.896 1 C-N-CA 127.824 5.683 . . . . 0.0 120.551 -166.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.602 ' O ' HG13 ' A' ' 67' ' ' ILE . 3.5 tt0 -43.89 -28.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.664 ' O ' HD22 ' A' ' 68' ' ' LEU . 16.5 tp -44.83 -51.1 9.86 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.223 0.609 . . . . 0.0 112.305 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.72 -34.73 37.02 Favored Glycine 0 N--CA 1.461 0.307 0 O-C-N 123.599 0.562 . . . . 0.0 113.321 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.596 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.71 -40.11 61.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.434 0.635 . . . . 0.0 110.026 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.1 mt -62.51 -47.52 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.828 -174.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.64 -62.35 1.33 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.949 0.781 . . . . 0.0 112.822 -173.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -88.96 -61.94 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -122.13 -12.81 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 59.9 38.01 21.33 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.5 p -106.7 159.39 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.586 -165.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.1 p -132.99 125.57 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.556 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.562 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -67.36 141.96 56.93 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.346 0.593 . . . . 0.0 110.712 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.78 100.16 2.23 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.392 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -61.32 102.26 0.22 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.244 0.545 . . . . 0.0 111.834 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 82' ' ' LEU . 3.2 m-85 -120.71 122.4 40.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.135 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.603 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.08 159.34 27.57 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 170.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -48.99 -36.78 18.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.45 0.469 . . . . 0.0 110.633 -172.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 6.5 t -72.36 -23.99 61.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.287 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.38 -40.17 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.08 -48.87 78.28 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.421 175.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.704 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.8 mtpt -66.53 -29.42 69.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 122.946 0.498 . . . . 0.0 112.218 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.12 -32.47 68.15 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 122.021 0.915 . . . . 0.0 109.299 173.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.1 -42.5 12.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.464 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' HB ' ' A' ' 98' ' ' ILE . . . 80.96 12.01 83.13 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.61 -172.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.9 tt -163.22 159.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 HD12 ' A' ' 82' ' ' LEU . 9.4 m -133.21 139.28 49.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 73' ' ' VAL . 4.3 m -107.37 129.81 54.87 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.505 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 21.4 t -71.44 165.83 22.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.498 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.3 tp -56.74 -30.15 63.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.787 0.803 . . . . 0.0 109.894 173.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 8.0 pt-20 -78.37 -22.96 47.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.48 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.13 11.76 27.1 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.34 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 90' ' ' SER . 73.4 m -88.83 122.29 32.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 122.44 -0.447 . . . . 0.0 111.99 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.3 137.71 32.79 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -128.05 130.08 23.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.509 177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.7 Cg_exo -72.57 134.91 23.13 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.023 1.815 . . . . 0.0 113.328 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -98.61 135.31 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.743 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 53.2 m80 -127.88 -178.81 4.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.682 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.75 100.3 0.16 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.094 -1.051 . . . . 0.0 113.204 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.91 -35.36 26.16 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.5 t-20 -144.2 -55.83 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.185 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 42.2 Cg_endo -85.72 174.04 6.88 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.163 1.909 . . . . 0.0 110.623 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.704 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 16.1 tp -72.89 151.02 42.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 43.5 mt-10 -140.99 106.33 5.04 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -109.12 132.28 57.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.033 -173.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HG2' HG22 ' A' ' 106' ' ' VAL . 12.2 ptmm? 55.36 -82.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.646 1.179 . . . . 0.0 112.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.504 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 22.8 p-10 -146.04 23.03 1.37 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.642 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -125.86 162.99 23.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.252 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.8 m -122.33 131.24 53.81 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 t -78.58 127.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.399 0.619 . . . . 0.0 111.695 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.03 -39.0 13.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.222 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.07 118.35 5.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.72 -174.23 3.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 10.5 m-20 66.26 27.15 10.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -173.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -85.0 114.16 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.5 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.1 mt-10 -66.24 108.83 2.43 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.389 0.614 . . . . 0.0 110.61 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.508 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.26 -172.75 3.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.705 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 3.2 pt-20 -53.26 -51.49 62.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 80.7 m-20 -120.12 -10.75 9.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.3 -118.23 1.17 Allowed Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.229 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 117' ' ' GLU . 19.3 mm -146.18 146.66 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.349 0.595 . . . . 0.0 111.622 -172.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 118' ' ' ALA . 45.3 mt -118.83 146.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.654 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -133.59 116.4 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 84.4 t -81.17 127.72 39.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.259 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.591 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -125.65 160.51 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.462 0.649 . . . . 0.0 110.724 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 42' ' ' ASN . 0.7 OUTLIER -98.16 9.21 43.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.904 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.642 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 23.1 m -146.94 129.17 15.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.18 0.514 . . . . 0.0 111.346 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' A' ' 53' ' ' THR . 89.0 t . . . . . 0 C--O 1.255 1.385 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.538 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.723 0.297 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.27 117.72 18.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.196 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -67.34 152.36 45.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.554 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.7 mp -49.75 -42.14 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.497 0.665 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.4 p -75.03 -36.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.14 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -52.14 -48.51 64.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.509 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 15.4 mt -56.88 -22.31 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.153 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.802 -0.561 . . . . 0.0 110.45 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.85 -18.38 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 110.111 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 40.4 t30 -95.95 -25.45 15.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.855 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 4.1 p -59.25 130.38 87.07 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.038 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.24 65.7 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.136 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.5 46.77 18.29 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.208 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.62 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -63.73 -174.56 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.072 0.463 . . . . 0.0 111.516 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.74 156.82 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 m -59.72 -18.17 40.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.322 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mp -54.12 -34.85 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.408 ' C ' ' HD3' ' A' ' 22' ' ' LYS . 3.5 m -79.93 -39.09 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -68.9 -26.29 65.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.944 -175.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.615 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -66.98 -37.23 83.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -37.08 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.606 0.717 . . . . 0.0 109.872 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 1.8 mtpp -58.52 -41.14 84.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.949 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 19' ' ' THR . 7.1 p -78.16 -36.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.168 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -72.85 -1.63 17.5 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.049 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.64 7.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.068 0.947 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 92' ' ' GLU . 9.6 mp -88.84 6.22 40.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.0 -0.438 . . . . 0.0 111.666 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.978 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.2 pt-20 -84.75 -22.16 29.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.812 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -73.25 -54.77 7.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.71 0.29 . . . . 0.0 111.571 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 HD23 ' A' ' 91' ' ' LEU . 25.3 mt -57.09 -14.66 4.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' OE1' HG13 ' A' ' 5' ' ' VAL . 5.0 mm100 -68.77 -3.31 11.83 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.03 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 p -49.47 115.84 5.3 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.933 0.397 . . . . 0.0 111.474 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.72 -18.26 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.87 2.38 . . . . 0.0 113.147 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 35' ' ' PRO . . . -78.4 -135.9 1.0 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.607 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 11.2 Cg_endo -85.78 166.56 10.1 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.027 2.485 . . . . 0.0 113.098 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 72' ' ' VAL . 60.3 m-85 -133.9 122.05 22.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.7 m -104.03 104.89 14.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.568 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' HB ' HG12 ' A' ' 123' ' ' ILE . 37.2 t -95.59 123.06 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.792 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 126' ' ' ILE . 98.4 m-85 -86.56 108.04 18.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.2 128.82 39.29 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.872 -170.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HB3' HG22 ' A' ' 129' ' ' VAL . 98.6 Cg_endo -79.91 126.86 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.129 1.886 . . . . 0.0 112.55 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -78.52 177.69 8.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.4 -32.7 65.06 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 14.2 t70 -83.85 -19.99 33.93 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.972 0.892 . . . . 0.0 108.945 -176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -84.37 -36.31 22.57 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.317 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -57.93 -20.34 36.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.15 0.976 . . . . 0.0 109.054 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -83.93 -9.29 58.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.789 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 27.8 mmmt -93.57 -25.82 17.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.184 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 34.9 mt -50.45 -49.68 76.11 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 37.9 Cg_endo -67.91 81.78 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.134 1.889 . . . . 0.0 112.846 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 49.69 63.19 2.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.705 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.02 -89.07 0.73 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.593 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.0 m -82.86 -53.55 5.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.385 0.612 . . . . 0.0 110.819 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 57' ' ' LEU . 1.4 mp -58.19 -23.72 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.452 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 85.3 m -57.67 -35.98 71.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.469 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -82.73 -25.35 32.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.839 0.828 . . . . 0.0 109.14 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 54' ' ' ILE . 8.6 mp -73.1 -27.3 61.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.81 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 8.1 p -79.38 -29.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.064 0.459 . . . . 0.0 109.764 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 55' ' ' THR . 18.8 mm-40 -70.89 -27.47 63.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.699 1.238 . . . . 0.0 108.347 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -82.16 168.07 26.25 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.882 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 22.2 Cg_exo -37.45 168.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 125.008 3.805 . . . . 0.0 116.18 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 36.5 Cg_exo -40.42 -9.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.871 5.047 . . . . 0.0 118.518 -171.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.516 ' O ' HG13 ' A' ' 67' ' ' ILE . 22.9 tt0 -43.76 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' O ' HD22 ' A' ' 68' ' ' LEU . 9.5 tp -44.39 -49.95 9.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.61 0.364 . . . . 0.0 110.928 173.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -53.37 -29.7 38.9 Favored Glycine 0 C--N 1.33 0.195 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.556 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -79.35 -39.73 31.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.245 0.545 . . . . 0.0 109.856 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 64' ' ' LEU . 54.6 mt -59.22 -45.39 92.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.524 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.05 -60.13 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -175.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -85.77 -63.09 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.437 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.97 -16.9 5.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -171.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 67.23 34.99 4.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 15.0 p -111.76 159.45 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.948 -167.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 89' ' ' THR . 1.6 p -132.59 131.78 59.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.9 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.622 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.23 144.32 57.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 111.661 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.41 99.86 2.59 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.226 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -57.22 110.31 0.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.824 0.849 . . . . 0.0 111.401 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 122' ' ' ILE . 10.5 m-85 -121.03 110.09 15.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.844 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HD3' HD12 ' A' ' 122' ' ' ILE . 20.3 mmtp -65.77 161.39 20.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 168.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.94 44.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 111.407 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 15.0 t -76.48 -31.38 57.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.646 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.29 -46.86 66.15 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.735 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -58.56 -54.06 51.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.136 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -68.47 -32.04 71.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.1 ttt180 -51.04 -45.22 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.757 0.789 . . . . 0.0 110.212 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.0 mtp -81.08 -39.24 26.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 12.82 79.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.846 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.7 tt -162.95 157.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.735 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -133.11 144.09 37.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.191 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.4 m -107.03 134.63 49.89 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.675 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 94' ' ' SER . 67.5 m -73.17 162.41 29.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.794 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.4 tp -52.82 -36.63 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.425 0.631 . . . . 0.0 110.527 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.37 -28.71 59.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.288 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.1 5.36 8.88 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.673 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' A' ' 90' ' ' SER . 1.4 m -80.32 120.43 24.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.818 0.809 . . . . 0.0 112.097 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -81.97 139.45 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.0 112.807 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.7 mp -127.69 127.85 23.98 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.617 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.578 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.1 Cg_exo -72.99 132.3 18.07 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.11 1.874 . . . . 0.0 113.102 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.438 HG13 ' HB3' ' A' ' 82' ' ' LEU . 41.2 mm -95.53 136.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.303 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 33.3 m-70 -127.53 178.14 6.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.771 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.86 115.19 0.32 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.463 -1.351 . . . . 0.0 113.294 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.89 -53.81 2.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.608 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 19.8 m120 -114.68 -59.9 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.287 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 17.2 Cg_endo -90.4 173.61 3.19 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.161 1.907 . . . . 0.0 110.916 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.0 tp -75.52 153.99 37.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 5.7 mm-40 -139.01 107.1 5.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.336 0.588 . . . . 0.0 109.691 -173.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.702 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -112.98 128.46 69.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.043 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 12.1 ptmm? 51.75 -138.23 1.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.592 0.558 . . . . 0.0 110.191 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -89.97 30.79 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.307 0.575 . . . . 0.0 110.084 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.11 159.22 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.113 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 m -126.2 137.59 53.57 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.8 t -80.47 125.62 39.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.552 0.691 . . . . 0.0 111.732 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.77 -35.72 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.458 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -157.01 114.86 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.504 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -137.41 -173.88 3.6 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.591 ' CG ' ' HD2' ' A' ' 78' ' ' LYS . 12.3 t70 71.58 31.45 2.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.717 1.246 . . . . 0.0 107.646 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 10.0 mt -94.67 116.43 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.461 -1.699 . . . . 0.0 109.538 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.73 107.3 2.52 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.088 0.471 . . . . 0.0 109.759 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.908 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -78.98 -177.05 5.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.126 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.86 -50.09 46.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.415 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -118.55 -16.09 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.924 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -149.01 -109.23 0.51 Allowed Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.556 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 78' ' ' LYS . 23.1 mm -141.06 150.77 20.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.055 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.908 HG13 ' HB2' ' A' ' 118' ' ' ALA . 82.5 mt -123.32 143.43 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.727 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -135.57 114.02 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 60.2 t -78.46 128.86 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -128.74 165.94 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 122.162 0.982 . . . . 0.0 111.412 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.892 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -97.6 10.61 39.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.114 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.598 ' O ' HG13 ' A' ' 126' ' ' ILE . 18.1 m -164.18 123.39 1.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.859 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 41' ' ' PRO . 21.4 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.903 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.239 0.542 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.78 168.45 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.733 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.427 HG22 HG12 ' A' ' 5' ' ' VAL . 32.9 m -71.26 144.55 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.088 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -56.3 -23.68 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.572 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.0 p -91.68 -36.55 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.276 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 9' ' ' VAL . 33.0 t70 -57.76 -46.42 84.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.046 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 11' ' ' THR . 14.0 mt -57.7 -25.28 24.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.579 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -31.49 72.06 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.176 -0.327 . . . . 0.0 111.021 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 6' ' ' ASP . 7.1 p -91.27 -12.75 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.238 0.542 . . . . 0.0 110.501 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' ILE . 82.2 m-20 -91.99 -14.72 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 7' ' ' ILE . 11.0 p -59.83 138.02 90.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.186 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.84 65.61 8.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.815 2.343 . . . . 0.0 111.962 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.6 47.41 41.68 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.058 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.46 -173.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.308 0.575 . . . . 0.0 111.977 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -62.76 166.22 5.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.748 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -63.13 -19.23 64.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.8 mt -53.52 -36.81 62.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.251 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.2 -27.98 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.619 0.723 . . . . 0.0 109.853 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.621 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -79.38 -26.62 41.96 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.446 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.3 -40.58 97.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.747 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 p -74.75 -36.1 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.855 -0.528 . . . . 0.0 110.288 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 24.1 mtmt -61.11 -44.16 97.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.258 0.551 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 19' ' ' THR . 9.0 p -75.42 -34.83 31.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.113 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.65 -1.58 22.37 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.757 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.85 7.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 112.849 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.7 mp -89.95 6.55 41.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.42 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.3 pt-20 -85.64 -17.71 35.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.262 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.72 -58.49 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 14.5 mt -51.91 -13.25 0.27 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' OE1' HG13 ' A' ' 5' ' ' VAL . 8.3 mm100 -66.33 -2.85 4.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.503 0.721 . . . . 0.0 112.73 -174.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -54.52 110.35 2.09 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 123.386 0.429 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.46 -18.02 9.79 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.698 2.265 . . . . 0.0 111.839 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -133.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.276 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 44.3 Cg_endo -80.78 159.1 21.52 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.025 1.817 . . . . 0.0 113.3 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -142.7 122.15 13.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.427 -169.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.493 ' HB ' HG13 ' A' ' 73' ' ' VAL . 51.6 m -118.71 123.24 44.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -172.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' HB ' HG12 ' A' ' 123' ' ' ILE . 81.8 t -117.46 143.53 27.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.303 0.573 . . . . 0.0 111.729 -174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HB3' HD12 ' A' ' 126' ' ' ILE . 97.8 m-85 -106.14 109.3 21.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -97.1 120.48 61.24 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.474 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' HG22 ' A' ' 129' ' ' VAL . 73.5 Cg_endo -77.24 136.47 16.09 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.661 2.241 . . . . 0.0 112.687 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.76 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.9 p30 -85.87 -173.78 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.2 -31.08 63.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 17.4 t70 -87.41 -21.5 25.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -79.04 -36.13 41.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.051 175.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.15 -21.51 61.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.116 0.96 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.69 -11.41 53.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.862 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 22.0 mmmt -88.42 -26.07 22.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.451 0.643 . . . . 0.0 109.441 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' CD2' HG21 ' A' ' 129' ' ' VAL . 38.2 mt -43.59 -49.49 18.6 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 114.292 -1.322 . . . . 0.0 114.234 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.26 -51.22 2.1 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.015 2.477 . . . . 0.0 113.071 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -164.73 93.91 0.66 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . -140.11 -146.47 4.85 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.991 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' HD13 ' A' ' 57' ' ' LEU . 94.1 m -64.5 -57.84 8.09 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.664 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.1 mp -54.68 -24.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.561 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.786 ' O ' HG12 ' A' ' 58' ' ' VAL . 84.7 m -60.03 -40.82 90.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.902 174.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.5 t -77.81 -34.51 52.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.22 1.009 . . . . 0.0 108.74 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 10.9 mp -66.8 -19.39 65.73 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.408 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 55' ' ' THR . 3.8 p -93.98 -21.02 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.539 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.1 mm-40 -71.11 -47.55 57.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.694 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -147.83 10.29 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -177.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.694 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 5.0 Cg_exo -93.46 152.67 2.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 CA-C-N 121.886 1.709 . . . . 0.0 112.226 157.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -63.97 -17.31 59.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.325 2.683 . . . . 0.0 112.789 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -51.06 -18.52 0.84 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 24' ' ' ALA . 3.9 tp -45.32 -47.42 13.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.592 0.357 . . . . 0.0 111.725 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -50.02 -33.32 21.29 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.352 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.591 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.53 -36.45 65.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.139 0.971 . . . . 0.0 109.932 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.752 HD11 ' NE2' ' A' ' 63' ' ' GLN . 38.8 mt -69.45 -44.71 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.286 -169.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.574 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -49.91 -53.51 25.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.725 0.641 . . . . 0.0 112.495 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -87.14 -63.01 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -124.31 -13.48 7.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t60 64.11 41.19 6.45 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.7 p -109.86 160.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.85 -165.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 89' ' ' THR . 2.1 p -136.86 135.67 48.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.302 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.8 141.19 51.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.176 0.512 . . . . 0.0 110.956 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 98.92 2.3 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.891 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -60.52 103.32 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.279 0.561 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -120.04 123.48 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.385 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -80.05 161.28 25.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.589 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.31 -38.35 12.58 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 123.459 0.474 . . . . 0.0 110.837 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.1 t -71.46 -25.29 62.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.973 -172.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.25 -40.62 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.677 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.29 -42.72 99.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.478 175.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.4 mtpt -72.78 -30.57 64.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 122.581 0.353 . . . . 0.0 111.8 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -38.07 75.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.6 mtt -77.25 -45.0 27.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.981 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 79.73 9.75 86.46 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.454 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.7 tt -162.97 159.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.677 HG12 HD12 ' A' ' 82' ' ' LEU . 8.3 m -135.01 138.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.496 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.8 m -111.68 135.94 51.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.056 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' A' ' 94' ' ' SER . 15.6 t -71.08 168.63 16.72 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.537 0.735 . . . . 0.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -52.7 -37.73 59.44 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.538 0.685 . . . . 0.0 109.468 172.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.79 -25.26 48.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.579 -173.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.74 12.44 9.43 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.252 -0.886 . . . . 0.0 113.537 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.549 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.7 OUTLIER -80.48 120.51 24.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.756 0.778 . . . . 0.0 111.205 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.34 137.95 31.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 112.522 178.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.7 mp -130.16 126.59 22.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.984 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HA ' HG13 ' A' ' 87' ' ' ILE . 5.0 Cg_exo -71.83 133.24 21.46 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.156 1.904 . . . . 0.0 113.192 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.3 mm -95.64 139.38 19.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.025 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 37.7 m-70 -139.94 -178.92 5.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.215 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.484 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 142.3 115.62 1.13 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.905 -1.14 . . . . 0.0 113.93 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -83.09 -48.8 10.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 40.5 t30 -116.71 -53.73 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.111 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 17.8 Cg_endo -90.09 174.06 3.27 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.09 1.86 . . . . 0.0 110.419 172.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.662 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 17.7 tp -80.02 155.38 27.64 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.645 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 33.7 mt-10 -138.08 111.25 7.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.378 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.41 118.96 51.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.976 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB3' HG23 ' A' ' 96' ' ' ILE . 22.7 pttt 48.3 -107.01 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.986 0.914 . . . . 0.0 112.269 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.23 9.48 25.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.453 0.644 . . . . 0.0 110.375 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -104.13 163.25 12.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.193 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -128.8 135.18 48.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 4.1 t -82.98 126.66 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.431 0.634 . . . . 0.0 111.434 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.7 mp -89.4 -39.24 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.783 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.49 116.57 4.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.334 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.48 -173.67 3.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.785 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 31.7 t70 71.15 28.4 3.08 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 122.867 1.317 . . . . 0.0 107.933 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 11.9 mt -89.54 111.13 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.69 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 122' ' ' ILE . 39.4 mt-10 -68.09 108.95 3.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.046 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.13 179.57 7.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.939 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 2.0 pt-20 -46.52 -50.76 16.68 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.817 0.698 . . . . 0.0 111.301 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 94.3 m-20 -120.58 -15.48 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.103 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.53 -118.77 1.39 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.625 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.706 HD13 ' HA ' ' A' ' 117' ' ' GLU . 16.3 mm -145.49 145.08 20.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.181 0.515 . . . . 0.0 111.747 -171.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 118' ' ' ALA . 22.7 mt -116.44 148.65 19.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.46 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -138.35 117.2 12.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 87.7 t -79.45 128.86 38.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.9 169.35 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 122.08 0.943 . . . . 0.0 110.909 -177.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.772 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.9 t70 -109.63 21.0 17.5 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.657 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.636 ' O ' HG13 ' A' ' 126' ' ' ILE . 10.7 m -163.99 124.6 2.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.669 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 49' ' ' LEU . 50.0 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.979 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.568 0.223 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.51 140.44 49.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.939 0.399 . . . . 0.0 110.702 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 5' ' ' VAL . 92.7 m -70.99 145.99 49.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.908 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -43.05 -50.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.19 0.519 . . . . 0.0 111.75 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.596 HG13 ' OE1' ' A' ' 31' ' ' GLN . 2.0 p -67.93 -37.13 77.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.973 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.23 -44.33 92.32 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.78 0.8 . . . . 0.0 110.173 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 11.1 mt -56.63 -22.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.7 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.23 -32.45 71.14 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.854 -0.529 . . . . 0.0 110.988 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.59 -30.39 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.415 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 55.3 t30 -74.2 -24.93 59.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.505 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.2 p -62.6 144.82 95.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.825 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -80.44 59.84 7.61 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.977 2.451 . . . . 0.0 112.117 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.24 46.71 62.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.497 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.579 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.47 -169.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.854 0.835 . . . . 0.0 112.864 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m -56.87 160.38 3.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -61.94 -19.46 62.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.601 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.0 tp -57.24 -33.57 67.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 m -80.7 -27.15 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 109.829 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.565 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.4 m -83.48 -27.58 29.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.95 81.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 0.0 111.609 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.48 -37.69 30.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.964 -0.46 . . . . 0.0 110.445 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 38.0 mtmt -62.19 -41.51 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.451 . . . . 0.0 111.175 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 19' ' ' THR . 7.3 p -74.5 -35.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.111 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.08 -7.72 53.56 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.181 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.95 16.96 7.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.566 1.146 . . . . 0.0 112.62 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.4 mp -92.83 9.35 35.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 121.999 -0.438 . . . . 0.0 112.097 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -59.44 -36.92 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.5 pt-20 -86.04 -19.07 30.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.011 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.15 -54.88 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 23.1 mt -55.61 -13.35 1.56 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.596 ' OE1' HG13 ' A' ' 5' ' ' VAL . 7.7 mm100 -66.16 -9.37 30.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 m -51.92 114.25 5.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 123.257 0.348 . . . . 0.0 111.221 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.38 -20.29 7.17 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.817 2.345 . . . . 0.0 113.628 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.3 -135.74 0.61 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -172.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 54.2 Cg_endo -78.76 162.66 26.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.819 2.346 . . . . 0.0 113.057 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 29.5 m-85 -136.62 121.97 19.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.651 -172.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 45.7 m -107.69 136.21 47.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.026 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -129.22 153.7 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.161 0.505 . . . . 0.0 110.492 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.72 107.23 16.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.55 111.43 53.92 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.677 -171.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 72.5 Cg_endo -77.33 130.17 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.058 1.839 . . . . 0.0 111.612 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.815 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 4.0 p30 -72.16 -176.34 1.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.69 -28.35 55.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 37.0 t70 -87.54 -24.18 24.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.842 0.829 . . . . 0.0 109.608 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.583 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -85.33 -33.27 22.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.427 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.68 -19.97 65.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -82.52 -8.99 59.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.786 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 25.9 mmmt -90.94 -25.89 19.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.775 0.798 . . . . 0.0 109.517 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 56.7 mt -53.66 -52.29 68.53 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.303 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 17.0 Cg_endo -58.52 94.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.681 2.254 . . . . 0.0 113.345 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 51.91 50.86 17.69 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.119 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.82 0.89 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.213 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.499 HG21 HG12 ' A' ' 129' ' ' VAL . 70.9 m -56.97 -59.13 5.52 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.539 0.335 . . . . 0.0 111.768 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp -59.47 -25.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.024 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.699 ' O ' HG12 ' A' ' 58' ' ' VAL . 98.6 m -65.15 -38.47 90.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.433 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -79.55 -27.59 41.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.0 109.201 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.0 mp -72.57 -27.94 62.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.21 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 55' ' ' THR . 7.8 p -77.9 -27.67 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.141 0.496 . . . . 0.0 109.938 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 55' ' ' THR . 22.5 mm-40 -71.55 -29.77 65.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.513 1.149 . . . . 0.0 108.842 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.91 166.08 46.14 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.64 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.0 Cg_exo -40.46 169.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.355 3.37 . . . . 0.0 114.171 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 31.2 Cg_exo -33.45 -8.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.047 1 C-N-CA 127.802 5.668 . . . . 0.0 120.175 -167.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -41.65 -25.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 HG23 ' A' ' 58' ' ' VAL . 10.6 tp -52.25 -50.89 61.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.599 0.36 . . . . 0.0 111.883 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -52.03 -31.09 32.1 Favored Glycine 0 N--CA 1.461 0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.348 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' NH1' HE22 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -74.76 -49.29 21.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.356 0.598 . . . . 0.0 110.587 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 64' ' ' LEU . 63.0 mt -44.88 -48.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.119 174.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -48.16 -65.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -166.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -89.44 -69.2 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.197 -1.001 . . . . 0.0 113.619 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.647 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -126.46 18.58 7.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -175.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.1 t60 59.24 30.98 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 164.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.647 HG11 ' CZ ' ' A' ' 70' ' ' TYR . 4.8 p -105.25 159.86 5.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.119 0.962 . . . . 0.0 113.517 -164.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 89' ' ' THR . 2.0 p -132.94 120.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.944 163.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.657 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.58 145.97 55.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 0.0 111.62 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 97.43 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.28 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -58.78 106.2 0.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.232 0.539 . . . . 0.0 111.105 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CB ' HD11 ' A' ' 82' ' ' LEU . 6.0 m-85 -115.64 119.78 37.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -77.05 158.75 30.35 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.21 -37.45 10.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.553 0.533 . . . . 0.0 111.268 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.7 t -74.98 -24.37 58.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 -168.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.47 -45.72 75.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.713 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -57.19 -52.32 65.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.461 177.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.97 -34.68 75.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.0 ttt180 -51.47 -43.29 62.1 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.102 0.953 . . . . 0.0 109.19 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.3 mtp -75.98 -42.91 46.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.014 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' ILE . . . 77.87 15.49 81.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.098 -172.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -163.66 157.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.713 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -130.7 143.06 42.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.396 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.1 m -110.6 133.52 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.924 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 94' ' ' SER . 70.9 m -77.31 166.18 23.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.138 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.8 tp -51.89 -37.59 52.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.125 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -76.54 -24.94 53.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.61 -178.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.51 20.08 5.57 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.597 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' SER . 8.2 t -88.16 119.41 28.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.156 0.478 . . . . 0.0 110.536 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.78 139.25 30.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.65 . . . . 0.0 112.636 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.617 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -131.93 128.12 21.41 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.938 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HA ' HG13 ' A' ' 87' ' ' ILE . 8.1 Cg_exo -69.16 133.27 26.25 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.142 1.895 . . . . 0.0 113.355 -173.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.546 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.7 mm -102.09 138.0 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.049 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -140.82 179.98 6.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.595 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.603 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 173.93 93.26 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.72 -172.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.89 -44.33 55.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 109.288 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.564 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 11.6 m-80 -140.83 -53.11 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.983 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.3 Cg_endo -88.17 173.28 4.87 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.165 1.91 . . . . 0.0 110.298 168.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.499 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 24.8 tp -73.34 153.67 40.42 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 26.8 mt-10 -140.91 106.78 5.14 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -105.74 126.52 61.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.823 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HG2' HG22 ' A' ' 106' ' ' VAL . 13.5 ptmt 46.52 -114.51 0.52 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.604 0.762 . . . . 0.0 112.046 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -102.99 22.14 14.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.203 0.525 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -123.97 166.48 15.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.938 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 m -128.78 137.44 51.54 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -81.02 129.89 36.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.545 0.688 . . . . 0.0 111.886 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.8 mp -91.6 -37.86 12.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.389 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.59 112.08 2.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.849 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.01 -173.25 3.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 71.46 26.28 3.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -90.46 109.66 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.738 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.783 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.52 110.97 3.36 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.278 1.037 . . . . 0.0 112.031 174.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.24 -170.5 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.465 -1.698 . . . . 0.0 111.772 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -50.94 -49.04 60.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.863 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -119.66 -18.35 8.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.072 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.54 -112.4 0.77 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.397 -173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.783 HD13 ' HA ' ' A' ' 117' ' ' GLU . 9.8 mm -146.56 142.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.547 0.689 . . . . 0.0 112.355 -174.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 118' ' ' ALA . 92.2 mt -113.19 146.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.619 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -137.22 113.3 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 57.6 t -81.12 128.08 39.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 123.178 0.299 . . . . 0.0 110.31 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -127.25 164.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 0.0 110.94 -176.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.8 t70 -108.89 19.47 19.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.752 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.647 ' O ' HG13 ' A' ' 126' ' ' ILE . 16.2 m -168.77 134.5 1.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 49' ' ' LEU . 73.1 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.637 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp -43.74 -52.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.797 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.723 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -70.8 -36.92 66.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.079 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.453 ' CA ' HE22 ' A' ' 31' ' ' GLN . 21.0 t70 -56.41 -44.42 80.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.81 0.814 . . . . 0.0 110.334 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 19.7 mt -53.86 -24.76 10.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.933 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.3 86.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.888 0.375 . . . . 0.0 111.057 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.15 -18.57 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.416 0.627 . . . . 0.0 110.46 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 44.9 t30 -89.84 -25.33 21.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.476 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 8.9 p -57.76 133.9 82.9 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -174.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -78.01 66.05 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.918 2.412 . . . . 0.0 111.884 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.93 47.04 26.64 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.219 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.74 -172.93 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.15 0.5 . . . . 0.0 111.605 177.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -58.81 163.22 3.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.853 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 m -62.58 -19.28 63.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.64 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.38 -35.24 50.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.705 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.3 -27.47 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.509 0.671 . . . . 0.0 109.908 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.589 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 m -83.38 -28.2 29.1 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.757 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.26 79.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.622 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.13 -36.81 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.978 -0.451 . . . . 0.0 110.427 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.1 mtmt -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.217 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 19' ' ' THR . 8.8 p -77.21 -34.66 21.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.544 0.688 . . . . 0.0 110.218 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.17 -2.47 31.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.368 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.84 15.4 10.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.125 0.97 . . . . 0.0 112.835 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 8.2 mp -91.46 7.62 40.31 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.927 -0.483 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -60.08 -37.02 71.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.492 . . . . 0.0 109.956 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.9 pt-20 -85.53 -18.89 32.12 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.788 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.76 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.2 mt -59.36 -10.47 3.16 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.723 ' NE2' HG13 ' A' ' 5' ' ' VAL . 47.0 mm-40 -67.97 -8.47 37.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -54.15 113.11 4.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.63 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.56 -12.89 15.1 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.725 2.284 . . . . 0.0 112.885 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.85 -137.34 0.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.711 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 57.9 Cg_endo -84.2 165.48 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.036 2.491 . . . . 0.0 113.967 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' VAL . 49.6 m-85 -139.15 122.7 17.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 36.1 m -106.65 118.0 35.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.253 0.549 . . . . 0.0 110.996 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.38 121.06 60.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.443 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.423 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 1.4 m-30 -82.86 111.46 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.741 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -95.82 112.39 59.1 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.52 133.42 15.81 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.06 1.84 . . . . 0.0 111.538 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.806 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 32.2 p30 -72.61 -172.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.722 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.82 -27.13 68.67 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.528 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.34 -21.28 24.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.186 0.993 . . . . 0.0 109.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.525 ' HB2' ' C ' ' A' ' 127' ' ' ASP . . . . . . . . 0 N--CA 1.439 -1.011 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.337 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.725 HD12 HD22 ' A' ' 57' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 121.028 0.442 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HG12 ' A' ' 58' ' ' VAL . 67.8 m -65.07 -40.59 94.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 t -79.82 -29.65 40.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.032 0.92 . . . . 0.0 109.16 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.75 HD23 HE22 ' A' ' 63' ' ' GLN . 6.8 mp -70.58 -26.01 63.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.222 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 55' ' ' THR . 9.9 p -80.01 -28.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.156 0.503 . . . . 0.0 109.755 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 55' ' ' THR . 24.4 mm-40 -70.56 -25.54 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.651 1.215 . . . . 0.0 108.519 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.47 168.64 26.23 Favored Pre-proline 0 N--CA 1.437 -1.094 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.282 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.2 Cg_exo -38.16 169.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 124.633 3.555 . . . . 0.0 115.424 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 51.9 Cg_exo -40.58 -8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 1 C-N-CA 126.632 4.888 . . . . 0.0 118.296 -172.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.75 HE22 HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -42.61 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 67' ' ' ILE . 13.4 tp -46.92 -50.98 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.35 0.26 . . . . 0.0 111.08 174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.26 -32.59 44.32 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.265 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.26 -51.38 21.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.528 0.68 . . . . 0.0 109.53 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 64' ' ' LEU . 62.2 mt -44.41 -53.89 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 113.969 -1.469 . . . . 0.0 113.359 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -47.19 -64.09 0.87 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.09 -62.06 1.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -122.48 -0.93 9.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.1 p80 43.04 51.6 5.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.775 0.798 . . . . 0.0 110.187 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 36' ' ' PHE . 12.9 p -120.98 159.15 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.903 -166.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 89' ' ' THR . 1.5 p -130.21 129.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 170.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.538 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.73 146.36 54.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.254 0.55 . . . . 0.0 111.168 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.81 99.1 2.57 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -63.65 101.9 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.162 0.506 . . . . 0.0 111.509 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -112.93 129.36 56.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.124 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -91.99 161.01 14.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -31.53 7.03 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.244 0.545 . . . . 0.0 112.046 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.9 t -72.39 -27.0 62.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.245 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.43 -50.36 14.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.718 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -54.38 -50.69 66.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.044 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -68.51 -35.85 78.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.747 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -56.88 -39.49 74.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.632 0.73 . . . . 0.0 110.115 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 81.1 mtp -80.49 -35.24 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.919 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.96 12.05 83.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.051 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -162.92 157.28 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.718 HG12 HD12 ' A' ' 82' ' ' LEU . 10.6 m -132.03 140.42 47.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.262 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.5 m -112.71 133.08 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.116 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 94' ' ' SER . 14.1 t -68.93 163.9 23.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.906 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.538 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -55.38 -30.77 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.479 0.657 . . . . 0.0 110.148 174.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.4 -25.85 35.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.152 -178.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.4 18.29 7.19 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.33 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.591 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.8 OUTLIER -88.1 121.3 30.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.299 0.55 . . . . 0.0 111.332 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.51 138.01 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.9 mp -127.63 127.01 24.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.8 Cg_exo -70.39 132.03 21.51 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 121.98 1.786 . . . . 0.0 113.036 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.465 ' CG1' HG13 ' A' ' 88' ' ' VAL . 40.5 mm -94.55 136.14 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.38 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 91.7 m-70 -121.0 -179.24 3.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.199 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.31 94.06 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.042 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.09 -48.21 13.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.453 0.645 . . . . 0.0 109.606 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.585 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 6.9 m-80 -138.53 -53.19 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.003 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -87.77 173.25 5.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.123 1.882 . . . . 0.0 109.99 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.808 HD23 HG21 ' A' ' 111' ' ' VAL . 16.3 tp -72.8 154.35 40.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 44.9 mt-10 -140.4 127.86 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.397 0.618 . . . . 0.0 109.523 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -129.08 122.61 56.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.013 -174.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 106' ' ' VAL . 10.9 ptmm? 46.51 -123.46 1.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.163 0.585 . . . . 0.0 111.237 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -96.94 23.55 7.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 110.608 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -118.85 166.04 13.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -128.29 138.04 52.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.808 HG21 HD23 ' A' ' 104' ' ' LEU . 88.1 t -86.2 126.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.686 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 127' ' ' ASP . 6.6 mp -89.63 -36.55 15.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.631 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.68 118.28 2.79 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.532 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.93 -174.54 3.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 32.2 t70 68.98 26.86 5.59 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -171.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -88.84 108.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.011 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.692 ' HA ' HD13 ' A' ' 122' ' ' ILE . 43.3 mt-10 -68.58 106.02 2.45 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.623 0.725 . . . . 0.0 110.72 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -81.38 178.89 8.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.716 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -44.2 -51.73 7.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.845 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -117.87 -14.61 10.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.365 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.73 -110.76 0.44 Allowed Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.169 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 117' ' ' GLU . 18.3 mm -142.66 143.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.097 -0.552 . . . . 0.0 111.387 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 116' ' ' ILE . 16.9 mt -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.222 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.547 ' CD2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.79 114.87 5.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.819 0.819 . . . . 0.0 112.043 -178.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 49.5 t -80.17 129.86 36.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.33 159.58 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.806 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -99.0 3.41 46.93 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.475 -173.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.616 ' O ' HG13 ' A' ' 126' ' ' ILE . 47.7 m -154.51 126.71 7.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.531 -172.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 54' ' ' ILE . 76.3 t . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 5' ' ' VAL . 13.5 m . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.678 0.275 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -57.67 -20.15 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.763 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.2 p -90.34 -37.3 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.557 . . . . 0.0 110.205 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.53 ' CA ' HE22 ' A' ' 31' ' ' GLN . 28.1 t70 -56.95 -50.93 71.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.204 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG22 HG23 ' A' ' 11' ' ' THR . 21.9 mt -54.42 -22.0 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.414 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.089 0.471 . . . . 0.0 110.607 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 37.8 t -74.48 -23.38 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.487 0.661 . . . . 0.0 110.291 175.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 50.6 t30 -87.26 -25.44 23.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.76 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 6.5 p -60.82 134.26 92.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -171.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -81.95 67.33 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.052 2.501 . . . . 0.0 111.808 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.34 11.72 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.098 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.7 OUTLIER -67.14 -170.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.204 0.525 . . . . 0.0 111.35 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -60.46 157.63 13.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.506 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m -60.56 -19.03 56.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.341 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.454 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.2 mm? -57.98 -30.33 65.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.18 -30.25 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.325 0.583 . . . . 0.0 109.803 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 2.2 m -83.52 -29.24 28.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.22 -31.4 71.93 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.111 0.257 . . . . 0.0 111.571 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 21' ' ' VAL . 1.2 p -81.44 -37.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.506 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 41.3 mtmt -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.13 0.491 . . . . 0.0 111.315 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 19' ' ' THR . 8.5 p -75.21 -36.04 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.663 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.38 -6.5 48.55 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.937 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 13.31 9.34 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.312 1.045 . . . . 0.0 113.172 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 92' ' ' GLU . 10.6 mp -85.77 8.97 17.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.972 -0.455 . . . . 0.0 111.437 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.68 -37.17 57.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.345 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.7 pt-20 -85.67 -20.77 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.692 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.79 -54.42 6.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.689 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 21.9 mt -58.76 -14.07 7.72 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.763 ' NE2' HG13 ' A' ' 5' ' ' VAL . 30.7 mm-40 -66.52 -5.75 12.42 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.768 0.427 . . . . 0.0 111.908 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -51.65 110.43 1.83 Allowed Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 123.423 0.689 . . . . 0.0 112.406 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.33 -17.86 8.77 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.126 2.55 . . . . 0.0 113.252 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.35 -140.5 0.8 Allowed Glycine 0 CA--C 1.518 0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.372 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 30.1 Cg_endo -76.2 163.08 33.24 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.018 1.812 . . . . 0.0 112.804 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -133.51 122.71 24.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.154 -171.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.6 m -116.6 136.27 53.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.168 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 123' ' ' ILE . 5.5 p -133.02 156.13 41.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.641 . . . . 0.0 111.36 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.461 ' HB3' HD12 ' A' ' 126' ' ' ILE . 93.3 m-85 -112.26 111.04 21.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -98.91 113.33 64.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.391 . . . . 0.0 111.513 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 130.59 10.79 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.588 2.192 . . . . 0.0 112.229 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.842 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.7 p30 -84.08 -174.14 5.11 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.675 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.42 -27.05 65.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 111.678 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.52 -22.71 34.92 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.693 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.639 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.5 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.254 0.549 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 92.1 m -65.67 -32.7 74.4 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.926 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 t -81.04 -25.54 37.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.68 0.752 . . . . 0.0 109.342 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.1 mp -74.93 -25.64 59.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.041 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 11.4 p -76.97 -31.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.228 0.537 . . . . 0.0 109.756 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.4 mm-40 -71.59 -28.39 63.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 122.68 1.229 . . . . 0.0 108.578 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 3.3 m-80 -81.78 169.39 18.89 Favored Pre-proline 0 N--CA 1.437 -1.085 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 19.9 Cg_exo -37.06 170.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 125.023 3.815 . . . . 0.0 115.607 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 48.0 Cg_exo -39.4 -9.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.607 1 C-N-CA 126.566 4.844 . . . . 0.0 118.029 -172.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.569 ' NE2' HD23 ' A' ' 57' ' ' LEU . 4.7 tp60 -41.67 -26.5 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.153 0.981 . . . . 0.0 113.096 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.616 HD13 HG23 ' A' ' 58' ' ' VAL . 5.5 tp -51.09 -50.89 57.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 111.754 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.29 -33.06 22.97 Favored Glycine 0 N--CA 1.459 0.174 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.928 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.98 -35.25 50.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.994 0.426 . . . . 0.0 110.656 -178.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 64' ' ' LEU . 51.6 mt -59.76 -46.52 93.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.258 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -45.81 -63.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.926 0.766 . . . . 0.0 113.003 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -88.99 -60.01 2.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -121.13 -16.37 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 70.6 m80 64.67 33.35 10.62 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.5 p -94.47 155.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.073 -166.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.471 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.4 p -141.43 119.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.625 -1.625 . . . . 0.0 108.888 166.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.665 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.52 142.21 58.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 111.216 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 112.24 98.27 2.38 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.98 102.67 0.09 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.175 0.512 . . . . 0.0 111.685 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.462 ' O ' HG21 ' A' ' 122' ' ' ILE . 12.4 m-85 -114.67 106.84 14.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.579 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.712 ' HD3' HD12 ' A' ' 122' ' ' ILE . 21.3 mmtp -60.67 157.54 14.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 167.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -49.52 -35.41 20.0 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 123.461 0.475 . . . . 0.0 110.36 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 9.4 t -75.62 -28.53 58.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.176 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.51 -35.53 79.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.721 HD12 HG12 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -66.34 -50.55 63.18 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.105 176.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -68.08 -30.62 69.86 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 123.199 0.6 . . . . 0.0 112.264 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.26 -31.48 67.46 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-O 121.664 0.745 . . . . 0.0 109.433 172.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.7 -40.51 14.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.679 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 78.72 14.32 82.19 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.982 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.0 tt -164.39 159.92 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 HD12 ' A' ' 82' ' ' LEU . 11.9 m -131.97 137.92 53.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.428 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 m -106.77 126.91 52.91 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.397 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' H ' ' A' ' 94' ' ' SER . 72.5 m -68.45 163.87 22.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.416 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -51.45 -36.28 43.35 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.612 0.72 . . . . 0.0 110.877 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.49 -28.06 52.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.447 -179.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.32 10.81 7.76 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.696 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.497 ' H ' ' HB2' ' A' ' 90' ' ' SER . 0.7 OUTLIER -83.44 120.69 26.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.951 0.875 . . . . 0.0 111.759 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.15 138.06 32.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.5 mp -130.4 126.74 22.25 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.549 ' HA ' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -68.29 133.44 28.43 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 113.533 -173.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.584 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.4 mm -103.25 142.75 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.4 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -141.19 177.3 8.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.682 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.08 121.31 0.55 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.091 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -101.34 -54.14 2.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 12.6 m120 -107.14 -61.8 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 172.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 16.0 Cg_endo -90.49 174.01 3.04 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.475 2.117 . . . . 0.0 111.244 174.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.585 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 21.3 tp -75.8 154.53 36.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -140.88 107.37 5.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.8 112.03 38.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.642 ' HB3' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER 48.54 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.321 1.448 . . . . 0.0 113.87 -174.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 3.1 p-10 -134.85 23.23 3.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.526 0.679 . . . . 0.0 109.573 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -129.25 157.51 41.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.077 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 44.4 m -121.9 134.31 54.86 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -78.59 127.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.613 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 112' ' ' LEU . 6.9 mp -88.82 -38.87 14.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.105 175.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.97 110.53 3.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.148 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -133.04 -173.58 3.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.65 ' OD1' ' HD2' ' A' ' 78' ' ' LYS . 20.4 t70 71.47 28.34 2.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 122.794 1.283 . . . . 0.0 107.604 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.4 mt -95.14 110.05 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.04 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.852 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.48 114.34 6.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.969 0.89 . . . . 0.0 112.391 172.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.842 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.77 -173.49 3.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.023 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -49.08 -51.19 32.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.123 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 4.2 m-20 -115.23 -20.57 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.644 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.72 -114.77 1.05 Allowed Glycine 0 CA--C 1.505 -0.539 0 C-N-CA 119.447 -1.359 . . . . 0.0 114.047 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 117' ' ' GLU . 17.8 mm -144.52 148.15 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.327 0.585 . . . . 0.0 110.951 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.842 HG13 ' HB2' ' A' ' 118' ' ' ALA . 94.6 mt -120.24 147.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.457 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -137.88 117.79 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 69.9 t -83.31 129.64 37.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.496 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -124.99 161.76 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.619 0.724 . . . . 0.0 110.457 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.842 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -95.8 5.36 51.52 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.52 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 51.0 m -148.92 126.63 11.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.813 -171.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG23 ' HB1' ' A' ' 45' ' ' ALA . 69.5 t . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.603 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 HG12 ' A' ' 5' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -54.86 -20.96 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.736 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -91.37 -37.23 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.155 0.502 . . . . 0.0 110.614 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.1 t70 -58.42 -44.5 89.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.373 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 9.1 mt -59.18 -21.69 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.637 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -34.15 76.29 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.826 -0.546 . . . . 0.0 110.751 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 6' ' ' ASP . 4.2 p -87.9 -9.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 110.112 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 54.4 t30 -92.72 -25.01 18.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.767 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 p -64.65 131.97 95.28 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.175 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.3 64.76 7.95 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.898 2.399 . . . . 0.0 112.288 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 46.96 11.95 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.898 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.63 -172.15 0.16 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.441 0.639 . . . . 0.0 112.508 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -61.3 163.13 6.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.559 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -61.44 -18.37 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.79 -37.78 52.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.35 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.85 -27.4 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.493 0.663 . . . . 0.0 110.116 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.584 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.8 m -81.64 -25.7 35.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.686 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.17 -35.07 77.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.673 0.273 . . . . 0.0 111.524 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -78.29 -37.35 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.6 mtmt -62.5 -43.55 98.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.964 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 19' ' ' THR . 7.8 p -72.73 -35.02 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.113 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.44 -5.14 46.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.043 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.36 8.46 6.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.962 1.305 . . . . 0.0 113.128 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.3 mp -85.42 9.24 16.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -37.66 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.84 -21.8 27.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.754 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -76.28 -55.4 5.6 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -176.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.9 mt -57.18 -13.83 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.209 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.736 ' NE2' HG13 ' A' ' 5' ' ' VAL . 45.9 mm-40 -65.16 -13.75 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.211 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 p -56.99 114.07 7.33 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.683 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.83 -14.25 11.3 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.982 2.455 . . . . 0.0 113.482 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.45 -149.87 1.04 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.275 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 37.8 Cg_endo -73.23 170.03 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.89 2.394 . . . . 0.0 112.821 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' HB3' HG21 ' A' ' 72' ' ' VAL . 45.2 m-85 -139.92 124.08 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 21.9 m -106.22 124.03 48.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 123' ' ' ILE . 41.3 t -113.88 134.07 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.962 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -100.25 116.27 31.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -104.93 117.78 57.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.317 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.79 125.86 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.023 1.816 . . . . 0.0 111.853 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -75.85 176.02 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.13 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -59.67 -35.4 74.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.83 -19.45 52.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.838 0.828 . . . . 0.0 108.816 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.568 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.482 177.6 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 58' ' ' VAL . 74.7 m -59.92 -32.55 70.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.83 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -83.56 -23.83 31.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.161 0.981 . . . . 0.0 109.121 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 9.0 mp -77.92 -20.39 52.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 55' ' ' THR . 8.0 p -91.71 -22.72 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.013 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 55' ' ' THR . 20.2 mm-40 -64.12 -44.87 90.91 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.67 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 64.2 t30 -162.9 14.33 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 4.0 Cg_exo -91.38 150.94 3.63 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 CA-C-N 121.202 1.465 . . . . 0.0 111.435 153.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 61' ' ' PRO . 24.2 Cg_exo -66.51 -15.61 48.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.087 2.525 . . . . 0.0 112.805 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 1.1 tt0 -46.85 -29.75 2.14 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 67' ' ' ILE . 9.3 tp -45.66 -50.03 13.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -44.91 -44.71 8.93 Favored Glycine 0 CA--C 1.511 -0.205 0 O-C-N 124.103 0.877 . . . . 0.0 114.218 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.71 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.63 -35.2 34.31 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.62 0.247 . . . . 0.0 110.57 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.5 mt -51.67 -47.51 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.184 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -45.92 -56.03 5.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.53 -64.0 1.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 79.1 m-85 -125.89 -0.78 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 14.7 p-80 43.99 53.35 6.4 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.726 0.774 . . . . 0.0 110.041 -168.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 36' ' ' PHE . 10.2 p -123.82 154.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.271 -166.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.466 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.8 p -125.27 127.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.657 171.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.518 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.56 143.83 57.64 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.077 0.465 . . . . 0.0 111.156 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.72 99.48 2.6 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.888 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . . . -61.8 98.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.579 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' HG21 ' A' ' 122' ' ' ILE . 5.1 m-85 -113.6 110.19 19.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.825 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.722 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.1 mmtp -59.66 160.68 6.97 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 165.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.35 -23.64 65.9 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.2 t -72.57 -31.08 64.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.58 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -73.77 -43.59 58.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.722 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -62.34 -55.39 28.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.914 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.94 -35.19 77.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.147 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -51.34 -44.52 62.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.664 0.745 . . . . 0.0 110.23 173.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -38.68 49.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.272 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.15 6.66 86.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.043 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.6 tt -163.07 158.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG12 HD12 ' A' ' 82' ' ' LEU . 14.1 m -129.98 140.89 47.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.093 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -110.1 126.27 53.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.66 0.743 . . . . 0.0 110.64 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 75.0 m -72.18 168.61 17.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.386 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 74' ' ' ALA . 4.7 tp -56.14 -37.7 69.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.873 0.844 . . . . 0.0 109.78 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.9 pm0 -75.36 -15.19 60.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.705 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.93 8.88 47.1 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.164 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -78.35 118.45 20.55 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -83.56 141.29 31.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.359 0.6 . . . . 0.0 111.997 176.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.594 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -133.99 126.22 18.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.957 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.6 Cg_exo -70.43 128.72 15.8 Favored 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 122.1 1.867 . . . . 0.0 112.604 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.559 ' CG1' HG13 ' A' ' 88' ' ' VAL . 39.0 mm -96.9 133.48 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.733 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 54.7 m80 -130.89 -179.77 5.51 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.589 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.67 114.01 0.4 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.653 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.98 -51.76 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.503 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 78.2 m-20 -132.83 -57.59 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.332 171.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 45.4 Cg_endo -85.02 172.8 8.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.153 1.902 . . . . 0.0 110.71 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.0 152.9 38.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.32 0.581 . . . . 0.0 110.72 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 8.7 mm-40 -130.96 106.93 8.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.454 -175.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.49 115.43 48.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.856 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.9 ptmt 55.74 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.71 1.604 . . . . 0.0 113.213 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 2.9 p-10 -149.69 24.26 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -126.9 166.11 18.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.399 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 41.7 m -126.59 132.34 51.31 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 t -74.75 131.89 34.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.477 0.656 . . . . 0.0 111.422 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 127' ' ' ASP . 7.1 mp -91.7 -46.64 7.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.781 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -145.97 114.12 6.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.7 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HB1' ' ND1' ' A' ' 124' ' ' HIS . . . -135.91 -173.39 3.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 49.2 m-20 67.81 28.47 7.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -172.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -86.62 114.32 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.104 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' HA ' HD13 ' A' ' 122' ' ' ILE . 37.1 mt-10 -67.96 106.91 2.48 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.928 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.7 -179.47 7.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.295 -175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.93 -49.53 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.6 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.06 -18.91 9.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.907 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -147.98 -108.08 0.49 Allowed Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 119.724 -1.227 . . . . 0.0 114.093 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.58 HD12 ' HD3' ' A' ' 78' ' ' LYS . 17.1 mm -142.9 153.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.401 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.928 HG13 ' HB2' ' A' ' 118' ' ' ALA . 89.0 mt -128.58 147.59 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.53 ' ND1' ' HB1' ' A' ' 114' ' ' ALA . 4.6 m-70 -138.09 117.4 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.736 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 95.4 t -82.2 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -122.97 156.33 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.028 0.918 . . . . 0.0 111.286 -176.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.886 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -98.68 19.52 14.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.971 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.552 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -158.89 131.47 6.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.874 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.689 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 5' ' ' VAL . 42.8 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -56.56 -19.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.735 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.8 p -91.24 -36.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 0.0 110.705 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.507 ' CA ' HE22 ' A' ' 31' ' ' GLN . 23.4 t70 -58.12 -45.47 87.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.566 0.698 . . . . 0.0 110.253 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 14.3 mt -56.86 -21.55 14.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.873 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.12 74.57 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.978 -0.451 . . . . 0.0 110.936 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.35 -24.35 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 110.114 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 60.2 t30 -81.04 -25.43 37.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.175 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 5.8 p -63.21 130.63 94.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.4 Cg_exo -79.26 68.87 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.94 2.427 . . . . 0.0 111.932 175.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.25 46.83 14.41 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.456 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 1.1 t80 -65.9 -169.72 0.07 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.354 0.597 . . . . 0.0 111.329 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 m -62.78 159.91 15.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -61.02 -17.95 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.39 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 mp -52.34 -37.02 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.215 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -80.02 -27.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.596 0.712 . . . . 0.0 109.805 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.601 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.5 m -83.29 -28.24 29.26 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.109 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.0 -32.38 72.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.708 0.29 . . . . 0.0 111.482 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.54 -37.44 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.499 171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 37.5 mtmt -61.97 -43.59 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.852 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 19' ' ' THR . 7.9 p -72.65 -35.57 50.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.8 -7.89 54.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.847 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.31 10.66 6.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.767 1.227 . . . . 0.0 112.772 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 66' ' ' ARG . 9.5 mp -85.9 9.13 17.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.976 -0.452 . . . . 0.0 112.111 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.1 t -58.14 -36.53 57.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.005 0.431 . . . . 0.0 109.932 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.54 -21.25 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.659 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.06 -52.41 8.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.71 0.291 . . . . 0.0 111.759 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 26.3 mt -57.71 -15.35 7.61 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.735 ' NE2' HG13 ' A' ' 5' ' ' VAL . 40.7 mm-40 -65.54 -13.17 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.237 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.9 m -56.02 112.95 4.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 123.469 0.48 . . . . 0.0 111.726 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.72 -9.36 13.33 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.015 2.477 . . . . 0.0 113.043 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.72 -145.13 0.15 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.797 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 76' ' ' ALA . 2.1 Cg_endo -78.32 169.02 20.75 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB3' HG21 ' A' ' 72' ' ' VAL . 35.6 m-85 -139.65 121.33 15.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.304 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.7 m -108.33 115.58 30.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.284 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.47 124.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.784 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.686 ' HD1' ' NE2' ' A' ' 124' ' ' HIS . 38.1 m-85 -84.01 110.43 18.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -96.47 122.19 58.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.572 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 129' ' ' VAL . 69.8 Cg_endo -76.69 126.77 9.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.159 1.906 . . . . 0.0 112.274 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.891 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -74.88 178.44 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.42 177.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -57.21 -36.71 71.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.65 -19.83 48.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.647 0.736 . . . . 0.0 109.053 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.735 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.296 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.631 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 121.147 0.498 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.684 ' O ' HG12 ' A' ' 58' ' ' VAL . 86.8 m -59.23 -35.26 73.33 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -82.74 -24.91 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.991 0.901 . . . . 0.0 109.291 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD23 HE22 ' A' ' 63' ' ' GLN . 8.8 mp -75.27 -25.62 58.14 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 55' ' ' THR . 7.3 p -78.3 -29.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.2 mm-40 -71.4 -26.6 62.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.477 1.132 . . . . 0.0 108.668 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.45 167.77 31.65 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.532 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 63' ' ' GLN . 38.4 Cg_exo -38.88 168.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.369 3.379 . . . . 0.0 114.734 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 39.5 Cg_exo -39.08 -8.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.675 1 C-N-CA 126.547 4.832 . . . . 0.0 118.06 -173.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.656 HE22 HD23 ' A' ' 57' ' ' LEU . 10.1 tt0 -42.2 -17.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.661 ' HA ' HD12 ' A' ' 67' ' ' ILE . 16.2 tp -47.51 -51.6 20.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.403 0.281 . . . . 0.0 111.399 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.414 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -54.62 -32.81 54.13 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.973 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.522 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.25 -50.57 45.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 109.573 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 64' ' ' LEU . 57.4 mt -46.92 -51.71 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.428 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -51.33 -61.55 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -171.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -81.76 -63.06 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -165.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.502 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 64.8 m-85 -124.39 -2.77 7.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.5 m80 59.63 34.21 22.18 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 70' ' ' TYR . 7.4 p -113.59 156.41 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -162.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.554 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.6 p -125.14 126.66 71.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.865 168.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.3 140.91 58.74 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 120.945 0.402 . . . . 0.0 110.609 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.41 97.26 2.32 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.001 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -60.87 108.4 0.85 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.443 0.64 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.01 132.34 55.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.129 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.73 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -88.86 165.42 14.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.9 58.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.255 0.55 . . . . 0.0 110.974 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 13.3 t -72.25 -26.08 61.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.585 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.35 -48.67 16.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.07 -51.26 70.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.605 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 98' ' ' ILE . 6.9 ttpm? -65.68 -35.39 80.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.033 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -51.75 -44.32 63.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.732 0.777 . . . . 0.0 110.326 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -73.29 -39.04 65.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.257 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.79 7.11 88.92 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.472 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.58 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.8 tt -163.27 159.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.657 HG12 HD12 ' A' ' 82' ' ' LEU . 8.5 m -130.17 138.0 55.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.189 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.494 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.7 m -114.29 133.2 55.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.092 0.473 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB2' ' OE2' ' A' ' 92' ' ' GLU . 58.3 m -85.41 178.27 7.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.479 -174.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 74' ' ' ALA . 1.7 tp -56.0 -39.35 71.75 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.728 ' OE1' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -84.42 -16.67 41.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 89' ' ' THR . . . 113.15 22.22 5.65 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.114 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.728 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 5.5 p -86.86 120.56 28.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 117.714 0.757 . . . . 0.0 110.541 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -93.08 138.32 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.0 mp -130.88 125.99 21.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.715 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' A' ' 87' ' ' ILE . 7.1 Cg_exo -68.76 133.79 28.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.192 1.928 . . . . 0.0 113.362 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.468 ' CG1' HG13 ' A' ' 88' ' ' VAL . 41.0 mm -98.95 136.03 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.317 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.53 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 18.0 m-70 -120.86 177.62 5.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.056 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.04 107.97 0.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.443 -1.36 . . . . 0.0 113.428 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -104.57 -41.09 5.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 109.908 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.9 t-20 -127.12 -63.98 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.186 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -84.9 174.19 7.6 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.018 1.812 . . . . 0.0 110.74 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 111' ' ' VAL . 14.8 tp -73.86 152.21 40.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 3.6 mm-40 -137.58 122.6 19.06 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.615 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -128.74 123.77 59.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.108 -175.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 11.2 ptmm? 46.9 -132.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.671 0.607 . . . . 0.0 110.768 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -88.27 25.67 1.58 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 0.0 110.473 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.87 163.1 22.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.759 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 81.0 m -127.88 140.89 51.74 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.746 HG21 HD23 ' A' ' 104' ' ' LEU . 38.4 t -84.5 125.51 40.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.43 0.633 . . . . 0.0 112.394 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.2 -36.45 16.79 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.293 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.25 111.56 2.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.505 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -135.82 -174.21 3.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 19.3 t70 69.84 25.8 4.92 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -90.79 105.92 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.774 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.1 108.54 3.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 122.284 1.04 . . . . 0.0 112.485 177.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -83.67 -177.54 6.74 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.591 -175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -43.98 -51.38 7.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.647 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.17 -13.61 9.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.878 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.44 -109.79 0.42 Allowed Glycine 0 CA--C 1.501 -0.825 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.356 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 117' ' ' GLU . 10.4 mm -145.62 144.19 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.558 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB2' ' A' ' 118' ' ' ALA . 29.3 mt -113.61 150.91 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.453 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.686 ' NE2' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.11 115.17 6.14 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 122.12 0.962 . . . . 0.0 111.767 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 40.7 t -82.3 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.181 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -122.75 160.32 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.313 1.054 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.891 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 28.8 t70 -93.98 1.61 56.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.534 -169.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.597 ' O ' HG13 ' A' ' 126' ' ' ILE . 4.6 m -159.36 131.05 6.29 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.22 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 45' ' ' ALA . 77.0 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.751 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.482 HG22 HG12 ' A' ' 5' ' ' VAL . 46.5 m . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.7 -21.83 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.753 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.4 p -91.42 -34.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 110.28 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.54 ' CA ' HE22 ' A' ' 31' ' ' GLN . 15.5 t70 -55.3 -48.43 74.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.831 0.824 . . . . 0.0 109.751 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 24.2 mt -55.05 -21.46 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.657 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.0 76.07 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.863 -0.523 . . . . 0.0 110.583 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.7 t -79.15 -15.38 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.453 0.644 . . . . 0.0 110.421 174.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 64.6 t30 -94.06 -24.5 17.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.1 p -60.55 130.34 90.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 3.8 Cg_exo -79.1 64.53 8.84 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.966 2.444 . . . . 0.0 112.506 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.56 45.36 7.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.594 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.606 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.16 -175.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -58.31 154.34 13.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.316 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -57.94 -18.86 26.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.69 -32.77 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.98 -28.84 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.398 0.618 . . . . 0.0 109.623 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.63 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.7 m -82.46 -27.72 31.7 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.79 -37.52 84.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -36.46 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.004 -0.435 . . . . 0.0 110.513 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 39.1 mtmt -62.08 -43.24 99.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 111.027 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 19' ' ' THR . 8.6 p -74.69 -34.13 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.23 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -75.31 -8.04 55.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.913 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 73.03 10.45 5.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.362 1.065 . . . . 0.0 112.976 177.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.83 6.9 26.05 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.99 -0.443 . . . . 0.0 112.038 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.22 -36.56 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.988 0.423 . . . . 0.0 110.455 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 4.0 pt-20 -86.21 -18.81 31.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.973 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.95 -54.92 5.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.694 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.5 mt -56.37 -13.9 2.56 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.753 ' NE2' HG13 ' A' ' 5' ' ' VAL . 42.8 mm-40 -64.39 -10.39 24.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.044 0.537 . . . . 0.0 112.215 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -61.62 110.77 3.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.346 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.48 -15.58 9.81 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.139 2.559 . . . . 0.0 113.593 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.68 -138.43 0.22 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.917 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 23.9 Cg_endo -74.85 165.37 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.223 1.949 . . . . 0.0 113.643 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.22 125.66 28.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.803 -170.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 38.1 m -124.6 119.79 30.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -118.0 152.1 20.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -108.95 106.94 17.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -99.23 112.22 62.73 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.24 130.61 13.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.407 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.779 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.6 p30 -81.55 -174.43 4.96 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.829 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -59.77 -30.0 68.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.654 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' A' ' 127' ' ' ASP . 15.4 t70 -81.84 -19.63 40.65 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.016 0.912 . . . . 0.0 109.17 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.74 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.047 177.209 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.392 0.615 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.688 ' O ' HG12 ' A' ' 58' ' ' VAL . 88.1 m -64.62 -34.13 77.55 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.367 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -81.81 -24.63 35.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.792 0.806 . . . . 0.0 109.101 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 7.6 mp -71.19 -31.29 67.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.993 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 55' ' ' THR . 9.8 p -73.72 -31.49 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.089 0.471 . . . . 0.0 109.731 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.9 mm-40 -73.0 -30.43 63.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.784 1.278 . . . . 0.0 108.325 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 1.6 m-80 -76.52 169.6 20.23 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.901 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 26.2 Cg_exo -37.31 168.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 124.439 3.426 . . . . 0.0 115.191 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 43.3 Cg_exo -40.03 -11.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 1 C-N-CA 126.537 4.825 . . . . 0.0 118.905 -168.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.679 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 32.6 tt0 -43.79 -25.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 68' ' ' LEU . 12.7 tp -46.98 -48.67 21.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.585 0.354 . . . . 0.0 111.905 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.473 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -49.64 -40.34 32.43 Favored Glycine 0 N--CA 1.458 0.14 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.829 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.697 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.61 -37.54 59.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.85 0.357 . . . . 0.0 110.049 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.6 mt -57.06 -45.19 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.717 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -48.93 -59.1 3.88 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.739 0.649 . . . . 0.0 112.673 -176.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -83.8 -64.46 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.527 -169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 71' ' ' HIS . 2.8 m-85 -125.98 -13.25 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 70' ' ' TYR . 11.1 t-80 68.09 40.44 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -175.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CD2' ' A' ' 36' ' ' PHE . 13.2 p -121.55 159.77 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.444 -165.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 72' ' ' VAL . 1.9 p -128.72 128.53 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.15 170.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' HD13 ' A' ' 91' ' ' LEU . . . -68.23 140.72 56.06 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.318 0.58 . . . . 0.0 110.854 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 113.36 97.96 2.3 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.755 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.12 101.24 0.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 122.909 0.483 . . . . 0.0 111.86 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' HD11 ' A' ' 82' ' ' LEU . 2.7 m-85 -119.03 117.54 29.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.706 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.9 mtpt -75.31 163.52 27.39 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.006 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.42 59.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.012 0.434 . . . . 0.0 110.714 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 10.0 t -71.29 -27.85 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.071 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -78.68 -49.07 13.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.323 0.582 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -55.41 -52.48 63.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.166 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.53 -33.9 75.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 80' ' ' THR . 1.1 ttt180 -54.51 -40.6 68.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.546 0.689 . . . . 0.0 110.077 176.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -80.21 -41.6 24.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.04 10.65 78.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.726 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.1 tt -162.64 156.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.694 HG12 HD12 ' A' ' 82' ' ' LEU . 13.3 m -131.1 139.13 51.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -107.3 128.02 54.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.648 0.737 . . . . 0.0 110.839 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.597 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 60.6 m -72.6 166.11 23.38 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.502 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 74' ' ' ALA . 5.0 tp -56.98 -36.18 70.05 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-O 121.946 0.879 . . . . 0.0 109.642 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.679 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 3.6 pm0 -76.65 -12.31 59.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.86 6.48 57.08 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.602 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 90' ' ' SER . 57.5 m -77.85 119.96 22.07 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.98 133.78 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.551 ' HB ' HG23 ' A' ' 88' ' ' VAL . 1.6 mp -122.23 127.05 26.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.2 Cg_exo -72.7 130.43 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.709 1.606 . . . . 0.0 112.852 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HG13 ' A' ' 88' ' ' VAL . 35.9 mm -94.53 134.34 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 68.8 m-70 -123.84 -179.27 4.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.738 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.87 97.04 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.998 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.07 -53.25 4.56 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.555 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 21.9 t-20 -118.0 -56.02 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 23.9 Cg_endo -90.7 174.13 2.89 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.613 2.209 . . . . 0.0 110.795 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 111' ' ' VAL . 13.0 tp -74.12 152.38 39.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 39.4 mt-10 -136.85 109.64 7.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 109.478 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.49 106.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -176.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 2.5 ptpt 43.49 -106.99 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 112.638 -170.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -89.26 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.622 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -108.55 166.04 11.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.454 0.645 . . . . 0.0 112.729 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.7 m -129.15 133.57 47.67 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.555 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 HD23 ' A' ' 104' ' ' LEU . 17.4 t -85.33 131.05 35.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.641 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.9 mp -88.99 -46.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.201 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -146.77 118.76 8.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.791 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -136.61 -174.7 3.78 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 27.5 m-20 67.74 27.09 7.63 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -87.06 116.2 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.386 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.696 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.35 108.61 2.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.959 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.85 -177.7 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.777 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 1.1 pt-20 -47.53 -53.51 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.567 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 46.5 m-80 -119.08 -9.36 10.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.4 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.32 -112.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.279 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 117' ' ' GLU . 32.1 mm -143.03 148.0 19.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.329 0.585 . . . . 0.0 111.328 -171.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.959 HG13 ' HB2' ' A' ' 118' ' ' ALA . 96.7 mt -119.18 147.7 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -137.57 118.75 14.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 85.1 t -83.12 128.04 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.04 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.459 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -120.97 162.26 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.85 0.833 . . . . 0.0 110.479 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.835 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.1 t70 -107.79 16.53 23.5 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.345 -170.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 109' ' ' ALA . 73.2 m -156.79 130.56 8.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.087 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.518 173.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 HG12 ' A' ' 5' ' ' VAL . 41.3 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.2 mp -44.13 -47.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.501 0.667 . . . . 0.0 111.08 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.742 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.3 p -71.89 -36.06 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.688 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.526 ' CA ' HE22 ' A' ' 31' ' ' GLN . 16.0 t70 -54.84 -46.36 74.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.939 0.875 . . . . 0.0 109.673 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.575 ' HA ' ' CB ' ' A' ' 10' ' ' ASN . 18.5 mt -56.8 -21.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.211 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . . . -61.39 -32.94 72.88 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.751 -0.593 . . . . 0.0 110.415 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.21 -34.85 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.381 0.61 . . . . 0.0 109.999 172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.575 ' CB ' ' HA ' ' A' ' 7' ' ' ILE . 17.5 t-20 -66.29 -25.22 66.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.529 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.2 p -62.45 138.48 96.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.043 -175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.7 Cg_exo -80.61 62.27 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.601 2.201 . . . . 0.0 112.315 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 46.84 20.51 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.998 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.73 -168.66 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.553 0.692 . . . . 0.0 112.423 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' HG22 ' A' ' 18' ' ' VAL . 4.6 m -58.57 158.94 7.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.856 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -60.49 -17.99 48.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -52.6 -35.27 53.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 8' ' ' ALA . 3.9 m -80.92 -28.45 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.686 0.755 . . . . 0.0 109.967 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.578 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -79.79 -29.05 40.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 -177.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.83 -35.66 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.818 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 -36.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.11 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 27.2 mtmt -61.5 -43.86 98.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.299 0.571 . . . . 0.0 110.982 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 19' ' ' THR . 8.3 p -73.52 -35.93 46.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.98 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.04 -4.19 33.95 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.656 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.15 9.68 7.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.272 1.029 . . . . 0.0 112.842 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.2 mp -87.25 7.34 28.91 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.91 -0.494 . . . . 0.0 111.805 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -59.41 -36.98 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.197 0.522 . . . . 0.0 109.792 176.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 6.1 pt-20 -85.85 -21.82 27.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.626 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.89 -54.89 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 19.8 mt -58.54 -9.81 1.86 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.742 ' NE2' HG13 ' A' ' 5' ' ' VAL . 39.7 mm-40 -70.98 4.64 2.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.826 0.45 . . . . 0.0 112.054 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.2 p -48.02 112.55 2.26 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 123.98 0.8 . . . . 0.0 112.412 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 32' ' ' SER . 4.5 Cg_exo -80.98 -12.57 11.9 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.24 2.627 . . . . 0.0 111.254 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.79 -135.11 1.91 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.147 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 17.7 Cg_endo -84.3 170.94 10.41 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.917 2.412 . . . . 0.0 113.174 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.702 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -139.08 122.96 17.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.702 HG21 ' CG ' ' A' ' 77' ' ' TYR . 0.4 OUTLIER -126.83 119.88 27.9 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -174.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 123' ' ' ILE . 7.4 p -117.42 145.03 23.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.245 0.545 . . . . 0.0 111.261 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.663 ' HD1' ' CE1' ' A' ' 124' ' ' HIS . 55.3 m-85 -93.06 109.25 20.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -91.35 111.86 51.08 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 120.673 0.273 . . . . 0.0 111.318 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.41 128.33 8.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.099 1.866 . . . . 0.0 111.739 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.849 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.2 p30 -80.91 -175.41 5.35 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.994 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.74 -32.0 59.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -83.22 -23.89 32.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.698 0.761 . . . . 0.0 109.185 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.788 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.621 177.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 57' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.438 -1.07 0 CA-C-O 121.012 0.434 . . . . 0.0 111.701 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 58' ' ' VAL . 63.0 m -55.36 -37.37 67.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.732 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -81.8 -27.24 33.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.91 0.862 . . . . 0.0 109.369 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 54' ' ' ILE . 10.1 mp -73.11 -25.17 60.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.838 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -79.14 -29.21 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 121.172 0.511 . . . . 0.0 109.865 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 55' ' ' THR . 27.5 mm-40 -71.79 -27.27 62.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 122.575 1.179 . . . . 0.0 108.706 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.58 166.69 37.17 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.057 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 30.5 Cg_exo -39.21 168.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.306 3.338 . . . . 0.0 114.641 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 21.6 Cg_exo -34.73 -10.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 1 C-N-CA 127.345 5.364 . . . . 0.0 119.393 -172.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.735 HE22 HD23 ' A' ' 57' ' ' LEU . 1.7 tt0 -42.34 -24.93 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.58 ' O ' HD22 ' A' ' 68' ' ' LEU . 11.5 tp -44.56 -49.02 10.31 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.378 0.671 . . . . 0.0 112.477 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.97 -31.73 33.06 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.843 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.595 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 0.0 110.02 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.696 HD13 HG13 ' A' ' 54' ' ' ILE . 36.0 mt -68.64 -46.97 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.362 -169.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -50.15 -59.37 3.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -174.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.79 -62.45 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -168.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.39 -13.78 7.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 t60 65.83 36.26 6.21 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.4 p -109.82 160.44 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.57 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.53 ' HB ' HH21 ' A' ' 66' ' ' ARG . 0.8 OUTLIER -136.63 131.39 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -70.2 138.84 52.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 120.69 88.39 1.04 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.308 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -56.22 98.53 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 112.124 -171.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 1.002 ' CG ' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -95.66 147.72 23.3 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.042 179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.668 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -110.73 152.75 26.21 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.37 -30.49 12.42 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 0.0 112.061 -169.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 12.2 t -75.42 -25.0 57.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.858 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.79 -51.61 18.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.857 0.836 . . . . 0.0 109.386 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.002 HD21 ' CG ' ' A' ' 77' ' ' TYR . 0.3 OUTLIER -57.72 -50.72 72.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.703 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -66.96 -33.0 74.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.741 0.305 . . . . 0.0 111.328 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -55.0 -40.95 70.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.432 0.634 . . . . 0.0 110.274 173.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.8 mtt -78.44 -41.82 31.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.716 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.85 10.71 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.907 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.1 tt -163.83 157.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 95' ' ' THR . 15.1 m -131.59 141.7 45.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.772 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.8 m -108.93 133.55 52.78 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.221 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 94' ' ' SER . 26.3 t -66.14 164.88 14.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.908 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.2 tp -56.89 -33.59 67.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.558 0.694 . . . . 0.0 109.78 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -27.24 41.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.749 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.21 3.27 11.88 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.893 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.531 ' H ' ' HB3' ' A' ' 90' ' ' SER . 1.8 m -78.34 120.44 23.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.788 0.794 . . . . 0.0 111.564 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -85.03 141.72 30.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.8 mp -127.28 127.27 24.26 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.645 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.2 Cg_exo -72.59 130.06 15.47 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.021 1.814 . . . . 0.0 113.35 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.564 ' CG1' HG13 ' A' ' 88' ' ' VAL . 42.1 mm -98.89 141.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.344 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.433 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 31.1 m80 -134.92 178.8 6.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.543 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.58 110.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.612 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.27 -48.1 8.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 8.1 t30 -128.13 -55.69 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.138 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 15.9 Cg_endo -90.47 173.71 3.12 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.264 1.976 . . . . 0.0 110.8 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 111' ' ' VAL . 14.5 tp -74.48 153.99 38.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 4.3 mm-40 -138.65 119.29 14.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.612 -174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.513 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -119.39 106.01 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.301 -173.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.672 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.8 pttp 49.83 -78.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.536 1.535 . . . . 0.0 113.812 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.481 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 30.3 p-10 -125.29 1.19 7.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.526 0.679 . . . . 0.0 109.344 -172.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -117.6 165.31 13.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.431 -173.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -125.46 136.21 53.14 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.874 HG21 HD23 ' A' ' 104' ' ' LEU . 99.0 t -83.18 127.47 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.234 -174.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.3 mp -93.25 -32.87 14.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.865 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -162.99 116.53 1.64 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.434 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.79 -175.77 4.01 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 29.7 t70 68.11 25.65 7.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -169.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.5 mt -85.06 109.09 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.114 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.554 ' HA ' HD13 ' A' ' 122' ' ' ILE . 35.8 mt-10 -67.56 106.92 2.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.471 0.653 . . . . 0.0 111.14 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.808 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -80.27 -175.17 4.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.399 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.09 -52.26 45.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.429 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.7 m-20 -117.78 -12.78 10.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -149.13 -111.45 0.59 Allowed Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.565 -1.302 . . . . 0.0 112.79 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.668 HG13 ' HE3' ' A' ' 78' ' ' LYS . 7.6 mm -145.31 149.14 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.539 0.685 . . . . 0.0 111.676 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.808 HG13 ' HB2' ' A' ' 118' ' ' ALA . 87.9 mt -114.4 151.17 16.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.462 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.713 ' NE2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.15 112.91 5.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.055 0.931 . . . . 0.0 112.178 -178.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 46.1 t -80.08 130.09 36.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.635 -174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.66 163.34 25.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.672 0.749 . . . . 0.0 110.123 176.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.849 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 34.7 t70 -106.32 14.71 27.07 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.017 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.643 ' O ' HG13 ' A' ' 126' ' ' ILE . 15.9 m -164.26 131.0 3.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.248 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.648 176.355 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.577 HG22 HG12 ' A' ' 5' ' ' VAL . 57.3 m . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.61 -20.9 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.699 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.6 p -92.39 -37.32 8.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.175 0.512 . . . . 0.0 111.003 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.581 ' HA ' HE22 ' A' ' 31' ' ' GLN . 13.9 t70 -50.05 -48.91 52.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.586 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 7.5 mt -59.48 -22.14 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.932 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.52 77.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.314 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.67 -26.6 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 110.259 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 47.6 t30 -77.28 -25.27 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.365 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 7' ' ' ILE . 12.6 p -65.89 138.9 96.58 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 59.12 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.516 2.811 . . . . 0.0 112.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.87 44.1 10.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.881 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -66.09 -178.31 0.6 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -55.43 158.34 3.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.985 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -58.37 -18.38 27.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.514 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -53.36 -35.94 60.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.112 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.26 -30.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.592 0.711 . . . . 0.0 110.064 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -80.82 -29.74 35.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.472 -173.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -64.66 -33.53 76.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -37.43 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 109.886 171.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 7.6 mtmt -61.52 -39.9 92.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.428 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' THR . 7.4 p -77.11 -36.18 24.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.393 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -73.84 -6.69 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.026 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 72.64 10.99 5.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.181 0.992 . . . . 0.0 112.276 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 66' ' ' ARG . 7.8 mp -87.23 7.03 30.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.714 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -36.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.19 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.8 pt-20 -85.38 -21.62 28.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.829 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.75 -53.75 8.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.1 mt -61.74 -5.65 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.299 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.699 ' NE2' HG13 ' A' ' 5' ' ' VAL . 41.7 mm-40 -74.29 10.44 1.27 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.497 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 m -92.85 95.27 1.05 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-O 120.944 0.402 . . . . 0.0 110.01 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 31' ' ' GLN . 53.8 Cg_endo -80.53 -8.01 13.7 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.072 2.515 . . . . 0.0 113.5 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -124.07 0.02 OUTLIER Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.881 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.464 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 37.9 Cg_endo -78.99 154.26 25.66 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.28 1.32 . . . . 0.0 112.597 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.657 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -138.69 121.67 16.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.128 -168.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.4 m -119.63 124.23 45.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.271 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' HG12 ' A' ' 123' ' ' ILE . 98.5 t -122.02 140.97 44.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.236 0.541 . . . . 0.0 111.949 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.49 115.3 29.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -105.65 117.98 56.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.167 -173.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.32 125.13 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.995 1.797 . . . . 0.0 111.582 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.768 HD22 ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -78.7 173.27 12.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.24 -46.01 8.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.609 0.719 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.9 -20.79 61.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.776 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 42' ' ' ASN . . . . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.314 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 120.993 0.425 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.742 ' O ' HG12 ' A' ' 58' ' ' VAL . 90.9 m -66.74 -35.64 80.58 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -79.3 -27.24 42.18 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.868 0.842 . . . . 0.0 109.262 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.3 mp -76.21 -25.71 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.43 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -75.28 -28.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.3 mm-40 -73.55 -27.14 61.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.64 1.21 . . . . 0.0 108.771 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 5.3 m-80 -84.44 168.37 21.7 Favored Pre-proline 0 N--CA 1.435 -1.197 0 CA-C-N 112.982 -1.917 . . . . 0.0 111.038 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 28.8 Cg_exo -38.3 168.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 124.543 3.495 . . . . 0.0 115.197 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 15.3 Cg_exo -34.08 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.896 1 C-N-CA 127.824 5.683 . . . . 0.0 120.551 -166.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.602 ' O ' HG13 ' A' ' 67' ' ' ILE . 1.2 tt0 -43.89 -28.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.664 ' O ' HD22 ' A' ' 68' ' ' LEU . 16.5 tp -44.83 -51.1 9.86 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.223 0.609 . . . . 0.0 112.305 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.72 -34.73 37.02 Favored Glycine 0 N--CA 1.461 0.307 0 O-C-N 123.599 0.562 . . . . 0.0 113.321 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.596 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.71 -40.11 61.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.434 0.635 . . . . 0.0 110.026 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.1 mt -62.51 -47.52 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.828 -174.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.64 -62.35 1.33 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.949 0.781 . . . . 0.0 112.822 -173.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -88.96 -61.94 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -122.13 -12.81 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 59.9 38.01 21.33 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.5 p -106.7 159.39 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.586 -165.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.1 p -132.99 125.57 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.556 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.562 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -67.36 141.96 56.93 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.346 0.593 . . . . 0.0 110.712 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.78 100.16 2.23 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.392 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -61.32 102.26 0.22 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.244 0.545 . . . . 0.0 111.834 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 82' ' ' LEU . 3.2 m-85 -120.71 122.4 40.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.135 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.603 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.08 159.34 27.57 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 170.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -48.99 -36.78 18.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.45 0.469 . . . . 0.0 110.633 -172.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 6.5 t -72.36 -23.99 61.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.287 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.38 -40.17 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.08 -48.87 78.28 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.421 175.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.704 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.8 mtpt -66.53 -29.42 69.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 122.946 0.498 . . . . 0.0 112.218 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.12 -32.47 68.15 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 122.021 0.915 . . . . 0.0 109.299 173.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.1 -42.5 12.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.464 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' HB ' ' A' ' 98' ' ' ILE . . . 80.96 12.01 83.13 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.61 -172.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.9 tt -163.22 159.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 HD12 ' A' ' 82' ' ' LEU . 9.4 m -133.21 139.28 49.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 73' ' ' VAL . 4.3 m -107.37 129.81 54.87 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.505 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 21.4 t -71.44 165.83 22.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.498 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.3 tp -56.74 -30.15 63.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.787 0.803 . . . . 0.0 109.894 173.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 8.0 pt-20 -78.37 -22.96 47.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.48 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.13 11.76 27.1 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.34 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 90' ' ' SER . 73.4 m -88.83 122.29 32.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 122.44 -0.447 . . . . 0.0 111.99 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.3 137.71 32.79 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -128.05 130.08 23.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.509 177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.7 Cg_exo -72.57 134.91 23.13 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.023 1.815 . . . . 0.0 113.328 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -98.61 135.31 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.743 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 53.2 m80 -127.88 -178.81 4.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.682 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.75 100.3 0.16 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.094 -1.051 . . . . 0.0 113.204 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.91 -35.36 26.16 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.5 t-20 -144.2 -55.83 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.185 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 42.2 Cg_endo -85.72 174.04 6.88 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.163 1.909 . . . . 0.0 110.623 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.704 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 16.1 tp -72.89 151.02 42.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 43.5 mt-10 -140.99 106.33 5.04 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -109.12 132.28 57.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.033 -173.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HG2' HG22 ' A' ' 106' ' ' VAL . 12.2 ptmm? 55.36 -82.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.646 1.179 . . . . 0.0 112.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.504 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 22.8 p-10 -146.04 23.03 1.37 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.642 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -125.86 162.99 23.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.252 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.8 m -122.33 131.24 53.81 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 t -78.58 127.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.399 0.619 . . . . 0.0 111.695 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.03 -39.0 13.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.222 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.07 118.35 5.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.72 -174.23 3.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 10.5 m-20 66.26 27.15 10.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -173.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -85.0 114.16 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.5 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.1 mt-10 -66.24 108.83 2.43 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.389 0.614 . . . . 0.0 110.61 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.508 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.26 -172.75 3.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.705 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 3.2 pt-20 -53.26 -51.49 62.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 80.7 m-20 -120.12 -10.75 9.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.3 -118.23 1.17 Allowed Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.229 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 117' ' ' GLU . 19.3 mm -146.18 146.66 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.349 0.595 . . . . 0.0 111.622 -172.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 118' ' ' ALA . 45.3 mt -118.83 146.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.654 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -133.59 116.4 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 84.4 t -81.17 127.72 39.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.259 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.591 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -125.65 160.51 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.462 0.649 . . . . 0.0 110.724 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 42' ' ' ASN . 0.7 OUTLIER -98.16 9.21 43.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.904 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.642 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 23.1 m -146.94 129.17 15.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.18 0.514 . . . . 0.0 111.346 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 C--O 1.255 1.385 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.538 172.457 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.7 mp -49.75 -42.14 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.497 0.665 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.71 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.4 p -75.03 -36.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.14 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' HA ' HE22 ' A' ' 31' ' ' GLN . 17.8 t70 -52.14 -48.51 64.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.509 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 15.4 mt -56.88 -22.31 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.153 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.802 -0.561 . . . . 0.0 110.45 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.85 -18.38 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 110.111 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 40.4 t30 -95.95 -25.45 15.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.855 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 4.1 p -59.25 130.38 87.07 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.038 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.24 65.7 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.136 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.5 46.77 18.29 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.208 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.62 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -63.73 -174.56 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.072 0.463 . . . . 0.0 111.516 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.74 156.82 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 m -59.72 -18.17 40.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.322 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mp -54.12 -34.85 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.408 ' C ' ' HD3' ' A' ' 22' ' ' LYS . 3.5 m -79.93 -39.09 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -68.9 -26.29 65.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.944 -175.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.615 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -66.98 -37.23 83.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -37.08 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.606 0.717 . . . . 0.0 109.872 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 1.8 mtpp -58.52 -41.14 84.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.949 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 19' ' ' THR . 7.1 p -78.16 -36.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.168 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -72.85 -1.63 17.5 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.049 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.64 7.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.068 0.947 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 92' ' ' GLU . 9.6 mp -88.84 6.22 40.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.0 -0.438 . . . . 0.0 111.666 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.978 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.2 pt-20 -84.75 -22.16 29.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.812 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -73.25 -54.77 7.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.71 0.29 . . . . 0.0 111.571 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 HD23 ' A' ' 91' ' ' LEU . 25.3 mt -57.09 -14.66 4.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.71 ' NE2' HG13 ' A' ' 5' ' ' VAL . 34.2 mm-40 -68.77 -3.31 11.83 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.03 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 p -49.47 115.84 5.3 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.933 0.397 . . . . 0.0 111.474 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.72 -18.26 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.87 2.38 . . . . 0.0 113.147 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 35' ' ' PRO . . . -78.4 -135.9 1.0 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.607 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 11.2 Cg_endo -85.78 166.56 10.1 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.027 2.485 . . . . 0.0 113.098 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 72' ' ' VAL . 60.3 m-85 -133.9 122.05 22.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.7 m -104.03 104.89 14.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.568 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.467 ' HB ' HG12 ' A' ' 123' ' ' ILE . 37.2 t -95.59 123.06 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.792 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 126' ' ' ILE . 98.4 m-85 -86.56 108.04 18.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.2 128.82 39.29 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.872 -170.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HB3' HG22 ' A' ' 129' ' ' VAL . 98.6 Cg_endo -79.91 126.86 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.129 1.886 . . . . 0.0 112.55 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -78.52 177.69 8.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.4 -32.7 65.06 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.85 -19.99 33.93 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.972 0.892 . . . . 0.0 108.945 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.725 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.317 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 57' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.235 0.541 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 85.3 m -57.67 -35.98 71.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.469 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -82.73 -25.35 32.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.839 0.828 . . . . 0.0 109.14 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.75 HD23 HE22 ' A' ' 63' ' ' GLN . 8.6 mp -73.1 -27.3 61.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.81 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 8.1 p -79.38 -29.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.064 0.459 . . . . 0.0 109.764 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 55' ' ' THR . 18.8 mm-40 -70.89 -27.47 63.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.699 1.238 . . . . 0.0 108.347 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -82.16 168.07 26.25 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.882 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 22.2 Cg_exo -37.45 168.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 125.008 3.805 . . . . 0.0 116.18 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 36.5 Cg_exo -40.42 -9.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.871 5.047 . . . . 0.0 118.518 -171.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.75 HE22 HD23 ' A' ' 57' ' ' LEU . 9.6 tt0 -43.76 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' O ' HD22 ' A' ' 68' ' ' LEU . 9.5 tp -44.39 -49.95 9.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.61 0.364 . . . . 0.0 110.928 173.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -53.37 -29.7 38.9 Favored Glycine 0 C--N 1.33 0.195 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.556 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -79.35 -39.73 31.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.245 0.545 . . . . 0.0 109.856 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 64' ' ' LEU . 54.6 mt -59.22 -45.39 92.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.524 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.05 -60.13 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -175.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -85.77 -63.09 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.437 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.97 -16.9 5.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -171.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 67.23 34.99 4.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 15.0 p -111.76 159.45 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.948 -167.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 89' ' ' THR . 1.6 p -132.59 131.78 59.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.9 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.622 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.23 144.32 57.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 111.661 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.41 99.86 2.59 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.226 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -57.22 110.31 0.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.824 0.849 . . . . 0.0 111.401 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 122' ' ' ILE . 10.5 m-85 -121.03 110.09 15.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.844 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HD3' HD12 ' A' ' 122' ' ' ILE . 20.3 mmtp -65.77 161.39 20.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 168.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.94 44.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 111.407 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 15.0 t -76.48 -31.38 57.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.646 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.29 -46.86 66.15 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.735 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -58.56 -54.06 51.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.136 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -68.47 -32.04 71.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.1 ttt180 -51.04 -45.22 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.757 0.789 . . . . 0.0 110.212 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.0 mtp -81.08 -39.24 26.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 12.82 79.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.846 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.7 tt -162.95 157.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.735 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -133.11 144.09 37.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.191 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.4 m -107.03 134.63 49.89 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.675 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 94' ' ' SER . 67.5 m -73.17 162.41 29.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.794 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.4 tp -52.82 -36.63 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.425 0.631 . . . . 0.0 110.527 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.37 -28.71 59.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.288 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.1 5.36 8.88 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.673 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' A' ' 90' ' ' SER . 1.4 m -80.32 120.43 24.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.818 0.809 . . . . 0.0 112.097 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -81.97 139.45 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.0 112.807 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.7 mp -127.69 127.85 23.98 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.617 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.578 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.1 Cg_exo -72.99 132.3 18.07 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.11 1.874 . . . . 0.0 113.102 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.438 HG13 ' HB3' ' A' ' 82' ' ' LEU . 41.2 mm -95.53 136.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.303 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 33.3 m-70 -127.53 178.14 6.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.771 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.86 115.19 0.32 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.463 -1.351 . . . . 0.0 113.294 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.89 -53.81 2.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.608 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 19.8 m120 -114.68 -59.9 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.287 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 17.2 Cg_endo -90.4 173.61 3.19 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.161 1.907 . . . . 0.0 110.916 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.0 tp -75.52 153.99 37.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 5.7 mm-40 -139.01 107.1 5.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.336 0.588 . . . . 0.0 109.691 -173.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.702 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -112.98 128.46 69.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.043 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 12.1 ptmm? 51.75 -138.23 1.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.592 0.558 . . . . 0.0 110.191 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -89.97 30.79 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.307 0.575 . . . . 0.0 110.084 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.11 159.22 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.113 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 m -126.2 137.59 53.57 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.8 t -80.47 125.62 39.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.552 0.691 . . . . 0.0 111.732 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.77 -35.72 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.458 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -157.01 114.86 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.504 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -137.41 -173.88 3.6 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.591 ' CG ' ' HD2' ' A' ' 78' ' ' LYS . 12.3 t70 71.58 31.45 2.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.717 1.246 . . . . 0.0 107.646 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 10.0 mt -94.67 116.43 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.461 -1.699 . . . . 0.0 109.538 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.73 107.3 2.52 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.088 0.471 . . . . 0.0 109.759 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.908 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -78.98 -177.05 5.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.126 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.86 -50.09 46.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.415 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -118.55 -16.09 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.924 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -149.01 -109.23 0.51 Allowed Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.556 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 78' ' ' LYS . 23.1 mm -141.06 150.77 20.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.055 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.908 HG13 ' HB2' ' A' ' 118' ' ' ALA . 82.5 mt -123.32 143.43 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.727 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -135.57 114.02 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 60.2 t -78.46 128.86 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -128.74 165.94 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 122.162 0.982 . . . . 0.0 111.412 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.892 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -97.6 10.61 39.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.114 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.598 ' O ' HG13 ' A' ' 126' ' ' ILE . 18.1 m -164.18 123.39 1.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.859 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 41' ' ' PRO . 21.4 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.903 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.427 HG22 HG12 ' A' ' 5' ' ' VAL . 32.9 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -56.3 -23.68 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.691 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -91.68 -36.55 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.276 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 9' ' ' VAL . 33.0 t70 -57.76 -46.42 84.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.046 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 11' ' ' THR . 14.0 mt -57.7 -25.28 24.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.579 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -31.49 72.06 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.176 -0.327 . . . . 0.0 111.021 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 6' ' ' ASP . 7.1 p -91.27 -12.75 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.238 0.542 . . . . 0.0 110.501 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' ILE . 82.2 m-20 -91.99 -14.72 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 7' ' ' ILE . 11.0 p -59.83 138.02 90.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.186 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.84 65.61 8.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.815 2.343 . . . . 0.0 111.962 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.6 47.41 41.68 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.058 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.46 -173.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.308 0.575 . . . . 0.0 111.977 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -62.76 166.22 5.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.748 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -63.13 -19.23 64.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.8 mt -53.52 -36.81 62.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.251 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.2 -27.98 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.619 0.723 . . . . 0.0 109.853 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.621 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -79.38 -26.62 41.96 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.446 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.3 -40.58 97.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.747 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 p -74.75 -36.1 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.855 -0.528 . . . . 0.0 110.288 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 24.1 mtmt -61.11 -44.16 97.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.258 0.551 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 19' ' ' THR . 9.0 p -75.42 -34.83 31.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.113 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.65 -1.58 22.37 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.757 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.85 7.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 112.849 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.7 mp -89.95 6.55 41.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.42 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.3 pt-20 -85.64 -17.71 35.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.262 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.72 -58.49 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 14.5 mt -51.91 -13.25 0.27 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.691 ' NE2' HG13 ' A' ' 5' ' ' VAL . 48.1 mm-40 -66.33 -2.85 4.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.503 0.721 . . . . 0.0 112.73 -174.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -54.52 110.35 2.09 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 123.386 0.429 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.46 -18.02 9.79 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.698 2.265 . . . . 0.0 111.839 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -133.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.276 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 44.3 Cg_endo -80.78 159.1 21.52 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.025 1.817 . . . . 0.0 113.3 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -142.7 122.15 13.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.427 -169.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.493 ' HB ' HG13 ' A' ' 73' ' ' VAL . 51.6 m -118.71 123.24 44.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -172.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' HB ' HG12 ' A' ' 123' ' ' ILE . 81.8 t -117.46 143.53 27.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.303 0.573 . . . . 0.0 111.729 -174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HB3' HD12 ' A' ' 126' ' ' ILE . 97.8 m-85 -106.14 109.3 21.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -97.1 120.48 61.24 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.474 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' HG22 ' A' ' 129' ' ' VAL . 73.5 Cg_endo -77.24 136.47 16.09 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.661 2.241 . . . . 0.0 112.687 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.76 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.9 p30 -85.87 -173.78 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.2 -31.08 63.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -87.41 -21.5 25.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.78 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.051 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.664 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 120.971 0.415 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.786 ' O ' HG12 ' A' ' 58' ' ' VAL . 84.7 m -60.03 -40.82 90.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.902 174.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.5 t -77.81 -34.51 52.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.22 1.009 . . . . 0.0 108.74 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 10.9 mp -66.8 -19.39 65.73 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.408 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 55' ' ' THR . 3.8 p -93.98 -21.02 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.539 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.1 mm-40 -71.11 -47.55 57.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.694 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -147.83 10.29 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -177.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.694 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 5.0 Cg_exo -93.46 152.67 2.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 CA-C-N 121.886 1.709 . . . . 0.0 112.226 157.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.451 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -63.97 -17.31 59.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.325 2.683 . . . . 0.0 112.789 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -51.06 -18.52 0.84 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 24' ' ' ALA . 3.9 tp -45.32 -47.42 13.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.592 0.357 . . . . 0.0 111.725 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -50.02 -33.32 21.29 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.352 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.591 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.53 -36.45 65.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.139 0.971 . . . . 0.0 109.932 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.752 HD11 ' NE2' ' A' ' 63' ' ' GLN . 38.8 mt -69.45 -44.71 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.286 -169.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.574 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -49.91 -53.51 25.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.725 0.641 . . . . 0.0 112.495 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -87.14 -63.01 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -124.31 -13.48 7.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t60 64.11 41.19 6.45 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.7 p -109.86 160.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.85 -165.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 89' ' ' THR . 2.1 p -136.86 135.67 48.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.302 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.8 141.19 51.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.176 0.512 . . . . 0.0 110.956 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 98.92 2.3 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.891 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -60.52 103.32 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.279 0.561 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -120.04 123.48 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.385 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -80.05 161.28 25.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.589 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.31 -38.35 12.58 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 123.459 0.474 . . . . 0.0 110.837 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.1 t -71.46 -25.29 62.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.973 -172.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.25 -40.62 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.677 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.29 -42.72 99.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.478 175.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.4 mtpt -72.78 -30.57 64.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 122.581 0.353 . . . . 0.0 111.8 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -38.07 75.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.6 mtt -77.25 -45.0 27.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.981 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 79.73 9.75 86.46 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.454 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.7 tt -162.97 159.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.677 HG12 HD12 ' A' ' 82' ' ' LEU . 8.3 m -135.01 138.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.496 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.8 m -111.68 135.94 51.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.056 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' A' ' 94' ' ' SER . 15.6 t -71.08 168.63 16.72 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.537 0.735 . . . . 0.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -52.7 -37.73 59.44 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.538 0.685 . . . . 0.0 109.468 172.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.79 -25.26 48.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.579 -173.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.74 12.44 9.43 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.252 -0.886 . . . . 0.0 113.537 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.549 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.7 OUTLIER -80.48 120.51 24.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.756 0.778 . . . . 0.0 111.205 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.34 137.95 31.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 112.522 178.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.7 mp -130.16 126.59 22.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.984 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HA ' HG13 ' A' ' 87' ' ' ILE . 5.0 Cg_exo -71.83 133.24 21.46 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.156 1.904 . . . . 0.0 113.192 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.3 mm -95.64 139.38 19.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.025 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 37.7 m-70 -139.94 -178.92 5.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.215 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.484 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 142.3 115.62 1.13 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.905 -1.14 . . . . 0.0 113.93 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -83.09 -48.8 10.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 40.5 t30 -116.71 -53.73 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.111 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 17.8 Cg_endo -90.09 174.06 3.27 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.09 1.86 . . . . 0.0 110.419 172.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.662 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 17.7 tp -80.02 155.38 27.64 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.645 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 33.7 mt-10 -138.08 111.25 7.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.378 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.41 118.96 51.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.976 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB3' HG23 ' A' ' 96' ' ' ILE . 22.7 pttt 48.3 -107.01 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.986 0.914 . . . . 0.0 112.269 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.23 9.48 25.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.453 0.644 . . . . 0.0 110.375 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -104.13 163.25 12.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.193 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -128.8 135.18 48.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 4.1 t -82.98 126.66 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.431 0.634 . . . . 0.0 111.434 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.7 mp -89.4 -39.24 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.783 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.49 116.57 4.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.334 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.48 -173.67 3.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.785 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 31.7 t70 71.15 28.4 3.08 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 122.867 1.317 . . . . 0.0 107.933 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 11.9 mt -89.54 111.13 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.69 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 122' ' ' ILE . 39.4 mt-10 -68.09 108.95 3.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.046 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.13 179.57 7.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.939 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 2.0 pt-20 -46.52 -50.76 16.68 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.817 0.698 . . . . 0.0 111.301 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 94.3 m-20 -120.58 -15.48 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.103 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.53 -118.77 1.39 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.625 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.706 HD13 ' HA ' ' A' ' 117' ' ' GLU . 16.3 mm -145.49 145.08 20.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.181 0.515 . . . . 0.0 111.747 -171.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 118' ' ' ALA . 22.7 mt -116.44 148.65 19.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.46 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.44 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 4.0 m80 -138.35 117.2 12.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 87.7 t -79.45 128.86 38.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.9 169.35 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 122.08 0.943 . . . . 0.0 110.909 -177.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.772 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.9 t70 -109.63 21.0 17.5 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.657 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.636 ' O ' HG13 ' A' ' 126' ' ' ILE . 10.7 m -163.99 124.6 2.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.669 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.5 ' C ' HD13 ' A' ' 54' ' ' ILE . 50.0 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.979 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 5' ' ' VAL . 92.7 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -43.05 -50.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.19 0.519 . . . . 0.0 111.75 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.746 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -67.93 -37.13 77.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.973 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.596 ' CA ' HE22 ' A' ' 31' ' ' GLN . 27.8 t70 -59.23 -44.33 92.32 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.78 0.8 . . . . 0.0 110.173 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 11.1 mt -56.63 -22.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.7 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.23 -32.45 71.14 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.854 -0.529 . . . . 0.0 110.988 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.59 -30.39 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.415 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 55.3 t30 -74.2 -24.93 59.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.505 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.2 p -62.6 144.82 95.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.825 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -80.44 59.84 7.61 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.977 2.451 . . . . 0.0 112.117 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.24 46.71 62.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.497 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.579 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.47 -169.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.854 0.835 . . . . 0.0 112.864 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m -56.87 160.38 3.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -61.94 -19.46 62.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.601 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.0 tp -57.24 -33.57 67.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 m -80.7 -27.15 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 109.829 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.565 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.4 m -83.48 -27.58 29.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.95 81.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 0.0 111.609 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.48 -37.69 30.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.964 -0.46 . . . . 0.0 110.445 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 38.0 mtmt -62.19 -41.51 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.451 . . . . 0.0 111.175 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 19' ' ' THR . 7.3 p -74.5 -35.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.111 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.08 -7.72 53.56 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.181 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.95 16.96 7.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.566 1.146 . . . . 0.0 112.62 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.4 mp -92.83 9.35 35.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 121.999 -0.438 . . . . 0.0 112.097 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -59.44 -36.92 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.5 pt-20 -86.04 -19.07 30.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.011 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.15 -54.88 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 23.1 mt -55.61 -13.35 1.56 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.746 ' NE2' HG13 ' A' ' 5' ' ' VAL . 46.1 mm-40 -66.16 -9.37 30.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 m -51.92 114.25 5.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 123.257 0.348 . . . . 0.0 111.221 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.38 -20.29 7.17 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.817 2.345 . . . . 0.0 113.628 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.3 -135.74 0.61 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -172.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 54.2 Cg_endo -78.76 162.66 26.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.819 2.346 . . . . 0.0 113.057 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 29.5 m-85 -136.62 121.97 19.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.651 -172.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 45.7 m -107.69 136.21 47.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.026 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -129.22 153.7 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.161 0.505 . . . . 0.0 110.492 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.72 107.23 16.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.55 111.43 53.92 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.677 -171.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 72.5 Cg_endo -77.33 130.17 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.058 1.839 . . . . 0.0 111.612 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.815 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 4.0 p30 -72.16 -176.34 1.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.69 -28.35 55.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.54 -24.18 24.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.842 0.829 . . . . 0.0 109.608 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 129' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.873 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.427 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 121.11 0.481 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.699 ' O ' HG12 ' A' ' 58' ' ' VAL . 98.6 m -65.15 -38.47 90.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.433 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -79.55 -27.59 41.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.0 109.201 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.622 HD23 ' NE2' ' A' ' 63' ' ' GLN . 8.0 mp -72.57 -27.94 62.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.21 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 55' ' ' THR . 7.8 p -77.9 -27.67 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.141 0.496 . . . . 0.0 109.938 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 55' ' ' THR . 22.5 mm-40 -71.55 -29.77 65.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.513 1.149 . . . . 0.0 108.842 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.91 166.08 46.14 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.64 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.0 Cg_exo -40.46 169.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.355 3.37 . . . . 0.0 114.171 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 31.2 Cg_exo -33.45 -8.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.047 1 C-N-CA 127.802 5.668 . . . . 0.0 120.175 -167.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.622 ' NE2' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -41.65 -25.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 HG23 ' A' ' 58' ' ' VAL . 10.6 tp -52.25 -50.89 61.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.599 0.36 . . . . 0.0 111.883 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -52.03 -31.09 32.1 Favored Glycine 0 N--CA 1.461 0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.348 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.76 -49.29 21.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.356 0.598 . . . . 0.0 110.587 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 64' ' ' LEU . 63.0 mt -44.88 -48.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.119 174.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -48.16 -65.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -166.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -89.44 -69.2 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.197 -1.001 . . . . 0.0 113.619 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.647 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -126.46 18.58 7.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -175.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.1 t60 59.24 30.98 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 164.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.647 HG11 ' CZ ' ' A' ' 70' ' ' TYR . 4.8 p -105.25 159.86 5.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.119 0.962 . . . . 0.0 113.517 -164.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 89' ' ' THR . 2.0 p -132.94 120.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.944 163.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.657 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.58 145.97 55.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 0.0 111.62 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 97.43 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.28 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -58.78 106.2 0.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.232 0.539 . . . . 0.0 111.105 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CB ' HD11 ' A' ' 82' ' ' LEU . 6.0 m-85 -115.64 119.78 37.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -77.05 158.75 30.35 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.21 -37.45 10.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.553 0.533 . . . . 0.0 111.268 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.7 t -74.98 -24.37 58.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 -168.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.47 -45.72 75.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.713 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -57.19 -52.32 65.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.461 177.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.97 -34.68 75.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.0 ttt180 -51.47 -43.29 62.1 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.102 0.953 . . . . 0.0 109.19 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.3 mtp -75.98 -42.91 46.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.014 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' ILE . . . 77.87 15.49 81.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.098 -172.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -163.66 157.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.713 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -130.7 143.06 42.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.396 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.1 m -110.6 133.52 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.924 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 94' ' ' SER . 70.9 m -77.31 166.18 23.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.138 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.8 tp -51.89 -37.59 52.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.125 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -76.54 -24.94 53.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.61 -178.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.51 20.08 5.57 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.597 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' SER . 8.2 t -88.16 119.41 28.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.156 0.478 . . . . 0.0 110.536 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.78 139.25 30.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.65 . . . . 0.0 112.636 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.617 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -131.93 128.12 21.41 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.938 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HA ' HG13 ' A' ' 87' ' ' ILE . 8.1 Cg_exo -69.16 133.27 26.25 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.142 1.895 . . . . 0.0 113.355 -173.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.546 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.7 mm -102.09 138.0 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.049 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -140.82 179.98 6.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.595 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.603 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 173.93 93.26 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.72 -172.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.89 -44.33 55.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 109.288 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.564 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 11.6 m-80 -140.83 -53.11 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.983 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.3 Cg_endo -88.17 173.28 4.87 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.165 1.91 . . . . 0.0 110.298 168.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.499 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 24.8 tp -73.34 153.67 40.42 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 26.8 mt-10 -140.91 106.78 5.14 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -105.74 126.52 61.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.823 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HG2' HG22 ' A' ' 106' ' ' VAL . 13.5 ptmt 46.52 -114.51 0.52 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.604 0.762 . . . . 0.0 112.046 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.423 HD22 ' C ' ' A' ' 108' ' ' ASN . 0.3 OUTLIER -102.99 22.14 14.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.203 0.525 . . . . 0.0 111.094 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -123.97 166.48 15.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.938 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 m -128.78 137.44 51.54 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -81.02 129.89 36.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.545 0.688 . . . . 0.0 111.886 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.8 mp -91.6 -37.86 12.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.389 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.59 112.08 2.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.849 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 124' ' ' HIS . . . -141.01 -173.25 3.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 71.46 26.28 3.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -90.46 109.66 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.738 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.783 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.52 110.97 3.36 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.278 1.037 . . . . 0.0 112.031 174.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.24 -170.5 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.465 -1.698 . . . . 0.0 111.772 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -50.94 -49.04 60.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.863 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -119.66 -18.35 8.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.072 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.54 -112.4 0.77 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.397 -173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.783 HD13 ' HA ' ' A' ' 117' ' ' GLU . 9.8 mm -146.56 142.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.547 0.689 . . . . 0.0 112.355 -174.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 118' ' ' ALA . 92.2 mt -113.19 146.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.619 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.543 ' CD2' ' HB1' ' A' ' 114' ' ' ALA . 10.6 m80 -137.22 113.3 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 57.6 t -81.12 128.08 39.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 123.178 0.299 . . . . 0.0 110.31 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -127.25 164.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 0.0 110.94 -176.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.8 t70 -108.89 19.47 19.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.752 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.647 ' O ' HG13 ' A' ' 126' ' ' ILE . 16.2 m -168.77 134.5 1.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 41' ' ' PRO . 73.1 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.637 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.792 0.33 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.21 151.93 24.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.849 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -68.09 143.96 55.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.904 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp -43.74 -52.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.797 -174.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.723 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -70.8 -36.92 66.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.079 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.453 ' CA ' HE22 ' A' ' 31' ' ' GLN . 21.0 t70 -56.41 -44.42 80.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.81 0.814 . . . . 0.0 110.334 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 19.7 mt -53.86 -24.76 10.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.933 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.3 86.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.888 0.375 . . . . 0.0 111.057 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.15 -18.57 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.416 0.627 . . . . 0.0 110.46 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 44.9 t30 -89.84 -25.33 21.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.476 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 8.9 p -57.76 133.9 82.9 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -174.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -78.01 66.05 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.918 2.412 . . . . 0.0 111.884 175.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.93 47.04 26.64 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.219 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.552 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.74 -172.93 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.15 0.5 . . . . 0.0 111.605 177.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -58.81 163.22 3.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.853 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.0 m -62.58 -19.28 63.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.64 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.38 -35.24 50.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.705 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.3 -27.47 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.509 0.671 . . . . 0.0 109.908 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.589 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.2 m -83.38 -28.2 29.1 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.757 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.26 79.26 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.622 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.13 -36.81 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 121.978 -0.451 . . . . 0.0 110.427 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.1 mtmt -62.93 -40.07 96.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.203 0.525 . . . . 0.0 111.217 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 19' ' ' THR . 8.8 p -77.21 -34.66 21.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.544 0.688 . . . . 0.0 110.218 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.595 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.17 -2.47 31.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.368 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.84 15.4 10.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.125 0.97 . . . . 0.0 112.835 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 8.2 mp -91.46 7.62 40.31 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.927 -0.483 . . . . 0.0 111.894 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -60.08 -37.02 71.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.134 0.492 . . . . 0.0 109.956 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.9 pt-20 -85.53 -18.89 32.12 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.788 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.76 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.2 mt -59.36 -10.47 3.16 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.723 ' NE2' HG13 ' A' ' 5' ' ' VAL . 47.0 mm-40 -67.97 -8.47 37.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -54.15 113.11 4.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.63 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.56 -12.89 15.1 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.725 2.284 . . . . 0.0 112.885 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.85 -137.34 0.65 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.711 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.546 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 57.9 Cg_endo -84.2 165.48 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.036 2.491 . . . . 0.0 113.967 -175.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB3' HG21 ' A' ' 72' ' ' VAL . 49.6 m-85 -139.15 122.7 17.35 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 36.1 m -106.65 118.0 35.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.253 0.549 . . . . 0.0 110.996 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.38 121.06 60.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.443 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.423 ' N ' ' HD1' ' A' ' 39' ' ' PHE . 1.4 m-30 -82.86 111.46 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.741 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -95.82 112.39 59.1 Favored Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.722 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.52 133.42 15.81 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.06 1.84 . . . . 0.0 111.538 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.806 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 32.2 p30 -72.61 -172.5 0.99 Allowed 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.722 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.82 -27.13 68.67 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.528 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 23.8 t70 -88.34 -21.28 24.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.186 0.993 . . . . 0.0 109.068 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -84.91 -35.54 22.07 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.337 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -62.21 -20.6 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.953 0.882 . . . . 0.0 108.746 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -81.19 -9.78 59.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.573 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 28.1 mmmt -89.08 -25.14 22.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.541 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 28.6 mt -54.31 -53.89 54.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.231 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 9.5 Cg_endo -53.29 95.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.203 2.602 . . . . 0.0 113.561 -170.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 t70 47.12 50.37 14.19 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.061 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.61 -99.56 0.96 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.589 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.436 HG21 HG12 ' A' ' 129' ' ' VAL . 32.3 m -61.97 -58.51 7.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.296 -0.452 . . . . 0.0 111.46 -175.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.725 HD12 HD22 ' A' ' 57' ' ' LEU . 1.2 mp -58.55 -25.53 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.929 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.732 ' O ' HG12 ' A' ' 58' ' ' VAL . 67.8 m -65.07 -40.59 94.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.6 t -79.82 -29.65 40.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.032 0.92 . . . . 0.0 109.16 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.75 HD23 HE22 ' A' ' 63' ' ' GLN . 6.8 mp -70.58 -26.01 63.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.222 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 55' ' ' THR . 9.9 p -80.01 -28.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 121.156 0.503 . . . . 0.0 109.755 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 55' ' ' THR . 24.4 mm-40 -70.56 -25.54 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.651 1.215 . . . . 0.0 108.519 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.47 168.64 26.23 Favored Pre-proline 0 N--CA 1.437 -1.094 0 CA-C-N 112.653 -2.067 . . . . 0.0 111.282 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.2 Cg_exo -38.16 169.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 124.633 3.555 . . . . 0.0 115.424 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 51.9 Cg_exo -40.58 -8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.668 1 C-N-CA 126.632 4.888 . . . . 0.0 118.296 -172.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.75 HE22 HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -42.61 -20.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.919 ' HA ' HD12 ' A' ' 67' ' ' ILE . 13.4 tp -46.92 -50.98 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.35 0.26 . . . . 0.0 111.08 174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.26 -32.59 44.32 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.265 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.558 ' HD2' ' HG2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -72.26 -51.38 21.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.528 0.68 . . . . 0.0 109.53 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 64' ' ' LEU . 62.2 mt -44.41 -53.89 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 113.969 -1.469 . . . . 0.0 113.359 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.646 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -47.19 -64.09 0.87 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.09 -62.06 1.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -122.48 -0.93 9.16 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.1 p80 43.04 51.6 5.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.775 0.798 . . . . 0.0 110.187 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 36' ' ' PHE . 12.9 p -120.98 159.15 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.903 -166.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 89' ' ' THR . 1.5 p -130.21 129.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.747 170.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.538 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.73 146.36 54.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.254 0.55 . . . . 0.0 111.168 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.81 99.1 2.57 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -63.65 101.9 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.162 0.506 . . . . 0.0 111.509 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -112.93 129.36 56.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.124 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -91.99 161.01 14.97 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -31.53 7.03 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.244 0.545 . . . . 0.0 112.046 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.9 t -72.39 -27.0 62.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.245 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.43 -50.36 14.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.718 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -54.38 -50.69 66.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.99 -1.004 . . . . 0.0 112.044 177.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -68.51 -35.85 78.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.747 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -56.88 -39.49 74.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.632 0.73 . . . . 0.0 110.115 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 81.1 mtp -80.49 -35.24 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.919 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.96 12.05 83.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.051 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -162.92 157.28 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.718 HG12 HD12 ' A' ' 82' ' ' LEU . 10.6 m -132.03 140.42 47.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.262 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.499 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.5 m -112.71 133.08 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.116 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 94' ' ' SER . 14.1 t -68.93 163.9 23.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.906 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.538 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -55.38 -30.77 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.479 0.657 . . . . 0.0 110.148 174.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -81.4 -25.85 35.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.152 -178.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.4 18.29 7.19 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.33 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.591 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.8 OUTLIER -88.1 121.3 30.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.299 0.55 . . . . 0.0 111.332 175.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.51 138.01 31.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.9 mp -127.63 127.01 24.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.8 Cg_exo -70.39 132.03 21.51 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 121.98 1.786 . . . . 0.0 113.036 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.465 ' CG1' HG13 ' A' ' 88' ' ' VAL . 40.5 mm -94.55 136.14 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.38 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 91.7 m-70 -121.0 -179.24 3.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.199 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.31 94.06 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.042 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.09 -48.21 13.6 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.453 0.645 . . . . 0.0 109.606 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.585 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 6.9 m-80 -138.53 -53.19 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.003 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -87.77 173.25 5.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.123 1.882 . . . . 0.0 109.99 168.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.808 HD23 HG21 ' A' ' 111' ' ' VAL . 16.3 tp -72.8 154.35 40.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 44.9 mt-10 -140.4 127.86 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.397 0.618 . . . . 0.0 109.523 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -129.08 122.61 56.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.013 -174.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HG2' HG22 ' A' ' 106' ' ' VAL . 10.9 ptmm? 46.51 -123.46 1.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.163 0.585 . . . . 0.0 111.237 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -96.94 23.55 7.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 110.608 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -118.85 166.04 13.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.296 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -128.29 138.04 52.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.808 HG21 HD23 ' A' ' 104' ' ' LEU . 88.1 t -86.2 126.8 40.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.686 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 127' ' ' ASP . 6.6 mp -89.63 -36.55 15.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.631 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.68 118.28 2.79 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.532 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.93 -174.54 3.63 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 32.2 t70 68.98 26.86 5.59 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -171.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -88.84 108.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.011 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.692 ' HA ' HD13 ' A' ' 122' ' ' ILE . 43.3 mt-10 -68.58 106.02 2.45 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.623 0.725 . . . . 0.0 110.72 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -81.38 178.89 8.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.716 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -44.2 -51.73 7.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.845 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -117.87 -14.61 10.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.365 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.73 -110.76 0.44 Allowed Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.169 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' A' ' 117' ' ' GLU . 18.3 mm -142.66 143.81 25.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.097 -0.552 . . . . 0.0 111.387 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 116' ' ' ILE . 16.9 mt -112.11 148.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.222 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' CD2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.79 114.87 5.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.819 0.819 . . . . 0.0 112.043 -178.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 49.5 t -80.17 129.86 36.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.113 -172.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.33 159.58 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.806 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -99.0 3.41 46.93 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.475 -173.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.616 ' O ' HG13 ' A' ' 126' ' ' ILE . 47.7 m -154.51 126.71 7.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.531 -172.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 54' ' ' ILE . 76.3 t . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.075 0.464 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.7 148.66 34.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.042 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 5' ' ' VAL . 13.5 m -61.11 145.02 52.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.398 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -57.67 -20.15 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.763 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.2 p -90.34 -37.3 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.271 0.557 . . . . 0.0 110.205 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.53 ' CA ' HE22 ' A' ' 31' ' ' GLN . 28.1 t70 -56.95 -50.93 71.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.204 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG22 HG23 ' A' ' 11' ' ' THR . 21.9 mt -54.42 -22.0 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.414 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.089 0.471 . . . . 0.0 110.607 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 37.8 t -74.48 -23.38 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.487 0.661 . . . . 0.0 110.291 175.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 50.6 t30 -87.26 -25.44 23.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.76 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 6.5 p -60.82 134.26 92.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -171.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -81.95 67.33 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.052 2.501 . . . . 0.0 111.808 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.92 47.34 11.72 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.098 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.618 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.7 OUTLIER -67.14 -170.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.204 0.525 . . . . 0.0 111.35 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -60.46 157.63 13.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.506 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m -60.56 -19.03 56.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.341 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.454 ' H ' HD22 ' A' ' 17' ' ' LEU . 3.2 mm? -57.98 -30.33 65.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.18 -30.25 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 121.325 0.583 . . . . 0.0 109.803 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 2.2 m -83.52 -29.24 28.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.22 -31.4 71.93 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.111 0.257 . . . . 0.0 111.571 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 21' ' ' VAL . 1.2 p -81.44 -37.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.506 171.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 41.3 mtmt -62.17 -41.57 98.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.13 0.491 . . . . 0.0 111.315 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 19' ' ' THR . 8.5 p -75.21 -36.04 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.663 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.38 -6.5 48.55 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.937 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 13.31 9.34 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.312 1.045 . . . . 0.0 113.172 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 92' ' ' GLU . 10.6 mp -85.77 8.97 17.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.972 -0.455 . . . . 0.0 111.437 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.425 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.68 -37.17 57.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.345 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.7 pt-20 -85.67 -20.77 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.692 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.79 -54.42 6.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.689 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 21.9 mt -58.76 -14.07 7.72 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.763 ' NE2' HG13 ' A' ' 5' ' ' VAL . 30.7 mm-40 -66.52 -5.75 12.42 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.768 0.427 . . . . 0.0 111.908 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p -51.65 110.43 1.83 Allowed Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 123.423 0.689 . . . . 0.0 112.406 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.33 -17.86 8.77 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.126 2.55 . . . . 0.0 113.252 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.35 -140.5 0.8 Allowed Glycine 0 CA--C 1.518 0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.372 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 30.1 Cg_endo -76.2 163.08 33.24 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.018 1.812 . . . . 0.0 112.804 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -133.51 122.71 24.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.154 -171.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 52.6 m -116.6 136.27 53.12 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.168 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 123' ' ' ILE . 5.5 p -133.02 156.13 41.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.641 . . . . 0.0 111.36 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.461 ' HB3' HD12 ' A' ' 126' ' ' ILE . 93.3 m-85 -112.26 111.04 21.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 171.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -98.91 113.33 64.45 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.391 . . . . 0.0 111.513 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.66 130.59 10.79 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.588 2.192 . . . . 0.0 112.229 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.842 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.7 p30 -84.08 -174.14 5.11 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.675 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.42 -27.05 65.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 111.678 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 34.2 t70 -82.52 -22.71 34.92 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.646 0.736 . . . . 0.0 109.25 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -79.84 -36.86 36.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.639 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.15 -24.26 62.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.969 0.89 . . . . 0.0 109.208 171.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.35 -9.97 55.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.931 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 29.2 mmmt -87.3 -24.59 24.27 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 49' ' ' LEU . 45.7 mt -42.52 -42.42 6.85 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 114.439 -1.255 . . . . 0.0 114.302 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 58.5 Cg_exo -41.2 -39.48 3.82 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.873 2.382 . . . . 0.0 113.508 171.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.72 -68.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.07 76.18 1.19 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.905 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' HD13 ' A' ' 57' ' ' LEU . 99.7 m -65.54 -52.15 54.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.26 0.552 . . . . 0.0 109.952 171.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.5 mp -57.98 -25.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.853 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 92.1 m -65.67 -32.7 74.4 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.926 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 t -81.04 -25.54 37.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.68 0.752 . . . . 0.0 109.342 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.1 mp -74.93 -25.64 59.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.041 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 11.4 p -76.97 -31.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 121.228 0.537 . . . . 0.0 109.756 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.4 mm-40 -71.59 -28.39 63.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 122.68 1.229 . . . . 0.0 108.578 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 3.3 m-80 -81.78 169.39 18.89 Favored Pre-proline 0 N--CA 1.437 -1.085 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.972 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 19.9 Cg_exo -37.06 170.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 125.023 3.815 . . . . 0.0 115.607 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 48.0 Cg_exo -39.4 -9.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.607 1 C-N-CA 126.566 4.844 . . . . 0.0 118.029 -172.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.569 ' NE2' HD23 ' A' ' 57' ' ' LEU . 4.7 tp60 -41.67 -26.5 0.08 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.153 0.981 . . . . 0.0 113.096 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.616 HD13 HG23 ' A' ' 58' ' ' VAL . 5.5 tp -51.09 -50.89 57.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 0.0 111.754 174.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.29 -33.06 22.97 Favored Glycine 0 N--CA 1.459 0.174 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.928 -172.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.98 -35.25 50.38 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.994 0.426 . . . . 0.0 110.656 -178.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 64' ' ' LEU . 51.6 mt -59.76 -46.52 93.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.258 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -45.81 -63.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.926 0.766 . . . . 0.0 113.003 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -88.99 -60.01 2.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -121.13 -16.37 8.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -167.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 70.6 m80 64.67 33.35 10.62 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 11.5 p -94.47 155.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.073 -166.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.471 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.4 p -141.43 119.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.625 -1.625 . . . . 0.0 108.888 166.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.665 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.52 142.21 58.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 111.216 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 112.24 98.27 2.38 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.98 102.67 0.09 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.175 0.512 . . . . 0.0 111.685 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.462 ' O ' HG21 ' A' ' 122' ' ' ILE . 12.4 m-85 -114.67 106.84 14.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.579 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.712 ' HD3' HD12 ' A' ' 122' ' ' ILE . 21.3 mmtp -60.67 157.54 14.42 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 167.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -49.52 -35.41 20.0 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 123.461 0.475 . . . . 0.0 110.36 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 9.4 t -75.62 -28.53 58.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.176 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.51 -35.53 79.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.721 HD12 HG12 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -66.34 -50.55 63.18 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.105 176.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -68.08 -30.62 69.86 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 123.199 0.6 . . . . 0.0 112.264 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.26 -31.48 67.46 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-O 121.664 0.745 . . . . 0.0 109.433 172.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.7 mtt -87.7 -40.51 14.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.679 172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 78.72 14.32 82.19 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.982 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.0 tt -164.39 159.92 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.721 HG12 HD12 ' A' ' 82' ' ' LEU . 11.9 m -131.97 137.92 53.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.428 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.2 m -106.77 126.91 52.91 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.397 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' H ' ' A' ' 94' ' ' SER . 72.5 m -68.45 163.87 22.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.416 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.665 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.7 tp -51.45 -36.28 43.35 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.612 0.72 . . . . 0.0 110.877 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.49 -28.06 52.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.447 -179.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.32 10.81 7.76 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.696 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.497 ' H ' ' HB2' ' A' ' 90' ' ' SER . 0.7 OUTLIER -83.44 120.69 26.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.951 0.875 . . . . 0.0 111.759 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.15 138.06 32.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.5 mp -130.4 126.74 22.25 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.549 ' HA ' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -68.29 133.44 28.43 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.124 1.883 . . . . 0.0 113.533 -173.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.584 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.4 mm -103.25 142.75 16.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.4 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -141.19 177.3 8.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.682 174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.08 121.31 0.55 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.091 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -101.34 -54.14 2.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 12.6 m120 -107.14 -61.8 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 172.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 16.0 Cg_endo -90.49 174.01 3.04 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.475 2.117 . . . . 0.0 111.244 174.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.585 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 21.3 tp -75.8 154.53 36.17 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -140.88 107.37 5.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.8 112.03 38.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.589 -173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.642 ' HB3' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER 48.54 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.321 1.448 . . . . 0.0 113.87 -174.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 3.1 p-10 -134.85 23.23 3.59 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.526 0.679 . . . . 0.0 109.573 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -129.25 157.51 41.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.077 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 44.4 m -121.9 134.31 54.86 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -78.59 127.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.613 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 112' ' ' LEU . 6.9 mp -88.82 -38.87 14.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.105 175.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.97 110.53 3.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.148 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -133.04 -173.58 3.24 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.65 ' OD1' ' HD2' ' A' ' 78' ' ' LYS . 20.4 t70 71.47 28.34 2.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 122.794 1.283 . . . . 0.0 107.604 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.4 mt -95.14 110.05 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.04 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.852 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.48 114.34 6.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.969 0.89 . . . . 0.0 112.391 172.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.842 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.77 -173.49 3.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.023 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -49.08 -51.19 32.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.123 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 4.2 m-20 -115.23 -20.57 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.644 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.72 -114.77 1.05 Allowed Glycine 0 CA--C 1.505 -0.539 0 C-N-CA 119.447 -1.359 . . . . 0.0 114.047 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 117' ' ' GLU . 17.8 mm -144.52 148.15 18.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.327 0.585 . . . . 0.0 110.951 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.842 HG13 ' HB2' ' A' ' 118' ' ' ALA . 94.6 mt -120.24 147.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.457 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -137.88 117.79 13.3 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 69.9 t -83.31 129.64 37.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.496 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -124.99 161.76 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.619 0.724 . . . . 0.0 110.457 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.842 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -95.8 5.36 51.52 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.52 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.683 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 51.0 m -148.92 126.63 11.76 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.813 -171.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG23 ' HB1' ' A' ' 45' ' ' ALA . 69.5 t . . . . . 0 C--O 1.252 1.23 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.603 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.88 119.36 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.723 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 HG12 ' A' ' 5' ' ' VAL . 28.5 m -61.24 146.81 46.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.094 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -54.86 -20.96 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.736 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.1 p -91.37 -37.23 8.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.155 0.502 . . . . 0.0 110.614 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.1 t70 -58.42 -44.5 89.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.373 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 9.1 mt -59.18 -21.69 20.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.637 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.5 -34.15 76.29 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.826 -0.546 . . . . 0.0 110.751 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 6' ' ' ASP . 4.2 p -87.9 -9.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 110.112 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 54.4 t30 -92.72 -25.01 18.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.767 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 p -64.65 131.97 95.28 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.175 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.3 64.76 7.95 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.898 2.399 . . . . 0.0 112.288 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.09 46.96 11.95 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.898 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.63 -172.15 0.16 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.441 0.639 . . . . 0.0 112.508 177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -61.3 163.13 6.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.559 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -61.44 -18.37 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.358 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.79 -37.78 52.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.35 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.85 -27.4 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.493 0.663 . . . . 0.0 110.116 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.584 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.8 m -81.64 -25.7 35.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.686 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.17 -35.07 77.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.673 0.273 . . . . 0.0 111.524 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -78.29 -37.35 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.453 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 36.6 mtmt -62.5 -43.55 98.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.964 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 19' ' ' THR . 7.8 p -72.73 -35.02 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.113 -177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -76.44 -5.14 46.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.043 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.36 8.46 6.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.962 1.305 . . . . 0.0 113.128 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.3 mp -85.42 9.24 16.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.12 -37.66 56.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 110.542 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -85.84 -21.8 27.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.754 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -76.28 -55.4 5.6 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -176.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.9 mt -57.18 -13.83 3.49 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.209 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.736 ' NE2' HG13 ' A' ' 5' ' ' VAL . 45.9 mm-40 -65.16 -13.75 58.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.211 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 p -56.99 114.07 7.33 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.683 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.83 -14.25 11.3 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.982 2.455 . . . . 0.0 113.482 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.45 -149.87 1.04 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.275 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 37.8 Cg_endo -73.23 170.03 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.89 2.394 . . . . 0.0 112.821 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' HB3' HG21 ' A' ' 72' ' ' VAL . 45.2 m-85 -139.92 124.08 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 21.9 m -106.22 124.03 48.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 123' ' ' ILE . 41.3 t -113.88 134.07 57.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.962 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -100.25 116.27 31.86 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -104.93 117.78 57.85 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.317 -172.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.79 125.86 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.023 1.816 . . . . 0.0 111.853 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.886 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -75.85 176.02 8.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.13 -179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -59.67 -35.4 74.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 12.4 t70 -78.83 -19.45 52.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.838 0.828 . . . . 0.0 108.816 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HA ' ' CG ' ' A' ' 48' ' ' LYS . . . -75.47 -40.93 56.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.482 177.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -61.34 -24.55 66.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.568 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.01 -21.46 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 28.5 mmmt -63.06 -44.68 95.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.256 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.53 HD21 HG21 ' A' ' 129' ' ' VAL . 94.6 mt -32.23 97.52 0.11 Allowed Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 125.724 1.89 . . . . 0.0 113.924 -164.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -88.38 82.28 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.055 1 C-N-CA 125.321 4.014 . . . . 0.0 111.825 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 64.31 14.9 9.08 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.111 0.481 . . . . 0.0 110.393 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . 92.39 99.16 1.38 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.211 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.687 ' HB ' HG12 ' A' ' 129' ' ' VAL . 95.5 m -59.04 -50.56 73.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.573 0.701 . . . . 0.0 110.044 174.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.574 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -58.29 -23.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.771 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 58' ' ' VAL . 74.7 m -59.92 -32.55 70.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.83 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 t -83.56 -23.83 31.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.161 0.981 . . . . 0.0 109.121 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 9.0 mp -77.92 -20.39 52.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 55' ' ' THR . 8.0 p -91.71 -22.72 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.013 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 55' ' ' THR . 20.2 mm-40 -64.12 -44.87 90.91 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -172.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.67 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 64.2 t30 -162.9 14.33 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 4.0 Cg_exo -91.38 150.94 3.63 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 CA-C-N 121.202 1.465 . . . . 0.0 111.435 153.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 61' ' ' PRO . 24.2 Cg_exo -66.51 -15.61 48.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.087 2.525 . . . . 0.0 112.805 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 1.1 tt0 -46.85 -29.75 2.14 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 67' ' ' ILE . 9.3 tp -45.66 -50.03 13.88 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -44.91 -44.71 8.93 Favored Glycine 0 CA--C 1.511 -0.205 0 O-C-N 124.103 0.877 . . . . 0.0 114.218 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.71 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -80.63 -35.2 34.31 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.62 0.247 . . . . 0.0 110.57 -174.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.5 mt -51.67 -47.51 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.184 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.597 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -45.92 -56.03 5.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.53 -64.0 1.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.407 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 79.1 m-85 -125.89 -0.78 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 66' ' ' ARG . 14.7 p-80 43.99 53.35 6.4 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.726 0.774 . . . . 0.0 110.041 -168.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 36' ' ' PHE . 10.2 p -123.82 154.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.271 -166.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.466 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.8 p -125.27 127.93 72.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.657 171.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.518 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.56 143.83 57.64 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.077 0.465 . . . . 0.0 111.156 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.72 99.48 2.6 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.888 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 121' ' ' GLY . . . -61.8 98.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.579 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' O ' HG21 ' A' ' 122' ' ' ILE . 5.1 m-85 -113.6 110.19 19.83 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.825 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.722 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.1 mmtp -59.66 160.68 6.97 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 165.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.35 -23.64 65.9 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 8.2 t -72.57 -31.08 64.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.58 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -73.77 -43.59 58.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.722 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -62.34 -55.39 28.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.914 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.94 -35.19 77.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.147 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -51.34 -44.52 62.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.664 0.745 . . . . 0.0 110.23 173.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.2 mtt -77.34 -38.68 49.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.272 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.15 6.66 86.19 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.043 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.6 tt -163.07 158.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG12 HD12 ' A' ' 82' ' ' LEU . 14.1 m -129.98 140.89 47.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.093 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.2 m -110.1 126.27 53.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.66 0.743 . . . . 0.0 110.64 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 75.0 m -72.18 168.61 17.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.386 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 74' ' ' ALA . 4.7 tp -56.14 -37.7 69.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.873 0.844 . . . . 0.0 109.78 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.9 pm0 -75.36 -15.19 60.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.705 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.93 8.88 47.1 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.164 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -78.35 118.45 20.55 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.172 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -83.56 141.29 31.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.359 0.6 . . . . 0.0 111.997 176.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.594 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -133.99 126.22 18.57 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.957 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.6 Cg_exo -70.43 128.72 15.8 Favored 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 122.1 1.867 . . . . 0.0 112.604 -175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.559 ' CG1' HG13 ' A' ' 88' ' ' VAL . 39.0 mm -96.9 133.48 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.733 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 54.7 m80 -130.89 -179.77 5.51 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.589 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.67 114.01 0.4 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.653 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.98 -51.76 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 78.2 m-20 -132.83 -57.59 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.332 171.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 45.4 Cg_endo -85.02 172.8 8.44 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.153 1.902 . . . . 0.0 110.71 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.0 152.9 38.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.32 0.581 . . . . 0.0 110.72 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 8.7 mm-40 -130.96 106.93 8.74 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.454 -175.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.49 115.43 48.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.856 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.9 ptmt 55.74 -73.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.71 1.604 . . . . 0.0 113.213 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 2.9 p-10 -149.69 24.26 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -126.9 166.11 18.11 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.399 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 41.7 m -126.59 132.34 51.31 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 t -74.75 131.89 34.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 121.477 0.656 . . . . 0.0 111.422 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 127' ' ' ASP . 7.1 mp -91.7 -46.64 7.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.781 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -145.97 114.12 6.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.7 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HB1' ' ND1' ' A' ' 124' ' ' HIS . . . -135.91 -173.39 3.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 49.2 m-20 67.81 28.47 7.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -172.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -86.62 114.32 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.104 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' HA ' HD13 ' A' ' 122' ' ' ILE . 37.1 mt-10 -67.96 106.91 2.48 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.928 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.7 -179.47 7.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.295 -175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.93 -49.53 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.6 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.06 -18.91 9.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.907 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -147.98 -108.08 0.49 Allowed Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 119.724 -1.227 . . . . 0.0 114.093 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.58 HD12 ' HD3' ' A' ' 78' ' ' LYS . 17.1 mm -142.9 153.45 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.401 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.928 HG13 ' HB2' ' A' ' 118' ' ' ALA . 89.0 mt -128.58 147.59 33.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.628 175.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.53 ' ND1' ' HB1' ' A' ' 114' ' ' ALA . 4.6 m-70 -138.09 117.4 12.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.736 175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 95.4 t -82.2 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -122.97 156.33 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 122.028 0.918 . . . . 0.0 111.286 -176.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.886 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -98.68 19.52 14.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.971 -169.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.574 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 19.3 m -158.89 131.47 6.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.874 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.687 HG12 ' HB ' ' A' ' 53' ' ' THR . 75.4 t . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.91 120.02 12.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.011 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 5' ' ' VAL . 42.8 m -60.16 145.62 46.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.72 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.1 pp -56.56 -19.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.735 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.8 p -91.24 -36.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 0.0 110.705 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.507 ' CA ' HE22 ' A' ' 31' ' ' GLN . 23.4 t70 -58.12 -45.47 87.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.566 0.698 . . . . 0.0 110.253 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 14.3 mt -56.86 -21.55 14.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.873 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.12 74.57 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.978 -0.451 . . . . 0.0 110.936 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.35 -24.35 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 110.114 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 60.2 t30 -81.04 -25.43 37.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.175 -176.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 5.8 p -63.21 130.63 94.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.4 Cg_exo -79.26 68.87 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.94 2.427 . . . . 0.0 111.932 175.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.25 46.83 14.41 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.456 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 1.1 t80 -65.9 -169.72 0.07 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.354 0.597 . . . . 0.0 111.329 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 m -62.78 159.91 15.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -61.02 -17.95 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.39 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 mp -52.34 -37.02 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.215 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 m -80.02 -27.55 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.596 0.712 . . . . 0.0 109.805 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.601 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.5 m -83.29 -28.24 29.26 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.109 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.622 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.0 -32.38 72.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.708 0.29 . . . . 0.0 111.482 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.54 -37.44 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.499 171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 37.5 mtmt -61.97 -43.59 98.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 110.852 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 19' ' ' THR . 7.9 p -72.65 -35.57 50.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.111 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.8 -7.89 54.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.847 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.31 10.66 6.7 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.767 1.227 . . . . 0.0 112.772 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 66' ' ' ARG . 9.5 mp -85.9 9.13 17.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.976 -0.452 . . . . 0.0 112.111 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.1 t -58.14 -36.53 57.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.005 0.431 . . . . 0.0 109.932 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.54 -21.25 28.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.659 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.06 -52.41 8.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.71 0.291 . . . . 0.0 111.759 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 26.3 mt -57.71 -15.35 7.61 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.735 ' NE2' HG13 ' A' ' 5' ' ' VAL . 40.7 mm-40 -65.54 -13.17 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.237 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.9 m -56.02 112.95 4.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 123.469 0.48 . . . . 0.0 111.726 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.72 -9.36 13.33 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.015 2.477 . . . . 0.0 113.043 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.72 -145.13 0.15 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.797 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 76' ' ' ALA . 2.1 Cg_endo -78.32 169.02 20.75 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB3' HG21 ' A' ' 72' ' ' VAL . 35.6 m-85 -139.65 121.33 15.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.304 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.7 m -108.33 115.58 30.38 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.284 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.47 124.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.784 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.686 ' HD1' ' NE2' ' A' ' 124' ' ' HIS . 38.1 m-85 -84.01 110.43 18.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -96.47 122.19 58.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.572 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' HG22 ' A' ' 129' ' ' VAL . 69.8 Cg_endo -76.69 126.77 9.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.159 1.906 . . . . 0.0 112.274 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.891 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -74.88 178.44 5.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.42 177.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -57.21 -36.71 71.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 26.4 t70 -79.65 -19.83 48.16 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.647 0.736 . . . . 0.0 109.053 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -81.79 -37.9 26.42 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.296 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -62.28 -20.66 64.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.979 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.16 -8.7 58.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.58 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 26.1 mmmt -89.98 -24.14 21.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.506 0.67 . . . . 0.0 109.45 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 38.2 mt -47.7 -48.66 59.39 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.51 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 19.6 Cg_endo -64.02 -10.49 23.26 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.139 1.893 . . . . 0.0 112.889 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -90.07 -14.68 33.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.404 0.621 . . . . 0.0 110.144 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.72 55.72 2.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.777 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 129' ' ' VAL . 88.8 m -67.45 -56.98 7.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.423 0.612 . . . . 0.0 110.442 175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.631 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.2 mp -58.02 -24.99 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.229 -176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.684 ' O ' HG12 ' A' ' 58' ' ' VAL . 86.8 m -59.23 -35.26 73.33 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -82.74 -24.91 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.991 0.901 . . . . 0.0 109.291 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD23 HE22 ' A' ' 63' ' ' GLN . 8.8 mp -75.27 -25.62 58.14 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 55' ' ' THR . 7.3 p -78.3 -29.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.2 mm-40 -71.4 -26.6 62.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.477 1.132 . . . . 0.0 108.668 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.45 167.77 31.65 Favored Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.532 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 63' ' ' GLN . 38.4 Cg_exo -38.88 168.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.369 3.379 . . . . 0.0 114.734 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 39.5 Cg_exo -39.08 -8.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.675 1 C-N-CA 126.547 4.832 . . . . 0.0 118.06 -173.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.656 HE22 HD23 ' A' ' 57' ' ' LEU . 10.1 tt0 -42.2 -17.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.661 ' HA ' HD12 ' A' ' 67' ' ' ILE . 16.2 tp -47.51 -51.6 20.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.403 0.281 . . . . 0.0 111.399 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.414 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -54.62 -32.81 54.13 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.973 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.25 -50.57 45.89 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 109.573 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 64' ' ' LEU . 57.4 mt -46.92 -51.71 4.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.428 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -51.33 -61.55 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -171.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -81.76 -63.06 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -165.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.502 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 64.8 m-85 -124.39 -2.77 7.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 68.5 m80 59.63 34.21 22.18 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 70' ' ' TYR . 7.4 p -113.59 156.41 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -162.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.554 HG13 ' HB ' ' A' ' 37' ' ' THR . 1.6 p -125.14 126.66 71.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.865 168.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.3 140.91 58.74 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 120.945 0.402 . . . . 0.0 110.609 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.41 97.26 2.32 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.001 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -60.87 108.4 0.85 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.443 0.64 . . . . 0.0 111.538 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.01 132.34 55.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.129 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.73 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -88.86 165.42 14.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.9 58.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.255 0.55 . . . . 0.0 110.974 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 13.3 t -72.25 -26.08 61.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.585 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.35 -48.67 16.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -57.07 -51.26 70.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.605 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.419 ' HA ' HG21 ' A' ' 98' ' ' ILE . 6.9 ttpm? -65.68 -35.39 80.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.033 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -51.75 -44.32 63.26 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.732 0.777 . . . . 0.0 110.326 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -73.29 -39.04 65.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.257 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.79 7.11 88.92 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.472 -175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.58 HG13 ' HA ' ' A' ' 97' ' ' PRO . 6.8 tt -163.27 159.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.657 HG12 HD12 ' A' ' 82' ' ' LEU . 8.5 m -130.17 138.0 55.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.189 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.494 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.7 m -114.29 133.2 55.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.092 0.473 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.646 ' HB2' ' OE2' ' A' ' 92' ' ' GLU . 58.3 m -85.41 178.27 7.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.479 -174.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 74' ' ' ALA . 1.7 tp -56.0 -39.35 71.75 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.728 ' OE1' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -84.42 -16.67 41.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.421 -179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.423 ' HA2' HG22 ' A' ' 89' ' ' THR . . . 113.15 22.22 5.65 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.114 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.728 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 5.5 p -86.86 120.56 28.27 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 117.714 0.757 . . . . 0.0 110.541 -177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -93.08 138.32 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.0 mp -130.88 125.99 21.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.715 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' A' ' 87' ' ' ILE . 7.1 Cg_exo -68.76 133.79 28.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.192 1.928 . . . . 0.0 113.362 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.468 ' CG1' HG13 ' A' ' 88' ' ' VAL . 41.0 mm -98.95 136.03 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.317 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.53 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 18.0 m-70 -120.86 177.62 5.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.056 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.04 107.97 0.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.443 -1.36 . . . . 0.0 113.428 175.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -104.57 -41.09 5.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 109.908 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.9 t-20 -127.12 -63.98 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.186 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 40.4 Cg_endo -84.9 174.19 7.6 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.018 1.812 . . . . 0.0 110.74 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 111' ' ' VAL . 14.8 tp -73.86 152.21 40.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 3.6 mm-40 -137.58 122.6 19.06 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.615 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -128.74 123.77 59.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.108 -175.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 11.2 ptmm? 46.9 -132.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.671 0.607 . . . . 0.0 110.768 -176.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -88.27 25.67 1.58 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 0.0 110.473 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.87 163.1 22.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.759 -175.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 81.0 m -127.88 140.89 51.74 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.746 HG21 HD23 ' A' ' 104' ' ' LEU . 38.4 t -84.5 125.51 40.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.43 0.633 . . . . 0.0 112.394 -177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.2 -36.45 16.79 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.293 175.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.25 111.56 2.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.505 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -135.82 -174.21 3.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 19.3 t70 69.84 25.8 4.92 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 9.8 mt -90.79 105.92 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.801 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.774 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.1 108.54 3.15 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 122.284 1.04 . . . . 0.0 112.485 177.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -83.67 -177.54 6.74 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.591 -175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -43.98 -51.38 7.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.647 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.17 -13.61 9.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.878 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.44 -109.79 0.42 Allowed Glycine 0 CA--C 1.501 -0.825 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.356 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 117' ' ' GLU . 10.4 mm -145.62 144.19 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.558 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB2' ' A' ' 118' ' ' ALA . 29.3 mt -113.61 150.91 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.453 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.686 ' NE2' ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -148.11 115.17 6.14 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 122.12 0.962 . . . . 0.0 111.767 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 40.7 t -82.3 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.181 -174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -122.75 160.32 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.313 1.054 . . . . 0.0 111.029 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.891 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 28.8 t70 -93.98 1.61 56.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.534 -169.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.597 ' O ' HG13 ' A' ' 126' ' ' ILE . 4.6 m -159.36 131.05 6.29 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.22 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.505 ' O ' HG21 ' A' ' 53' ' ' THR . 77.0 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.751 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.61 0.243 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.87 108.75 16.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.869 0.366 . . . . 0.0 110.153 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.482 HG22 HG12 ' A' ' 5' ' ' VAL . 46.5 m -60.77 150.57 32.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.976 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.7 -21.83 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.753 HG13 ' NE2' ' A' ' 31' ' ' GLN . 1.4 p -91.42 -34.32 6.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 110.28 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' CA ' HE22 ' A' ' 31' ' ' GLN . 15.5 t70 -55.3 -48.43 74.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.831 0.824 . . . . 0.0 109.751 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 24.2 mt -55.05 -21.46 8.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.657 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.0 76.07 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.863 -0.523 . . . . 0.0 110.583 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.7 t -79.15 -15.38 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.453 0.644 . . . . 0.0 110.421 174.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 64.6 t30 -94.06 -24.5 17.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.163 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.1 p -60.55 130.34 90.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 3.8 Cg_exo -79.1 64.53 8.84 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.966 2.444 . . . . 0.0 112.506 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.56 45.36 7.38 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.594 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.606 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.6 OUTLIER -66.16 -175.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 175.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -58.31 154.34 13.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.316 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -57.94 -18.86 26.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.69 -32.77 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.98 -28.84 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.398 0.618 . . . . 0.0 109.623 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.63 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.7 m -82.46 -27.72 31.7 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.79 -37.52 84.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -36.46 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.004 -0.435 . . . . 0.0 110.513 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 39.1 mtmt -62.08 -43.24 99.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.299 0.571 . . . . 0.0 111.027 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 19' ' ' THR . 8.6 p -74.69 -34.13 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.23 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -75.31 -8.04 55.58 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.913 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 73.03 10.45 5.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.362 1.065 . . . . 0.0 112.976 177.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 66' ' ' ARG . 8.3 mp -85.83 6.9 26.05 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.99 -0.443 . . . . 0.0 112.038 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG21 ' HG2' ' A' ' 22' ' ' LYS . 1.1 t -57.22 -36.56 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.988 0.423 . . . . 0.0 110.455 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 4.0 pt-20 -86.21 -18.81 31.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.973 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.95 -54.92 5.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.694 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 25.5 mt -56.37 -13.9 2.56 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.753 ' NE2' HG13 ' A' ' 5' ' ' VAL . 42.8 mm-40 -64.39 -10.39 24.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.044 0.537 . . . . 0.0 112.215 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -61.62 110.77 3.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 111.346 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.48 -15.58 9.81 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.139 2.559 . . . . 0.0 113.593 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.68 -138.43 0.22 Allowed Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.917 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.483 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 23.9 Cg_endo -74.85 165.37 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.223 1.949 . . . . 0.0 113.643 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.789 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.22 125.66 28.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.803 -170.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 38.1 m -124.6 119.79 30.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.567 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.668 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -118.0 152.1 20.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -108.95 106.94 17.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -99.23 112.22 62.73 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.24 130.61 13.19 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.407 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.779 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.6 p30 -81.55 -174.43 4.96 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.829 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -59.77 -30.0 68.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.654 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 15.4 t70 -81.84 -19.63 40.65 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.016 0.912 . . . . 0.0 109.17 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . . . -78.75 -40.33 33.64 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.047 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -64.3 -24.71 67.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.237 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.63 -21.17 38.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.235 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -61.39 -43.77 98.3 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.423 173.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.473 ' CD2' HG11 ' A' ' 129' ' ' VAL . 97.0 mt -40.46 103.63 0.3 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 O-C-N 125.707 1.88 . . . . 0.0 112.542 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.09 -80.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.992 3.128 . . . . 0.0 111.493 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -122.01 27.65 7.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . 89.52 101.49 1.07 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.216 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.799 ' HB ' HG12 ' A' ' 129' ' ' VAL . 61.6 m -59.51 -48.6 81.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.617 0.722 . . . . 0.0 109.875 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -57.82 -24.43 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.662 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.688 ' O ' HG12 ' A' ' 58' ' ' VAL . 88.1 m -64.62 -34.13 77.55 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.367 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -81.81 -24.63 35.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.792 0.806 . . . . 0.0 109.101 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 7.6 mp -71.19 -31.29 67.45 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.993 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 55' ' ' THR . 9.8 p -73.72 -31.49 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.089 0.471 . . . . 0.0 109.731 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.9 mm-40 -73.0 -30.43 63.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.784 1.278 . . . . 0.0 108.325 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 1.6 m-80 -76.52 169.6 20.23 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.901 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 26.2 Cg_exo -37.31 168.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 124.439 3.426 . . . . 0.0 115.191 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 43.3 Cg_exo -40.03 -11.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 1 C-N-CA 126.537 4.825 . . . . 0.0 118.905 -168.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.679 ' HA ' ' OE2' ' A' ' 92' ' ' GLU . 32.6 tt0 -43.79 -25.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 68' ' ' LEU . 12.7 tp -46.98 -48.67 21.59 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.585 0.354 . . . . 0.0 111.905 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' C ' HD22 ' A' ' 26' ' ' LEU . . . -49.64 -40.34 32.43 Favored Glycine 0 N--CA 1.458 0.14 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.829 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.697 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.61 -37.54 59.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.85 0.357 . . . . 0.0 110.049 -177.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 64' ' ' LEU . 55.6 mt -57.06 -45.19 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.717 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -48.93 -59.1 3.88 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.739 0.649 . . . . 0.0 112.673 -176.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -83.8 -64.46 1.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.527 -169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' A' ' 71' ' ' HIS . 2.8 m-85 -125.98 -13.25 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 70' ' ' TYR . 11.1 t-80 68.09 40.44 2.22 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -175.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.789 HG21 ' CD2' ' A' ' 36' ' ' PHE . 13.2 p -121.55 159.77 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.444 -165.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 72' ' ' VAL . 1.9 p -128.72 128.53 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.15 170.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' HD13 ' A' ' 91' ' ' LEU . . . -68.23 140.72 56.06 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.318 0.58 . . . . 0.0 110.854 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 113.36 97.96 2.3 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.755 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.12 101.24 0.09 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 122.909 0.483 . . . . 0.0 111.86 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.436 ' CB ' HD11 ' A' ' 82' ' ' LEU . 2.7 m-85 -119.03 117.54 29.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.166 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.706 ' O ' HD22 ' A' ' 82' ' ' LEU . 26.9 mtpt -75.31 163.52 27.39 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.006 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.42 59.06 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.012 0.434 . . . . 0.0 110.714 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 10.0 t -71.29 -27.85 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.071 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -78.68 -49.07 13.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.323 0.582 . . . . 0.0 109.456 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.706 HD22 ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -55.41 -52.48 63.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.166 178.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.53 -33.9 75.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.407 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 80' ' ' THR . 1.1 ttt180 -54.51 -40.6 68.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.546 0.689 . . . . 0.0 110.077 176.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 79.6 mtp -80.21 -41.6 24.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.04 10.65 78.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.726 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.571 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.1 tt -162.64 156.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.694 HG12 HD12 ' A' ' 82' ' ' LEU . 13.3 m -131.1 139.13 51.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -107.3 128.02 54.07 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.648 0.737 . . . . 0.0 110.839 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.597 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 60.6 m -72.6 166.11 23.38 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.502 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 74' ' ' ALA . 5.0 tp -56.98 -36.18 70.05 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-O 121.946 0.879 . . . . 0.0 109.642 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.679 ' OE2' ' HA ' ' A' ' 63' ' ' GLN . 3.6 pm0 -76.65 -12.31 59.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.86 6.48 57.08 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.602 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 90' ' ' SER . 57.5 m -77.85 119.96 22.07 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.98 133.78 33.9 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 176.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.551 ' HB ' HG23 ' A' ' 88' ' ' VAL . 1.6 mp -122.23 127.05 26.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.571 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.2 Cg_exo -72.7 130.43 15.83 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.709 1.606 . . . . 0.0 112.852 -176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HG13 ' A' ' 88' ' ' VAL . 35.9 mm -94.53 134.34 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 68.8 m-70 -123.84 -179.27 4.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.738 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.87 97.04 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.998 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.07 -53.25 4.56 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.555 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 21.9 t-20 -118.0 -56.02 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 23.9 Cg_endo -90.7 174.13 2.89 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.613 2.209 . . . . 0.0 110.795 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 111' ' ' VAL . 13.0 tp -74.12 152.38 39.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 39.4 mt-10 -136.85 109.64 7.57 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 109.478 -175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.49 106.73 20.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -176.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 106' ' ' VAL . 2.5 ptpt 43.49 -106.99 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 112.638 -170.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -89.26 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.622 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HA ' ' HB ' ' A' ' 128' ' ' THR . . . -108.55 166.04 11.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.454 0.645 . . . . 0.0 112.729 -172.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.7 m -129.15 133.57 47.67 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.555 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG21 HD23 ' A' ' 104' ' ' LEU . 17.4 t -85.33 131.05 35.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.641 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.835 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.9 mp -88.99 -46.79 8.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.201 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -146.77 118.76 8.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.791 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -136.61 -174.7 3.78 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 27.5 m-20 67.74 27.09 7.63 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.6 mt -87.06 116.2 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.386 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.696 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.35 108.61 2.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.959 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -82.85 -177.7 6.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.777 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 1.1 pt-20 -47.53 -53.51 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.567 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 46.5 m-80 -119.08 -9.36 10.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.4 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -152.32 -112.68 0.53 Allowed Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.279 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' A' ' 117' ' ' GLU . 32.1 mm -143.03 148.0 19.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.329 0.585 . . . . 0.0 111.328 -171.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.959 HG13 ' HB2' ' A' ' 118' ' ' ALA . 96.7 mt -119.18 147.7 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -137.57 118.75 14.51 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 85.1 t -83.12 128.04 39.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.04 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.459 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -120.97 162.26 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.85 0.833 . . . . 0.0 110.479 -179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.835 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.1 t70 -107.79 16.53 23.5 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.345 -170.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.619 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 73.2 m -156.79 130.56 8.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.087 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.799 HG12 ' HB ' ' A' ' 53' ' ' THR . 43.3 t . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.518 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.848 0.356 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.99 110.71 20.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.585 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 HG12 ' A' ' 5' ' ' VAL . 41.3 m -59.43 149.8 28.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.065 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.2 mp -44.13 -47.55 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.501 0.667 . . . . 0.0 111.08 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.742 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.3 p -71.89 -36.06 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.688 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.526 ' CA ' HE22 ' A' ' 31' ' ' GLN . 16.0 t70 -54.84 -46.36 74.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.939 0.875 . . . . 0.0 109.673 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.575 ' HA ' ' CB ' ' A' ' 10' ' ' ASN . 18.5 mt -56.8 -21.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.211 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . . . -61.39 -32.94 72.88 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.751 -0.593 . . . . 0.0 110.415 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.21 -34.85 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.381 0.61 . . . . 0.0 109.999 172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.575 ' CB ' ' HA ' ' A' ' 7' ' ' ILE . 17.5 t-20 -66.29 -25.22 66.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.529 -177.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 3.2 p -62.45 138.48 96.46 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.043 -175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 4.7 Cg_exo -80.61 62.27 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.601 2.201 . . . . 0.0 112.315 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.08 46.84 20.51 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.998 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.73 -168.66 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.553 0.692 . . . . 0.0 112.423 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' HG22 ' A' ' 18' ' ' VAL . 4.6 m -58.57 158.94 7.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.856 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 m -60.49 -17.99 48.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.157 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.3 mt -52.6 -35.27 53.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.43 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 8' ' ' ALA . 3.9 m -80.92 -28.45 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 121.686 0.755 . . . . 0.0 109.967 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.578 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -79.79 -29.05 40.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.142 -177.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -62.83 -35.66 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.818 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 -36.28 20.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.11 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 27.2 mtmt -61.5 -43.86 98.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.299 0.571 . . . . 0.0 110.982 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 19' ' ' THR . 8.3 p -73.52 -35.93 46.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.98 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.578 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.04 -4.19 33.95 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.656 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.15 9.68 7.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.272 1.029 . . . . 0.0 112.842 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.2 mp -87.25 7.34 28.91 Favored 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 121.91 -0.494 . . . . 0.0 111.805 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG21 ' HG2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -59.41 -36.98 67.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.197 0.522 . . . . 0.0 109.792 176.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 6.1 pt-20 -85.85 -21.82 27.88 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.626 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.89 -54.89 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 19.8 mt -58.54 -9.81 1.86 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.742 ' NE2' HG13 ' A' ' 5' ' ' VAL . 39.7 mm-40 -70.98 4.64 2.49 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.826 0.45 . . . . 0.0 112.054 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 5.2 p -48.02 112.55 2.26 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 123.98 0.8 . . . . 0.0 112.412 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 32' ' ' SER . 4.5 Cg_exo -80.98 -12.57 11.9 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.24 2.627 . . . . 0.0 111.254 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.79 -135.11 1.91 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.147 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 17.7 Cg_endo -84.3 170.94 10.41 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.917 2.412 . . . . 0.0 113.174 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.702 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -139.08 122.96 17.72 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.702 HG21 ' CG ' ' A' ' 77' ' ' TYR . 0.4 OUTLIER -126.83 119.88 27.9 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.526 -174.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 123' ' ' ILE . 7.4 p -117.42 145.03 23.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.245 0.545 . . . . 0.0 111.261 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.663 ' HD1' ' CE1' ' A' ' 124' ' ' HIS . 55.3 m-85 -93.06 109.25 20.72 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 169.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -91.35 111.86 51.08 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 120.673 0.273 . . . . 0.0 111.318 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.41 128.33 8.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.099 1.866 . . . . 0.0 111.739 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.849 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 2.2 p30 -80.91 -175.41 5.35 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.994 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -54.74 -32.0 59.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 11.4 t70 -83.22 -23.89 32.6 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.698 0.761 . . . . 0.0 109.185 -174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -80.44 -34.57 35.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.621 177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -61.49 -22.94 65.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.875 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.52 -9.0 58.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.686 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.651 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 27.7 mmmt -91.09 -25.99 19.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.795 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' CD2' HG21 ' A' ' 129' ' ' VAL . 38.9 mt -46.09 -48.41 42.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.825 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 18.2 Cg_endo -63.25 -21.12 71.93 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.901 1.734 . . . . 0.0 112.859 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.53 -35.17 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.367 0.603 . . . . 0.0 110.081 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.18 56.92 1.09 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.222 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.501 HG21 ' O ' ' A' ' 129' ' ' VAL . 97.6 m -68.31 -57.75 5.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.486 0.66 . . . . 0.0 109.993 174.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 57' ' ' LEU . 1.1 mp -58.91 -24.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.701 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 58' ' ' VAL . 63.0 m -55.36 -37.37 67.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.732 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -81.8 -27.24 33.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.91 0.862 . . . . 0.0 109.369 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 54' ' ' ILE . 10.1 mp -73.11 -25.17 60.76 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.838 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -79.14 -29.21 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 121.172 0.511 . . . . 0.0 109.865 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 55' ' ' THR . 27.5 mm-40 -71.79 -27.27 62.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 122.575 1.179 . . . . 0.0 108.706 177.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.58 166.69 37.17 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.057 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 30.5 Cg_exo -39.21 168.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.306 3.338 . . . . 0.0 114.641 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 21.6 Cg_exo -34.73 -10.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 1 C-N-CA 127.345 5.364 . . . . 0.0 119.393 -172.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.735 HE22 HD23 ' A' ' 57' ' ' LEU . 1.7 tt0 -42.34 -24.93 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 ' O ' HD22 ' A' ' 68' ' ' LEU . 11.5 tp -44.56 -49.02 10.31 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.378 0.671 . . . . 0.0 112.477 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.97 -31.73 33.06 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.843 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.595 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 0.0 110.02 -178.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.696 HD13 HG13 ' A' ' 54' ' ' ILE . 36.0 mt -68.64 -46.97 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.362 -169.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -50.15 -59.37 3.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -174.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.79 -62.45 1.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -168.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.39 -13.78 7.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.7 t60 65.83 36.26 6.21 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -173.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.4 p -109.82 160.44 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.57 -166.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.53 ' HB ' HH21 ' A' ' 66' ' ' ARG . 0.8 OUTLIER -136.63 131.39 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -70.2 138.84 52.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 120.69 88.39 1.04 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.308 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -56.22 98.53 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.148 0.579 . . . . 0.0 112.124 -171.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 1.002 ' CG ' HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -95.66 147.72 23.3 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.042 179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.668 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -110.73 152.75 26.21 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.37 -30.49 12.42 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 0.0 112.061 -169.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 12.2 t -75.42 -25.0 57.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.858 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.79 -51.61 18.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.857 0.836 . . . . 0.0 109.386 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.002 HD21 ' CG ' ' A' ' 77' ' ' TYR . 0.3 OUTLIER -57.72 -50.72 72.27 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.703 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -66.96 -33.0 74.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.741 0.305 . . . . 0.0 111.328 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -55.0 -40.95 70.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.432 0.634 . . . . 0.0 110.274 173.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.8 mtt -78.44 -41.82 31.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.716 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.85 10.71 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.907 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.1 tt -163.83 157.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 95' ' ' THR . 15.1 m -131.59 141.7 45.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.772 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.8 m -108.93 133.55 52.78 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.221 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 94' ' ' SER . 26.3 t -66.14 164.88 14.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.908 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.2 tp -56.89 -33.59 67.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.558 0.694 . . . . 0.0 109.78 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -79.37 -27.24 41.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.749 -177.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.21 3.27 11.88 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.893 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.531 ' H ' ' HB3' ' A' ' 90' ' ' SER . 1.8 m -78.34 120.44 23.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.788 0.794 . . . . 0.0 111.564 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -85.03 141.72 30.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.8 mp -127.28 127.27 24.26 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.645 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' HG13 ' A' ' 87' ' ' ILE . 3.2 Cg_exo -72.59 130.06 15.47 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.021 1.814 . . . . 0.0 113.35 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.564 ' CG1' HG13 ' A' ' 88' ' ' VAL . 42.1 mm -98.89 141.69 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.344 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.433 ' C ' ' HB2' ' A' ' 105' ' ' GLU . 31.1 m80 -134.92 178.8 6.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.543 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 168.58 110.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.612 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -86.27 -48.1 8.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 8.1 t30 -128.13 -55.69 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.138 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 15.9 Cg_endo -90.47 173.71 3.12 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.264 1.976 . . . . 0.0 110.8 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 111' ' ' VAL . 14.5 tp -74.48 153.99 38.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' C ' ' A' ' 99' ' ' HIS . 4.3 mm-40 -138.65 119.29 14.01 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.612 -174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.513 HG11 ' NE2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -119.39 106.01 18.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.301 -173.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.672 ' HB3' HG23 ' A' ' 96' ' ' ILE . 20.8 pttp 49.83 -78.75 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.536 1.535 . . . . 0.0 113.812 -175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.481 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 30.3 p-10 -125.29 1.19 7.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.526 0.679 . . . . 0.0 109.344 -172.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -117.6 165.31 13.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.431 -173.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -125.46 136.21 53.14 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.874 HG21 HD23 ' A' ' 104' ' ' LEU . 99.0 t -83.18 127.47 39.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.234 -174.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.3 mp -93.25 -32.87 14.18 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.865 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -162.99 116.53 1.64 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.434 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' ASP . . . -134.79 -175.77 4.01 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 29.7 t70 68.11 25.65 7.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -169.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 12.5 mt -85.06 109.09 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.114 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.554 ' HA ' HD13 ' A' ' 122' ' ' ILE . 35.8 mt-10 -67.56 106.92 2.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.471 0.653 . . . . 0.0 111.14 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.808 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -80.27 -175.17 4.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.399 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.09 -52.26 45.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.429 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.7 m-20 -117.78 -12.78 10.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -149.13 -111.45 0.59 Allowed Glycine 0 CA--C 1.495 -1.162 0 C-N-CA 119.565 -1.302 . . . . 0.0 112.79 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.668 HG13 ' HE3' ' A' ' 78' ' ' LYS . 7.6 mm -145.31 149.14 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.539 0.685 . . . . 0.0 111.676 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.808 HG13 ' HB2' ' A' ' 118' ' ' ALA . 87.9 mt -114.4 151.17 16.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.462 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.713 ' NE2' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -148.15 112.91 5.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 122.055 0.931 . . . . 0.0 112.178 -178.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 46.1 t -80.08 130.09 36.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.635 -174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.66 163.34 25.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.672 0.749 . . . . 0.0 110.123 176.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.849 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 34.7 t70 -106.32 14.71 27.07 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.017 -174.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.651 ' HA ' ' HG3' ' A' ' 48' ' ' LYS . 15.9 m -164.26 131.0 3.12 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.248 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.501 ' O ' HG21 ' A' ' 53' ' ' THR . 54.6 t . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.648 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.56 0.219 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.46 122.17 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.577 HG22 HG12 ' A' ' 5' ' ' VAL . 57.3 m -63.68 148.7 48.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.4 172.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.3 pp -54.61 -20.9 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.699 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.6 p -92.39 -37.32 8.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.175 0.512 . . . . 0.0 111.003 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.581 ' HA ' HE22 ' A' ' 31' ' ' GLN . 13.9 t70 -50.05 -48.91 52.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.586 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 7.5 mt -59.48 -22.14 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.932 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.52 77.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 111.314 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.67 -26.6 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 110.259 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 47.6 t30 -77.28 -25.27 51.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.365 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 7' ' ' ILE . 12.6 p -65.89 138.9 96.58 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 59.12 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.516 2.811 . . . . 0.0 112.399 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.87 44.1 10.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.881 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -66.09 -178.31 0.6 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.9 m -55.43 158.34 3.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.985 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -58.37 -18.38 27.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.514 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -53.36 -35.94 60.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.112 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.26 -30.8 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-O 121.592 0.711 . . . . 0.0 110.064 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -80.82 -29.74 35.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.472 -173.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -64.66 -33.53 76.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.18 -37.43 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.3 0.571 . . . . 0.0 109.886 171.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 7.6 mtmt -61.52 -39.9 92.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.428 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' THR . 7.4 p -77.11 -36.18 24.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.393 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -73.84 -6.69 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.026 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER 72.64 10.99 5.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.181 0.992 . . . . 0.0 112.276 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 66' ' ' ARG . 7.8 mp -87.23 7.03 30.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.714 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -36.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.19 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 3.8 pt-20 -85.38 -21.62 28.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.829 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -75.75 -53.75 8.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 20.1 mt -61.74 -5.65 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.299 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.699 ' NE2' HG13 ' A' ' 5' ' ' VAL . 41.7 mm-40 -74.29 10.44 1.27 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.497 -175.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 m -92.85 95.27 1.05 Allowed Pre-proline 0 C--N 1.316 -0.863 0 CA-C-O 120.944 0.402 . . . . 0.0 110.01 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 31' ' ' GLN . 53.8 Cg_endo -80.53 -8.01 13.7 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.072 2.515 . . . . 0.0 113.5 -173.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -124.07 0.02 OUTLIER Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.881 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.464 ' CB ' ' HB2' ' A' ' 76' ' ' ALA . 37.9 Cg_endo -78.99 154.26 25.66 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.28 1.32 . . . . 0.0 112.597 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.657 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -138.69 121.67 16.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.128 -168.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 51.4 m -119.63 124.23 45.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.271 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' HG12 ' A' ' 123' ' ' ILE . 98.5 t -122.02 140.97 44.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.236 0.541 . . . . 0.0 111.949 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -99.49 115.3 29.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -105.65 117.98 56.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.167 -173.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.32 125.13 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.995 1.797 . . . . 0.0 111.582 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.768 HD22 ' HA ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -78.7 173.27 12.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 -178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.24 -46.01 8.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.609 0.719 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.9 -20.79 61.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.776 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -78.8 -38.59 37.97 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.314 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -62.82 -26.02 68.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.026 0.917 . . . . 0.0 109.02 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.94 -22.57 39.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.209 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 128' ' ' THR . 26.9 mmmt -62.46 -46.6 87.79 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.948 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 129' ' ' VAL . 95.3 mt -33.64 101.8 0.2 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 O-C-N 125.879 1.987 . . . . 0.0 113.576 -166.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' A' ' 51' ' ' ASP . 72.7 Cg_endo -84.1 -141.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 124.87 3.713 . . . . 0.0 110.796 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 50' ' ' PRO . 6.8 m-20 -56.19 -32.91 64.79 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 171.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.55 105.72 0.47 Allowed Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.591 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.648 ' HB ' HG12 ' A' ' 129' ' ' VAL . 58.3 m -56.89 -54.35 47.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 172.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 mp -63.76 -25.57 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.648 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.742 ' O ' HG12 ' A' ' 58' ' ' VAL . 90.9 m -66.74 -35.64 80.58 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.764 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -79.3 -27.24 42.18 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.868 0.842 . . . . 0.0 109.262 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 8.3 mp -76.21 -25.71 55.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.43 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 55' ' ' THR . 9.0 p -75.28 -28.05 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 55' ' ' THR . 26.3 mm-40 -73.55 -27.14 61.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.64 1.21 . . . . 0.0 108.771 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 5.3 m-80 -84.44 168.37 21.7 Favored Pre-proline 0 N--CA 1.435 -1.197 0 CA-C-N 112.982 -1.917 . . . . 0.0 111.038 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 28.8 Cg_exo -38.3 168.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.482 0 C-N-CA 124.543 3.495 . . . . 0.0 115.197 177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 15.3 Cg_exo -34.08 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.896 1 C-N-CA 127.824 5.683 . . . . 0.0 120.551 -166.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.602 ' O ' HG13 ' A' ' 67' ' ' ILE . 1.2 tt0 -43.89 -28.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.664 ' O ' HD22 ' A' ' 68' ' ' LEU . 16.5 tp -44.83 -51.1 9.86 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.223 0.609 . . . . 0.0 112.305 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -51.72 -34.73 37.02 Favored Glycine 0 N--CA 1.461 0.307 0 O-C-N 123.599 0.562 . . . . 0.0 113.321 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.596 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.71 -40.11 61.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.434 0.635 . . . . 0.0 110.026 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.1 mt -62.51 -47.52 92.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.828 -174.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -45.64 -62.35 1.33 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.949 0.781 . . . . 0.0 112.822 -173.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -88.96 -61.94 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -122.13 -12.81 8.26 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -170.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 59.9 38.01 21.33 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.5 p -106.7 159.39 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.586 -165.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 37' ' ' THR . 2.1 p -132.99 125.57 52.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.556 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.562 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -67.36 141.96 56.93 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.346 0.593 . . . . 0.0 110.712 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.78 100.16 2.23 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.392 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -61.32 102.26 0.22 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.244 0.545 . . . . 0.0 111.834 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 82' ' ' LEU . 3.2 m-85 -120.71 122.4 40.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.135 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.603 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -79.08 159.34 27.57 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 170.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -48.99 -36.78 18.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.45 0.469 . . . . 0.0 110.633 -172.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 6.5 t -72.36 -23.99 61.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.287 -172.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -72.38 -40.17 67.48 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.654 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.08 -48.87 78.28 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.421 175.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.704 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.8 mtpt -66.53 -29.42 69.5 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 122.946 0.498 . . . . 0.0 112.218 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -58.12 -32.47 68.15 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 122.021 0.915 . . . . 0.0 109.299 173.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.1 mtp -87.1 -42.5 12.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.464 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' HB ' ' A' ' 98' ' ' ILE . . . 80.96 12.01 83.13 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.61 -172.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.9 tt -163.22 159.14 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG12 HD12 ' A' ' 82' ' ' LEU . 9.4 m -133.21 139.28 49.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.666 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 73' ' ' VAL . 4.3 m -107.37 129.81 54.87 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.505 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 21.4 t -71.44 165.83 22.99 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.498 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.3 tp -56.74 -30.15 63.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.787 0.803 . . . . 0.0 109.894 173.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 8.0 pt-20 -78.37 -22.96 47.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.48 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.13 11.76 27.1 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.34 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 90' ' ' SER . 73.4 m -88.83 122.29 32.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 122.44 -0.447 . . . . 0.0 111.99 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -85.3 137.71 32.79 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.3 mp -128.05 130.08 23.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.509 177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.584 ' HA ' HG13 ' A' ' 87' ' ' ILE . 2.7 Cg_exo -72.57 134.91 23.13 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.023 1.815 . . . . 0.0 113.328 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 82' ' ' LEU . 37.4 mm -98.61 135.31 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.743 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 53.2 m80 -127.88 -178.81 4.65 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.682 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.75 100.3 0.16 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.094 -1.051 . . . . 0.0 113.204 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.91 -35.36 26.16 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 26.5 t-20 -144.2 -55.83 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.185 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 42.2 Cg_endo -85.72 174.04 6.88 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.163 1.909 . . . . 0.0 110.623 171.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.704 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 16.1 tp -72.89 151.02 42.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 43.5 mt-10 -140.99 106.33 5.04 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.571 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -109.12 132.28 57.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.033 -173.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HG2' HG22 ' A' ' 106' ' ' VAL . 12.2 ptmm? 55.36 -82.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.646 1.179 . . . . 0.0 112.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.504 ' H ' ' HG3' ' A' ' 107' ' ' LYS . 22.8 p-10 -146.04 23.03 1.37 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.642 ' CB ' ' HB ' ' A' ' 128' ' ' THR . . . -125.86 162.99 23.89 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.252 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 4.8 m -122.33 131.24 53.81 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 t -78.58 127.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.399 0.619 . . . . 0.0 111.695 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.03 -39.0 13.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.222 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -153.07 118.35 5.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.72 -174.23 3.72 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 78' ' ' LYS . 10.5 m-20 66.26 27.15 10.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -173.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -85.0 114.16 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.5 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.1 mt-10 -66.24 108.83 2.43 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.389 0.614 . . . . 0.0 110.61 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.508 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.26 -172.75 3.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.705 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 3.2 pt-20 -53.26 -51.49 62.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 119' ' ' GLU . 80.7 m-20 -120.12 -10.75 9.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.3 -118.23 1.17 Allowed Glycine 0 CA--C 1.502 -0.774 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.229 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 117' ' ' GLU . 19.3 mm -146.18 146.66 18.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.349 0.595 . . . . 0.0 111.622 -172.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 118' ' ' ALA . 45.3 mt -118.83 146.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.654 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -133.59 116.4 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 84.4 t -81.17 127.72 39.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.259 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.591 ' HB ' ' HB1' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -125.65 160.51 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.462 0.649 . . . . 0.0 110.724 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 42' ' ' ASN . 0.7 OUTLIER -98.16 9.21 43.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.904 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.642 ' HB ' ' CB ' ' A' ' 109' ' ' ALA . 23.1 m -146.94 129.17 15.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.18 0.514 . . . . 0.0 111.346 -174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' A' ' 53' ' ' THR . 89.0 t . . . . . 0 C--O 1.255 1.385 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.538 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.723 0.297 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.27 117.72 18.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.196 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -67.34 152.36 45.84 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.554 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.7 mp -49.75 -42.14 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.497 0.665 . . . . 0.0 110.481 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.4 p -75.03 -36.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.14 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' HA ' HE22 ' A' ' 31' ' ' GLN . 17.8 t70 -52.14 -48.51 64.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.509 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 15.4 mt -56.88 -22.31 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.153 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.802 -0.561 . . . . 0.0 110.45 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.85 -18.38 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 110.111 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 40.4 t30 -95.95 -25.45 15.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.855 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 4.1 p -59.25 130.38 87.07 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.038 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.24 65.7 7.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.136 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.5 46.77 18.29 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.208 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.62 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -63.73 -174.56 0.1 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.072 0.463 . . . . 0.0 111.516 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -56.74 156.82 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.696 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 m -59.72 -18.17 40.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.322 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 mp -54.12 -34.85 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.408 ' C ' ' HD3' ' A' ' 22' ' ' LYS . 3.5 m -79.93 -39.09 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -68.9 -26.29 65.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.944 -175.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.615 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -66.98 -37.23 83.85 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.88 -37.08 19.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.606 0.717 . . . . 0.0 109.872 172.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 1.8 mtpp -58.52 -41.14 84.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.949 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 19' ' ' THR . 7.1 p -78.16 -36.3 21.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.168 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -72.85 -1.63 17.5 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.049 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.64 7.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.068 0.947 . . . . 0.0 112.552 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 92' ' ' GLU . 9.6 mp -88.84 6.22 40.06 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 122.0 -0.438 . . . . 0.0 111.666 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -37.32 57.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.978 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.2 pt-20 -84.75 -22.16 29.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.812 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -73.25 -54.77 7.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.71 0.29 . . . . 0.0 111.571 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 HD23 ' A' ' 91' ' ' LEU . 25.3 mt -57.09 -14.66 4.11 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.71 ' NE2' HG13 ' A' ' 5' ' ' VAL . 34.2 mm-40 -68.77 -3.31 11.83 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.03 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 p -49.47 115.84 5.3 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.933 0.397 . . . . 0.0 111.474 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.72 -18.26 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.87 2.38 . . . . 0.0 113.147 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 35' ' ' PRO . . . -78.4 -135.9 1.0 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.607 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 75' ' ' GLY . 11.2 Cg_endo -85.78 166.56 10.1 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.027 2.485 . . . . 0.0 113.098 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.403 ' HB3' HG21 ' A' ' 72' ' ' VAL . 60.3 m-85 -133.9 122.05 22.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.7 m -104.03 104.89 14.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.568 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' HB ' HG12 ' A' ' 123' ' ' ILE . 37.2 t -95.59 123.06 47.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.792 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 126' ' ' ILE . 98.4 m-85 -86.56 108.04 18.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 169.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.2 128.82 39.29 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.872 -170.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.606 ' HB3' HG22 ' A' ' 129' ' ' VAL . 98.6 Cg_endo -79.91 126.86 6.68 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.129 1.886 . . . . 0.0 112.55 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.892 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 0.2 OUTLIER -78.52 177.69 8.35 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.4 -32.7 65.06 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 14.2 t70 -83.85 -19.99 33.93 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.972 0.892 . . . . 0.0 108.945 -176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -84.37 -36.31 22.57 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.317 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -57.93 -20.34 36.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.15 0.976 . . . . 0.0 109.054 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -83.93 -9.29 58.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.789 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 27.8 mmmt -93.57 -25.82 17.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.184 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 34.9 mt -50.45 -49.68 76.11 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 37.9 Cg_endo -67.91 81.78 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.134 1.889 . . . . 0.0 112.846 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 49.69 63.19 2.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.705 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.02 -89.07 0.73 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.593 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.0 m -82.86 -53.55 5.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.385 0.612 . . . . 0.0 110.819 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 57' ' ' LEU . 1.4 mp -58.19 -23.72 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.452 -175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 58' ' ' VAL . 85.3 m -57.67 -35.98 71.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.469 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -82.73 -25.35 32.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.839 0.828 . . . . 0.0 109.14 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.75 HD23 HE22 ' A' ' 63' ' ' GLN . 8.6 mp -73.1 -27.3 61.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.81 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 55' ' ' THR . 8.1 p -79.38 -29.32 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.064 0.459 . . . . 0.0 109.764 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 55' ' ' THR . 18.8 mm-40 -70.89 -27.47 63.83 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.699 1.238 . . . . 0.0 108.347 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -82.16 168.07 26.25 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 112.704 -2.044 . . . . 0.0 110.882 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 22.2 Cg_exo -37.45 168.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 125.008 3.805 . . . . 0.0 116.18 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 36.5 Cg_exo -40.42 -9.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.871 5.047 . . . . 0.0 118.518 -171.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.75 HE22 HD23 ' A' ' 57' ' ' LEU . 9.6 tt0 -43.76 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' O ' HD22 ' A' ' 68' ' ' LEU . 9.5 tp -44.39 -49.95 9.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.61 0.364 . . . . 0.0 110.928 173.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -53.37 -29.7 38.9 Favored Glycine 0 C--N 1.33 0.195 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.556 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -79.35 -39.73 31.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.245 0.545 . . . . 0.0 109.856 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 64' ' ' LEU . 54.6 mt -59.22 -45.39 92.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.524 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -51.05 -60.13 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -175.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -85.77 -63.09 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.437 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.97 -16.9 5.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -171.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 67.23 34.99 4.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 15.0 p -111.76 159.45 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.948 -167.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 89' ' ' THR . 1.6 p -132.59 131.78 59.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.9 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.622 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -65.23 144.32 57.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.279 0.562 . . . . 0.0 111.661 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 35' ' ' PRO . . . 104.41 99.86 2.59 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.226 -177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.473 ' H ' ' HG2' ' A' ' 35' ' ' PRO . . . -57.22 110.31 0.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.824 0.849 . . . . 0.0 111.401 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 122' ' ' ILE . 10.5 m-85 -121.03 110.09 15.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.844 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HD3' HD12 ' A' ' 122' ' ' ILE . 20.3 mmtp -65.77 161.39 20.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 168.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -24.94 44.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 111.407 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 15.0 t -76.48 -31.38 57.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.646 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.29 -46.86 66.15 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.735 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -58.56 -54.06 51.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.136 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -68.47 -32.04 71.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.1 ttt180 -51.04 -45.22 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.757 0.789 . . . . 0.0 110.212 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.0 mtp -81.08 -39.24 26.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 12.82 79.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.846 -175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.7 tt -162.95 157.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.735 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -133.11 144.09 37.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.191 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.542 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.4 m -107.03 134.63 49.89 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.675 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 94' ' ' SER . 67.5 m -73.17 162.41 29.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.794 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 74' ' ' ALA . 2.4 tp -52.82 -36.63 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.425 0.631 . . . . 0.0 110.527 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.37 -28.71 59.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.288 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.1 5.36 8.88 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 113.673 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.44 ' H ' ' HB2' ' A' ' 90' ' ' SER . 1.4 m -80.32 120.43 24.37 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.818 0.809 . . . . 0.0 112.097 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -81.97 139.45 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.0 112.807 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 88' ' ' VAL . 1.7 mp -127.69 127.85 23.98 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.957 -1.019 . . . . 0.0 108.617 176.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.578 ' HA ' HG13 ' A' ' 87' ' ' ILE . 6.1 Cg_exo -72.99 132.3 18.07 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.11 1.874 . . . . 0.0 113.102 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.438 HG13 ' HB3' ' A' ' 82' ' ' LEU . 41.2 mm -95.53 136.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.303 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 33.3 m-70 -127.53 178.14 6.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.771 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.86 115.19 0.32 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.463 -1.351 . . . . 0.0 113.294 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.89 -53.81 2.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.608 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 19.8 m120 -114.68 -59.9 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.287 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 102' ' ' ASN . 17.2 Cg_endo -90.4 173.61 3.19 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.161 1.907 . . . . 0.0 110.916 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.0 tp -75.52 153.99 37.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 5.7 mm-40 -139.01 107.1 5.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.336 0.588 . . . . 0.0 109.691 -173.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.702 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -112.98 128.46 69.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.043 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 106' ' ' VAL . 12.1 ptmm? 51.75 -138.23 1.1 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.592 0.558 . . . . 0.0 110.191 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -89.97 30.79 1.03 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.307 0.575 . . . . 0.0 110.084 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -124.11 159.22 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.113 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 m -126.2 137.59 53.57 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.8 t -80.47 125.62 39.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.552 0.691 . . . . 0.0 111.732 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.5 mp -88.77 -35.72 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.458 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -157.01 114.86 3.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.504 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 111' ' ' VAL . . . -137.41 -173.88 3.6 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.591 ' CG ' ' HD2' ' A' ' 78' ' ' LYS . 12.3 t70 71.58 31.45 2.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.717 1.246 . . . . 0.0 107.646 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 10.0 mt -94.67 116.43 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.461 -1.699 . . . . 0.0 109.538 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HA ' HD13 ' A' ' 122' ' ' ILE . 36.7 mt-10 -67.73 107.3 2.52 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.088 0.471 . . . . 0.0 109.759 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.908 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -78.98 -177.05 5.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.126 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -49.86 -50.09 46.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.415 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -118.55 -16.09 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.924 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 76' ' ' ALA . . . -149.01 -109.23 0.51 Allowed Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.556 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 78' ' ' LYS . 23.1 mm -141.06 150.77 20.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.96 -0.62 . . . . 0.0 110.055 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.908 HG13 ' HB2' ' A' ' 118' ' ' ALA . 82.5 mt -123.32 143.43 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.727 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -135.57 114.02 11.64 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 60.2 t -78.46 128.86 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -128.74 165.94 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 122.162 0.982 . . . . 0.0 111.412 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.892 ' HA ' ' ND2' ' A' ' 42' ' ' ASN . 32.1 t70 -97.6 10.61 39.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.114 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.598 ' O ' HG13 ' A' ' 126' ' ' ILE . 18.1 m -164.18 123.39 1.95 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.859 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 41' ' ' PRO . 21.4 t . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.903 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.239 0.542 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.78 168.45 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.733 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.427 HG22 HG12 ' A' ' 5' ' ' VAL . 32.9 m -71.26 144.55 50.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.088 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 5' ' ' VAL . 2.2 pp -56.3 -23.68 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.691 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -91.68 -36.55 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.389 0.614 . . . . 0.0 110.276 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 9' ' ' VAL . 33.0 t70 -57.76 -46.42 84.55 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.046 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 11' ' ' THR . 14.0 mt -57.7 -25.28 24.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.579 178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -31.49 72.06 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.176 -0.327 . . . . 0.0 111.021 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 6' ' ' ASP . 7.1 p -91.27 -12.75 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.238 0.542 . . . . 0.0 110.501 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 7' ' ' ILE . 82.2 m-20 -91.99 -14.72 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 7' ' ' ILE . 11.0 p -59.83 138.02 90.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.186 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 2.8 Cg_exo -77.84 65.61 8.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.815 2.343 . . . . 0.0 111.962 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.6 47.41 41.68 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.058 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -65.46 -173.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.308 0.575 . . . . 0.0 111.977 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.0 m -62.76 166.22 5.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.748 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 m -63.13 -19.23 64.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.8 mt -53.52 -36.81 62.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.251 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 m -81.2 -27.98 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.619 0.723 . . . . 0.0 109.853 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.621 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -79.38 -26.62 41.96 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.446 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.3 -40.58 97.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.747 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 p -74.75 -36.1 39.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 121.855 -0.528 . . . . 0.0 110.288 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 24.1 mtmt -61.11 -44.16 97.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.258 0.551 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 19' ' ' THR . 9.0 p -75.42 -34.83 31.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.113 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.65 -1.58 22.37 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.757 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.81 9.85 7.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 112.849 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 92' ' ' GLU . 8.7 mp -89.95 6.55 41.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.42 59.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 31' ' ' GLN . 5.3 pt-20 -85.64 -17.71 35.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.262 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 91' ' ' LEU . . . -79.72 -58.49 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 14.5 mt -51.91 -13.25 0.27 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.691 ' NE2' HG13 ' A' ' 5' ' ' VAL . 48.1 mm-40 -66.33 -2.85 4.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.503 0.721 . . . . 0.0 112.73 -174.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -54.52 110.35 2.09 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 123.386 0.429 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.46 -18.02 9.79 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.698 2.265 . . . . 0.0 111.839 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -133.36 0.49 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.276 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 120' ' ' ASN . 44.3 Cg_endo -80.78 159.1 21.52 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.025 1.817 . . . . 0.0 113.3 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.712 ' CD2' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -142.7 122.15 13.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.427 -169.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.493 ' HB ' HG13 ' A' ' 73' ' ' VAL . 51.6 m -118.71 123.24 44.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -172.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' HB ' HG12 ' A' ' 123' ' ' ILE . 81.8 t -117.46 143.53 27.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.303 0.573 . . . . 0.0 111.729 -174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HB3' HD12 ' A' ' 126' ' ' ILE . 97.8 m-85 -106.14 109.3 21.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -97.1 120.48 61.24 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.474 -170.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' HG22 ' A' ' 129' ' ' VAL . 73.5 Cg_endo -77.24 136.47 16.09 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.661 2.241 . . . . 0.0 112.687 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.76 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 3.9 p30 -85.87 -173.78 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.2 -31.08 63.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 17.4 t70 -87.41 -21.5 25.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -79.04 -36.13 41.54 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.051 175.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.15 -21.51 61.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.116 0.96 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -85.69 -11.41 53.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.862 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 22.0 mmmt -88.42 -26.07 22.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.451 0.643 . . . . 0.0 109.441 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' CD2' HG21 ' A' ' 129' ' ' VAL . 38.2 mt -43.59 -49.49 18.6 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 114.292 -1.322 . . . . 0.0 114.234 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.26 -51.22 2.1 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.015 2.477 . . . . 0.0 113.071 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -164.73 93.91 0.66 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 55' ' ' THR . . . -140.11 -146.47 4.85 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.991 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' HD13 ' A' ' 57' ' ' LEU . 94.1 m -64.5 -57.84 8.09 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.664 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.1 mp -54.68 -24.64 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.561 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.786 ' O ' HG12 ' A' ' 58' ' ' VAL . 84.7 m -60.03 -40.82 90.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.902 174.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.5 t -77.81 -34.51 52.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.22 1.009 . . . . 0.0 108.74 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HB2' ' HA ' ' A' ' 54' ' ' ILE . 10.9 mp -66.8 -19.39 65.73 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.408 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 55' ' ' THR . 3.8 p -93.98 -21.02 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.539 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 55' ' ' THR . 25.1 mm-40 -71.11 -47.55 57.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.694 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -147.83 10.29 0.02 OUTLIER Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -177.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.694 ' HD3' ' H ' ' A' ' 60' ' ' ASN . 5.0 Cg_exo -93.46 152.67 2.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 CA-C-N 121.886 1.709 . . . . 0.0 112.226 157.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -63.97 -17.31 59.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.325 2.683 . . . . 0.0 112.789 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -51.06 -18.52 0.84 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -174.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 24' ' ' ALA . 3.9 tp -45.32 -47.42 13.19 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.592 0.357 . . . . 0.0 111.725 175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' HB2' ' A' ' 26' ' ' LEU . . . -50.02 -33.32 21.29 Favored Glycine 0 CA--C 1.518 0.222 0 CA-C-N 115.262 -0.881 . . . . 0.0 114.352 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.591 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.53 -36.45 65.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.139 0.971 . . . . 0.0 109.932 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.752 HD11 ' NE2' ' A' ' 63' ' ' GLN . 38.8 mt -69.45 -44.71 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.286 -169.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.574 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -49.91 -53.51 25.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.725 0.641 . . . . 0.0 112.495 -176.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -87.14 -63.01 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -124.31 -13.48 7.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t60 64.11 41.19 6.45 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 36' ' ' PHE . 14.7 p -109.86 160.18 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.85 -165.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 89' ' ' THR . 2.1 p -136.86 135.67 48.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.302 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.8 141.19 51.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.176 0.512 . . . . 0.0 110.956 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.06 98.92 2.3 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.891 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' CB ' ' A' ' 35' ' ' PRO . . . -60.52 103.32 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.279 0.561 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -120.04 123.48 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.385 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HE3' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -80.05 161.28 25.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.589 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.31 -38.35 12.58 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 123.459 0.474 . . . . 0.0 110.837 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.1 t -71.46 -25.29 62.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.973 -172.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.25 -40.62 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.677 HD12 HG12 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -62.29 -42.72 99.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.478 175.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HG2' ' CD1' ' A' ' 104' ' ' LEU . 2.4 mtpt -72.78 -30.57 64.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 122.581 0.353 . . . . 0.0 111.8 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.89 -38.07 75.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.6 mtt -77.25 -45.0 27.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.981 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' LEU . . . 79.73 9.75 86.46 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.454 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 97' ' ' PRO . 5.7 tt -162.97 159.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.677 HG12 HD12 ' A' ' 82' ' ' LEU . 8.3 m -135.01 138.66 48.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.496 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG21 ' A' ' 73' ' ' VAL . 2.8 m -111.68 135.94 51.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.056 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.549 ' HB3' ' H ' ' A' ' 94' ' ' SER . 15.6 t -71.08 168.63 16.72 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.537 0.735 . . . . 0.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -52.7 -37.73 59.44 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-O 121.538 0.685 . . . . 0.0 109.468 172.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.79 -25.26 48.86 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.579 -173.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.74 12.44 9.43 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.252 -0.886 . . . . 0.0 113.537 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.549 ' H ' ' HB3' ' A' ' 90' ' ' SER . 0.7 OUTLIER -80.48 120.51 24.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.756 0.778 . . . . 0.0 111.205 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -90.34 137.95 31.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 112.522 178.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.7 mp -130.16 126.59 22.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.984 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.544 ' HA ' HG13 ' A' ' 87' ' ' ILE . 5.0 Cg_exo -71.83 133.24 21.46 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.156 1.904 . . . . 0.0 113.192 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 82' ' ' LEU . 39.3 mm -95.64 139.38 19.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.025 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 37.7 m-70 -139.94 -178.92 5.66 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.215 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.484 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 142.3 115.62 1.13 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.905 -1.14 . . . . 0.0 113.93 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -83.09 -48.8 10.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . 40.5 t30 -116.71 -53.73 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.111 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 102' ' ' ASN . 17.8 Cg_endo -90.09 174.06 3.27 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.09 1.86 . . . . 0.0 110.419 172.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.662 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 17.7 tp -80.02 155.38 27.64 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.645 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 99' ' ' HIS . 33.7 mt-10 -138.08 111.25 7.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.378 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -103.41 118.96 51.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.976 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB3' HG23 ' A' ' 96' ' ' ILE . 22.7 pttt 48.3 -107.01 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.986 0.914 . . . . 0.0 112.269 -174.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.23 9.48 25.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.453 0.644 . . . . 0.0 110.375 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -104.13 163.25 12.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.193 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -128.8 135.18 48.81 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 4.1 t -82.98 126.66 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.431 0.634 . . . . 0.0 111.434 -175.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.7 mp -89.4 -39.24 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.783 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.49 116.57 4.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.334 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -137.48 -173.67 3.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.785 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 114' ' ' ALA . 31.7 t70 71.15 28.4 3.08 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 122.867 1.317 . . . . 0.0 107.933 -173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 11.9 mt -89.54 111.13 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.69 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 122' ' ' ILE . 39.4 mt-10 -68.09 108.95 3.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.046 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.13 179.57 7.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.939 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 120' ' ' ASN . 2.0 pt-20 -46.52 -50.76 16.68 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.817 0.698 . . . . 0.0 111.301 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 35' ' ' PRO . 94.3 m-20 -120.58 -15.48 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.103 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -142.53 -118.77 1.39 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.625 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.706 HD13 ' HA ' ' A' ' 117' ' ' GLU . 16.3 mm -145.49 145.08 20.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.181 0.515 . . . . 0.0 111.747 -171.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 118' ' ' ALA . 22.7 mt -116.44 148.65 19.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.46 177.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.44 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 4.0 m80 -138.35 117.2 12.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 87.7 t -79.45 128.86 38.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -124.9 169.35 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 122.08 0.943 . . . . 0.0 110.909 -177.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.772 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.9 t70 -109.63 21.0 17.5 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.657 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.636 ' O ' HG13 ' A' ' 126' ' ' ILE . 10.7 m -163.99 124.6 2.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.669 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' A' ' 49' ' ' LEU . 50.0 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.979 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.568 0.223 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.51 140.44 49.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.939 0.399 . . . . 0.0 110.702 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.472 HG22 HG12 ' A' ' 5' ' ' VAL . 92.7 m -70.99 145.99 49.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.908 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 4' ' ' ILE . 4.1 mp -43.05 -50.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.19 0.519 . . . . 0.0 111.75 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.746 HG13 ' NE2' ' A' ' 31' ' ' GLN . 2.0 p -67.93 -37.13 77.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.973 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.596 ' CA ' HE22 ' A' ' 31' ' ' GLN . 27.8 t70 -59.23 -44.33 92.32 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.78 0.8 . . . . 0.0 110.173 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 10' ' ' ASN . 11.1 mt -56.63 -22.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.7 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.23 -32.45 71.14 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.854 -0.529 . . . . 0.0 110.988 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.59 -30.39 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.4 0.619 . . . . 0.0 110.415 172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 55.3 t30 -74.2 -24.93 59.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.505 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' A' ' 14' ' ' PHE . 12.2 p -62.6 144.82 95.72 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.825 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 11' ' ' THR . 5.8 Cg_exo -80.44 59.84 7.61 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.977 2.451 . . . . 0.0 112.117 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.24 46.71 62.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.497 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.579 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -58.47 -169.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.854 0.835 . . . . 0.0 112.864 -178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.3 m -56.87 160.38 3.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -61.94 -19.46 62.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.601 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.0 tp -57.24 -33.57 67.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 m -80.7 -27.15 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 109.829 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.565 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 1.4 m -83.48 -27.58 29.34 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.861 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -61.13 -36.95 81.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.766 0.317 . . . . 0.0 111.609 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 p -76.48 -37.69 30.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.964 -0.46 . . . . 0.0 110.445 172.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 19' ' ' THR . 38.0 mtmt -62.19 -41.51 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.451 . . . . 0.0 111.175 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 19' ' ' THR . 7.3 p -74.5 -35.98 40.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.111 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -74.08 -7.72 53.56 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.181 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.95 16.96 7.57 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.566 1.146 . . . . 0.0 112.62 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.4 mp -92.83 9.35 35.67 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 121.999 -0.438 . . . . 0.0 112.097 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -59.44 -36.92 67.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 4.5 pt-20 -86.04 -19.07 30.84 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.011 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.15 -54.88 5.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 23.1 mt -55.61 -13.35 1.56 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.746 ' NE2' HG13 ' A' ' 5' ' ' VAL . 46.1 mm-40 -66.16 -9.37 30.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 m -51.92 114.25 5.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 123.257 0.348 . . . . 0.0 111.221 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.38 -20.29 7.17 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.817 2.345 . . . . 0.0 113.628 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.3 -135.74 0.61 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -172.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 54.2 Cg_endo -78.76 162.66 26.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.819 2.346 . . . . 0.0 113.057 -175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' O ' ' HA3' ' A' ' 121' ' ' GLY . 29.5 m-85 -136.62 121.97 19.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.651 -172.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 45.7 m -107.69 136.21 47.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.026 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.613 HG12 HG12 ' A' ' 123' ' ' ILE . 3.5 p -129.22 153.7 39.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.161 0.505 . . . . 0.0 110.492 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.72 107.23 16.71 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 125' ' ' VAL . . . -94.55 111.43 53.92 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.677 -171.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 72.5 Cg_endo -77.33 130.17 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.058 1.839 . . . . 0.0 111.612 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.815 ' ND2' ' HA ' ' A' ' 127' ' ' ASP . 4.0 p30 -72.16 -176.34 1.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.69 -28.35 55.16 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 37.0 t70 -87.54 -24.18 24.13 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.842 0.829 . . . . 0.0 109.608 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.583 ' HA ' ' HG2' ' A' ' 48' ' ' LYS . . . -85.33 -33.27 22.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.427 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.68 -19.97 65.34 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -82.52 -8.99 59.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.786 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HG2' ' HA ' ' A' ' 45' ' ' ALA . 25.9 mmmt -90.94 -25.89 19.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.775 0.798 . . . . 0.0 109.517 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 56.7 mt -53.66 -52.29 68.53 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.303 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 17.0 Cg_endo -58.52 94.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.681 2.254 . . . . 0.0 113.345 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 51.91 50.86 17.69 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.119 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.8 -102.82 0.89 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.213 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.499 HG21 HG12 ' A' ' 129' ' ' VAL . 70.9 m -56.97 -59.13 5.52 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.539 0.335 . . . . 0.0 111.768 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 1.4 mp -59.47 -25.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.024 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.699 ' O ' HG12 ' A' ' 58' ' ' VAL . 98.6 m -65.15 -38.47 90.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.433 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.2 t -79.55 -27.59 41.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.0 109.201 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.622 HD23 ' NE2' ' A' ' 63' ' ' GLN . 8.0 mp -72.57 -27.94 62.5 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.21 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 55' ' ' THR . 7.8 p -77.9 -27.67 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.141 0.496 . . . . 0.0 109.938 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 55' ' ' THR . 22.5 mm-40 -71.55 -29.77 65.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.513 1.149 . . . . 0.0 108.842 177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -77.91 166.08 46.14 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-N 112.894 -1.957 . . . . 0.0 111.64 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 48.0 Cg_exo -40.46 169.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.355 3.37 . . . . 0.0 114.171 173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' PRO . 31.2 Cg_exo -33.45 -8.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.047 1 C-N-CA 127.802 5.668 . . . . 0.0 120.175 -167.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.622 ' NE2' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -41.65 -25.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 HG23 ' A' ' 58' ' ' VAL . 10.6 tp -52.25 -50.89 61.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.599 0.36 . . . . 0.0 111.883 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' CA ' HD22 ' A' ' 26' ' ' LEU . . . -52.03 -31.09 32.1 Favored Glycine 0 N--CA 1.461 0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 113.348 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -74.76 -49.29 21.46 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.356 0.598 . . . . 0.0 110.587 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 64' ' ' LEU . 63.0 mt -44.88 -48.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 0.0 113.119 174.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -48.16 -65.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -166.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -89.44 -69.2 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.197 -1.001 . . . . 0.0 113.619 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.647 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -126.46 18.58 7.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -175.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.1 t60 59.24 30.98 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.608 0.718 . . . . 0.0 110.914 164.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.647 HG11 ' CZ ' ' A' ' 70' ' ' TYR . 4.8 p -105.25 159.86 5.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.119 0.962 . . . . 0.0 113.517 -164.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 89' ' ' THR . 2.0 p -132.94 120.04 39.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.981 -1.463 . . . . 0.0 108.944 163.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.657 ' H ' HD13 ' A' ' 91' ' ' LEU . . . -64.58 145.97 55.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 0.0 111.62 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 97.43 2.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.28 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -58.78 106.2 0.38 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.232 0.539 . . . . 0.0 111.105 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CB ' HD11 ' A' ' 82' ' ' LEU . 6.0 m-85 -115.64 119.78 37.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HE3' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -77.05 158.75 30.35 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -47.21 -37.45 10.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.553 0.533 . . . . 0.0 111.268 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 7.7 t -74.98 -24.37 58.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.445 -168.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.47 -45.72 75.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.713 HD12 HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -57.19 -52.32 65.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.461 177.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -68.97 -34.68 75.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 80' ' ' THR . 2.0 ttt180 -51.47 -43.29 62.1 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.102 0.953 . . . . 0.0 109.19 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.3 mtp -75.98 -42.91 46.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.014 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' ILE . . . 77.87 15.49 81.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.098 -172.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 97' ' ' PRO . 4.9 tt -163.66 157.05 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.713 HG12 HD12 ' A' ' 82' ' ' LEU . 11.0 m -130.7 143.06 42.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.396 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 73' ' ' VAL . 3.1 m -110.6 133.52 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.924 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 94' ' ' SER . 70.9 m -77.31 166.18 23.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.138 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 74' ' ' ALA . 3.8 tp -51.89 -37.59 52.97 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.401 0.62 . . . . 0.0 111.125 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -76.54 -24.94 53.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.61 -178.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.51 20.08 5.57 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.597 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' SER . 8.2 t -88.16 119.41 28.52 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.156 0.478 . . . . 0.0 110.536 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -86.78 139.25 30.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.65 . . . . 0.0 112.636 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.617 HG23 ' HB3' ' A' ' 107' ' ' LYS . 1.3 mp -131.93 128.12 21.41 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.938 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HA ' HG13 ' A' ' 87' ' ' ILE . 8.1 Cg_exo -69.16 133.27 26.25 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.142 1.895 . . . . 0.0 113.355 -173.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.546 ' CG1' HG13 ' A' ' 88' ' ' VAL . 37.7 mm -102.09 138.0 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.049 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -140.82 179.98 6.39 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.595 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.603 ' HA2' ' HG3' ' A' ' 105' ' ' GLU . . . 173.93 93.26 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.72 -172.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.89 -44.33 55.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 109.288 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.564 ' H ' ' HD2' ' A' ' 103' ' ' PRO . 11.6 m-80 -140.83 -53.11 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.983 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 40.3 Cg_endo -88.17 173.28 4.87 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.165 1.91 . . . . 0.0 110.298 168.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.499 ' CD1' ' HG2' ' A' ' 83' ' ' LYS . 24.8 tp -73.34 153.67 40.42 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 26.8 mt-10 -140.91 106.78 5.14 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -105.74 126.52 61.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.823 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HG2' HG22 ' A' ' 106' ' ' VAL . 13.5 ptmt 46.52 -114.51 0.52 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.604 0.762 . . . . 0.0 112.046 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.423 HD22 ' C ' ' A' ' 108' ' ' ASN . 0.3 OUTLIER -102.99 22.14 14.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.203 0.525 . . . . 0.0 111.094 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 126' ' ' ILE . . . -123.97 166.48 15.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.938 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 m -128.78 137.44 51.54 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 t -81.02 129.89 36.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.545 0.688 . . . . 0.0 111.886 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 127' ' ' ASP . 6.8 mp -91.6 -37.86 12.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.389 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -158.59 112.08 2.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.849 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 124' ' ' HIS . . . -141.01 -173.25 3.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 71.46 26.28 3.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 14.0 mt -90.46 109.66 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.738 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.783 ' HA ' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.52 110.97 3.36 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 122.278 1.037 . . . . 0.0 112.031 174.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB2' HG13 ' A' ' 123' ' ' ILE . . . -79.24 -170.5 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.465 -1.698 . . . . 0.0 111.772 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -50.94 -49.04 60.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.863 175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -119.66 -18.35 8.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.072 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 36' ' ' PHE . . . -145.54 -112.4 0.77 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.397 -173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.783 HD13 ' HA ' ' A' ' 117' ' ' GLU . 9.8 mm -146.56 142.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.547 0.689 . . . . 0.0 112.355 -174.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.854 HG13 ' HB2' ' A' ' 118' ' ' ALA . 92.2 mt -113.19 146.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.619 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.543 ' CD2' ' HB1' ' A' ' 114' ' ' ALA . 10.6 m80 -137.22 113.3 9.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 57.6 t -81.12 128.08 39.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 123.178 0.299 . . . . 0.0 110.31 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.647 HG13 ' O ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -127.25 164.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 0.0 110.94 -176.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD11 ' A' ' 112' ' ' LEU . 38.8 t70 -108.89 19.47 19.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.752 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.647 ' O ' HG13 ' A' ' 126' ' ' ILE . 16.2 m -168.77 134.5 1.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.551 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 49' ' ' LEU . 73.1 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.637 176.388 . . . . . . . . 1 1 . 1 stop_ save_